[
  {
    "id": "3d9cfe7aec2f6e400d5614b9feb48fd0",
    "title": "Boehringer Ingelheim Ohio Subsidiary Enters Consent Decree - CHEManager",
    "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPZ1JmQzNFTXdpY290STRFckRYNDJiS0t4OVF6RVJjYzhvNEtvMS1QT3ZCVEdiN29GbTF1a2xpWFdJUzlINUpGbnY4Sks5cGJQSVhlOTJDSTQ3S1dBM0k3N3kxd18zZ21JdW1pQnJLQ0p3RG00RlpUZzhpSWphVVQ5aXc3Y0dKQ2JkTFNqd3BJWkZZb0FiRzB2SEF6Nm8?oc=5",
    "date": "2025-05-15T22:05:27.000Z",
    "dateFormatted": "15/05/2025",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Boehringer Ingelheim Ohio Subsidiary Enters Consent Decree  CHEManager",
    "company": "Boehringer Ingelheim Ohio Subsidiary Enters Consent Decree",
    "types": [
      "consent_decree"
    ],
    "severity": 10,
    "priority": 3
  },
  {
    "id": "e5e43d1c47f237331321a27d37971a4c",
    "title": "FDA obtains permanent injunction against Deltex Pharmaceuticals - Reliable Plant",
    "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOVWZ1MFJvdzFsa1dSRmF5TmdRYkYyTzhtTy1LRmlCeFhJaUV1T0hUeTV2Q3h1dl9fQUhrNGZJNTR1bi1aQ09WNXozWS1ORUpGWU12b3habU9SelNvajFDanlyVjE3cU9uV2dUVGd4NXJqR29tN3l4U0c2dFVkTExrOExDbWc?oc=5",
    "date": "2025-01-18T08:00:00.000Z",
    "dateFormatted": "18/01/2025",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA obtains permanent injunction against Deltex Pharmaceuticals  Reliable Plant",
    "company": "Fda Obtains Permanent Injunction Against Deltex",
    "types": [
      "consent_decree"
    ],
    "severity": 10,
    "priority": 3
  },
  {
    "id": "f6f27de85c93271e4088569d0f5857bb",
    "title": "FDA, DOJ Enter Consent Decree of Permanent Injunction Against Boosted LLC - CSP Daily News",
    "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPbER3Z0JOVnRaTlZCRjNvYko3akJGN292dmhJRDZvOEhqMnRlWWNXZ09objJNWm9xdlBRMzlmR1ZvY1ExRUFLOTNFU09KRlYtMjNVOVBYWkJXd0RSb3drSXplVVl0SFNhOWNSQ2VBMjZ2Wmhtc2tiLTlYOXQ3NzRRZmhlbnFJbXJwcDd2TFU5V0FxX09uRF9WWkZSeG9yLUFXUkFlQQ?oc=5",
    "date": "2024-06-17T07:00:00.000Z",
    "dateFormatted": "17/06/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA, DOJ Enter Consent Decree of Permanent Injunction Against Boosted LLC  CSP Daily News",
    "company": "Fda, Doj Enter Consent Decree Of Permanent Injunction Against Boosted",
    "types": [
      "consent_decree"
    ],
    "severity": 10,
    "priority": 3
  },
  {
    "id": "c942947af249eb384b1119a701762678",
    "title": "U.S. Court Vacates Modified Consent Decree Imposed on Xellia’s Cleveland Facility - Contract Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPbFFaSS1yZUhkOUpHdXhtVS16WWhMZ2R3NDV6Ym5qR096WVFmTGpGTmpOWXl1d1o5enl0Y1lNZG9CRXphMGhjWTRJZ2lSOUxGS0R2NEluU19Danc4M2NIcUhtWWdGRmxqZEhDd1FwUWxSVmp5RU9pblFLQlVUcXJrZlRaN2x0QWpwajBXSFJaT002V2hXd3ZTY1BOcENrR1hjM2M0bElWNGtfamt0SkpVNzFFWGMzVGdnWWtRam5DQTl5dw?oc=5",
    "date": "2024-04-29T07:00:00.000Z",
    "dateFormatted": "29/04/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "U.S. Court Vacates Modified Consent Decree Imposed on Xellia’s Cleveland Facility  Contract Pharma",
    "company": "Unknown Company",
    "types": [
      "consent_decree"
    ],
    "severity": 10,
    "priority": 3
  },
  {
    "id": "5052f206ced0756d228cbca511b965ed",
    "title": "Philips consent decree ‘worst case scenario’ for respiratory business - MedTech Dive",
    "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNU1EtanVqMnZWMDU5VXhrc1BXQ0JtWWszYXhRTkRYbWd3YzdNNU1QTXhUV01nVkxrZkRhVzBONVdhLXpMaWNkZ3FqcW1xakt4NmFleGNhUUV4NkllNi12WFotc0ZwSl9vMFpJTU8tUUluOHBoT0FXWDhyV0lLLUtBTk5CLUdyZVNE?oc=5",
    "date": "2024-02-06T08:00:00.000Z",
    "dateFormatted": "06/02/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Philips consent decree ‘worst case scenario’ for respiratory business  MedTech Dive",
    "company": "Unknown Company",
    "types": [
      "consent_decree"
    ],
    "severity": 10,
    "priority": 3
  },
  {
    "id": "36ccb0c0c1a819f2164b5ec35316a420",
    "title": "Deconstructing the Consent Decree: A Primer and Recent Trends for FDCA Injunctions - Food and Drug Law Institute (FDLI)",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNNXUtLWlFQ21fc2hXWF9Eb0VIRUhZRG1meHNSUEo3RXFDdEJ6SUotWEZnUE9oVUlDUXhwZW4xSmNKZkpldlVXS0pvVHJiQ0tmYXpwSDUwNS1IRnFCSnJwZ1cyYXNLZW4zVy1UMlJFV1FWdjJSdzJNNHM3NlFRaXJTUWc5dWdidFhmVjU4SVhqN1VrWGdCX2dmZG1zaExROVhCQ09nTFlGejdiWGlzcnJlQw?oc=5",
    "date": "2020-11-15T08:00:00.000Z",
    "dateFormatted": "15/11/2020",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Deconstructing the Consent Decree: A Primer and Recent Trends for FDCA Injunctions  Food and Drug Law Institute (FDLI)",
    "company": "Deconstructing The Consent Decree",
    "types": [
      "consent_decree"
    ],
    "severity": 10,
    "priority": 3
  },
  {
    "id": "33ccad55dd5471dbedb198e77b605426",
    "title": "J&L Grocery enters consent decree with DOJ, FDA - Southwest Times Record",
    "link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPSE94NHkyN2FmbkcwUEFpRG81cjVrak5yaVVDQXRMT2hvZmFjRXRpMDNST3dKRjBhQ3U1dXpwM2dubkQ3NUJIUzhpR2RSUDZjVnhEbmR3VEVIRjZkS05naVN5c2dVSGJPUUN0ZEdDZlFhMTU2LWFYYWdXOGdRY0FmNGpDOUd0d3Yyd1lzd3NuUQ?oc=5",
    "date": "2019-07-19T07:00:00.000Z",
    "dateFormatted": "19/07/2019",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "J&L Grocery enters consent decree with DOJ, FDA  Southwest Times Record",
    "company": "J&l Grocery Enters Consent Decree With Doj, Fda",
    "types": [
      "consent_decree"
    ],
    "severity": 10,
    "priority": 3
  },
  {
    "id": "42c6859a732ddb484fc2ef8d6d952d63",
    "title": "FDA modifies consent decree for Xellia on closed Ben Venue plant - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQN05yeWdUY1hRbS03aFd6V1JzTko5cXhkSk9LWGhvSUNkVV92bWNqUjFVT1ZPQzBhV3ZNS29URXJJc0RMM1RaLVZXQ3lnM3A0Rks0eHFtSzktNEJENXd5bjNJNE9aRy1XZTc5NFlwaTJNQU9HdFJVODRuZ3NqWldJVkYxQVN1T09sLUNvUXVqZzk3WnozUmRLVWlJZzlKSWI0OGk2VmdXYw?oc=5",
    "date": "2016-05-03T07:00:00.000Z",
    "dateFormatted": "03/05/2016",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA modifies consent decree for Xellia on closed Ben Venue plant  Fierce Pharma",
    "company": "Fda Modifies Consent Decree For Xellia On Closed Ben Venue Plant",
    "types": [
      "consent_decree"
    ],
    "severity": 10,
    "priority": 3
  },
  {
    "id": "90f0bae10920066c4f02931fccdd2624",
    "title": "FDA Releases Complete Response Letter on Declining MDMA-Assisted Therapy for PTSD - Psychiatric Times",
    "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZHRsazkyS0JNOFlrbU1kTHBZYkxkZlR6Y05vMlFwRGZYVHdFR1RoM1ppc0dRd0ZaWFZ5YmU5Vi03Mi03cE5aWHlPc1R0aDNmUmZJZXFyQ3pmWmszUkpremFMNWljNTdmQVZWLWlhbU5JM3hfT3ZJOWstUVFjamlBWTIxZUdYUUd4WFNQNWttNVlJcXVCbGhNRmNFaC1KR05NQXZlQXNWMmZ5SzBTVUR0VTJIUzBiOVMxNWZF?oc=5",
    "date": "2025-09-05T18:56:15.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Releases Complete Response Letter on Declining MDMA-Assisted Therapy for PTSD  Psychiatric Times",
    "company": "FDA Releases Complete Response Letter on Declining MDMA",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "600d153f3a65e5b719345b193cf0ffca",
    "title": "FDA to publish CRLs in real time; PEPFAR to distribute Gilead’s Yeztugo",
    "link": "https://www.biopharmadive.com/news/fda-complete-response-letters-gilead-pepfar-yeztugo-ac-immune-layoffs/759306/",
    "date": "2025-09-05T15:15:00.000Z",
    "dateFormatted": "05/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "The FDA also unveiled a batch of 89 previously unpublished complete response letters, including rejection notices to Capricor and Replimune.",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "b9dd2f8cf67297a8d9e5daf4771895e2",
    "title": "89 Complete Response Letters For Unapproved Drugs, One Huge Leap For US FDA Transparency - insights.citeline.com",
    "link": "https://news.google.com/rss/articles/CBMipAJBVV95cUxOcEZXX3lHVGtLX3BPSXR1UHBOdldTRzdJU0lhRlVHRDRETko2X3ZVU3pweklvQjk4cW1GWDJpeE0xbjdScVBGa2lUNWQtbGZJWHlYMkZXQmRwQVhRRnlDZkpfVklENVN3ZUNXMUExRGdNWjNwV0lJemQwZ2FZMHR3TFRadUlwYnF1TjJPQlhKdEw1cHZDSV9MS0JpckVhemtSRlJBNlJFV25IZ1dEQk9mSHUweVExYVExczlVY01ER3pqak1weWpXX2VrbjRjUVFNTEZHdXVkUnc5SldtZ2ZrUmxjVVhCX3ZFaXNNYnY0Wmhwd0VEQnhnb3hSMVRONVRzWGdwVHJuQjNTX1c3VV9VY2wtX0NhOEJXSGVYcExfd2JOVmpV?oc=5",
    "date": "2025-09-05T02:37:30.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "89 Complete Response Letters For Unapproved Drugs, One Huge Leap For US FDA Transparency  insights.citeline.com",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "e594d4be1fa880121240843648ec8211",
    "title": "MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy - GlobeNewswire",
    "link": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxPbTRkZFdNRi1Sb0tNQUhQYjFuVnZZVTdJWDJYb2hpOTNLcFRBb0liQmdna1N4amdGak03bHpHVzJ1cUhXMDNyLWJKYmR0QlJGdlk5QmYzYTBpVEVJRFNSSnQzUk1oSWFvNngwZTl1SDFMZTE4VzRZcFp5X2hTRkJ1V0U0aGs4WGtRa0VocHJ3M0l4Zm5acjZNMThaQ0k5QUxrekFoUFVMSWZZTUZrUnJqakZiQTJTUXZ6dWdJOG9fTENFeE5SdGxpUmFWWUJSRlUyZlFFQWZla3l4OHNZU18xal9XWVBwR0o5VUdVbDZQWGdwcWg2dnB3?oc=5",
    "date": "2025-09-05T00:09:00.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy  GlobeNewswire",
    "company": "MDMA",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "3903ec6d5750072d9d02c8693c4736db",
    "title": "FDA publishes drug rejection letters for ongoing applications for the first time",
    "link": "https://endpoints.news/fda-for-the-first-time-publishes-drug-rejection-letters-for-ongoing-applications/",
    "date": "2025-09-04T19:20:52.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "On Thursday, the FDA finally did what several prior agency commissioners only promised to do: publish redacted complete response letters for drugs that are still under consideration by the agency despite the initial rejection.  ...",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 2
  },
  {
    "id": "990d9ccf7dffaadddc56b1e2727efae1",
    "title": "BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL) - Psychedelic Alpha",
    "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPLTd0czdNWWo3UkdpTTNsT2FLUmZpVTlWZFBjUU9oRkRwMjFQdGcyZ2pPUmRuQkNkM0M1ZjBocTBFVWtvaTR3ZUVlYU1odjBtbF93dXJEbGI1dnVWM0k3TUJkdHlPYktNRlRSLXpuZXBnY0czZjdtcnZtYXBEWXJkQnZHTjRQYjhqZjZzS2M2RnFlNTF3c3Jzc1VneklDVTVsakhEcS16ZUU5RWhBbUE?oc=5",
    "date": "2025-09-04T16:10:06.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)  Psychedelic Alpha",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "ce6a56b732279eb4723932a35e3df836",
    "title": "Astellas receives Complete Response Letter from FDA for Izervay sNDA - MSN",
    "link": "https://news.google.com/rss/articles/CBMi0gJBVV95cUxQNDV4NGotbFBTUmlpWXlhWUFNSTRsMENiSmlTcENtODNFRllNRlRCdF9IcmhMWTdfNndEcXlHMi12cXNkcnN3MFdQSDhDb25hTE1OQ1VTaWw2MFRiQ01xSGJHem9SZ1Jzb3N0SmI2dV9HVDlRV19FdFVSLTE0NEpaRDNsejQ5OW5icmd6WmJFOC1HUVNWbzMzM2FOOFVsdmV4NGFkUTJQWE9ZbFh4QlJTb1B1cjBBQ0RNdmdBUTRDTS1rZDkwQk9yQUN0MjgzU0U2ZDdlcFZqbGc5OFBtVG0wSGhLU2FLUUw3ZXZUZ0JJZzMxcS1yQTFRVFJSZUxnc3QycmR1MGMzNDl3ZWpIbVhBaHc3Uk9JdDBPSzc5MXIxLWFaWlpFckhvRk1EWDlTZE9mWHU1ZU5Tdl9udzY4cWtDajRzZGFfZjdtRV9RZmc5VGZHUQ?oc=5",
    "date": "2025-09-04T15:41:33.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Astellas receives Complete Response Letter from FDA for Izervay sNDA  MSN",
    "company": "Astellas",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "a387f952dbc047cb286f23729bc3b4e1",
    "title": "FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-announces-real-time-release-complete-response-letters-posts-previously-unpublished-batch-89",
    "date": "2025-09-04T13:23:32.000Z",
    "dateFormatted": "04/09/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Food and Drug Administration today announced that it will release future complete response letters (CRLs) promptly after they are issued to sponsors.",
    "company": "FDA Announces Real",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 1
  },
  {
    "id": "20454a1bf18d91b8a792959c5d5b450f",
    "title": "FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNVFdoVlBOSnBCeWZqcUs5by1MMXJwU29qMUlEelRwRFZXYk0yUUlrQmpPSmUtb0ZkNVU0SlRHeVk0bjNjbDRibVNKeTRyX3NmMU41UjREQ1NwQ1N4MC04WXBTRDZwelAydml6Q0RPV2hkME5paWxEWXlFOVR1dXBxWGlZRG9HMVVFeXJkT0NaOUdXSkNjQW90OTRVemszYm9BcUlsNmNXX01xRXBJZzhyX0dnNEltRkVtUnFoakxrSFdWS20yMFZvVzJyOG1BUTM3bE5QMEcyVVFnOU1NenM4Uw?oc=5",
    "date": "2025-09-04T04:00:00.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89  fda.gov",
    "company": "FDA Announces Real",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "6f9c48d566c48a1628fb77e08a7a7746",
    "title": "FDA Issues Complete Response Letter to Outlook Therapeutics - TipRanks",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPVzdiX0sxNnREVi0tSHBPaDhrZngtQkRYRnE4c1VKVFRzcHVtSVZRN3l2TW53a19QeUlEdlROaHd3cWxITVdFODM2bWV4LW5mclVYLWFHNlRIYnpTSHpMUkJ6ZjFDMG5DSVd6ZDk1V2R3LUg1ZzE1eFFfUHNpVFRUY01POTVveHRtTl9lWlczdUZkNHVRd0o0cFptT3JJSnpBMWdCSllEWEI5Sk4wX2lYZA?oc=5",
    "date": "2025-09-02T21:45:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter to Outlook Therapeutics  TipRanks",
    "company": "Outlook",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "69ab508957df49afd34b3c5e074aa215",
    "title": "Telix Pharmaceuticals (ASX:TLX) Falls 24% in a Week After FDA Complete Response Letter - Yahoo Finance",
    "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZmF0a0F4VGs4MjA3QlpBRGJxcjlzODF4dlN6XzVYbnN4OElBWFdxNUpNOTBvZG9ya2JWWWVDV1VfdjNyUkpLSW41QmYxSGdGSWZESzA3emJGQUROcnpfU0JKa3RvT1JHN0JLaEc0SlJBSHlSU1ZwcHZZcFpfVHd6Q3NfYmxzSkh1?oc=5",
    "date": "2025-09-02T17:28:42.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Telix Pharmaceuticals (ASX:TLX) Falls 24% in a Week After FDA Complete Response Letter  Yahoo Finance",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "1e5c75709e0a5ead11d28f285a1e7b54",
    "title": "Replimune Schedules Meeting With FDA for RP1 Complete Response Letter to Treat Melanoma - MarketScreener",
    "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQcjNUVWlfM2wxTnQ1RTlLU0wyYVAtZWNiQnpITDN0Z1dIeTNUS3ZYTXY4SnppYmpReWdpWUI5TlgzUWtMQVVMd0tzVGFYTUE3ZThyMjZPWEM4ZWhDMGJHajZrZDJ1LTZ0VUJNUlZkRDhCWmFOakVjZVJzY1BRTG04U3B5WEl4MlZYSzFiWWdLUmtiVEZabXZ6cHZ3ZmNVTjFTanNQTktvUExmbnJaa3RDUUFCN3A2Q3pxQlJYRE1HVVprdFFVZlVPYldCSm1KaUlnQ1FIQU55aw?oc=5",
    "date": "2025-09-02T12:56:17.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Replimune Schedules Meeting With FDA for RP1 Complete Response Letter to Treat Melanoma  MarketScreener",
    "company": "Treat",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "697634c3cb7acc1128dc756458bb740e",
    "title": "Outlook Therapeutics Requests Type A Meeting with FDA to Address Complete Response Letter for ONS-5010 Biologics License Application - Quiver Quantitative",
    "link": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNcWk5bGNVVFJRbTlzZnJ0VFp0SFVHcVUyZkZxdS1TSS1aTjBkRlAteTNXbTJYN3dwcDNxYjlrMzFVc2dyX0dLRzdMNmhoVm9hajY0U0xrM3dWaDJfX2UxdkNQVVIxTENQclM1VzJPN0NVdnFXYzZaLUEtbmlNTmxXV05rdEMtVjJxMFhIRmJrZjhtWUtrX2J0cFAwdl9YcFl6cHZqdTFPRGEtb1A1ZXZ3eXJQa1REazdPYWkxZXp6bFE5RkktMXFScjdyWVMtZFM3V2QwVjlsZ1p5WlM1Q2lkM1gyc0dGc3FUTmR0Vk1wQ2dzeXBVaG9TTw?oc=5",
    "date": "2025-09-02T12:44:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Outlook Therapeutics Requests Type A Meeting with FDA to Address Complete Response Letter for ONS-5010 Biologics License Application  Quiver Quantitative",
    "company": "Outlook Therapeutics Requests Type A Meeting with FDA to Address Complete Response Letter for ONS",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "4c3a9f4c519e1aaa741c4c40ae669ccf",
    "title": "FDA issues complete response letter to Outlook Therapeutics for resubmitted BLA for ONS-5010 - Ophthalmology Times",
    "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPbHdlN1pFRHhxazgxN1dwTWVOY3B6Uk9tM1hqQ19KNDNOSlNkZE5RUk9qMVZtSDA2WWpfeWFlaDJCOHdlMWgta09FMnU0RkwwQ05fODRpbFpOUDgtNE0zcnJOMUN3b1AtNUk5TzRzdVNnMEdJb2ZjU09KNzRjcURfdU1ZbXE5aHRXMk9fUjNTSzFJT3ZrQVRIdzlIc0dvWXE1dWswUjAxTm5ISHBxSGctU1IxSW81a0FiLVowOGRFLVlUbHlORGdmVlhJRm4?oc=5",
    "date": "2025-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA issues complete response letter to Outlook Therapeutics for resubmitted BLA for ONS-5010  Ophthalmology Times",
    "company": "Outlook",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "0b29f4ba31eaa7984e2a5ba6ade2f3f9",
    "title": "FDA issues complete response letter for 89Zr-DFO-girentuximab in ccRCC - Urology Times",
    "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQTENaRm5KN0ZXT2V2dUpYWWRiTU5RSDA1R18xcU5IcWplcms4b0VxYU8zTllCQUJJU2RJZDNCWGxGS0VUZXhPMGEwTmV0M2gxbXRBMHZFTHlJVC1iZzhTWXlkYnVySWJtZUI1aVN5eFp1R0JGOVhFRlkxcTFIaTU1LUJfaUY2VUxPWXJkd3RqYWVXdk10U3Uya2lvYnUwNWRvTVh6Wm03QQ?oc=5",
    "date": "2025-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA issues complete response letter for 89Zr-DFO-girentuximab in ccRCC  Urology Times",
    "company": "FDA issues complete response letter for 89Zr",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "2baa7fe8d43d843fc7a9cdc1730fc294",
    "title": "Outlook Therapeutics Receives Complete Response Letter from FDA for ONS-5010 BLA Resubmission - Quiver Quantitative",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOejFVV01XY3BDalhBT3lkQU9OSE1icjl3dkJWRjI3aDNxeHNjTXhBdXl5c19DMTh1S3FpM1ZtTFRBX2FDZFltbGRkVEt5VlVDLWF1SEJCdDZKNFZfeWozX00wQTZ2UTBFRXZWeDdoRzcySldnRHZrZ21EcVpQd0dSaXVDVEdxOUlmUm1mNWZpMXJORUNYVnBrN0dwUkxJRzlzVHlCNm1jM2xRRWQ4SWpOY3BabDVJT2N3S3NFal8xOU94U3ZG?oc=5",
    "date": "2025-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Outlook Therapeutics Receives Complete Response Letter from FDA for ONS-5010 BLA Resubmission  Quiver Quantitative",
    "company": "Outlook",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "2a0c82a7b56c7c79747aa0eecc276183",
    "title": "Telix stock plunges after FDA issues Complete Response Letter - Investing.com",
    "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNQzhRQXF1ZTZPeVg1NDFjUndCMGNWWEYyYlFkb2tuMnR3cnNvWGlrdjQzZkUxQklENG16UTJjU2VyVXlNTzRMTXpzOHJLVE1BaHFDcUV4YzdOUWFUUHR5b1JjTVZ1Q0htZ0tqSFN1SXE4RjI5N0FkcTRucWlGcU1CSGE1TTZTRFhYWjJmQ2R2MWpqRkRDLUFCenRiS2F1emVEQmxPTzBoaEo4MkFvd3RGSXZuS1A2d0FGWC16bWZxU1o?oc=5",
    "date": "2025-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Telix stock plunges after FDA issues Complete Response Letter  Investing.com",
    "company": "Telix stock plunges after FDA issues Complete Response Letter",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "aefc0a2136acc5d84217b86ad565292b",
    "title": "FDA received complete response letter from FDA for Columvi in DLBCL - PPF Group",
    "link": "https://news.google.com/rss/articles/CBMioAJBVV95cUxNWXhMcURoaGVLOVlfV2lBN01uc2VuRTU1TVlxcE1kdkFQekNETjRFRW83M3huT3lIRFMxY0xCOWtCVzFKd0JSczc2TV94bXN5TlVWWjVKQm5nMkUzRWhwdDZPYWdrZ3l0d2JUYWFSQXNCeE44aTNQTGVBRG5vVWhvRExPUnhUMzBibUFJTFIyWGFjOGpGblR0Y0hHUy1oTDQ3RjdTY29jS0VzX1hzWF9QYktyaHlPR2RmMGVCX0xGSVRMNC1iUjlacnRlZndmeG5qVVl6ZFdMRkRBUGhpd3BFbjhhWVZWQlRoNFloYWYyQ25jTUZRZXhkSGFzY0ljODVxbjBCZHhKN2pCSmloR3oxSzdxRXJCbGNlaXVwOGVlNnU?oc=5",
    "date": "2025-08-27T22:51:27.000Z",
    "dateFormatted": "27/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA received complete response letter from FDA for Columvi in DLBCL  PPF Group",
    "company": "FDA received complete response letter from FDA for Columvi in DLBCL",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "fc52320fed3dd7784110b99b937a0bf0",
    "title": "FDA Issues Complete Response Letter for Johnson & Johnson’s sBLA on Darzalex Faspro - geneonline.com",
    "link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNSHMyWmRFQ0VxOUE2VW9zdkg3MzQ1S0NnWldQNTcxeV9UM3RERjNKNFZSdzFFZnF2OHRHTThPWDN5cm40Nk1STTNoTkZWUTNwc1BNbkRDTnRaT0F0VzJWUVVTbjMtWEtKanVjRnkwNHZ2ZVM2S1BpUFZhS3FjNnAyVElJRXozdkxGanp4ZHdOdmxQS0FjbEVSaFVvVnk3eUJiYzlURGZEbFh4WW5p?oc=5",
    "date": "2025-08-21T07:00:00.000Z",
    "dateFormatted": "21/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter for Johnson & Johnson’s sBLA on Darzalex Faspro  geneonline.com",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "b4f1c291ccb309df5913d394b9b09d2d",
    "title": "FDA Issues Complete Response Letter to PTC Therapeutics Over Insufficient Efficacy Data for Vatiquinone in Treating Friedreich’s Ataxia - geneonline.com",
    "link": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxQdEhEZjBoaVlxbHNHc0drWWxWdzd6cVBIdkhNd2FYeXpyZ0NISnI5Y2VVT3FqSGlVOUdIZ3Rqc0hxeUhja1UwSk9QeEFiZjJkbVB3ZlluaVFyMEkzendEZC10UWZNLWpGTzFkYXpKSmxDMnE0cUdtV05XSzJCRXZvWFEzVUxKUVJIemFJVnNNUHhOX0NINmxiRnFGX1Y2ckF5dmVsX1phVmphbkFtbmU2MW5LTURFbkdVMzh5UmhXYTZLZHR6VG04UUZkSlhwUUR3REZuU29EMGR2RnhMMlRNX2tlT2FBNDVvS292cnBNUlk2ZWIy?oc=5",
    "date": "2025-08-20T18:08:52.000Z",
    "dateFormatted": "20/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter to PTC Therapeutics Over Insufficient Efficacy Data for Vatiquinone in Treating Friedreich’s Ataxia  geneonline.com",
    "company": "PTC",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "e66824ed54c7a4e9b981727be58f8c39",
    "title": "FDA Gives Complete Response Letter for Darzalex Faspro Quadruplet Regimen - Curetoday",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPNi0yMDRsekFtZmMwZFB3cjdOekF6WGxiUnJPWnBPMU5RQVBkaVZCVlh3SlJKSGgtaXdTcjZraTNJSVpzMXBNUDR5aHJZUlF4YzNQUk85VVpsRFRKNzZmOTFKNWcwc21oeGQ1dkY5UDBpZWdpaUdLbFhBdkdIVkF0VUdfZXd5ek5PQklmM2dQU1Rtb2hQQUE?oc=5",
    "date": "2025-08-20T07:00:00.000Z",
    "dateFormatted": "20/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Gives Complete Response Letter for Darzalex Faspro Quadruplet Regimen  Curetoday",
    "company": "FDA Gives Complete Response Letter for Darzalex Faspro Quadruplet Regimen",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "1497aa7c4cbf64c9c035f7d0ee1006ae",
    "title": "FDA Issues Complete Response Letter for PTC’s Vatiquinone NDA - Contract Pharma",
    "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPN1Zpanp6WWlzNWUzRnl4NXRpOFdWWVRRRE1laGZZdGRJbDVzWFZ6Q0N5T1F0MkRQbEgwc1FmNzB3X1Jqc1lTa3VEMm1vMExiRUFtNENZRUNabWR4anQzMWJGcXZHcXV5NUI5QjZBQmxINnQxMnJlN0JOTEh2aXJpUGVqczFPTU01N1QtUFdBNjhzNHN1VVlFOTZ0WjdtcUlTSWxBWA?oc=5",
    "date": "2025-08-19T13:56:19.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter for PTC’s Vatiquinone NDA  Contract Pharma",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "9555319419e5bd90505943352e927fb5",
    "title": "PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA - Yahoo Finance",
    "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxObE5VdV8wSVA2X2owbDVmal8tUEptWW1FNmpEQjRWU3BMb0dSOXgyaUJuRmRsWFd0TU13bWJnZ2FTLWRDdUphdmxJUUVRYldOb1l6aUxXN0lKSWtOWXhiLWVFdmVwbUJYTVgzdTl2VkgtdDFXY3g3QWhyU1JRdWRFZlBkV0Y4NElDeWN6RVEwMkRPSWM?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA  Yahoo Finance",
    "company": "PTC",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "7cab5af129025a1de42f61686d406584",
    "title": "PTC Therapeutics Receives FDA Complete Response Letter - MSN",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZmI0WlRSMDNhNURtOWxSbkJrLVY3UFFNODhiTmxEc3NxeTB6VEhVSURFWEh5VUxCTFZKLUJsT2lEZjVlcEhlM3Rpb2htdjdLcnVoLURIcHhxaDcxVFI2YVRtOWNET0Q0OVVEU3ZtQkZVaGpTQWNuUXR2anotbHdpY3ZGTkZzU2V3OGQ2bFoxVDdtaG5CWDgyRnhHRXNkWXJqY2lpVzlKeEc?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "PTC Therapeutics Receives FDA Complete Response Letter  MSN",
    "company": "PTC Therapeutics Receives FDA Complete Response Letter",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "a3bcd45975121bed4a4ba29f7842cfa6",
    "title": "FDA Hands Capricor Complete Response Letter for Deramiocel as DMD Cardiomyopathy Treatment - Neurology live",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQSEJkaW1DYnZ3THRNTWdpc2hNMFh6dXNPUHdFUXoyRjlwWnRQVzZybXNGMmtDOHdsVnA1M0NIU0UxVUlGQTYxLWVIM0FmcGlFMWY2VFlXMTZINVNfRmppWjMxRlY1VWVXUE1GVjJubTRZTEdrOE1GZXNqV1QwbEZLcFBNYTFYTVNRTno5UUhibG04QW5LUUNuTFZTdFcxTERoYWo3Y2tLQ3lvV1ZkS0EzcUY4Ulp5LXd5V0E?oc=5",
    "date": "2025-07-30T07:00:00.000Z",
    "dateFormatted": "30/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Hands Capricor Complete Response Letter for Deramiocel as DMD Cardiomyopathy Treatment  Neurology live",
    "company": "FDA Hands Capricor Complete Response Letter for Deramiocel as DMD Cardiomyopathy Treatment",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "add6447f71a5057d1052e3deeadd53c1",
    "title": "FDA Gives RP1 Combo Complete Response Letter in Advanced Melanoma - CancerNetwork",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPeUpKUXVENG1XWnEtZHRPR0ttTkdJOUNidUMwMUJvY3pTY3ctS1VNeUd6Wi1TaS1KVks5REdYTERpcUxmTndpVnk5VGtfd2pqUGZvSUFvT2JJTGxOWHpKczh2LUl5ai1NSG9IV1VsLVg0aHlwRThsOXpVZUFiNlBtVVdRUjJ0Skk0eTRkU0g4d3FGQVJRSnFSLUV4OTVxRDVHOHc?oc=5",
    "date": "2025-07-22T07:00:00.000Z",
    "dateFormatted": "22/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Gives RP1 Combo Complete Response Letter in Advanced Melanoma  CancerNetwork",
    "company": "FDA Gives RP1 Combo Complete Response Letter in Advanced Melanoma",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "3ce5d146cf7179cc30fdbf8a1cb7e08e",
    "title": "FDA Issues Complete Response Letter to Replimune Over Insufficient Efficacy Data for Advanced Melanoma Treatment - geneonline.com",
    "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOTHUxdXliYVhkdDUzQTJtZFBuN3oxQzlub3FHaVVtclNlOHQtTHNSdWNPYzhiWXdST2V1VnlMSlBmLVdvSFEwLUsxMXk4WTgzUkE3N1ZSOUp6Mk1tTnZCb0tLY1RITmRoY3YzdS1PVkdBVW5nYkJFV1dDdVdFNzFhWFhSX2QzQ3gxa21vMEhSYWJfZWREMFZRckN2ZFJaTmNGZ01jNHhXc0NIaEZuM0RieV80dnFpZmFNM2J5MHRLODdJYnBJMi1EeDQ5aWs2ZUJ4WW80bkxUaw?oc=5",
    "date": "2025-07-22T07:00:00.000Z",
    "dateFormatted": "22/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter to Replimune Over Insufficient Efficacy Data for Advanced Melanoma Treatment  geneonline.com",
    "company": "Replimune",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "2bf6fe0a74e9530abc32e11d05ea8289",
    "title": "FDA Issues Complete Response Letter for Glofitamab in R/R DLBCL Combination Therapy - Targeted Oncology",
    "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZXlhSFNScVd3dFNhSDBQemMyMVpNUExDeXRYNDlYeFNhZ1F5RGlFcmhPbURGX05tZUhkNFpNdVVrYzRQWnpFS0pyZFFabnNZUXRjNzdRazBZdmV4RS1ZLVFUNFVlbjI1ZVZTQ1RZTzJ3NU9hbzZJZ1dDZ1lremdyUENyU2tlRkZwSVNsTHJweWlXLWtXRVZjRVNSYnNMVW1xTUFMZXlHZllZVHFWR3c4MkptbFpjTGM?oc=5",
    "date": "2025-07-21T07:00:00.000Z",
    "dateFormatted": "21/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter for Glofitamab in R/R DLBCL Combination Therapy  Targeted Oncology",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "a5d2830f004982dba0d3e308e6fd0a68",
    "title": "FDA Issues Complete Response Letter for Glofit-GemOx in R/R DLBCL - Pharmacy Times",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPOEp5QUp6MFBYajNKQlptc0lpeWc2MGZYb3E1ckR5MW1GUUhDS2w0TWhWdjFpeVpUbWh3THZPRWJaeDZQWFloem5sZnJUaHh1cTFtWDd4dnJBb2h3MTdWTDBHVnd6cjdtREt0MGFiWjJWcEF5dldvajV5ZlFyQjRKRDBxYTNtUGg3ZHljdnBhdEo5UmFibE1CcVFnNFVBaWhnaHc?oc=5",
    "date": "2025-07-18T07:00:00.000Z",
    "dateFormatted": "18/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter for Glofit-GemOx in R/R DLBCL  Pharmacy Times",
    "company": "FDA Issues Complete Response Letter for Glofit",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "86f5dfcf877f324fa6dcb78d361b10db",
    "title": "Ultragenyx receives complete response letter for UX111 BLA - Pharmaceutical Technology",
    "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOVUszb2g2NjVsalpmZlZPTmpybFNBVHBiWFRvNHY3NVJhRm1LaTNiMkdjTklkMndSWmFUMDFFTkt6ZXFNYU1ZYkM5QzZEa2NCN1g0MzlmLVRaN1VYdVdCbkdOVzlJRlBXYUVjM3U5Yk5WbEFVVl9KV0NZZjkwSkpMQWc4UDVkekJDUmRTNVFqWllYTHM?oc=5",
    "date": "2025-07-14T07:00:00.000Z",
    "dateFormatted": "14/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Ultragenyx receives complete response letter for UX111 BLA  Pharmaceutical Technology",
    "company": "Ultragenyx",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "521a0ccbc7fae49239acb9ef3e5ff520",
    "title": "Capricor Therapeutics: Buying Opportunity Following FDA's Complete Response Letter - Seeking Alpha",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQNk02ME02b1NUMHltNGRvNHl4eTRVcTBsZzVVc1NXVEFMX1RCN1lZczg4T2NDNm13VmxWWGpUdFhGNk1rSmlMNS1NcHkxZEREdk5sZ1lwcU9hV2NhQTg4RUo0WGxTLWdZYk1zdm1Jb1FGS0hxRXB1Vi1Kd3ZjVzhxeWQtVlFxeHliZ1FjOTZPVi16eXdFMzJlQmRMRjVpNjhNc0l1aC03T1hPbE43UjBhejRrQXRRNnFITF84TXpEX2haMDJ0?oc=5",
    "date": "2025-07-14T07:00:00.000Z",
    "dateFormatted": "14/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Capricor Therapeutics: Buying Opportunity Following FDA's Complete Response Letter  Seeking Alpha",
    "company": "Capricor",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "767150bd601dae9e316b7b00b5b78f15",
    "title": "Ultragenyx Receives FDA Complete Response Letter for UX111 Biologics License Application - geneonline.com",
    "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNT0w3NDFEdGlZTG51M1VtMnZhS21xSGlCNjA5U0dTeTZmS01iUDFHbGNvR3R4Szl2LThwcE1ETjVtTmFOUFQ5ZzFZQUdwa3ZSWEZGR2s5YnBOZzVkZHpaNVQ5MHlVRndUaHlCZXRjVXd4cnY0UmhxbVBycjVSX19oaVNKdnI5UmlLQWZwSUllLVBqQ3RvQTNHN3JCUzdxT3M5S0E0X2ZWVEJWelBZR3Fyek9XNUZhcGc?oc=5",
    "date": "2025-07-14T07:00:00.000Z",
    "dateFormatted": "14/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Ultragenyx Receives FDA Complete Response Letter for UX111 Biologics License Application  geneonline.com",
    "company": "Ultragenyx Receives FDA Complete Response Letter for UX111 Biologics License Application",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "28587d874d993cd193e91f21b6bef8b3",
    "title": "FDA Publishes Hundreds of Complete Response Letters From First Half of the Decade - Pharmacy Times",
    "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQbF8zbDVUalRyb19zVnJOMmMxWVZWc1U3UEgtRWpWTHhUOTVzemwyQ3A3Ykw0dHlqTl92VWVRWkphZ3ZaUVEwVXd6RHIxSFZKbUw1ZDNRN0d6b2k2cl9xbmZ6UDVUTDAwcnJ2U0w1XzI4blhzMVlCQjRjX2RlVVE4V0J3bXUzRHhFOExDR1N2V09pWlZ0SU0tRGx0ckJWVDA1STh4QXJIQUdDazFMRFYzTHhObTNLQTQ?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Publishes Hundreds of Complete Response Letters From First Half of the Decade  Pharmacy Times",
    "company": "FDA Publishes Hundreds of Complete Response Letters From First Half of the Decade",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "2d14bffec6d13d8211ae76a932ab09c7",
    "title": "Ultragenyx gets FDA complete response letter for Sanfilippo gene therapy - FirstWord Pharma",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBBalJyWmlNZjQzUWxrRFpsVm9XTGhwMlFBWVd6QUw3S280U1JWX0NQbWZVTEEyVVhvVHF6VHBlenJoOTFHTlB2UnhNOHZqSW9Cck5v?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Ultragenyx gets FDA complete response letter for Sanfilippo gene therapy  FirstWord Pharma",
    "company": "Ultragenyx gets FDA complete response letter for Sanfilippo gene therapy",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "f9a74b43925fbbd421601069c19dfddd",
    "title": "FDA issues complete response letter for Ultragenyx gene therapy application - Investing.com",
    "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQdS1qUDhaaDlELTdWRElCUG1mT0RlNDVLc1ZmSndvNEVMSlk2ZjVoSjk0cENpTV9lRU1SQ1V5SzMwckxLck51N2VkQ3ZkSUFEeTNESjZjLUREOTVaV3VHa3VDOWNfS0VxaXpWTk1pRUdQaWZkdi1BdlRORGRaaWdXeExBWmk5am4xUXBpWkFDNWg5bmZmUTUxeEhMSE1zZUVIS29YWmV2VHB3VnRvOW51WVctODF2dW5iMVBxdzFPcnpyZGUtNk1aSktEYw?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA issues complete response letter for Ultragenyx gene therapy application  Investing.com",
    "company": "FDA issues complete response letter for Ultragenyx gene therapy application",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "71416ef449bfe41908ebbfd0e4054415",
    "title": "Ultragenyx Receives Complete Response Letter from FDA for - GlobeNewswire",
    "link": "https://news.google.com/rss/articles/CBMiqAJBVV95cUxQenU5QmFnQWU2bXNmUGZrM2pZVkhXLUw5RHBQc2huSFc0UlFQdkhMVVJyM2FwdmNvTHRYR2RWbVRtWGNxeVdoOFZvX1gwWmdDX2ZBVzVKVTdOenNOMHh0X0tEa3Vxa3lDQmFGUGlPTThFSUxINFNBeGIyQmMyeW5HdFF6WGNmNHJIU3ZGc05GX1hiMEFnYXA1aERGdEhDNTdfc0gxVV9laS1YOHZ0Z3Y3NV9MdFNkaC1RQzNpMUtaYXZKT3Z3bUV1YVBBXy1HZDk5cGhlYW1udkZVQmVnTGtJWGp4bFlnMkFSQnlGSWg3YjB4eXB3b2M1R05YaE5FdUU1V1VxczBGX0V2aV82STZiMDFOQ0loSVZPNF9XQXM4dmhHWlpzZDVKUw?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Ultragenyx Receives Complete Response Letter from FDA for  GlobeNewswire",
    "company": "Ultragenyx",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "2dd1d0f45d22c49818f80cf66ffa6ce8",
    "title": "Ultragenyx Pharmaceutical Inc. Receives Complete Response Letter from FDA for UX111 Gene Therapy for Sanfilippo Syndrome Type A - Quiver Quantitative",
    "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxNM0Z0cGZfaXhxSDVIRU5MazJHU1ZQZGV2UHdLeGR0bFhOMHZuRDZ4V0w0MjZlamlIeDcwbkxOeWFwWEtVdWVtQTRBcnZtVmpjVGk4OUhsRWRfWU9JcEQ3VlVTY1YwRkpMX3RncmVlbXBwbkJhS0NVNFV3QTY0VWJ3WnJ4MW5heGVQd3I0QjdfZzZnX2E4UnRrRHFvVWgxS1p3UzNKVWgxZGRDUlpnUkU5S3dpblk5cDBfeFZaRk9sWTBEcy1OeEI0RVNoOW1SdmpfNmV4eDFGaTAzb0ZObkxuN2RSWS1uQVg0dkp4eFJwN2c1dw?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Ultragenyx Pharmaceutical Inc. Receives Complete Response Letter from FDA for UX111 Gene Therapy for Sanfilippo Syndrome Type A  Quiver Quantitative",
    "company": "Ultragenyx",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "e20a147ab55011c0aa7142edaea49555",
    "title": "FDA issues complete response letter for Ultragenyx’s MPS IIIA therapy - Investing.com",
    "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOdV90QmVuOUpBcXoyc01JNWFHYXVRdFktRDBHNndBM09EbmlFOUtrdy1qR1BQSHp2MnN3MUpiNHozZk4yNWphRzFlcjJPSDJXMkd1X1p3QzFsRHp2SzlJMkltbm5zMERJRjcwVlpHSDh4VTRSYkRNTEU5dm0yMUwyWjV1WGNsNFRrcUtUenhiU0Y0THpLMS1PbEphcC1GSnlzLW1sUmpUcGxFTV9qY1ZkdzAyS1QxM2dSRFkyVl9SMFNtWHM?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA issues complete response letter for Ultragenyx’s MPS IIIA therapy  Investing.com",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "ef91aca42d02ab7b6b0d70f7592e6a20",
    "title": "Just how radical is the FDA's complete response letter move? - pharmaphorum",
    "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOQlpqYUp3SmJZY2JTam1VUGhNdHh3YWFjdXN3OWYxYkhDbnNLWVJqUWoySHpqWnlwdnRlNXJYWGwwclBwOW9NdllJX1c0RWRjaHpleDVpbHlMVkFkM0NxUzA4N0wwU0FUQXNBMWpIWnpWMVV1OUl2U1liY3luODUzQzRUcG9NNmxs?oc=5",
    "date": "2025-07-10T07:00:00.000Z",
    "dateFormatted": "10/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Just how radical is the FDA's complete response letter move?  pharmaphorum",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "0769fbfb09721c840928e340a934950c",
    "title": "FDA Issues Complete Response Letter to Manufacturer of OLC, Treatment for CKD-Related Hyperphosphatemia - Pharmacy Times",
    "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQMWtoZlFGel9acHZOWlQyMm9sS3FhYUpjd240RVZRTGY3WmZkNENTZndFSGVfSUx2UWRBcHJybzlyZWZQTHMxZmNRNWZaWTVJeXBRYmhnM3gxTVA2bFBLY1RRLWNtRFF6dTJjdHpsajh4UXE0aU9PeGtjV1Fsclc1QUNTRWNZZG4zRjVzQWFxd1BhQjhWN1pwODNicXY1VERZYWZTMFBheTBuY2FDMVlXZjFwU0dTSnI4RGd5dllFbGZEYjczemlyRXdKMHBRTVotQXVB?oc=5",
    "date": "2025-07-02T07:00:00.000Z",
    "dateFormatted": "02/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter to Manufacturer of OLC, Treatment for CKD-Related Hyperphosphatemia  Pharmacy Times",
    "company": "Manufacturer",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "a9c9c263b72a1c00967ea0691c42a031",
    "title": "Unicycive stock falls as FDA plans complete response letter for OLC - Investing.com",
    "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNbWJhY2x1N1FEYVBlMktadHBUWE1mSUpMdVRQa21zWVZ6dG5oZ0t1c1ZhYktWZHdiOTEwTzdGQUNPVFhqT3V4UUhrS1huU0M2czZNOFBoNUlWb0x5ZFBzVFJVUkpOM3lZUDRwMHNydmJSZk1kRzBiWFVBcHZ4OGdvaDloWVJ1bXZic2RjY1Zvclh1MUhZc2p2NjVMVDNET2hPajBoU3lXX3FBTk95MVJCQnQ4dENTaU9JMUFGWjJxbUEwc2xWQWc?oc=5",
    "date": "2025-07-01T07:00:00.000Z",
    "dateFormatted": "01/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Unicycive stock falls as FDA plans complete response letter for OLC  Investing.com",
    "company": "Unicycive stock falls as FDA plans complete response letter for OLC",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "8b4d2c762b12c315381c24ddaea2061a",
    "title": "FDA hits Unicycive with manufacturing-related complete response letter, delaying hopes for kidney disease prospect - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcHNsMWNuaTNURmo2SVJ0MkZwczNsNkREY2g1bG1XRnRZREUyTlFreVZNYXdlNkJYMjZBV3FwQ2twZmQtOHRPUzNvR2tRNVpFbWxVT01paU9VcGFSQjhMblpFZzg3U25iRlNIZGxaQXFVUTBYb1R6dTVrbzYxamZtUERSazFfS2xIY0g5dGR5ekI0RndTM0lyN3pPc2pnTGhPaklOUVJpZ0FfbW04eUNwVW1kMDAxSmh6QnhRYXlkS18?oc=5",
    "date": "2025-06-30T07:00:00.000Z",
    "dateFormatted": "30/06/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA hits Unicycive with manufacturing-related complete response letter, delaying hopes for kidney disease prospect  Fierce Pharma",
    "company": "FDA hits Unicycive with manufacturing",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "ae75b24704a70de2acbc98362e3fb4e2",
    "title": "FDA issues complete response letter for Unicycive’s kidney drug - Investing.com",
    "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNek9uUkVPNnlxOWU1Ykdia3RQaDFUTjVXc1FUeHYwMHBGNENSUVlhR3RZUEFoLWhRZlRzUHVwMVowOV9MV1V2Z3UzWHVqaUhDdkx3bXBWTjhDQkRPb0hibllsVnV4MDJVeC1aWkp0eW9rNVQwcVd5UEtUR1ZPSlh2aW5wLW5JR1hOaER5NnMxZ3JtMllGcmZZaHBhTUhLZ0hET1gycEw2WWhfbXVFVkxURXJqVEx3VXBRS2cw?oc=5",
    "date": "2025-06-30T07:00:00.000Z",
    "dateFormatted": "30/06/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA issues complete response letter for Unicycive’s kidney drug  Investing.com",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "ff4eae7a5fbcfd05e69fbe2bbf95c447",
    "title": "Milestone submits response to FDA Complete Response Letter over Cardamyst - Seeking Alpha",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxONHV4ZmJtTkl4X21OZVFyU0t4VkpBVTFmMWZVS3JSd3BBa1Y3Zzk1OHo3NFNwNldHUjBSU1BoRlhnZWpRWFQ0Y3lDRlYyWk1QVUhlaHZaX0tXbFNyMnFxeTZKMmw2LTBfalF2ZFRQRmdMd19vMklBRkZiQkFjTWZBTGZCbWcta21MNGIzVUpOOXFPT3FzenNrMUJabTNfS3RmWEZ3MzVR?oc=5",
    "date": "2025-06-16T07:00:00.000Z",
    "dateFormatted": "16/06/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Milestone submits response to FDA Complete Response Letter over Cardamyst  Seeking Alpha",
    "company": "Milestone submits response to FDA Complete Response Letter over Cardamyst",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "ebbdc9970e010bf31230af24ad180ba8",
    "title": "TLX101-CDx Given Complete Response Letter for Glioma Imaging - Oncology Nursing News",
    "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxQVmIyemZUbEpPZmx3cGNyNTg1blVBQ1hUNEN1R0JXRDlST05aNzVuTTU3ZXJHbW5LREFmdnU0c3pad0lmN0pycnY5ZW0yU2lBLWgtY0R1aHpnbkNLQktHTlp3eW5GSkoxWDdfcm1fcmMxWnVYcGFRdGh0c29kWWNrMWw1NENHS0RKMVFsdTIwV2JmU0NWTUJ0by1QWXp1Qmd6ZmhWYlducDBaYTlkX19UcU41NzN4LUo2MWpKb0FpMUhNTU40aGczVTJOZ2dhZm1GT1VldExRNkhLalMxSk42TXF4WFFFRVA4S0FqZw?oc=5",
    "date": "2025-05-06T07:00:00.000Z",
    "dateFormatted": "06/05/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "TLX101-CDx Given Complete Response Letter for Glioma Imaging  Oncology Nursing News",
    "company": "TLX101",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "3d3776a9a4741e1d83a19c067353bf14",
    "title": "Reproxalap Receives Complete Response Letter From FDA for Use in Dry Eye Disease - AJMC",
    "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPTVJjUHd1RjA1bWxfSGppdGtNZ1RwcVlOTEY0VGR2S3J6NFd0bFdHUy04VlNKMk9aMU5NOTMzc3dta2ZBZENwT0gyNzdmdUJnenR5em1ZTUNSVVMwTUNyMW9WX1JMRlh2TUxDdVc5eVJaRmFYMEg5b2VuSHpfYnM1WHUtMzJoQQ?oc=5",
    "date": "2025-04-03T07:00:00.000Z",
    "dateFormatted": "03/04/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Reproxalap Receives Complete Response Letter From FDA for Use in Dry Eye Disease  AJMC",
    "company": "Reproxalap",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "3f5c46764dc7fc47be3a7c577bba8f9e",
    "title": "FDA Issues Complete Response Letter for Etripamil for PSVT - Yahoo Finance",
    "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPRTF1MV9aZ28xSjc4c2dMQ1ZEaFlqa0tHQUZBMkhnY1R6Y0x6eC1aVnQtVV9rQVpWeFpPOFo4MldTRlgwN3MtMWdJZ1pLVVJsUFBWeFBqejVPQTBkMEdrUDNKYURTeTBaR3RLVlBqdTZmWkJIdWhDMDdiTEIxUDBRNGVfUENPeHJM?oc=5",
    "date": "2025-03-28T07:00:00.000Z",
    "dateFormatted": "28/03/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter for Etripamil for PSVT  Yahoo Finance",
    "company": "FDA Issues Complete Response Letter for Etripamil for PSVT",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "53b49b96d48d6c09b0ddf9ef5baf43bb",
    "title": "FDA Issues Complete Response Letter for Tab-cel in EBV+ PTLD - Targeted Oncology",
    "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPRWpwOHNXTXU1SnYwOElkLXphQ010LWtqUWFva2Z0bjVLS1p0d0Z1VGpLRnlaUTVFRDZpQWlBME9xZURmaWlGNWdfMTZiMl9KN3FJbTRlbEQzODhXWHMyRnd5cGQ4d2E1N3p4WVQ0a05FQzRES0pZUGtjanpyZDhLMVNSUTZ6V2lQQTZxNkphOEtGMkdlb2Q4?oc=5",
    "date": "2025-01-16T08:00:00.000Z",
    "dateFormatted": "16/01/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter for Tab-cel in EBV+ PTLD  Targeted Oncology",
    "company": "FDA Issues Complete Response Letter for Tab",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "27714a8be06e46b6decd46f9c87e039a",
    "title": "Complete Response Letter, Warning Letter and Shareholder Lawsuit Follow FDA Data Integrity Findings - JD Supra",
    "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQUGhhVWRtUDA3TEtVa0p6VElTMGE1eXNMcl9mMG1fY3FsdU1xSFdIODBGNWdMVlUtekUxUVFDbFVtZmpxVTF5WVdEblE0MTI0aFllWHJ2ZEM0UkhRcWNYRUdwbTlibUlJUzdPMmEwOUFRdWlTVXZGc2VMa0tvS3NaRXhRRHM4SGQwZGc?oc=5",
    "date": "2025-01-15T08:00:00.000Z",
    "dateFormatted": "15/01/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Complete Response Letter, Warning Letter and Shareholder Lawsuit Follow FDA Data Integrity Findings  JD Supra",
    "company": "Complete Response Letter",
    "types": [
      "warning_letter",
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "e98f3bdf0991eebd9c3d975e2a807ce4",
    "title": "FDA Issues Complete Response Letter for Much-Anticipated GLP-2 Analog - Pharmacy Times",
    "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPWWFneWJYcGkyU3JDOTJtd0s0RERBdGVTenhmRnc3ZEZyWk1jd2V1akNTLU5Ka190WEtVd1NQdHgzTVVxR3NjeVpZWnl0SmtOZ2dkcnhpZHhIMmRNdTlDME1aekJmQkk5SVB4ZE8wclBHd2YzUm5FalY5eDFhamhMY05JUDR4NE8yNkI4enVMZFZTczIxVWhUdlRUMDBqRnFaaFhmdDdXUQ?oc=5",
    "date": "2024-12-21T08:00:00.000Z",
    "dateFormatted": "21/12/2024",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter for Much-Anticipated GLP-2 Analog  Pharmacy Times",
    "company": "FDA Issues Complete Response Letter for Much",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "28103c6d531d0dbca377068904873c04",
    "title": "FDA Issues Complete Response Letter to Subcutaneous Amivantamab BLA in EGFR+ NSCLC - OncLive",
    "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNcDhYRTAzSEdTSzI5OGJ5UGFnWGxWMERJME9Vam1vUTdmYkZtNnJua082QVJaQnB1UEEzbWVDVVpaMGJPaWZrZ1o4YnE0aFVWUzBaai1rVGVwLUFQbWFkRkRpaUd6RTA0aG9GUXRnd1NJQlVYSFRrdEFlSVRXdjdEUUpDSzdpZHplT2ljdGlkOXBjNDdndi1tbk1XOWNscWhSUXpwXy1rZkpuRXFMUmQw?oc=5",
    "date": "2024-12-17T08:00:00.000Z",
    "dateFormatted": "17/12/2024",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Complete Response Letter to Subcutaneous Amivantamab BLA in EGFR+ NSCLC  OncLive",
    "company": "Subcutaneo",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "58fa5522fc70f926166fdf91665ef570",
    "title": "US FDA issues Complete Response Letter for avacincaptad pegol intravitreal solution (IZERVAY) - Modern Retina",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNZUhiM1ZrQ20xX0NZb3hEQlZzczhsV04yQlZkdldQMjBzTm94UjBfd3A3TlhjX0xVMGtHWWZzak9ONnBjR1JMTUFqYlpIMW9zNHFLTzRoc3dtV1Fqa05KVlVxckVWUXRSakJTNV9sb2RoWGpEUFpvZjY2TDhMT2tiTjV4TUhJcGNyR2NuSXBDam9mU0VUazVWWlAtRjJMU3A1Ymw1TXZRb21rZXh4Tjc5N2xfUnZpX2hyMXo2WjVEUGMxRjky?oc=5",
    "date": "2024-11-19T08:00:00.000Z",
    "dateFormatted": "19/11/2024",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "US FDA issues Complete Response Letter for avacincaptad pegol intravitreal solution (IZERVAY)  Modern Retina",
    "company": "Unknown Company",
    "types": [
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "d19e5649b123818d4327ae1eefb6b500",
    "title": "Homeopathic Educational Services dba Homeopathic Family Medicine",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/homeopathic-educational-services-dba-homeopathic-family-medicine-708635-08252025",
    "date": "2025-09-08T13:00:00.614Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Homeopathic Educational Services Dba Homeopathic Family Medicine 708635",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "8abbd075e24a7c39b7662d085fc133ae",
    "title": "Mel Honey US",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mel-honey-us-709535-08252025",
    "date": "2025-09-08T13:00:00.614Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Mel Honey Us 709535",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "5a20d1a7a194a64c4a0a6ca6748b8dd2",
    "title": "Green Vitality dba Gr33n",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/green-vitality-dba-gr33n-710151-08252025",
    "date": "2025-09-08T13:00:00.614Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Green Vitality Dba Gr33n 710151",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "ae5b21cd6981f03a1ad2b88ba128f3ea",
    "title": "My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/my-holistic-honey-co-shenzhen-qanhai-wanb-express-supply-chain-co-ltd-712052-08252025",
    "date": "2025-09-08T13:00:00.614Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "My Holistic Honey Co Shenzhen Qanhai Wanb Express Supply Chain Co Ltd 712052",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "a8892c538a01fff2eb2ef5623d24a394",
    "title": "Life Enthusiast Co-op",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/life-enthusiast-co-op-709315-08252025",
    "date": "2025-09-08T13:00:00.614Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Life Enthusiast Co Op 709315",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "7aecec1f30d7c70a695bcb56ee35a32b",
    "title": "Amneal Pharmaceuticals, LLC",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amneal-pharmaceuticals-llc-709894-08272025",
    "date": "2025-09-08T13:00:00.614Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Amneal Pharmaceuticals Llc 709894",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "d9e9cbdd3c527948a787ee52cb279c38",
    "title": "Synergy Animal Products, Inc.",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/synergy-animal-products-inc-712860-07162025",
    "date": "2025-09-08T13:00:00.613Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Synergy Animal Products Inc 712860",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "89dcf1f4371c8e69da2c0f30f67fb266",
    "title": "Wisconsin Pharmacal Company, LLC",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wisconsin-pharmacal-company-llc-710329-08222025",
    "date": "2025-09-08T13:00:00.613Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Wisconsin Pharmacal Company Llc 710329",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "9dccd5928ff7d622fa1d0a785bc5e4f3",
    "title": "Supply Center USA",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/supply-center-usa-710859-08252025",
    "date": "2025-09-08T13:00:00.613Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Supply Center Usa 710859",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "670bc7527b124022282c75c77aec7b57",
    "title": "Trew Balance",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trew-balance-709880-08252025",
    "date": "2025-09-08T13:00:00.613Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "Trew Balance 709880",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "b7b5688ba0ccdc91e819f31781a33caa",
    "title": "Staying Ahead of Enforcement: Executive Strategies To Prevent FDA Warning Letters - Med Device Online",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOMlh0TnFnZkd6d2hLOEF3dUhfN1RKQmZQQ3J0UGl6SXdraUhiWXZYd2JZMVltRzRJRkZXUWQ0NU5ncE1UcUIyalVEcU1sQnpfQXdYZEdONzhySk9uMUJvakRGNmhtd0xYVGhMbXA4WnJmZ0RaWWF4ZE1IaVhQaEhiZmFrZEFUN0ZMcHdKdGxIdzdmY29qRHJpRXdLcGJ6VVFzWWgzd1J6VXdCWF9fVnZJdzdFZjZxVU8wMnRSellR?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Staying Ahead of Enforcement: Executive Strategies To Prevent FDA Warning Letters  Med Device Online",
    "company": "Staying Ahead of Enforcement",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c11661754318fec7eedc1a4bd75f5785",
    "title": "The Warning Letter Wake-Up Call In 2025: What FDA Enforcement Is Really Telling Us - Med Device Online",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSWFHZV9SUHFlSUYzbS1VQVlBdURxT3dXR0k5QzlYOF9fM3VzOVZ1S250V290cE9FQ21Oa1liS2VWZkliVlVRYUJGcUhJZVFpOE1pWTNpVHZXLUg1TTJSaVU2QlBpWVpTUkZJQmVVN0NsSDBnbDNZLVJZRTRodDRWV1pLZ1E0WVZUNVhuQmdUTFpxd0QwSWd4Q3p2SWlXcm5XMWRMQzFKODBteDZMS0MtRWNLZFV3MXpW?oc=5",
    "date": "2025-08-12T07:00:00.000Z",
    "dateFormatted": "12/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "The Warning Letter Wake-Up Call In 2025: What FDA Enforcement Is Really Telling Us  Med Device Online",
    "company": "the",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "0f15ab0e84965de81f480bfab55914c3",
    "title": "How to Avoid FDA Warning Letters - Quality Digest",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPUGFtcW8tNVkzQlRvell6cmZ6YU9IWlJYTkV4OHdINlcxTGRudlI1RnFLRWpXbjhYTU9fX25RbFd2UEp4dHRLcGQ2OXczNXE3eS1IWWhGMXVYRlZPS0xHOHZyVDYxQVdma19fSXBEYjhzSl9fSS1UR2dMLXJCREhReXlST2tBLTQxT2dDNGF4Z21SXy01UHZzN0R5Y05GcTI5a3Z3?oc=5",
    "date": "2025-06-17T07:00:00.000Z",
    "dateFormatted": "17/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "How to Avoid FDA Warning Letters  Quality Digest",
    "company": "How to Avoid FDA",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "296af6549532a9e22f672045193907cd",
    "title": "India's Aspen Biopharma Labs hit with FDA warning letter citing infrastructure, contamination and records problems - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPWjNlOVMwM2ZqWHVoYWFaRHFrYzd5bGlvNDZiTkYyTGNiaF9odWpQSGJ5RUIwNXI1RTUyRjhCZ2ZLeVVhLUdhRFppeE9XTm1RZjV5aWZTSjBrME9Mc210UXhTRzNFamlpWHYtdHFGWklpYm9qbklkdUFmSHF0NFN2RzhRaTY1T3JFNjlTSExackZHLXJMVVNYdl9zUmF1VldyS3dCNXJjVmpsZnJYZXA1a1N6dVdrZ3NUT1hGNnAxX1BzR0E?oc=5",
    "date": "2025-03-26T07:00:00.000Z",
    "dateFormatted": "26/03/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "India's Aspen Biopharma Labs hit with FDA warning letter citing infrastructure, contamination and records problems  Fierce Pharma",
    "company": "India's Aspen Biopharma Labs Hit With Fda",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "7350caed97f8524d9b2ac175560b0180",
    "title": "Lytgobi Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1hbkNVUXl3dGVocUdqdjhfYlFRcnl1ODBPaUFsbTkwRjRaelRCWVJmWjhTcFd6T2FqemZFOS1reTMwb1lpN0RvOWVlai0tdGF1VGMw?oc=5",
    "date": "2025-03-21T07:00:00.000Z",
    "dateFormatted": "21/03/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Lytgobi Untitled Letter  fda.gov",
    "company": "Lytgobi Untitled Letter",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "8aaa4e7f4ed3eb0f1c1b18c9b55ad722",
    "title": "Dexcom receives warning letter based on FDA inspections of 2 plants - MedTech Dive",
    "link": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1kZDFOS1BEdVY5c3h0X3NBWWxRdWhpUW1VTWRldDRSVXloWDAyUTdGUGZHcDZ0YlFhLVF6TF9vVndpaXVQR3gySWNKeXlFR0t3MG9mRU1uMzRQLXcxcngxbHkwZVZzV2FwekFnZ3JfeEdfeW1t?oc=5",
    "date": "2025-03-10T07:00:00.000Z",
    "dateFormatted": "10/03/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dexcom receives warning letter based on FDA inspections of 2 plants  MedTech Dive",
    "company": "Dexcom receives",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "9dcd324bcaa46828dcab8f9faa52fc34",
    "title": "FDA hits pair of Indian API makers with warning letters, import alerts - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOcXZfQ0h3UUNRNHloVkowSHFBa1hyblNzMklrdGloN3NtakVTbDhlSjFVYXlxVzR2YmFVaVEyWWwzazQ4dU84RGxGd3hnYWxMVUFmNGNtbEM0T215cTEzd2NtSGZ6TE92b3ZmWGZyUlVkaHVQVktpRDBWWEx5R0lNNzh3ZWExX2NfR1o2OWw0dDlKZGx6bW9rd3BB?oc=5",
    "date": "2025-02-20T08:00:00.000Z",
    "dateFormatted": "20/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA hits pair of Indian API makers with warning letters, import alerts  Fierce Pharma",
    "company": "Fda Hits Pair Of Indian Api Makers With",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "3e338bd22b90c9a126b44682caa40143",
    "title": "FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOckJqX1lIckFjTEQ1c3R3YWRlZnp4cVFfb2VtVVRoUC1SeTVMMGxFSGI3WEhXUUR1c0lVN0JHU2JKdGd0Zml6TjhXNy1wZ0hNME85d0cxaFZTemc5dXVTVS10RE9iN1FTUWprRWk0T0ZPRDR4Y3FIQWN5ZVM3Q2Q1dURDQzVTc3lhWVN1V0xxMTktRlhIM3VOSC1tdXNuRWR5UTh5TTBDb1VrOWx2bFpPOEV5TDRKRVVxSGJGWU5HSVJIajRt?oc=5",
    "date": "2025-02-11T08:00:00.000Z",
    "dateFormatted": "11/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls  Fierce Pharma",
    "company": "Fda Slaps China",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f38cabfb892ae9c4209eb38d5d5e4cb7",
    "title": "Hemady Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5kdEExSnlhODhtc0RISHdGRFNuZjlyNHNRUVcweUFTNmltY1BzXzlmV05qZkU3S1kydWwzWWEtb3BQLTNVTDQ3VnB5aFlJZFNCeU5j?oc=5",
    "date": "2025-02-03T08:00:00.000Z",
    "dateFormatted": "03/02/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Hemady Untitled Letter  fda.gov",
    "company": "Hemady Untitled Letter",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "b58de356e28630cd3382f0587a15cd2b",
    "title": "FDA warning letter reveals quality control, data integrity issues at Viatris plant in India - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNLVZtZVpSekVIb2VmQXJFQzJNamNBc3Z0ek83MkNMdHp3cHlhQjhuN0NIVlFNR1pxX25FR2xkNG01X0R4cjdINUNSZGZCd3llem5fWjl0S2xHVlRVaDdjYzFoVWRjYUFhRnc3alVPa193RWVNY3BjZFVzOVQwNDQ3VkVJNUVpSWNpcVNtT1A1cDZJakVqbm4xdWZtQnVJMUJETE4yM2VtRDJrdUVwWVRJQ3FNcHpCcTBteUtZYld6Vjk0Zw?oc=5",
    "date": "2025-01-06T08:00:00.000Z",
    "dateFormatted": "06/01/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letter reveals quality control, data integrity issues at Viatris plant in India  Fierce Pharma",
    "company": "FDA",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "0c2875415389e002d4d9257d35a5ce9b",
    "title": "Viatris says India plant hit with FDA warning letter, import ban on 11 products - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQU1djX0V1eHMxNzQxTnRva3Zhaldfa2VxN2Z3ckFTS20waFh3TlhfQ1ZoMnlod3pKZzJRSzdZZFA3WUhlWjZ6UlBub01SRFNyc284aTJPN0xNS3locmtnamF3SkVSSEVLdTFXOFRLTF9sYkYzYlNlQkJoY3JNS3h4R0RfY2Y2ekhsVnc2eW4zQ19wRDBrN3MtYW5laWVNTXE2N2g1RHVzaE1aNkdWWXc?oc=5",
    "date": "2024-12-23T08:00:00.000Z",
    "dateFormatted": "23/12/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Viatris says India plant hit with FDA warning letter, import ban on 11 products  Fierce Pharma",
    "company": "Viatris Says India Plant Hit With Fda",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c91be7c0b73ac97dcc828170dde6e0e7",
    "title": "Krazati Untitled Letter Close-out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9qUEFwVmhXTDdZVjZqSmRXU2NwNk45MlpFTF9JQzdGeEFwUU9CQXJXS05tMGxMcTRRUXhlNEc0Q1NpMmZKZGVMTTd2VndlcVlUc2Yw?oc=5",
    "date": "2024-12-11T08:00:00.000Z",
    "dateFormatted": "11/12/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Krazati Untitled Letter Close-out  fda.gov",
    "company": "Krazati Untitled Letter Close",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "6d39f3c75305d4dfd8d1418d2b1d595f",
    "title": "Xeomin Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE05S0tqazhsQklPTVhoYm1sVWVISXJoQXVjUFhETWlpTHZlMDR4R3pJNENqS2pCWmRtcmZRUlQ2MDRjbzk1dFR1Q1pDUVF0bDROeFo0?oc=5",
    "date": "2024-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Xeomin Untitled Letter  fda.gov",
    "company": "Xeomin Untitled Letter",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "d8c80c5ffa2efcb1e995df4da283dc6f",
    "title": "Ubrelvy Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1KRUhxeG5PM0xrZHRsQnQxOFYyc0xQNWNUNVdmYjB4MzE3OGZHZEsxV1BxQjRYenptTnNleXpNYjUwelo0OUdQVk9ET1lQaWxCc2U0?oc=5",
    "date": "2024-10-30T07:00:00.000Z",
    "dateFormatted": "30/10/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Ubrelvy Untitled Letter Close-Out  fda.gov",
    "company": "Ubrelvy Untitled Letter Close",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "de841bb8c62e3d80ccd8187b4f7234cf",
    "title": "Auvi-Q Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFA1NzJybGdldjd1UVhCcmlrOGtieU1wTEJPUlFtR2hYTHItQTJER3VXNXJjeDMtVWlUbGJHcXpoclZjV0pqcUVGSTRlVHI5R0JwazNB?oc=5",
    "date": "2024-09-27T07:00:00.000Z",
    "dateFormatted": "27/09/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Auvi-Q Untitled Letter Close-Out  fda.gov",
    "company": "Auvi",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "8ca1311f532ccef7fabb7519aa364e04",
    "title": "India's Zydus hit with warning letter as FDA flags glass contamination concerns and more - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPdUJnWl9iUGV2TDhjaVVORHBacVJMdlFzMUYxQ0tYWFJucGdxNE5hQU9NTWhYNUxub21pdEpzTF9CeWMwcldpd3h1a2tyanY4U1d1VVBJSTFpNVdiU3h2QUdTOTFGMVZVUmVLS2MtYjREMTZQdWtXV3hubkRwLTh4RjdEclpDcmhST01FQ0lleVhkdkw2NzJpc0FGUjNoenVfSVp6ZWdKbDhLRVhhSERNcE9oaw?oc=5",
    "date": "2024-09-11T07:00:00.000Z",
    "dateFormatted": "11/09/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "India's Zydus hit with warning letter as FDA flags glass contamination concerns and more  Fierce Pharma",
    "company": "India's Zydus Hit With",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "1f03ab9457416fa4dc314ad6de51588a",
    "title": "FDA scrutiny of India’s Zydus results in warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPRXZjSjVUeGNPbmx2ZFRReEFsTXVwcF9UeU1janhzR1g1LWdaV0hMRGtoaVdUUVhUYldkdU1iekxmUU5Fd1NPeWZtOW1YVTlSWDh1NlRKZW1lb2N3YVNJMFZfRmZ5ajNmR3RfaDFYS3hNb2RsamNuMTZiRjFrQUJlMkNjVEJFNjVsWGNGMGpFMWp2RDhMRnc?oc=5",
    "date": "2024-09-03T07:00:00.000Z",
    "dateFormatted": "03/09/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA scrutiny of India’s Zydus results in warning letter  Fierce Pharma",
    "company": "Unknown Company",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "ba453436752facbf16061f42b7b561c1",
    "title": "Untitled Letter for Ubrelvy - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9yalJfd1ZKUUZ3cDNKbjZCdjlxb3kzZEgyWkVuLXM1UGY0UWRNS05fM2c3Zk1neXFCT1JuVDI5bllBNmJTakZSLWRvdGJQNzMyekI4?oc=5",
    "date": "2024-08-29T07:00:00.000Z",
    "dateFormatted": "29/08/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter for Ubrelvy  fda.gov",
    "company": "Untitled Letter For Ubrelvy",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "74af9bdfd91db35ae99bee9b73af7900",
    "title": "Untitled Letter Krazati - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9lRk91bnpySjZ5ZnJEQWlzOHNxSm9uS01BVGVrVVFuZVJhTGhVYU1XYXpCU2VrclZCcnRMZm5rSWc0aktIMHZiZ1pLWDRqNWExbXdZ?oc=5",
    "date": "2024-08-01T07:00:00.000Z",
    "dateFormatted": "01/08/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Krazati  fda.gov",
    "company": "Untitled Letter Krazati",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "95487d6cd2ce69608139701a363fa21f",
    "title": "Untitled Letter Auvi-Q - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE12dkF5Vl9GT0NTeFhHNHNmSV9hNDZCUnBkSWlzazRBWUtVcWs0LV9KUjVlTmwzdUxkX2R2a0xUOFhZWUhXdXRQRkpsZllrblRpRHV3?oc=5",
    "date": "2024-07-17T07:00:00.000Z",
    "dateFormatted": "17/07/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Auvi-Q  fda.gov",
    "company": "Untitled Letter Auvi",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "d3899623c852e7f945461179e81d3d34",
    "title": "FDA Issues Warning Letters to 14 Online Retailers for Selling Unauthorized E-Cigarettes - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdU1HSlNGLXo1dVlyX01Ub1Bqam9zNUcxc2lncU9oOWVOdkE2WXhRT3Z4eEhRQWRUU0RxUTBWbEpSUmtkRFpkRmo5LXRUT1BVRmtNRG1mOF9wSE5aLVNQYkxPNjhDYy03d2JEdlRfZ240ZkVLUGpHbHMxTEx1TEN5NEprRGFmZXIzX2p6eTZjSnU1LWE0SXEwVS15MXZHcWcxSnRTVHdnLUwyZ25SS2F0Q1hUaEFMcWRYSWJIYlR5NUlYaE1LT1N2WGNn?oc=5",
    "date": "2024-05-01T07:00:00.000Z",
    "dateFormatted": "01/05/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Issues Warning Letters to 14 Online Retailers for Selling Unauthorized E-Cigarettes  fda.gov",
    "company": "USFDA issues",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "3d852e123542f3711bf1640737e5fb44",
    "title": "Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat - ThePrint",
    "link": "https://news.google.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?oc=5",
    "date": "2024-04-23T07:00:00.000Z",
    "dateFormatted": "23/04/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat  ThePrint",
    "company": "Rx Import Alert",
    "types": [
      "warning_letter",
      "import_alert",
      "recall"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "9dff1dc11010fe79c916219b460f4821",
    "title": "Kisqali Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBDbGloT2FuMEozdXVocG9JVzJSNU5MR2E3TDdNN1R3YjE0S1JJNEZPNTR4UlBYY2p6aWJlcUxLYTlVNkJmYk5GVnJXYjlKX0M2MU53?oc=5",
    "date": "2024-03-15T07:00:00.000Z",
    "dateFormatted": "15/03/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Kisqali Untitled Letter Close-Out  fda.gov",
    "company": "Kisqali Untitled Letter Close",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a5e55e89d3af282c5afa2a85940da4ef",
    "title": "“Modernized” Food Manufacturing Enforcement: Trends in FDA Warning Letters - Food and Drug Law Institute (FDLI)",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNdkRnbllwMnU3bWxjaWFEOEE3TV9hT19oQ2RlNkh0OTBoTzRiZG01clZsWVZfWXB1UHk2SjNOUkNUSEpBcnBJdlB1YjByU3VISlpnY1ZIYWJwMWk1bHJqeUdaQl9CeEE5Q052cXp1dkNPWGV0M09NQ0UxZjEweWtQanZZTGNVN1JtZi1SSDhHZGx3eGx6cGdOQWJhV1habmc2VUFR?oc=5",
    "date": "2024-03-08T08:00:00.000Z",
    "dateFormatted": "08/03/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "“Modernized” Food Manufacturing Enforcement: Trends in FDA Warning Letters  Food and Drug Law Institute (FDLI)",
    "company": "Unknown Company",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "b4accb3a1423135ec09e3e269cfb6e05",
    "title": "FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPaV9WcHBaQ09CSjBXQlpDMmJyVm9SX0hhU205NlRNUlhNNzFYR3dMcWt3OTRoLUdYd1VlVGUxclNTV1B2N0o2djVIcllXQUgxWEhvZGNsckh2ejNoeFdab1E1c3F6ZXY4UU4zcXpyUTJZUTJFSGJTc3Z0OGlTWF82Y2tOMWFRZTlwaEdDOFJuaU5lRnY4SDRTelVaVnNTX1VrZ2xaU1lDd2tLS2t6RXZMeWxab1hiT0NzcW9JdDlYSm91TlZ5?oc=5",
    "date": "2024-02-14T08:00:00.000Z",
    "dateFormatted": "14/02/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic  Fierce Pharma",
    "company": "Fda Unleashes Multiple",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "1562367e29b60b3e52bdfc10f6afadf7",
    "title": "Issuance of Untitled Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNUEVmaE1sTE92WWpYLXUxSjE1ckxTR2NMbXVVNUNKS2lzTzVVOHpoVHJ5bHpIZDFMNjNLSjI1ZTQ0dDVRbVoydlE4LW96SnVFd2oxalJnM0VGYTdQOU1VR2lGX1k5TWo3UmVUa1JGZWt1bllOcVVRbjZuVFNrUzJZeWZDc0lIbE1VYUhHTTNaOTdYODd4b2JPTE5BQk52NFpKeWV3eW1acTU1Uk1zRUMwS3huR0E2TVlOV29URTl6SFlvbjdZRWJTR0haX1gtZFhRRTZaZndBa2FWQQ?oc=5",
    "date": "2024-02-07T08:00:00.000Z",
    "dateFormatted": "07/02/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Issuance of Untitled Letters  fda.gov",
    "company": "Issuance Of Untitled Letters",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "0d921959944b98813a00363bcec2132a",
    "title": "Untitled Letter Kisqali - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1ycENkVW5IWnZVcVNjZlJ5UGJXOXp1dTkyWUxaelNrXzJsTV9xUnFENDgzNExLcmdkQUV4QlVpMVIwWmVkcTVWbmRSNDU3WnBzc0hJ?oc=5",
    "date": "2024-01-18T08:00:00.000Z",
    "dateFormatted": "18/01/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Kisqali  fda.gov",
    "company": "Untitled Letter Kisqali",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "453530ac109c2c4d622e92e589d02c82",
    "title": "Untitled Letter Close-Out Phexxi | January 2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE81dnlKMHUxSko2dFcxZkp0U3c0azd4WGVfQy1Ecmo1aXFsSWJNSkJxUDdPeW9kd3FHV1hDMHl0RGtKaXgxa2xDdUJaMHlLd2p3Rkl3?oc=5",
    "date": "2024-01-05T08:00:00.000Z",
    "dateFormatted": "05/01/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Phexxi | January 2024  fda.gov",
    "company": "Untitled Letter Close",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "b7554396b4ff01a236c6ad8401de255c",
    "title": "Untitled Letter Close-Out Rexulti - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBDNENpUzJxVnNRYUVhSkM1bFduRUNxXzlRVDlIY00wdWJtejJNbjBPRXlxVGcyN1YzMEhsaWhSc25xQl9oNTNKRlcxeFNQeWVHSnY4?oc=5",
    "date": "2023-12-20T08:00:00.000Z",
    "dateFormatted": "20/12/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Rexulti  fda.gov",
    "company": "Untitled Letter Close",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "2cb9afed68096581c179f30d1c9ef98e",
    "title": "Intas Pharmaceuticals Hit with Another FDA Warning Letter, Put on Import Alert - BioSpace",
    "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPVVRudEJxcG1NTnJ1c2phcm5nQ3ZDcGRqXzVEeXdXclJMMy1Fendobk1WamNBNDFrZHZRQU9LNWFrRE92TWpUbEhvSS1FTWJCRW9YNFJnamZxN21xcF8tVmdkeFhuNjdyYnpUYkhSaTlTR1YzT3pWSEZnMkNuVWZvWTZsS1M0RkhnRjdjTlJiMG1WMjQ0bUxmMHUtQ05scHRONzVhaQ?oc=5",
    "date": "2023-11-30T08:00:00.000Z",
    "dateFormatted": "30/11/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Intas Pharmaceuticals Hit with Another FDA Warning Letter, Put on Import Alert  BioSpace",
    "company": "Intas Pharmaceuticals Hit With Another Fda",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a200281995efed5dff8ce01102463e0a",
    "title": "Intas on import alert as FDA flags data manipulation, management failures in warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQLWJaYmJ6bmdjMDU1ZHl4TVU4eWxtcFZwVUhaZnQ2M1BmOEphQ1JFRE82V2NZamFNNVNPUHBNcmZvTDFHbEJkV3NKbzJBN25PTVlaZ2N6OTFZalFmYnA5ai0tcXFnVklLWEtmVjJDRDVEa19mQ2tSMkJQbkhPbmdKME02dWEzc0tfVGVZTU5HbVotTnQzc1A3T3luNkdNbjR0LWFYVnYzUjJ1U1BBZ2s1Rw?oc=5",
    "date": "2023-11-29T08:00:00.000Z",
    "dateFormatted": "29/11/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Intas on import alert as FDA flags data manipulation, management failures in warning letter  Fierce Pharma",
    "company": "Intas On Import Alert As Fda Flags Data Manipulation, Management Failures In",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "854b90159e8c39fedc5829cf077ad478",
    "title": "Untitled Letter Rexulti - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE01TkNQOFZyTXprWkVONXVtYnpiWk03TkMtMnNoUGNJZ3hxSEl6V09XTUtfczJMUFZxMFpwRHFjdFBJWnE3M3hpOVh2Nl9WZURUZjZJ?oc=5",
    "date": "2023-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Rexulti  fda.gov",
    "company": "Untitled Letter Rexulti",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "7df1b941de7cc7e0a23df1e66b3fbe4a",
    "title": "Untitled Letter Phexxi - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9TdV92Slg0Sm5rYVdQT2RUQk1VeWVQaWxpLURlQ0E4YURvSjF0YmVOQ1dnaF9DbnhSbEI2dzE3eXNRTDZaTW1iZ0xNXzBTeDNNTm40?oc=5",
    "date": "2023-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Phexxi  fda.gov",
    "company": "Untitled Letter Phexxi",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "7a6c16687cbaa2112b8b2cee3170eef4",
    "title": "Office of Prescription Drug Promotion Untitled Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPbTF2UUdtQmpZempPSVVJZlhlS1BMMmQ4ZHdCRkpVT01KOWJ4ZEpoX00ydGxLcmJTemZTZGRzRFpMQUNaY09ZZ1FHNzFNNVBjUE92ZFNwYXNVRlNuR1pXZFQway1POGhUaTFOcDY0dElHN0Rpb250TDRsM1hidThXb1JPYXB6MmxUc0dQQ2JsY0xuR2VWT09oUG5wemJIS2FJMndUZEZqcTFodXd5YkJoSHZR?oc=5",
    "date": "2023-10-25T20:05:34.000Z",
    "dateFormatted": "25/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Office of Prescription Drug Promotion Untitled Letters  fda.gov",
    "company": "Office Of Prescription Drug Promotion Untitled Letters",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "cc6cae3daa2e63033a0df5dbef9bbf57",
    "title": "Warning Letters and Notice of Violation Letters to Pharmaceutical Companies - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQOWhBYlN5dHpxRS13ZXBES2QyLXVfRk90WDBxY2pjSGFBSW5Za3JJN2pVNHJORjVRdmRWTXBGLXFpOHE3WUxjU0hzOW43V04tMjFxUWRoUjBsMk1CdWVuZzhVRVd1VHZkNkZaUW5uN0o0QkszU21KMVRLVUYwaDVFLWJzNWt2c2lTa3h2eUhJQnJ0Sy1CQzVvQ0JpQWRMR1JnRWs1QmlvalhNWXp5ZHlBMFFGVy1lTGNOb1l4RUFscw?oc=5",
    "date": "2023-10-25T07:00:00.000Z",
    "dateFormatted": "25/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Warning Letters and Notice of Violation Letters to Pharmaceutical Companies  fda.gov",
    "company": "Warning Letters And Notice Of Violation Letters To Pharmaceutical Companies",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "4fbba383ea5195b46b182c15973cd42b",
    "title": "Untitled Letters and Warning Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBzR05pWDI5TGtuejJSX1plbVpNa2U5Q3hmdDZjV2ZSS08zS0ZBOTRHdTJYakdzYk1Fa0t1SWcySzhSWEF3TWNnRVVmajNXR2NialQw?oc=5",
    "date": "2023-09-28T07:00:00.000Z",
    "dateFormatted": "28/09/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Untitled Letters and Warning Letters  fda.gov",
    "company": "Untitled Letters And",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "791413b06784efd7ef2eaee13527a0b8",
    "title": "FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOc1VHNmJUR3dFN2lEMWtTeXF5eFduR1hpclZHd21OaHJVXzNKNFhucXdIS19LYng4cDNMMl9jd0pibXpleWFDc0Y4ZHJoSE1WUTBrdUYtcUpIZ1RjUU9iX3dqbEVNRDgxYWNjVDNXaHp4dk9HZmVYSjdrQUw1aUNqS0JYdmk3TnFKal9xa0NwY1gxLTNuN0xtdVJPN0ZPbzFOTTVJZVBpMEFvcFNjVVhBU2lwQUNCanVwRUE?oc=5",
    "date": "2023-09-12T07:00:00.000Z",
    "dateFormatted": "12/09/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products  fda.gov",
    "company": "USFDA issues",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a6d6b3cb97bd1d3c50c208b49dba9690",
    "title": "Untitled Letter for Slynd - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBtUmZzU3BteEN5WktDRHJSYU5YNkMwQzIzbUQyY1lUSHhfZGtERnZFMkZVNl85cXBEUWJIR3NmYXRGQXIzeE5UM3NSUlU4LXhDdnVZ?oc=5",
    "date": "2023-08-11T07:00:00.000Z",
    "dateFormatted": "11/08/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter for Slynd  fda.gov",
    "company": "Untitled Letter For Slynd",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "055331520c36145913ae8bb7bf3aab32",
    "title": "Untitled Letter Close-Out Recorlev - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBFNk5wOW1xS2JHYVBUTFhNWFBqOHY2el9QR2tYVUx0WWtPUGdDMUZMN3hDRWMwM2FnSXdsVktrQkU3QUNZeko5bmlfcnNWQTVWcjFR?oc=5",
    "date": "2023-08-09T07:00:00.000Z",
    "dateFormatted": "09/08/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Recorlev  fda.gov",
    "company": "Untitled Letter Close",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "352a8ca8ee047b24898e6a22598ae7d5",
    "title": "Untitled Letter Recorlev - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1JY2dLc1UwLXlWakpqZUROeVEyU3BFaG9oYkNOelZOblh0eGo2S2xGNFNnaE0xdDN3Q2Y4Sm9QZW9senl4NDZ0NDBTQk9RMGRLUFQ4?oc=5",
    "date": "2023-07-06T07:00:00.000Z",
    "dateFormatted": "06/07/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Recorlev  fda.gov",
    "company": "Untitled Letter Recorlev",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "ca770a51c8c85eae09242e2055c96bcd",
    "title": "Sun Pharma facility under an import alert handed a warning letter - Endpoints News",
    "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxORV8yakNTNHpLTi1La05mSEdOSFYzZkw4Q3EtUXlzcDAzdGxhTEpiRk5vbUd2WEVmYVd6N1FMdmU4RlJYT3BXdjRXTldna1k0bVphLXJObzlyTVFINldjMHI2dkFtUXdiOEJsWnNVTGxtQjlScnRaMk9HUnU4YlZOc2tnby1YWHZ6MWlwdUEwQ2lQckk?oc=5",
    "date": "2023-01-11T08:00:00.000Z",
    "dateFormatted": "11/01/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma facility under an import alert handed a warning letter  Endpoints News",
    "company": "Sun Pharma Facility Under An Import Alert Handed A",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a0aa8e39edf2c5f98432572b4090dcb2",
    "title": "Mexico's Glinsa suffers warning letter and import alert after refusing FDA manufacturing inspection - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPY1NQeEVCRFFGMGdOQXg4R1E4T1pzYmFucmZFZWthX2pvY2I3RTkxQktHTlNSWHRNc2pmbGpEbmVIYUxXUjNlN0tnUFkzTUZLMXRfUDFjUENlclB6Z1hsSUhOcV9fQVlPR09iOUl6d1hoY0ZTLU9HYWVJTXNFNFRUd1ZRMTZGVDdDaXN1cFZpMkVKNDNtNjdZOHBGUUFEa2htYkNBN1BzaW82R0J0eXl3QXZjRnZpdEhFX3pKSGRCbU82N3dC?oc=5",
    "date": "2022-06-23T07:00:00.000Z",
    "dateFormatted": "23/06/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Mexico's Glinsa suffers warning letter and import alert after refusing FDA manufacturing inspection  Fierce Pharma",
    "company": "Mexico's Glinsa Suffers",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a46e8ca6732aa7411546a419c9bd30fd",
    "title": "Untitled Letter Close-Out Roszet - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9saUNudmY4SUsxcFVCVzY5dFFHZ2w5bzJEcFl0NkEyVEdvWmlOWlZDdzRhZ0RQZ3JKWGozaHF1ZGlQQUJKN3I1Mk9JUUp2NnVEWW9r?oc=5",
    "date": "2022-06-15T07:00:00.000Z",
    "dateFormatted": "15/06/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Roszet  fda.gov",
    "company": "Untitled Letter Close",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c4d6689785f8287a508989f9decc1948",
    "title": "Untitled Letter Roszet - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE95R1JUMkZWRmxNU2QyalV1bkgxd1FXdEoyQWhxcGZDa05PUDVkMWp2VF9GVDZMcUZtLTJhY0gweF9tRm9iZm1pU281QUxod3ZrOFJF?oc=5",
    "date": "2022-06-02T07:00:00.000Z",
    "dateFormatted": "02/06/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Roszet  fda.gov",
    "company": "Untitled Letter Roszet",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "1c868674c0abe3a4badfadd14564dd79",
    "title": "Untitled Letter DUOBRII - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9yeUFKQVhWNzItMUZyV0lmUkhOM2s5dTVNdGxmTW5qSWM2NE9lSFB5ZVl5RUVIZGZQdkE3WjFua1dIS1daRG5XTG5EX1RzQXdYclBJ?oc=5",
    "date": "2022-03-31T07:00:00.000Z",
    "dateFormatted": "31/03/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter DUOBRII  fda.gov",
    "company": "Untitled Letter Duobrii",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "cbed24ce7f4574035f7679be33f9aec3",
    "title": "Untitled Letter | NEULASTA® (pegfilgrastim) injection, for subcutaneous use - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9jT1pjaC1aWVJPSS1FdEQ3SU9aejhsdDJuTGlXRy1ESFBDUWhVSWVhWHdUZEZHTmdsbzRFQnRLMEdEcnp4RTdMWmljX0tlc3k3ZEI4?oc=5",
    "date": "2022-01-11T08:00:00.000Z",
    "dateFormatted": "11/01/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | NEULASTA® (pegfilgrastim) injection, for subcutaneous use  fda.gov",
    "company": "Unknown Company",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "004e4f10d5ef54117f7fd5d4b7818f2a",
    "title": "RESPONSE TO UNTITLED LETTER | EMGALITY - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBlbzNtdXNnZEJLaWlwNnVWVXBWSTd2TlRaa2w3eUpFbzJDazVvNzJEMlJZcmZyTHFtT09ybDVrQUJnbGRKX0kxQklzeXd3UFVrWTgw?oc=5",
    "date": "2021-12-21T08:00:00.000Z",
    "dateFormatted": "21/12/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "RESPONSE TO UNTITLED LETTER | EMGALITY  fda.gov",
    "company": "Unknown Company",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "e8470ad2bc53197c027fb625f5fdfd39",
    "title": "Emgality Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBfN0szeDVZTG1TRXNKa2FhRTJkUFhhTnhmejFKa1Y1NjhYMzZRUnJ5TmI1NFR4MXM3UWxad0R5TW9VM2UyUU1fUW04Z0JtUFNJUlNV?oc=5",
    "date": "2021-12-13T08:00:00.000Z",
    "dateFormatted": "13/12/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Emgality Untitled Letter  fda.gov",
    "company": "Emgality Untitled Letter",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "ef815d7b6cddc8ba76291ffec826967c",
    "title": "Untitled Letter | NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5DWWhZUVQ2cldOTDdFb2tKRUl1TkhrUmdteHYwYTJIdGhzRjJXMHhNUmMzZ3ZVY3laOGppYnVqZlZWdWdNR1VNaGpmazB5Q1J1V3pR?oc=5",
    "date": "2021-11-19T08:00:00.000Z",
    "dateFormatted": "19/11/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use  fda.gov",
    "company": "Unknown Company",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "11c36ad90ec402c1461b76ab2f5a322a",
    "title": "After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNTktObVVMQXZ2QlMwWVlVNFBPakZkSEVwTDMtaVFPalBrQVA1dDhfSHpobnVMWG1JcFRCSXJubkFFRUtQb2R6UFEtaEJXLUVodnRySENkNXVvNjAteUg0NUhldmVDN3h4NlowTm5PbmxkYTlRS0dIUmlGTjA3RU90Y0tSWEtEaGN1LWsxSHJPaXBkbHZ2WmRmZzAzd0FHaTJ5X3BXeE1XQnpQV0IxbnRlb0xIdHdLa2gwRm5vaG9uMlptZU4t?oc=5",
    "date": "2021-11-15T08:00:00.000Z",
    "dateFormatted": "15/11/2021",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letter  Fierce Pharma",
    "company": "After Triggering A Global Valsartan Recall 3 Years Ago, Chinese Drug Manufacturer Overcomes Fda",
    "types": [
      "warning_letter",
      "recall"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "fabc63a2dec079c99dbb7087462f5113",
    "title": "Untitled Letter | ALKINDI® SPRINKLE (hydrocortisone) oral granules - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBtX3doR00zQVlRWGVTLS1mRXNMTDlIZWJSZ1p3RWdLS3RiU2JkLXphQjB0VFhTeWYzZEVSTlNtd29NTjJ6WExqMFpDYUFRRmlDVVdz?oc=5",
    "date": "2021-10-04T07:00:00.000Z",
    "dateFormatted": "04/10/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | ALKINDI® SPRINKLE (hydrocortisone) oral granules  fda.gov",
    "company": "Unknown Company",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "bcacb5632b9f95295d3eecdbd0633d06",
    "title": "FDA warning letters detail violations at China, Mexico drugmakers already under import alert - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPdG5panZOR0dXUjZrbUh4VjM1c01NNnB2NzNvdHZzMWdiOXVHQm5tQVdJMWlneFJTSHAxUHppQU9mSWhQNlc5SEtTOERuMGo2Y0dORmRoYXBTMl9yNGMxaGt6bm1YNVBJN2RoeEpjc2RzNlBocmJlODZrOGpnYmdNSzAxUVFvMTd4UlpFeHBMem02SGxQS2hqbEdfb1NxaTJZTmNrSWVLOA?oc=5",
    "date": "2021-03-17T07:00:00.000Z",
    "dateFormatted": "17/03/2021",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letters detail violations at China, Mexico drugmakers already under import alert  Fierce Pharma",
    "company": "FDA",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a60553bb222aa0b5780f59cc7b06171d",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYTFRCbFBpYnp2c0JLSDhwRThuajFFZjF3Z0ZtTDl3Si1TM3k1RW9VdDhQcUQ4Q1ZYRDRyd0lqZ1JYdjZyenU0aFZpOWV5VEc2c05F?oc=5",
    "date": "2020-09-22T07:00:00.000Z",
    "dateFormatted": "22/09/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "Warning Letter",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "6f033557f078ccca0a10234929059703",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFA3eGJVXzVDSGxHclRKYTRqRDFqY1dVZE8wcEJTb1FIWW5QSmYybTNJam9vUjRKOUNjaVluRlRYeXlQSHBkNmVOTG94OFZJVnoyTTJF?oc=5",
    "date": "2019-08-16T07:00:00.000Z",
    "dateFormatted": "16/08/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "Warning Letter",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "7899cc29cf011484a6023c2c346313f9",
    "title": "An Analysis Of FDA FY2018 Drug GMP Warning Letters - Pharmaceutical Online",
    "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNQV9IQVAxQWhXZnh3ZUN3cWl0aFlWZjNIN3ZmRmNfRVExM0R6U0lWbEk5R3A4OU1sN1BrWDdYazdnLXoxb19tTmJRdWtKUENVLWNnM2JiVXJYbmRRMGV5MFFFYVhFcEVJNGNlSGhMWXZVTVBxTG9fZHVyWERxb1EzNEE3aER1VkRtdnNkbldxdU1fdTNrVGJz?oc=5",
    "date": "2019-02-01T08:00:00.000Z",
    "dateFormatted": "01/02/2019",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "An Analysis Of FDA FY2018 Drug GMP Warning Letters  Pharmaceutical Online",
    "company": "An Analysis Of Fda Fy2018 Drug Gmp",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "e0e69bb95474e16e00aca5c30e337331",
    "title": "Dear Dr. Woodcock, I am writing to bring to your attention a Warning Letter that Vanda received from the FDA on October 22, whic - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE51ZFIybzZCOG0tY3oyWVZrTGpDbEhkODNncUNYYXI0dWU4bDI5TnZYMzFYQjh0eWlNNEV2Y0lGMVUzZ2JTYUVkczE5RTJjM0NGMWtB?oc=5",
    "date": "2018-10-22T07:00:00.000Z",
    "dateFormatted": "22/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Dear Dr. Woodcock, I am writing to bring to your attention a Warning Letter that Vanda received from the FDA on October 22, whic  fda.gov",
    "company": "Dear Dr. Woodcock, I Am Writing To Bring To Your Attention A",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "9a7897532dd3aba13a86faa6aacbc939",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE10aThhZ3k1N3pKUE9xd1JhazU2dUNaQmlLamxmeWFmZGZKeFZCbGFNYzVYOVJUSFAtVlV3LTI3ZThaejBfYTVMS1hrRnl5ODF0Qzkw?oc=5",
    "date": "2018-10-22T07:00:00.000Z",
    "dateFormatted": "22/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "Warning Letter",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "66e729268436d36689c4aa08ca808aed",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE50czRfM05aa2dzMmluM3E0ZVg3T0cyaGppcFczeEZRalVrVWEtN2RlSkJEblFmVGRrTkdjTXlLbURkMXFXcG5BUlN4WUNsMTdVTXEw?oc=5",
    "date": "2018-10-05T07:00:00.000Z",
    "dateFormatted": "05/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "Warning Letter",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "b18c4b9a63a26873acca1d5d1b4f3ea8",
    "title": "FDA warning letter tells India's Goran Pharma to get professional help - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOcnVvdlRNOGt2dV9pa1lvS0VvT1VIQ1U2OVhXMFRUV3J6ZWJsS2RsbUdXcVo3MkNGVndBa3JCc0g5UHJrUzR0czg4TTRLRkhRbVRRSkJaN1RZVTJ2RDVvZ2JURFVRZ1NfZ0xvMDJGTjJhMkw2QnkybFNWbWN5UlhTS1hSSmstMDU2anQzQVBMYnBxYmQteEFLTWR4TndNNWd1Sk1HWDRDVlJLaW1sano2MkxHUQ?oc=5",
    "date": "2018-05-10T07:00:00.000Z",
    "dateFormatted": "10/05/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letter tells India's Goran Pharma to get professional help  Fierce Pharma",
    "company": "FDA",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "90226208e7c63b9d75edb947b63ea592",
    "title": "FDA hits Dominican Republic drug manufacturing plant with warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxONF8yZEliV1J5b1EwNm1ISjc5YUF4VjhSTVdURFdKaDkySEZManc2Um5ic2g1R2ppU2ZTUkUtenlDWlFBemxOYWNDNDJHV0NnSTJxTm13NTZvdUhQRURleko0em9YaDdCWGU3aDNYSkdsWl9WdWJEcnBuQ3lfbWFHWHFNaUJGX0UtWjFnekNmRzg2dWN2U0dhd3hNWVVRS0JrZGZibk1CbFN5S0tmbnJj?oc=5",
    "date": "2018-04-03T07:00:00.000Z",
    "dateFormatted": "03/04/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA hits Dominican Republic drug manufacturing plant with warning letter  Fierce Pharma",
    "company": "Fda Hits Dominican Republic Drug Manufacturing Plant With",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "e492e6c635846f902158d3db4f6b4375",
    "title": "February 27, 2018 Untitled Letter - IDELVION - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPTU1UV1RVdjlHbENseVIwTXJKdnBHTEtpM1FTUWp1cUd6OVR6d2k5Xzl0RV9FM2xZdEtDT0d6SjBGdEFTbkNWUkxYYU9DdWdQRDdqdFVWamFRWDdYa3VHeWVueGdsNjZrR3RmM05aZk81ck1HOHlGbEFxTmt4UjJOR0N4dVBTSGR6TWVnOWdyU0dJbUxJdUJyRVdFSHJzSVJHamxNMS14cVp3NWRNVFA4c2h4ZEZLMVIxc0Nsb2VOdw?oc=5",
    "date": "2018-02-27T08:00:00.000Z",
    "dateFormatted": "27/02/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "February 27, 2018 Untitled Letter - IDELVION  fda.gov",
    "company": "February 27, 2018 Untitled Letter",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "663ccae3c91dd6e1f4a763bc840dde91",
    "title": "Lost in translation, FDA slaps Chinese drugmaker with warning letter for mixing up APIs - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPbXdmN25YWDA2MURzYkhXMFNNS2YxVWRBdkZxQzBHb19oRWxHRklyQ2lJT1NwSXFvZVM3ZWtoTmNHMjc1SUJaTGZUWl9IOHYtLVZrZW9MZ1FPQXVXWVgwMEtSSFBsVXpBODhpcl9TWG1MejA5TXBjNV9WMnMyOXYyNDlBOXVabEpMU3RQVXl3dmktM1VYYVIxank2LS1EX0tvQVJHOEhGWVR6OWRmMExKbDNNUXZJRUdvRS1KVFVn?oc=5",
    "date": "2017-11-08T08:00:00.000Z",
    "dateFormatted": "08/11/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Lost in translation, FDA slaps Chinese drugmaker with warning letter for mixing up APIs  Fierce Pharma",
    "company": "Lost In Translation, Fda Slaps Chinese Drugmaker With",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "926247b67dd1602cc73aff072651ce03",
    "title": "South Korean drugmaker slapped with FDA warning letter, import alert - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUFc1MzVUdUdrNk5Ud3hFMG5qTjhrdW1uMjlocWRleTZydExIU1RidmRqM21ibjFwUkh1VG5DRXNGYzF1MUh5UmhIZTZrYnBKUEEyaGFidHExZUlTVDNNdVFJWllMZnVMQlBYTEZIbWowaGw5bjJjU2RyNVZMQkJIWUItTFV5MUdTY3hrc1dYS05BRVdXRDRHbTFfcU5iTEVldHl3bzA3MkE?oc=5",
    "date": "2017-09-21T07:00:00.000Z",
    "dateFormatted": "21/09/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "South Korean drugmaker slapped with FDA warning letter, import alert  Fierce Pharma",
    "company": "South Korean Drugmaker Slapped With Fda",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "52360bb793d0512afbd43c42e6d3b8ab",
    "title": "Orexigen Therapeutics, Inc. (Contrave) Untitled Letter 5/18/2017 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPQ3JlRXQ1eG9BcWp1RG5iR0h1aW11blJvMkRGXzI1ZWJNZ2RCd1N0bTlwSVpCVHpISUVEWExwRWNpN013NFdIbk1MTWRxVDM0ODBHbGlQUjhMeU1YazFWdFk5d2FxbmZOYnM4NjhCOFU1dXJTVUJmODFfYzZtYXE4cUVvbVNQb3hYMTRiV2VTUUlMV1M4Mkx4WVItQzVJNndxd3B2NkY1TUY2NGZYNEFid2dfdFdMOHNJSnM5R28tdG5QUURHVkFYbTBiUmtWZllkRTBSZTZoODJtdEZZT2xzelZtQjNSVm9yeVE?oc=5",
    "date": "2017-05-23T07:00:00.000Z",
    "dateFormatted": "23/05/2017",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Orexigen Therapeutics, Inc. (Contrave) Untitled Letter 5/18/2017  fda.gov",
    "company": "Unknown Company",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "9efe101f0088a259c0f66ae0227687e3",
    "title": "Import ban extended as India's Pan Pharma racks up third FDA warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQS0RQc0FMZm5LYmRKa1dqV1ZPbVJINmxJUGVVX0w1cWJRbFVLcXZJOF9oclcwd3pZNFRZaWFtRGxVd1ZFeGM4azFaLVNKZzFkcmpjODJ6cnVaMGc4RGpFRlRuUlZGSDRhX2k2cFk1Z2hPNndCVjNxRzR5SEg3bVI4RTRoZklNbUxDWTMxZWx6QmpLblcxUXFnclg1Z3BkVkxtR095T2ZyblJpOGs?oc=5",
    "date": "2016-09-07T07:00:00.000Z",
    "dateFormatted": "07/09/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Import ban extended as India's Pan Pharma racks up third FDA warning letter  Fierce Pharma",
    "company": "Import Ban Extended As India's Pan Pharma Racks Up Third Fda",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "d48173d1ab60b16a5eab301e61c0ca48",
    "title": "FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingredients",
    "date": "2025-09-05T15:05:29.000Z",
    "dateFormatted": "05/09/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market.",
    "company": "FDA Launches Green List to Protect Americans from Illegal Imported GLP",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "c02319771858c8f3ae20381a9c8d4825",
    "title": "Endico Potatoes Inc. Recalls 2.5lb Bags of Frozen “Peas And Carrots” and “Mixed Vegetables” Because of Possible Health Risk - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxPeVU5TjBJMEMwSlUxLU5xODJHZDU1RlJyVjVZRFA4Z0hVZ3NBNUhOOVNXbXJaM3ladTFpS1h0UDJJWXdOakx1RThaVnhPeEcwbDBoUjAtLXY4aXBKTHVuSDYtU2tTMnlsUDgtMUxxWjVsVVlLUTc1UURzSERDR3piNGY3dFVFWEtyNVJucXkybzd4c3lyWk10b1ZwdFFOUm1aYlhjZnZVZ041dzdVTkdiZnVaYXc1dVFGaG9fUUFkRVJNNEJTRmNJb2hvVzBmRnlNa1Z1WXBTUi1JRllaRXZyQnUtcHZPdWhqT0xtaHc2N2VkcHBmSldXYk1aUQ?oc=5",
    "date": "2025-09-03T15:26:00.000Z",
    "dateFormatted": "03/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Endico Potatoes Inc. Recalls 2.5lb Bags of Frozen “Peas And Carrots” and “Mixed Vegetables” Because of Possible Health Risk  fda.gov",
    "company": "Unknown Company",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "1fc36eebe94b136f65c4c4ee57ee074e",
    "title": "Updated Release: Southwind Foods, LLC Recalls Frozen Shrimp Because of Possible Health Risk - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPQ0NVa0VaRVNTMGN2QTNsSkNMQjN2TUloeV8wdjN0a2hlUTQxemdVTldFY0txMTU3a2VyYzYtbEEyNmpoSjVYYzItYVJwbWFpYlV6ZmFlUUxMZWN5WkE5QXo5dWVxOENCNUZxcVI5aVNhVHBuQnNIbGtZNU54THNaX1VvUTJxZ1h4ejVxeWVGWmxNQTdUZEh3azRLRnFrdjFIWDhFOHRIOUtjZlhaZWJld2RtOEpXTHFCUkNSMlUzaFdjYUs4dXBHVnhERGlTR0NFX2hCU1MzS0xZcFhaYmZPQVhjaTl3a29JTHc?oc=5",
    "date": "2025-08-29T07:00:00.000Z",
    "dateFormatted": "29/08/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Updated Release: Southwind Foods, LLC Recalls Frozen Shrimp Because of Possible Health Risk  fda.gov",
    "company": "Updated Release",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "5e94fcf16a0e758bc073e8a8bfcba822",
    "title": "Breathing Circuit Set Recall: Hamilton Medical, Inc. Removes Coaxial Breathing Circuit Set Due to Possible Inner Blue Tube Cracks That May Impact Ventilation",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/breathing-circuit-set-recall-hamilton-medical-inc-removes-coaxial-breathing-circuit-set-due-possible",
    "date": "2025-08-29T04:00:00.000Z",
    "dateFormatted": "29/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Hamilton Medical is recalling certain coaxial breathing sets due to a defect that may cause cracks in the inner tube, risking patient rebreathing exhaled gases.",
    "company": "Breathing Circuit Set Recall",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "970730f7b26542075dd35ca21ce4876e",
    "title": "Manual Resuscitator Recall: Ambu Inc. Removes SPUR II Resuscitators Due to Blocked Manometer Port",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/manual-resuscitator-recall-ambu-inc-removes-spur-ii-resuscitators-due-blocked-manometer-port",
    "date": "2025-08-29T04:00:00.000Z",
    "dateFormatted": "29/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "A blocked manometer port on the Ambu SPUR II resuscitator may delay ventilation or cause barotrauma",
    "company": "Manual Resuscitator Recall",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "b92f29addb10ae6d8c2eb6e9b1feb4bd",
    "title": "Mobile Power Unit AC Power Cord Recall: Abbott Medical Removes AC Power Cord Associated with HeartMate Mobile Power Unit (MPU) Due to Potential Risk of the Cord Not Locking into Place",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/mobile-power-unit-ac-power-cord-recall-abbott-medical-removes-ac-power-cord-associated-heartmate",
    "date": "2025-08-29T04:00:00.000Z",
    "dateFormatted": "29/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Abbott Medical is removing power cords associated with the HeartMate Mobile Power Unit due to a potential risk of the cord not locking into place.",
    "company": "Mobile Power Unit Ac Power Cord Recall",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "643982af0096d07242dd1a3db5a217d5",
    "title": "Aquastar (USA) Corp Recalls Cocktail Shrimp 6oz Because of Possible Health Risk - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNNnhHdnpSV0hRYlVld1pnYW5MSDJUVDB3VjdhM3FFeGd3Q1djcVlXRjBSMUNQcmtJZTR3a0R0YWNtWEZHX3V6NFVVdnBQczZnU3NZYTE1UHY2RU9ZOGZUenRxd0g3UDJSVUg4Yk1rcEtpbTgwOGNmeVVVdzNjMGVDb25zYWF6dUlXRDktRjl1NXVfZ2pMdVFGVExtcjY0MzBFQ1hDZzhiQ3pnQzlObnJxcFl1N2FpT3R4YXJ6N2IwMlRmRVVWRFYzRXNBTEYxSG55c0Z4cW9VU1pmQQ?oc=5",
    "date": "2025-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Aquastar (USA) Corp Recalls Cocktail Shrimp 6oz Because of Possible Health Risk  fda.gov",
    "company": "Unknown Company",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "3c56a9f9739055e878f2dba15e1ccc36",
    "title": "Applicator Recall: Integra LifeSciences Removes Extended Tip Applicator Due to Potential Sterility and Endotoxin Concerns",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/applicator-recall-integra-lifesciences-removes-extended-tip-applicator-due-potential-sterility-and",
    "date": "2025-08-28T04:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Extended Tip Applicator recall due to potential non-sterile product and high endotoxin levels. May cause inflammation or infection if used.",
    "company": "Applicator Recall",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "e00e08c1a044214b7c2f0a042ba92a7b",
    "title": "DermaRite Industries Expands Voluntary Nationwide Recall Due to Potential  Burkholderia cepacia Contamination",
    "link": "http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dermarite-industries-expands-voluntary-nationwide-recall-due-potential-burkholderia-cepacia",
    "date": "2025-08-28T04:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "DermaRite Industries, LLC is expanding the voluntary recall initiated on July 16, due to potential microbial contamination identified as Burkholderia cepacia complex. Out of an abundance of caution the voluntary recall has expanded to include additional products and lots, which can be found in the t",
    "company": "Unknown Company",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "2d59b559b6ff2f2113ddab0088ae2ce7",
    "title": "DermaRite Industries Expands Voluntary Nationwide Recall Due to Potential Burkholderia cepacia Contamination - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxQcDlSOTY4Tk13MVJyQTJkQjdrM041bmU5OXdPOHhLY0llbkNUc0lSMUVOYmpRRWFRTjFLLUV2UFlaNERZTEdSVnpVZ0tyNnA2WXI2eVJHQ0JUMWNydzdPTU5ZU0Q3UUZ2aDIwbTQ3QUFyRVZzLVJDZDZiMG55TFJUZ1VOdndZN2l6R3BBaUJLb25CZ0NVcVNzSHQyWGlvbW82RDI1OUduY0pLRlhhMVprMnpLVHAzNy0wUXpwSG9Vdl8xc081QlZqZnlCSzdIM21ZOHEzMFZsU3lZVUFkT2l4V3hXX3lqeE9INEtjb09zMnU?oc=5",
    "date": "2025-08-27T07:00:00.000Z",
    "dateFormatted": "27/08/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "DermaRite Industries Expands Voluntary Nationwide Recall Due to Potential Burkholderia cepacia Contamination  fda.gov",
    "company": "Dermarite Industries Expands Voluntary Nationwide Recall Due To Potential Burkholderia Cepacia Contamination",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "a1fedf94b5b41e47da582b51d734ffb4",
    "title": "Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling",
    "link": "http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/unichem-pharmaceuticals-usa-inc-issues-voluntary-nationwide-recall-cyclobenzaprine-hydrochloride",
    "date": "2025-08-27T04:00:00.000Z",
    "dateFormatted": "27/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "08/27/2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level. The Cyclobenzaprine 10mg (90ct) label was inadvertently placed on a bottle containing Meloxicam",
    "company": "Unknown Company",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "6b151f9aa6cdca5093adf82be8ac73bd",
    "title": "Vascular Stent Recall: Boston Scientific Removes Carotid WALLSTENT Monorail Endoprosthesis Due to Risk of Resistance During Device Withdrawal",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/vascular-stent-recall-boston-scientific-removes-carotid-wallstent-monorail-endoprosthesis-due-risk",
    "date": "2025-08-22T04:00:00.000Z",
    "dateFormatted": "22/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Boston Scientific Removes Carotid WALLSTENT Monorail Endoprosthesis due to risk of resistance during device withdrawal",
    "company": "Vascular Stent Recall",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "78565bb7368c82a08f9da68746bd8793",
    "title": "B. Braun Medical Issues Voluntary Nationwide Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter",
    "link": "http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/b-braun-medical-issues-voluntary-nationwide-recall-lactated-ringers-injection-usp-1000-ml-and-09",
    "date": "2025-08-19T04:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "For Immediate Release - BETHLEHEM, PA – August 19, 2025 – B. Braun Medical Inc. (B. Braun) is voluntarily recalling two lots of Lactated Ringers Injection USP 1000 mL,and 0.9% Sodium Chloride Injection USP 1000 mL to the hospital level due to the presence of particulate matter inside the container.",
    "company": "Unknown Company",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "ce7b09897a32a273419710cdc3f4ca77",
    "title": "Early Alert: Cardiac Cannula Issue from Medtronic",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-cardiac-cannula-issue-medtronic",
    "date": "2025-08-15T04:00:00.000Z",
    "dateFormatted": "15/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program",
    "company": "Early Alert",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "241696a4465ddfed3d79eeac48e2eb64",
    "title": "Breathing System Filters Recall: Draeger Removes SafeStar and TwinStar Filters Due to Risk of Misleading Carbon Dioxide (CO₂) Readings",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/breathing-system-filters-recall-draeger-removes-safestar-and-twinstar-filters-due-risk-misleading",
    "date": "2025-08-12T04:00:00.000Z",
    "dateFormatted": "12/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Draeger recalls SafeStar, TwinStar filters due to misleading carbon dioxide waveforms, may result in unnecessary treatment, potentially causing harm or death",
    "company": "Breathing System Filters Recall",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "f4b0b0d7d7892029bb6ecbed918b6039",
    "title": "Max Mobility / Permobil Announces Worldwide Expanded Recall and Removal of all SpeedControl Dials from the Market Due to Intermittent Cable Connection Concerns of the Dial with the SmartDrive MX2+ Motor. Users Must Use an Alternate Control Method for their SmartDrive MX2+ Power Assist Device. ",
    "link": "http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/max-mobility-permobil-announces-worldwide-expanded-recall-and-removal-all-speedcontrol-dials-market",
    "date": "2025-08-12T04:00:00.000Z",
    "dateFormatted": "12/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Max Mobility/Permobil has voluntarily expanded its recall of the SpeedControl Dial, a wired control option for the SmartDrive MX2+ Power Assist Device, due to safety and performance concerns. This voluntary action applies to all SpeedControl Dials manufactured and distributed between the dates of Ap",
    "company": "Unknown Company",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "de2be0026e73b2a8763c5f6306789ef9",
    "title": "DermaRite Industries Issues Voluntary Nationwide Recall of DermaKleen, Dermasarra, Kleenfoam, and Perigiene Products Due to Burkholderia cepacia Contamination",
    "link": "http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dermarite-industries-issues-voluntary-nationwide-recall-dermakleen-dermasarra-kleenfoam-and",
    "date": "2025-08-09T04:00:00.000Z",
    "dateFormatted": "09/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "DermaRite Industries, LLC is voluntarily recalling individual lots of products in the table below due to microbial contamination identified as Burkholderia cepecia.",
    "company": "Unknown Company",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 1
  },
  {
    "id": "d3f77e63cefa75e45d75b689e53367e8",
    "title": "FDA Adds Firms to Import Alert Due to PFAS in Clams - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOZmNSWGJXT1lsWUh0UGxTd3ZndHV0Sk9idkJMUElLdHR2dllZOGNja2FRWmZuZm1HWHNsZTdreXVBOWEyWHp4NktXbWxoNGlKeFA3MHFZeWMzaVZnbWU5ZzFNTk9CQXZZZ3N3SnZoUjYyYzZQbkhVeld6aUJmaHBYNEFsUGNKcFZvbS1iTnRkcXJMdWlJdEE?oc=5",
    "date": "2025-02-18T08:00:00.000Z",
    "dateFormatted": "18/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA Adds Firms to Import Alert Due to PFAS in Clams  fda.gov",
    "company": "Fda Adds Firms To Import Alert Due To Pfas In Clams",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "e316568b6b56d045ba012c1594d27612",
    "title": "FDA puts two Chinese API makers on import alert after failed inspections - Endpoints News",
    "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNb3gtX0daUzZFT3M3cWFEMjd4YmthbThjWHk3T0p2SXk1NXpLTnZFc19OR3lBSG5XR3B2TmtrbldER0w2ckVqdlc0ZEFxQjFGdkhoOWduWG9IWjdqSkJfZmZoc2p0VXV6ckJ3cmRFTDByY2NYczhmdUpKbEQ5OFY5NV83bWp1WEtsTFduVmhLOHBlNG5PSUpTMk12bHM?oc=5",
    "date": "2025-02-11T08:00:00.000Z",
    "dateFormatted": "11/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA puts two Chinese API makers on import alert after failed inspections  Endpoints News",
    "company": "Fda Puts Two Chinese Api Makers On Import Alert After Failed Inspections",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "2253306154c912e61bcdeab194dba6f4",
    "title": "Another Disappointing Drug Import Alert from India - The People's Pharmacy",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPMnZ3QTI4ZG5mdy0wd194QXU3TkZYeFVkTlNWc2xIOVNFLXQzOFU0UGFXWFRBTE81TDl5S1B6WWV1RjgtU0k0VXpuTmg0b2l6bFNaUFEyc00weUFPZkdjOXo1cmpwRWRuM2FWRjJ6enBjZ1UwNE9Tb25leFpSRWFORHk3Sk9SZlVrYVBqbjNjb3daYmJNb1E?oc=5",
    "date": "2025-01-13T08:00:00.000Z",
    "dateFormatted": "13/01/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Another Disappointing Drug Import Alert from India  The People's Pharmacy",
    "company": "Another Disappointing Drug Import Alert From India",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "7ebb8b0629faf62fe244ea88dab40363",
    "title": "Rx Import Alert: CVS Branded Generic Drugs Singled Out In Bloomberg Report For Most Recalls - Coalition For A Prosperous America",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQSkpGOG5oUF9MNUZ0akJ4MjNiRGFNOUZjUTk5WGxTY0I2SWU5eDJYVkY1TzZxenQxWmhfZ1NJcmRFZmw0bGVEdGlwckxTcmN5YW8yZlpZaWw0U0lQZm9yUFBLWDhQY1hWd085bDVlRFowSlNFVW0zUDFUOGFDbGFZdjdwM0tyTVFhSUZMMmlRVTFqaXdYcVBBUVRLb2twQS0zSm9XeHd6OGNRc2xYak1PZE9WNVE4UlYxcFZZQVpR?oc=5",
    "date": "2024-06-13T07:00:00.000Z",
    "dateFormatted": "13/06/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Rx Import Alert: CVS Branded Generic Drugs Singled Out In Bloomberg Report For Most Recalls  Coalition For A Prosperous America",
    "company": "Rx Import Alert",
    "types": [
      "import_alert",
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "af9ed250b83e20959cbb7ee2eafadaab",
    "title": "FDA issues import alert, additional recommendations against using plastic syringes made in China - American Hospital Association",
    "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOelVWVDlETVIwU1pMbnR4YklmeVBMdVpFbnk2bTQ1b3VySjZuVUR3S3QyWlR3eFJVT1ZoRkhMZFRNOEI0aXpzTXhiMDhvc2l4anFuc2dQYW1FU1ItQTh1aVFFYnIzeEtWWFNJVElhLXIzeU5DandPWUpTT2FzZGU2OWpFQjVJY1FncF9MeXVFTXctM2NJeDhMcVhya0tpMzBaREdyUUUwOG9rMkp0QnZiRGg3LXlndC1vNmlNZkdRTXRubjFBTnBOSkRTdHlrLXNPbmlF?oc=5",
    "date": "2024-05-17T07:00:00.000Z",
    "dateFormatted": "17/05/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA issues import alert, additional recommendations against using plastic syringes made in China  American Hospital Association",
    "company": "Fda Issues Import Alert, Additional Recommendations Against Using Plastic Syringes Made In China",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "37b4510c55aee8717c636c253ee84b1d",
    "title": "FDA issues import alerts against 2 more plastic syringe manufacturers - MedTech Dive",
    "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQQ1h3Y2lyczZScFdHa19neURiS1AtcGpYdjE2Z2QwekRYd0cxanl2VzdvdXo4MEFwdHg0Y0J6eWtQZnFwSTRISjlEWl85d1IwN1BtUFVBTjlCR01ZQ1E3bzM1aVJtVHJFWnRGanQxbU15RmU2Q053ZnNpRk5idmV5bUhiUTRKaE91X0haYVBuY2MtZUhWTjVLWXV3?oc=5",
    "date": "2024-05-17T07:00:00.000Z",
    "dateFormatted": "17/05/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA issues import alerts against 2 more plastic syringe manufacturers  MedTech Dive",
    "company": "Fda Issues Import Alerts Against 2 More Plastic Syringe Manufacturers",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "d70a870cbf8306e15a1d7dbd851c34ca",
    "title": "US FDA issues import alert guidance on PFAS contaminants - SeafoodSource",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxObFFmN3N2QmZOUHJ2RGczNTNNbllKRHBnSW8tOV8tN1lTTzBPeUxBLURHcVpVVTltblFlUFdLT0dCODItVGhOT0JfVnZDQkczWlhvWFQxVk5jU0tEaTg3cHNGZVp4cmRTdHg3Y2hTcFBRVXRHd1VzTzZKVWtTb2RHcXBXazhGM2Z2bEhfd3JXeUJYQTB5S0FxbVpuZkVKY3FRdl91QUdqSHVZUy11UzU2dVJYMW43NzdJZk50LVhR?oc=5",
    "date": "2024-03-27T18:01:27.000Z",
    "dateFormatted": "27/03/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA issues import alert guidance on PFAS contaminants  SeafoodSource",
    "company": "Us Fda Issues Import Alert Guidance On Pfas Contaminants",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "13769bfc6594e881c9f3ba597743d1df",
    "title": "Ipca Labs undergoes crucial US FDA inspection at Ratlam facility amid import alert - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2023-06-06T07:00:00.000Z",
    "dateFormatted": "06/06/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Ipca Labs undergoes crucial US FDA inspection at Ratlam facility amid import alert  CNBC TV18",
    "company": "Ipca Labs Undergoes Crucial Us Fda Inspection At Ratlam Facility Amid Import Alert",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "2d638dfe8855cc6ff8ea9008843116ef",
    "title": "India’s Intas gets more bad news from FDA with an import alert - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOeUJ0LXhfRWozMXJhMndnZG54Y0wxYXFBZm1ZeDh1MnFTR0hETm1mNFdqdTJtNzc1V2VWa3h4NHRPR05XUVBBZC1STlhsUmxNZFNJYmxveFF0bEdaZHNtaFJvaExYM1Y4R21JbnAzdVRQQWVzQTlUSno0VmxiU0FOQ0JnSGFJczVWandGMjFGZ3VwRF9WSUE?oc=5",
    "date": "2023-06-05T07:00:00.000Z",
    "dateFormatted": "05/06/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "India’s Intas gets more bad news from FDA with an import alert  Fierce Pharma",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "fe23b3e621b287b2823474054f381e67",
    "title": "Intas Pharma’s Ahmedabad facility gets import alert from US FDA - Forbes India",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPdFdBV0FraFJHd09qM0U1clZ1enItZnZvWFFsalRLS3lBRnVsaHFyTy1FQTJLR1NjNXFnSGpVdDdmOFVuZU5nSEdxXzlrZHlXdTBzUlFjVndaNlNVR21VNWZwSmprd21sU1I1bUtzV0QzT2JOcTNVQ2g5am5zYWVNbzF6d24tdFFDWENpLUhXUENXQTBLS3FFVmI3WGhPdFBvQ2VJX29RZ0h2SFJpS3ItOA?oc=5",
    "date": "2023-06-05T07:00:00.000Z",
    "dateFormatted": "05/06/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Intas Pharma’s Ahmedabad facility gets import alert from US FDA  Forbes India",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "4eccd848344b55f50170893fabc32468",
    "title": "Intas gets USFDA ‘Import Alert’ but allowed to supply 24 critical drugs - The Hindu BusinessLine",
    "link": "https://news.google.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?oc=5",
    "date": "2023-06-03T07:00:00.000Z",
    "dateFormatted": "03/06/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Intas gets USFDA ‘Import Alert’ but allowed to supply 24 critical drugs  The Hindu BusinessLine",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "030cf518022d3b82aadb30b91277015f",
    "title": "US import alert for Sun Pharma’s Halol plant could lead to sales loss: Nomura, Credit Suisse - Moneycontrol",
    "link": "https://news.google.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?oc=5",
    "date": "2022-12-09T08:00:00.000Z",
    "dateFormatted": "09/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US import alert for Sun Pharma’s Halol plant could lead to sales loss: Nomura, Credit Suisse  Moneycontrol",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "d9bf714903f77ebb09c00f22e23a9d08",
    "title": "US FDA Issues Import Alert On Sun Pharmas Halol Facility - Zee Business",
    "link": "https://news.google.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?oc=5",
    "date": "2022-12-09T08:00:00.000Z",
    "dateFormatted": "09/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA Issues Import Alert On Sun Pharmas Halol Facility  Zee Business",
    "company": "Us Fda Issues Import Alert On Sun Pharma's Halol Facility",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "6efaef59941a4259fd0b55051c569771",
    "title": "FDA slaps Sun Pharma plant with import alert after inspectors find production problems - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOQTlveWdFcFpoRjd6SERNMzhRU3BpZlZhUVF5ODNuZVY4TFdNVkRyVWl4a0dPRVJ0XzFGelFDZ2NPUWdHeFU0NEp3eU1uWlVVeDI4TXNMQTkyUG1WTEE5N1RuNktiM3NScHMzYVNNdjZid2V0SlhROHdRYlZMY0xYRzF3YWdnOU93bDNDazFnX0g0ZkQ1bVU5aG8xd29FcjlQ?oc=5",
    "date": "2022-12-08T08:00:00.000Z",
    "dateFormatted": "08/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA slaps Sun Pharma plant with import alert after inspectors find production problems  Fierce Pharma",
    "company": "Fda Slaps Sun Pharma Plant With Import Alert After Inspectors Find Production Problems",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "3568ffaf14bc90b211bcba37acf74ae1",
    "title": "Sun Pharma says Halol unit listed under US FDA import alert, shares slip nearly 3% - Mint",
    "link": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNU2Z0bnhBSlp5Y0kwYzl1ZGp0VmdSNjBJNXFKNFRIOEhCektvNWgxQmlrTmNYcEFmbmpJVjZJd2JQYnFnVUgtUEhKTXBRRTlheTRieGc5ZkFEbTBiT3pGeUNhT2ZhczhMQU1ucllqa1NxX05wcFJNYnFxT3FmUnhPSWF1LVBFQk8tZUlHUml5Y0FBUUFRZEFPTkFXQkRyWVdrWi1TWUxqM3hna1hQc0dSUXdjdDRBdlFCNE9NUkpGclRSaHVrSEhqc0RoS2ZPZUdMa1U2QTZQNDJxWThXWkJUcXBR?oc=5",
    "date": "2022-12-08T08:00:00.000Z",
    "dateFormatted": "08/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma says Halol unit listed under US FDA import alert, shares slip nearly 3%  Mint",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "52e6c34a562d6cf7aa432729106f2a04",
    "title": "US FDA issues import alert on Sun Pharma's Halol facility - The Economic Times",
    "link": "https://news.google.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?oc=5",
    "date": "2022-12-08T08:00:00.000Z",
    "dateFormatted": "08/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA issues import alert on Sun Pharma's Halol facility  The Economic Times",
    "company": "Us Fda Issues Import Alert On Sun Pharma's Halol Facility",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "e69bcafab04230151931ac163197f8e5",
    "title": "Sun Pharma’s Halol facility listed under U.S. FDA import alert - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2022-12-08T08:00:00.000Z",
    "dateFormatted": "08/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma’s Halol facility listed under U.S. FDA import alert  The Hindu",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "9c4bc3567236ec5b49d3a829dcd907c6",
    "title": "US FDA lists Sun Pharma's Halol unit under 'import alert' - The Economic Times",
    "link": "https://news.google.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?oc=5",
    "date": "2022-12-08T08:00:00.000Z",
    "dateFormatted": "08/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA lists Sun Pharma's Halol unit under 'import alert'  The Economic Times",
    "company": "Us Fda Lists Sun Pharma's Halol Unit Under 'Import Alert'",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "61e664a6dc3d0555e05e358f28fd237a",
    "title": "Sun Pharma clarifies on US FDA import alert on Halol plant - Moneycontrol",
    "link": "https://news.google.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?oc=5",
    "date": "2022-12-08T08:00:00.000Z",
    "dateFormatted": "08/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma clarifies on US FDA import alert on Halol plant  Moneycontrol",
    "company": "Sun Pharma Clarifies On Us Fda Import Alert On Halol Plant",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "64272a2b73fca4d0c4b6cb3d9738b8e7",
    "title": "Sun Pharmaceuticals' Halol plant gets 'import alert' from USFDA - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2022-12-08T08:00:00.000Z",
    "dateFormatted": "08/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharmaceuticals' Halol plant gets 'import alert' from USFDA  Business Standard",
    "company": "Sun Pharmaceuticals' Halol Plant Gets 'Import Alert' From Usfda",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "94a0c849dbd9bc2a1a27d53b82b42a03",
    "title": "USFDA issues import alert on Glenmark Pharma's Baddi manufacturing plant - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2022-10-26T07:00:00.000Z",
    "dateFormatted": "26/10/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "USFDA issues import alert on Glenmark Pharma's Baddi manufacturing plant  Business Standard",
    "company": "Usfda Issues Import Alert On Glenmark Pharma's Baddi Plant",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "c6ad7d29740d57dbde9a3ea9be266e9c",
    "title": "FDA slaps import alert on India's Shilpa after sterile injectables issues multiply - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNUmNTS3V2elVTWkVxYkRtSllqLUM2c2Q2TDdsR2pvRngyeG4xQVlwR0xXOE84dTJXNUt5Z1NkSFdPLUppTzlDYkNzaE1TRUxVbjRxWVNaeU03VUZkV1VhYVlaeDVhenlveVVQOWlHeU5VVFhocm5WT3BTdU02UGNxNW1NUWFuaU1BZVdsbHJhMkVSWnJROVVNcENqQmhxd1BuTDI2dEFOV0l1LXh6ZTA3WVVKUThyOVNoS3RqNlBfOVNKWUp5bVE?oc=5",
    "date": "2021-02-19T08:00:00.000Z",
    "dateFormatted": "19/02/2021",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA slaps import alert on India's Shilpa after sterile injectables issues multiply  Fierce Pharma",
    "company": "Fda Slaps Import Alert On India's Shilpa After Sterile Injectables Issues Multiply",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "14d4e1f91cb9d68eca720e6c32abc3a2",
    "title": "Dietary Supplement Manufacturer ABH PHARMA Recalls All Products - Food Poisoning Bulletin",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPSFFCcWcxbHpXTllvczREUmdXTmpfMVZVTkh0MUxZdDFyaEdLZzc1ZFNrSlpTdWE2eXU1V2ZtWFVZa2ZPX0dYYTFBZ1BDMFJFeTRlcDJtbTN0VW9WSExxUXNrNUZPbVpTTDNJOW9rVjBRd2VmZmVSVGlrc3FWZDBUZE1BZ2Z0SDNIZTFBTjk5dDI2YVg5NXZod1haeE56SFdGVHRyZUVn?oc=5",
    "date": "2020-01-22T08:00:00.000Z",
    "dateFormatted": "22/01/2020",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Dietary Supplement Manufacturer ABH PHARMA Recalls All Products  Food Poisoning Bulletin",
    "company": "Dietary Supplement Manufacturer Abh Pharma Recalls All Products",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "8b0cfbab24eed870cc5406687ee3c7b3",
    "title": "FDA grades new Medtronic SynchroMed II recall as Class I event - MedTech Dive",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNUmgzVjY2X3VNRV9Mdy1RM3B6MDEzX09oSjJyN3ZfVE91WXFwamZGU1lTeC1Nd043Wk04TUZhTFJQN3c1MjNMaFVEMlVFREtpQ09CY1JQZHAxSHB1bmplZlhxTVJaRnIyMy1uY0NMMzZfb2hGSV91OGxtUnN5YTZZNGxmMGZsZGtDdDZ6Wlc3dW52U2s4Rld1ZzgySFRxYWlScU5Qa1F3?oc=5",
    "date": "2019-12-05T08:00:00.000Z",
    "dateFormatted": "05/12/2019",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA grades new Medtronic SynchroMed II recall as Class I event  MedTech Dive",
    "company": "Fda Grades New Medtronic Synchromed Ii Recall As Class I Event",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "33bc959d74354d3bb91f747276247100",
    "title": "Recall Alert: FDA Warning About Two Thyroid Medications - CBS News",
    "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE80UkJodTdPc3pEZ0JTd1o5SjRodjJoYy00RGFGbVQySGtOV185YVF5T3lwUm44WUx6aFp1anU2WUhzUF8zbE1jTVdfRUJSU2xJbUR3S0FkM2tyTGJGSTRyRnJPQUJ6WklqZ2ZqaXVVcm5QZG5JT3V1NWhKdw?oc=5",
    "date": "2018-08-15T07:00:00.000Z",
    "dateFormatted": "15/08/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Recall Alert: FDA Warning About Two Thyroid Medications  CBS News",
    "company": "Recall Alert",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "21e0a0152ebff8ae7082b9ba4bc59931",
    "title": "Cracking Down on Kratom: FDA Investigation, Enforcement, Seizure, and Recall of Products Reported to Contain Kratom - Food and Drug Law Institute (FDLI)",
    "link": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxONWJzZElXQmlnek9hcHYzWXdlWE9ham50WUJITzR4NC16OHh0cjllSjF1Slh0bGJ1Qng0RVhOTWpZaU9keV82RmlJOUpGdHdZR2RrRGpNcjBVRUlTaF9hY1dpOFo4Uk5qMk1TbENvX0dvM3VrTW1MWmRFN2VFXzBGNXlOSlVHTFcwOURuX0NnVTAtaDlpQWJmT0pnSl8xa013TV9NeFMzNTRkejdCcjdYZElTelNBRGxRbTB6ckpDWWlqdzctdGE0ekxNc012ZGl4WjNGYUVHSmE1Ym5qaU5mRFN3?oc=5",
    "date": "2018-08-14T03:08:35.000Z",
    "dateFormatted": "14/08/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Cracking Down on Kratom: FDA Investigation, Enforcement, Seizure, and Recall of Products Reported to Contain Kratom  Food and Drug Law Institute (FDLI)",
    "company": "Cracking Down On Kratom",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "5a206f34101472764196d4621c935f69",
    "title": "US FDA lifts import alert on Divi’s Lab unit - Mint",
    "link": "https://news.google.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?oc=5",
    "date": "2017-11-15T08:00:00.000Z",
    "dateFormatted": "15/11/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA lifts import alert on Divi’s Lab unit  Mint",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "92635563662a88d51451f941d1ceb724",
    "title": "India's Mahendra Chemicals API plant put on FDA import alert list - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQcTFtdmZ0WExmVjRIbE5WM3JJSWxMZlpmX285OTA0Y2pueEJNdi1uMkttX2JiaThBTU4ta01CYXpRcmtORkFzSXVwQ0RNSGZGU1Faa1FIaXA3SWp0NWFIcjlYSmdtSnNVVXBRZENlQkxmWFpieXhsM3ZVR0tTeVJ4MWZja0s3RV9pX29uLVBGVnJnSGJ2V0ktcjI5RFhMT0RYaVA3VzB4SlE?oc=5",
    "date": "2017-08-30T07:00:00.000Z",
    "dateFormatted": "30/08/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "India's Mahendra Chemicals API plant put on FDA import alert list  Fierce Pharma",
    "company": "India's Mahendra Chemicals Api Plant Put On Fda Import Alert List",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "919812542d34d42817a09dc2799ff2e4",
    "title": "FDA outlines data integrity problems with Chinese API maker under import ban - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNWUpZYnNQTHJ6bGo0ZE5mZzlfUHd2WFhmbVd4UTRyU2NQX096bzVkOWkwc281OEphVjk1NUxmMG43ZEVOMzFBYnRwYUNBdV93VE8zRjFoMGsxUld5RFFuM2lTa2xfOG85dTBMMXBZZjZYUU1Mbnk3OUd1UWRfcFVSclByRTB2MVo2WTloVlNPdGdqcU55T3hLdWJjRTVJdWZONldkelg2b3lrdjNRc1BBZC1xOE0?oc=5",
    "date": "2017-06-21T07:00:00.000Z",
    "dateFormatted": "21/06/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA outlines data integrity problems with Chinese API maker under import ban  Fierce Pharma",
    "company": "Fda Outlines Data Integrity Problems With Chinese Api Maker Under Import Ban",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "5c509c163ef2c4cd1400baa0bbf06071",
    "title": "Divi’s Labs says US FDA import alert on Vizag unit to hit revenue by less than 5% | Company Business News - Mint",
    "link": "https://news.google.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?oc=5",
    "date": "2017-03-28T07:00:00.000Z",
    "dateFormatted": "28/03/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Divi’s Labs says US FDA import alert on Vizag unit to hit revenue by less than 5% | Company Business News  Mint",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "4e9e03195185e21d61002245919d7a5b",
    "title": "Divi's Labs barred from exports to US after FDA import alert on Vizag unit - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2017-03-22T07:00:00.000Z",
    "dateFormatted": "22/03/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Divi's Labs barred from exports to US after FDA import alert on Vizag unit  Business Standard",
    "company": "Divi's Labs Barred From Exports To Us After Fda Import Alert On Vizag Unit",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "d8ecb7d375fe5fa808aa6c3a53461439",
    "title": "Sun Pharma says US FDA to lift import alert on Mohali drug plant - Mint",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbWpjVU82TE5UQnk1T2t2SmxSaDI5WEhWZnJveV95amNQd1FKd1VVamFmSElUdWxKUE5KbkFSUFZDQnFjV19sZVJGV3NPSnNPZHl4a09Zc3VTelU5RktkYVpraTRFRGJDUHppU0Fsa3RuRTAxTFoyMXQxNkwyTkI4WUxfaGdQVDRadEYydERUZC15bE9pY280Q1JZamlHbXhGNnpIODBDUm5aQU9yWWdPeDh0Ui1NWFd4?oc=5",
    "date": "2017-03-14T07:00:00.000Z",
    "dateFormatted": "14/03/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma says US FDA to lift import alert on Mohali drug plant  Mint",
    "company": "Sun Pharma Says Us Fda To Lift Import Alert On Mohali Drug Plant",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "cd7b267572f467dda59afb9090156d71",
    "title": "US FDA issues import ban on Ajanta Pharma’s Kamagra tablets - Mint",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxObWFOQXVxTnA2U0ZtR2Z4U0RzaG9DUkw2d2xXcm5lUVA5UFlTX2hsSGN1NnoyRGhiekJpZTJEWFJOQ2NFMEU4Q19DZnpFTndkcllrNGlISVEtSmc2a1BXbEJfMWExMXRMcnVsZFFZLW1tbVpqUnRZMGMtU09kd05KeDA5SnczWGV4LVBndW9sckR3amtWRHpGdjZXaGhuX01SelZ0RTduT2phWHpPVXR2R2Z3TnhxaDd1ZnlvSFVn?oc=5",
    "date": "2017-01-24T08:00:00.000Z",
    "dateFormatted": "24/01/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA issues import ban on Ajanta Pharma’s Kamagra tablets  Mint",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "641b37fef5880592944824a31d44fd68",
    "title": "Wockhardt gets import alert from US FDA - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2016-08-06T07:00:00.000Z",
    "dateFormatted": "06/08/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Wockhardt gets import alert from US FDA  Business Standard",
    "company": "Wockhardt Gets Import Alert From Us Fda",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "e1ef25a282becf2b8a9e326baa36d772",
    "title": "FDA lifts import ban on Chinese API to prevent shortages - Generics and Biosimilars Initiative (GaBI)",
    "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUkwwNjJXOVFRemVmZDhpZFkzSUF5RDVUQVEtMEVzVU0xSXg4MVB5RVYzRGlKZm93NUFERkY4UnlGZFNpX08tcFlNSi1uYlFtNzNhUTNkRzdwZndVejMtTG5ZbkFfbi1XcU9fVy1qMEZnMllkSWczcHF4cl9TejBxWGN4eUNrOEoyUVA4d1UtSzZXVHN4eFpvVW9jVmZXWmZoX0hGMk5BU3lWVWJUMzVrb09uei03djlldHdVQ0RCTFdZRFlMUmZocg?oc=5",
    "date": "2016-03-18T07:00:00.000Z",
    "dateFormatted": "18/03/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA lifts import ban on Chinese API to prevent shortages  Generics and Biosimilars Initiative (GaBI)",
    "company": "Fda Lifts Import Ban On Chinese Api To Prevent Shortages",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "9a9d5955b9e498a4b27dd3f54b553d55",
    "title": "Ipca Labs: Under pressure after US FDA import alert on Ratlam plant - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2015-01-27T08:00:00.000Z",
    "dateFormatted": "27/01/2015",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Ipca Labs: Under pressure after US FDA import alert on Ratlam plant  Business Standard",
    "company": "Ipca",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "2c30ae28dad245f0ae48d49ec4906d5e",
    "title": "Import Alert: FDA Working Toward Consistency, Better Decision Making - insights.citeline.com",
    "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOY1hZTlU4LUNSa25NZVZjZFdSaXVtc055cWV2U1VjWnBlRG5kclVGbDFBU0dUVXY1SmhfU1I3elc5NWo5aWo4VXlhOUw5aGZyVl9IOHVhcDEycDlLcU5GeGpialBxNC12d0ZCYmtiNHFlNllkMVdaQ1J6MU9FZmxpbGFqVWpfVXFpVkRrZHdITVBEcnFIWHRLUE03ajBqNmJZcUMxaHNqZHVwT3BlcmtVQXZCbDhnZ1BlSVBTVE5rekJkcElsb0VhS0V2MkV5Z1Fkc0dv?oc=5",
    "date": "2014-10-12T07:00:00.000Z",
    "dateFormatted": "12/10/2014",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Import Alert: FDA Working Toward Consistency, Better Decision Making  insights.citeline.com",
    "company": "Rx Import Alert",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "08c52415dac60815242c841f0109d2d7",
    "title": "FDA import alert for Sun Pharma’s Karkhadi plant - Mint",
    "link": "https://news.google.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?oc=5",
    "date": "2014-03-14T07:00:00.000Z",
    "dateFormatted": "14/03/2014",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA import alert for Sun Pharma’s Karkhadi plant  Mint",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "4a88bc01db26672815864584a25baa4b",
    "title": "FDA imposes import ban on Ranbaxy’s Mohali plant - European Pharmaceutical Review",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPYTRMRHUyRGFvR2pvelV4b2tZUjJHUkRFd1dSMGxaLUsydndjaFo5NjR0VGlTa2M1UDVjcHBicWFRM3VjaFJCUFY5cDJURU1LTWV0cU1rY0FkMnlqM3ZvMVF2MmtPSlFFX3l6S25RNUxuQUIwX1ZKMFFMelE4OENucnhwZ0xCcTJZeDRVNUpBN0NnNTlxNUhvbVp2WlFjMWVveTRN?oc=5",
    "date": "2013-09-24T07:00:00.000Z",
    "dateFormatted": "24/09/2013",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA imposes import ban on Ranbaxy’s Mohali plant  European Pharmaceutical Review",
    "company": "Unknown Company",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "d33029095586b000faee1180b9df5930",
    "title": "US FDA imposes import alert on Ranbaxy drugs - BioSpectrum Asia",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNbWJNbFExWXV3eFBCVlBaYmRhVlI4QU54N0g3LWRCT2pHRV93d0ZWVjZaQ1BtRFgtMC1ESk82SUNiTF9DNE02eWQ1SVdTRmxyS3ZVcUIxZjJpei1rdmZkQXB5MVh0SEkyWjRpdUFNaXEtcDdiOTdyZ2ZyU3lmQ3lxRkItQ0QyR0NKaVlGOGNmV0JLczQ1cFY0S0REN2EzeEtiT1E?oc=5",
    "date": "2013-09-17T07:00:00.000Z",
    "dateFormatted": "17/09/2013",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA imposes import alert on Ranbaxy drugs  BioSpectrum Asia",
    "company": "Us Fda Imposes Import Alert On Ranbaxy Drugs",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "bca1b27bee6e93182fbfb48265d78433",
    "title": "USFDA issues import alert on Ranbaxy Laboratories' Mohali plant - Business Today",
    "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNQUo5bThjbnAzeHRxbTN6aXJCMmlyb0RSams5R3hnZm1Dc0N2NnE4eXluTGhubHhSLUd5Vm9vNDRsSWk4Y2ZOM1RBaXo2Q3VmMGZSb2JmaTYtWFVSTVJMVFdRZ1Ffd0lucEExSFFETUNKNDY1VU1TQS1wMUFwYkdLZUo5cl9QeVVtb3dhMVBIbHhuY0MwaGNBWXdxSW1McGxqVDZxbWVjLW4zZDE1SWk0bkZMVnNBV1ozLVNzLTNpNHBfQQ?oc=5",
    "date": "2013-09-16T07:00:00.000Z",
    "dateFormatted": "16/09/2013",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "USFDA issues import alert on Ranbaxy Laboratories' Mohali plant  Business Today",
    "company": "Usfda Issues Import Alert On Ranbaxy Laboratories' Mohali Plant",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "cc431828005ebeb168ba9b045c878ae2",
    "title": "Dabur gets US FDA import alert - Business Standard",
    "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQbFpyaDEySVl0QXRWNWdBZnJJT0VNWGI3bWlpM1RkOHV3ZndVMzdKUTA2S3pac1J6ZFpQZzBCVUxsLTZkYVM4ckJ3ajhkeVFRZWtIcGdNdXRxYnFTbDlscHZoZHNYQlNNaXFIZC1VZkZpM3dUZFgwalptTThEMXJTT3NZX2tVVEJtNlVjX1ljTndLTXlGLVNYZXJ6MHFLN2hiMmlCQtIBqgFBVV95cUxOak5SWjVkSExoS1FYdnlIalFuLWJ4RHh5X3Rjd3M3d3VIb2ZicUdVQkhscEp3S2FYbU1jd0dHLUVId19wODBjamxLMkU0cEtURW1WczNhMW1ZWkJfem1PeUN4Z1lydmVvT1ZPM1J4Z083RHFVUjJDd0RFX3lTam9mR1A2cUZ6UXZQbmotOXc1YW1QQm4xd1AyZ0dfcDNvcTBCck5YMl95QkRaUQ?oc=5",
    "date": "2013-06-15T07:00:00.000Z",
    "dateFormatted": "15/06/2013",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Dabur gets US FDA import alert  Business Standard",
    "company": "Dabur Gets Us Fda Import Alert",
    "types": [
      "import_alert"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "c52f5d313d8fe23ce77ea28bf61c85a5",
    "title": "FDA Requires Federal Oversight of J&J Plants After String of Drug Recalls - AboutLawsuits.com",
    "link": "https://news.google.com/rss/articles/CBMiakFVX3lxTE5rMW1mR001M2hIUnJfd3R1WXprX2xGcE12cW1sclJXYXR0TGJ3MTcxbmRHQkVRTGRObUZ0Q2hJLUs0aTdpZ2t6X1NyaWhEZGp1OVY4U3V5OWM3cWRTaG51T1ZhTU0ycmg2WVE?oc=5",
    "date": "2011-03-11T08:00:00.000Z",
    "dateFormatted": "11/03/2011",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA Requires Federal Oversight of J&J Plants After String of Drug Recalls  AboutLawsuits.com",
    "company": "Fda Requires Federal Oversight Of J&j Plants After String Of Drug Recalls",
    "types": [
      "recall"
    ],
    "severity": 7,
    "priority": 3
  },
  {
    "id": "f90756d10a45db7b12a07b1d8aac6bfa",
    "title": "USFDA issues Form 483 with 8 observations to Aurobindo's Telangana unit - The Economic Times",
    "link": "https://news.google.com/rss/articles/CBMi_AFBVV95cUxOandHTGphc2JfNWV6N1V4eEpsR090a29QWWxwOWVGVlF0ZV9fZXRJSXZERXpqZDNIcXRiS3owZWNJaVc2QzhGblFUWEFmU1lFa1BNdng1RnMycmZFWENDR3pSYW01SXBhYnh4UlZ6U1RTQUxob0VmZGJiUnRHamVIeXJrYTZzOC16cG4yZFU3MnpxV2RGanFYTkJCbGRLSmlvaFhrTTRFdFNYbU01ZE5vODhPVm9IUHRjLU05S3U2UE9FY050Q3FVVGppQW8tSXZDcmRLa01vT1RJellYcGN3NlVZbjhqR1FzclZsN1p0akJCQUxHMnhOc0dGbVrSAYICQVVfeXFMTVltYnc5UFhyWE9mZjF2UkwxWElRejNJWGNuV1hJQ2plTTYyX3VkeC0wSmxXVlNmblF6eWtLZjhZdW02d1ZEMVQ5b0NVVmNCczhZVFZYX0pUdW1NRlB4RjhOOUMyV0lMdHFnc0JSLV9lSkF5UUpEdEdzbE43Q1FERmc5ZG50cDhlZzl5QmJ5T203MFVvUWJzTll5eGFTeVMwYmhrQjJmX0JEeks5Ri1IOWZmeVNiTTQtV3daWFRXZHZXSmV0U3pqamw2YUNtc0lSN3FLdjZFT2J4QnU3aUx3VGFobWZWWjljME5ZXzV2cTRqNEVzWmRrWGw4WkxMVG0xcXFR?oc=5",
    "date": "2025-09-05T14:59:30.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "USFDA issues Form 483 with 8 observations to Aurobindo's Telangana unit  The Economic Times",
    "company": "Aurobindo's Telangana Unit",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "750c7e68863042ce270451f9d9b7236b",
    "title": "FDA 483 Observations Highlight Ongoing Issues in Quality Control and cGMP Compliance - geneonline.com",
    "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOeU9EMEZNc0kxSG8wekZiUWtmWVlxVHNhelFmck9IYlcyeFhBYl85UnJqWUh3M0JDNW00UWVnZi1BNENYdFBaRzRlcm9jeHp5MHphTGE4R1dWTGRMUnJLWERBZ0FOM3A1U2dISjU1VXMxNk9iemx1VnF4U05PZmdPVzNPT1BaYUtGeVZVM1drOTZsT3VwakpsS3ZKUUZZMmViYzMzajFISnBKQmdTM2h2XzJB?oc=5",
    "date": "2025-08-28T14:08:33.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA 483 Observations Highlight Ongoing Issues in Quality Control and cGMP Compliance  geneonline.com",
    "company": "FDA 483 Observations Highlight Ongoing Issues in Quality Control and cGMP Compliance",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "9418757a0cfdb17430076f35434110a0",
    "title": "A Shifting Trend In FDA Form 483 Disclosure Obligations - Law360",
    "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNbjc4YTFOYWxET0dKcVZzWWdZd2dVWW55bzN5Q0djRlBYdk9Jd2JnQUl1M2lqalU2TVJ6d3RJbzcwMWthckc1OGFjejRuMEpJM0o0VTRFcVRnclVaVEFQeTJrQnFmUDFSMGROLUV1WmQtbllqVmJ6OW5rMFM1eHd1cHVkVWNfWVlPcVZNNGxVR0lld1RXLUxpTFluNlo2RU8wTFh5a19XTHF3YVVoVGFwRlhFS2stVW_SAXJBVV95cUxNN3ZYQlVIQVgtb2d3MEVsSmZyQmJqaFR2MktlbnF5MGpDVXByQUthaUNqRTFxUGgzZklraTdhLWRHai1vZ0FZS191OFZaWFlNQ1VBZWE2VW4xY1VhSnJ1QVR3SFR6YzgtSG16WThyaXFlbXc?oc=5",
    "date": "2025-08-22T21:08:00.000Z",
    "dateFormatted": "22/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "A Shifting Trend In FDA Form 483 Disclosure Obligations  Law360",
    "company": "A Shifting Trend In FDA",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "aa6e483d23aa85cce2b4faa543fbd291",
    "title": "Novo plant acquired in Catalent buyout faces renewed FDA scrutiny with Form 483: Stat - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbHR0a3hLWml2bzhKdWl0RWszdXM3ZlQ4THY1LU05SkwzU24tbDdnaHpQeFFOSTRBemxUeFpPVWJWWG5PVWlpYmt2MFpfcXExdGk5MEVOSnFzVElGU2JJaXlEbHVGRUxiVXFvaFdPMzFrUnVMT2ZXc3FDNGJNUmpYTlh2NndnR0ZpTDJHN25TYy1PcHRPTnplVVpQc0ExTl94NHNsVHFUZzNzS2VEeVZDQ0Zjd1liNFlpdVpB?oc=5",
    "date": "2025-08-22T07:00:00.000Z",
    "dateFormatted": "22/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Novo plant acquired in Catalent buyout faces renewed FDA scrutiny with Form 483: Stat  Fierce Pharma",
    "company": "Novo plant acquired in Catalent buyout faces renewed FDA scrutiny with",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "01e53b327859430e5c2d350e7f2d6916",
    "title": "Dr Reddys Gets Form 483 With Seven Observations From USFDA After Inspection At Andhra Unit - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOOFByMHpFSDBaTVpURTd2ak0tY2Q1QXFMa0pKajA2WWJOTUxOalV1MklJRktfWkZXWjdYOVlpbWFRN2VQUW1NdjBSRXlzcTFGWVRaNno5cnhjTkRRajRnRjFraFZqRkdQc2t0NHdRWm1rME1lVWZNa19md1BHbGloSmQ5NUlDUVVrSmRwSXBaSjNycGdleUVVSzBjWXZJbFU4SjUxRzdnZXYxSFJGaDdpLXc5ZTZReWR1aWdIMC12NC1BaTk10gHKAUFVX3lxTE5HNG9CVVh3S0VTWWhrTWpPdmNMQzFHZnZ2Z3pRZ1JieExCUzV3ZDYwS2NDa1JHNG9Bck1aZVFvaGRERUp3TGRRMm9OZF9jOE9Uck1pc21iREdGM3BmN3JJUWpwTFJjWHJMeUNSRUtXRWxTZzd3dTlFa1lTWUkyNG1rTVhsQ2RYWXVPOXBPMXFBdEJuMi1UbWI2b2RJdlhDMS1iWS1HcnhueDhxWTNtSDVkUmdDV0FNanBUOXJkWFpzcVUwZ3BZaV9KVlE?oc=5",
    "date": "2025-07-18T07:00:00.000Z",
    "dateFormatted": "18/07/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr Reddys Gets Form 483 With Seven Observations From USFDA After Inspection At Andhra Unit  NDTV Profit",
    "company": "Dr Reddys Gets",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "b71d4aa98d974b16afb49c9f0c3e779f",
    "title": "Lupin receives Form 483 with 4 observations from USFDA for Pithampur unit-2 - Indian Pharma Post",
    "link": "https://news.google.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?oc=5",
    "date": "2025-07-18T07:00:00.000Z",
    "dateFormatted": "18/07/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Lupin receives Form 483 with 4 observations from USFDA for Pithampur unit-2  Indian Pharma Post",
    "company": "Pithampur unit",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "dc7c82793037b76edec97579bf94ccd4",
    "title": "Granules India receives Form 483 with 1 observation from USFDA for Bonthapally API unit 1 - Indian Pharma Post",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQdTBGaXNDb1ktYURkZ3FfQjhTbmxnTTRvVlN1aWVfWkZwaURpYmNXZjhmNk91c25ZZ0d0dkZLUDRVek9TVG9UbzE4WUFGaGROQkdJY0t6dW1HbkFkTVNLTUJscm9taU5FMU9NazhoZDBvYkhlcXZzQXFULWxualRsdWNJc2haZ1NXVnZDandCRWtfdkpQMEZzWEFadTJ6MGtqVzNMNEJSZWRJbTBpQ2FWeVlzLXF0ay1tMVpTcE1RMnA1TkdSN1RpYUFpVmM2X3NacnhMNzhYSjlKZw?oc=5",
    "date": "2025-06-23T07:00:00.000Z",
    "dateFormatted": "23/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Granules India receives Form 483 with 1 observation from USFDA for Bonthapally API unit 1  Indian Pharma Post",
    "company": "Bonthapally API unit 1",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "b922eebe6a6f5558065912fdead8a043",
    "title": "NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation post US FDA audit - Business Standard",
    "link": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxNV3Y2eS1EMHMzN3JYVmd4VHItZ2xyQllZTW52N0hMaHNlVDZRSjBTb2F1ZzIxYU1USXlMeHNJTEh4QUFzNzctS2ptYURWUFdIN2RtNTVmREpuWFlINHU3VnBHR0lPWHYwYzNXTUF5a0hWVGMzdXgxTTI3NGd3YThONkUzdXVhZWxLYTRBOFNXVENCRmNHSXloUGdEa0RiMG5FSlRtSEVTX0hQcHJNMFBuaWctSUlnQ1RUQ24wTWRVajM3U3hBMF8ta1Qwd1hsS1IzdWxTVUp1VlFkWE8zbVhEeEtSLVQ2T2sxUjhHRGVQZ1RfTjB4OG5ER1BR0gH_AUFVX3lxTE8yTUJ4N0xocHZvdUFXOHR3aEJhdUtPRmJ4WUF0aF80elRXc2RZV0hVMURFeHUwb0QzeGFmNnFOOExyakhJU3djVDNESXR0VXZCY0xxTGVpYjhIYnBFNWNwREhDTEw3M0JDd1FabUVJQ1RiRzEtbEFDU2FkRXRjb044eXN5YmtTTkU4YTZwVXp5ZkpKTXh5OVFhNGxWMF9xakQ0UnhaVmhVd1JYOFBvZ0tKdEdRYUFrVGMybDJqbzM2TG1zVUJFT3BYRGFCV3huRFBQRWhfSm10MnZkWE1LdlNMUm15b253ZFpaTHA3RzlpQzFHTWREYWk5TmZFaUhmdw?oc=5",
    "date": "2025-06-14T07:00:00.000Z",
    "dateFormatted": "14/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation post US FDA audit  Business Standard",
    "company": "Natco Pharma's Hyderabad",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "e453f68b6fd5f9107c4c27d87dec1641",
    "title": "US FDA inspects Sun Pharma’s Halol plant, issues Form 483 with 8 observations - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-14T07:00:00.000Z",
    "dateFormatted": "14/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "US FDA inspects Sun Pharma’s Halol plant, issues Form 483 with 8 observations  CNBC TV18",
    "company": "Unknown Company",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "4d6e17274fbc033c96e2e3e96332a3ed",
    "title": "Dr Reddys Labs' manufacturing facility gets two form 483 observations from US FDA - Business Standard",
    "link": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxPODYzUlZIeXpuOEJEdVNCQjNNc0d5U2d4T1N3V1lTVGJhbDh1Z0ZrY1BvQjJzX3JxYjdBZk02Y3BubnpONGdGeWljaGFvSHoyNWRRYktwZXpSRzIxQnRHSWZWUUJjYVRuR3h0Y0lJSTJ1NzZIb0cxOHoxMVZneDBKaFJITm9kYzNrc3lVZFVqNnoyZTlxOUN1OS1KT2RrYS1TSmtDMlYxMkZHX3I0dGMwa0czT3JwajlNUUZXbHJNWVI0S0RhaE50Rzk2WFNDbXItb0gya2c0di12Mm5Udy1hdnNzQUlkRENycXR5ajhRemtJTkZH0gH6AUFVX3lxTE1HRVVRMUY5V1RMZmJpWTZpMjZpWXdUY2RCRU5Zamc5TmN6b3ZUcVcyX25ObV9YbEFia3c3ZHBPTzJVenlTUXNQYUluMEJoV1hhZVFaMGRRSFhyUWpMU2h4V0xWUk9mTmdCbU1jLWdUU1d4SmdCRzlKVGdNdGVEZmV2djU5Z1lCS285bFdHa1dCZDdHV1FCZEJDQVp3OEpsejd2WG0zUk5NU2dSYWtPWFpjdVNQczg0QzJwNmhqWElweGhubW5QODM5Mi1odHRvT1owMjRaUDRGRDRYQTlCTVU4bGI0Ujl0UENLb2Q5MHBhWG9qaDZwR1JUblE?oc=5",
    "date": "2025-05-26T07:00:00.000Z",
    "dateFormatted": "26/05/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr Reddys Labs' manufacturing facility gets two form 483 observations from US FDA  Business Standard",
    "company": "Dr Reddys Labs' Manufacturing Facility Gets Two",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "c981c4cfec39fccca44a939b56f25a19",
    "title": "Dr Reddy's NY API plant gets USFDA Form 483 with 2 observations - MSN",
    "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQbjZjajl3ZjVoRk5BYV9nUkdRQ0twV1hVVFVJYWVmWG9IblJxV1ZQY3BCQklGSDAzWDJYdDJxT0hjLUtGX09fX0dNY2wyUVcwYlMyZzh3TW16ek0yWnhHU0x2cXF0S285WVpSWkZGblVsUU9WR0c3a25yLUpXeF9wVWxudENNaVZNMXd4NFJpd3lDbHZzVGtrajVXek1WbHF0clRHX3ExZjNOQThRZ3cyWk8xQWt5MzlkUXg1RnhVRjdfcmxfcnpMamI5aFVZaHN1RUI2QThUdWx1NFZB?oc=5",
    "date": "2025-05-17T17:34:26.000Z",
    "dateFormatted": "17/05/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr Reddy's NY API plant gets USFDA Form 483 with 2 observations  MSN",
    "company": "Dr Reddy's Ny Api Plant Gets Usfda",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "00f9d2df4bde09658e542e7d8d84d89c",
    "title": "Dr Reddy's NY API plant gets USFDA Form 483 with 2 observations - The Times of India",
    "link": "https://news.google.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?oc=5",
    "date": "2025-05-17T07:00:00.000Z",
    "dateFormatted": "17/05/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr Reddy's NY API plant gets USFDA Form 483 with 2 observations  The Times of India",
    "company": "Dr Reddy's Ny Api Plant Gets Usfda",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "5a401fd873ce8f7459cc2d834d78def8",
    "title": "Aurobindo gets Form 483 scolding from FDA at North Carolina inhaler plant - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQdUNLZzdXMDZhVExlZlNXeldtWWk5RHpQTHpDQ3l5S1JqckFNNmtOUFpUX3NhU3RnNVB6ZFJ6S1U1VWItNkY5a3NuUFFLaXFENmx1WDByMmd3RkR3cmxGS0xBUkY0ZFNoLW85aG95ZlRDdUZqMzZBQUZTRC1DRGY1MzBMNVUzbFNJUmUzVXlTNmdHa29jTzVQd0lTNWtmQVdUb3FMRDdRNW9pZw?oc=5",
    "date": "2025-04-14T07:00:00.000Z",
    "dateFormatted": "14/04/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Aurobindo gets Form 483 scolding from FDA at North Carolina inhaler plant  Fierce Pharma",
    "company": "Aurobindo gets",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "4eb4abe22414de65649660102972d057",
    "title": "USFDA issues Form 483 with 11 observations to Raleigh plant of Aurobindo Pharma arm - The Economic Times",
    "link": "https://news.google.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?oc=5",
    "date": "2025-04-11T07:00:00.000Z",
    "dateFormatted": "11/04/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "USFDA issues Form 483 with 11 observations to Raleigh plant of Aurobindo Pharma arm  The Economic Times",
    "company": "Raleigh plant of Aurobindo Pharma arm",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "5b98daece86da7b1e029f10e6983ba5b",
    "title": "Aurobindo Pharma's Aurolife plant in North Carolina faces US FDA scrutiny, gets Form 483 with 11 observations - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2025-04-11T07:00:00.000Z",
    "dateFormatted": "11/04/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Aurobindo Pharma's Aurolife plant in North Carolina faces US FDA scrutiny, gets Form 483 with 11 observations  CNBC TV18",
    "company": "Aurobindo Pharma's Aurolife Plant In North Carolina Faces Us Fda Scrutiny, Gets",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "dc214091320eff36862063f686b59ce2",
    "title": "Alembic Pharma's Vadodara facility gets one Form 483 observation from US FDA - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2025-03-08T08:00:00.000Z",
    "dateFormatted": "08/03/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Alembic Pharma's Vadodara facility gets one Form 483 observation from US FDA  Business Standard",
    "company": "Alembic Pharma's Vadodara Facility Gets One",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "ae13ced378690638942b96a866246757",
    "title": "Shilpa Medicare's Raichur units gets Form 483 with one observation from US FDA - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2025-03-08T08:00:00.000Z",
    "dateFormatted": "08/03/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Shilpa Medicare's Raichur units gets Form 483 with one observation from US FDA  Business Standard",
    "company": "Shilpa Medicare's Raichur Units Gets",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "10c0c38afcac539b00e55343fc77d2c3",
    "title": "USFDA issues Form 483 with 3 observations to Gland Pharma's Sterile APIs unit - Indian Pharma Post",
    "link": "https://news.google.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?oc=5",
    "date": "2025-02-27T08:00:00.000Z",
    "dateFormatted": "27/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "USFDA issues Form 483 with 3 observations to Gland Pharma's Sterile APIs unit  Indian Pharma Post",
    "company": "Gland Pharma's Sterile Apis Unit",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "b197720a352f1185b802c47b649d3245",
    "title": "FDA dings Piramal API plant with Form 483 detailing problems tied to quality control, equipment cleaning and more - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUlJZeTVjUGkzaXhRcjcwamh2ZmxIVnFldjgxYVFTMS1TMGhBX2xTZFZQczRkMXhJYVFmNnlTWGpRSkZ2UEN2M1FWb0k4YnJpZERJVE1zQUVpSXVRbnViM1I0OVhTRW1hczdPTDJHMk5MV0VrSUVfWTRDRklkcUYtdEpYWE9HX0Z3V3FyWk9ZU3ZUbDU5bGJQMm5fM0oxcW9Bbm9aOEU3b1cweE80VzdMZFFFWnFES2dESGpN?oc=5",
    "date": "2025-02-26T08:00:00.000Z",
    "dateFormatted": "26/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA dings Piramal API plant with Form 483 detailing problems tied to quality control, equipment cleaning and more  Fierce Pharma",
    "company": "quality control",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "1d9f5ad72fddb9ceee6afc0e2c65de16",
    "title": "USFDA issues Form 483 with 3 three observations to Gland Pharma's Visakhapatnam unit - The Economic Times",
    "link": "https://news.google.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?oc=5",
    "date": "2025-02-25T08:00:00.000Z",
    "dateFormatted": "25/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "USFDA issues Form 483 with 3 three observations to Gland Pharma's Visakhapatnam unit  The Economic Times",
    "company": "Gland Pharma's Visakhapatnam Unit",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "f5ba4f2f7edd131ef0703af2026e50b5",
    "title": "Piramal Pharma declines after US FDA issues Form 483 with 6 observations to Turbhe unit - Business Standard",
    "link": "https://news.google.com/rss/articles/CBMi_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?oc=5",
    "date": "2025-02-19T08:00:00.000Z",
    "dateFormatted": "19/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Piramal Pharma declines after US FDA issues Form 483 with 6 observations to Turbhe unit  Business Standard",
    "company": "Turbhe unit",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "b0001d90936006b2cc691a63cba2c647",
    "title": "Lupin's Somerset -based facility completes US FDA inspection with zero Form 483 observations - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2025-02-03T08:00:00.000Z",
    "dateFormatted": "03/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Lupin's Somerset -based facility completes US FDA inspection with zero Form 483 observations  Business Standard",
    "company": "Lupin's Somerset",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "17c768b3e8dc676011a02afb8ae8b524",
    "title": "Laurus Labs' US arm gets Form 483 from FDA after 'adverse experience' probe - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2025-01-22T08:00:00.000Z",
    "dateFormatted": "22/01/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Laurus Labs' US arm gets Form 483 from FDA after 'adverse experience' probe  CNBC TV18",
    "company": "Laurus Labs' Us Arm Gets",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "98891eb33a3b1e32abf736c00b54bf27",
    "title": "Cipla's Goa-based facility gets one form 483 observation from US FDA - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2025-01-21T08:00:00.000Z",
    "dateFormatted": "21/01/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Cipla's Goa-based facility gets one form 483 observation from US FDA  Business Standard",
    "company": "Cipla's Goa",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "f800b1ef1433269f0dee64589a5f7ef5",
    "title": "FDA Releases Form 483 to Taylor Farms Colorado Springs Facility - Food Safety Magazine",
    "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQNTVlWEdUOXJncDJRT2dBZkc2WTZJaEwwVUVob0M1S1liRnZuN3F5U3VGQ3A1QWVSSTF5YklwUkpfbUwyNl9ZVW1wM2k3OGFUVDhaalVPVV9TRkJnenhuaDNFZS04NDdXMk5PT01rT2hXbXZGRWF3MjJYQm52blRJVDlBSk9PNldOM1BjOTBLNWl1bU1CU01XZDFfRUVEX1AxbktGbGpKVzladw?oc=5",
    "date": "2025-01-14T08:00:00.000Z",
    "dateFormatted": "14/01/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA Releases Form 483 to Taylor Farms Colorado Springs Facility  Food Safety Magazine",
    "company": "Taylor Farms Colorado Springs Facility",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "2aad697fcb766629b4801878313921f4",
    "title": "Dr. Reddy’s API unit issued Form 483 with 7 observations by U.S. FDA - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2024-11-19T08:00:00.000Z",
    "dateFormatted": "19/11/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr. Reddy’s API unit issued Form 483 with 7 observations by U.S. FDA  The Hindu",
    "company": "Unknown Company",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "d544de7a1676242c1b15525ac615e4fb",
    "title": "Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2024-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility  Business Standard",
    "company": "Bengaluru facility",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "6fea6ef6109ed903a4d6c5cfd87dd984",
    "title": "Apitoria Pharma gets Form 483 with 10 observations from USFDA - Indian Pharma Post",
    "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPc0E4a2cwYTl0YWs5YUJxa3lvTlQ1RTdrcGpnTVNXLUVXSW1XbUVzWjBlUDhWZmtHTlBiemJaOTBRZ2lleFFTWGRPenNSLUk3ejYxVXdBd0l5ZWJIRnFQcmhla2t6bzBCYUNxVURDZG5uSXRzWHN0R2pGZWQzNlFJLXQ3YUJ4S0xua0ZjMk41YWlqQUVBYWptVDlwSmJSeHp4dzlQVGVUZS12MDc1LW9PZVBfdETSAbsBQVVfeXFMTXdkRmNVUGZhYUt6MFdHZzhNOWVZd1lKdEFDa1FiZVBlNHdvQno3SjFEWm5odmlUWHZ3NkVqdFdCdFZ0clpEaHIzWXhzN092SUdIdlVqQ0NDMlpCRXV3dWNZaS1wVlZQZzJ3cE1TZHliUUdHTENvalN5Y0FUY3B5Qkl4UlZvZ0xoN2EzLThqWWg5RFFEUjVtNzlhNUlVMndNaHdhRnJJYjZwUTBYWjY3UjlpX3ZzNWV5YkY3MA?oc=5",
    "date": "2024-10-01T07:00:00.000Z",
    "dateFormatted": "01/10/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Apitoria Pharma gets Form 483 with 10 observations from USFDA  Indian Pharma Post",
    "company": "Apitoria Pharma gets",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "9d792bdab5222a541f9e17b4d8b1cd30",
    "title": "FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRFZDZXhpX2U1U2RjMHN1c1B2WGY1aVIyNExmOEo5TGE0VDlQTEJfcVVwejNza0JjdTN2Y1I3Qk1jQnZ4cW4zOTRRWjJDTWVjTTNXbl9JUXU3dW9wNGlYSklOR1BOcFlCT3JRLU5xWC1vTkFSSUw4cDJUbXdlUXVCTy05UG1mMzZEVll0LVQ4SnlSWjgwOHZNbV9KRDkyMjlRd1gtX09nRVhZZTA?oc=5",
    "date": "2024-09-10T07:00:00.000Z",
    "dateFormatted": "10/09/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections  Fierce Pharma",
    "company": "Japanese",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "e07e1bf12e0df6c571ff29ad0e7d7a04",
    "title": "API maker Global Calcium stung with Form 483 filing after FDA inspection of Indian plant - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPOGVwY1NZaktiWnJxNDEySjlsRUQ4dS1ENW1maHF5dEN6V2syVjZQQzFVQ3BYclFHcDNGNlBuNmxGeFVRVk1wTjVfOG83Q3FzSUNtdDBJT0RBeUhnN0JaTm5UTXpmOFJEbmRoNlYwcHJvaG45TnJ6Y3RHaDZCeWZ5ZTJVM3hjcl9tVF8zTG1qWXNIUFJid1hObVhaQmFkNnowQ2VrTldtQnB4TVBBNXhuc0s0dw?oc=5",
    "date": "2024-08-29T07:00:00.000Z",
    "dateFormatted": "29/08/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "API maker Global Calcium stung with Form 483 filing after FDA inspection of Indian plant  Fierce Pharma",
    "company": "API maker Global Calcium stung with",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "e81e78baa5c8e639a64f6898d66b8314",
    "title": "That Time FDA was ‘Unusually Thorough’ on a Form 483 - Medical Device and Diagnostic industry",
    "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPUDV4YWgyWHZ4YmNWYk8ya2lxSFNZMWozR3JmakNGU2QwSlNmOUQ4eVRjYzM4dWRTXzJaTTl5a0t0eW5EbDl1NkV2S3I0dDN2Zm9wTEl5cG9IMjRUdW40OUVSak1ULXBXdUYtdzd1MWlBRGx1RjJXQ2dYY2w5X0k3SngzQW5jNExrYjlB?oc=5",
    "date": "2024-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "That Time FDA was ‘Unusually Thorough’ on a Form 483  Medical Device and Diagnostic industry",
    "company": "Unknown Company",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "a8b5b959b6ab99ebb9e547f0c35cc598",
    "title": "2023–2024 Trends In FDA Form 483s For Pharmaceutical Formulation Facilities - Pharmaceutical Online",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNRUFyTmtXYWsyTWRvX29VU1pkTUFKSkQ2amdscHQ4b0lSTDRjSVNaLVhhSEduVEJOOE5zZ2kweEFfM3JWaXFHTG5GaEdLTGZYS01NSVdURzJXXzJybVdIU2h5NDNqU2JzME5BdUgzVk16QXB1ZG5tZnhJdDlOVFRWY05IYzBOQlBrdmdrcjR0QXBhZ0VVTGdFazZueFVkcktVRnRza3c0OTFQU25GQ0pSeFFEclUtMzlMZzJGRnBB?oc=5",
    "date": "2024-08-01T07:00:00.000Z",
    "dateFormatted": "01/08/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "2023–2024 Trends In FDA Form 483s For Pharmaceutical Formulation Facilities  Pharmaceutical Online",
    "company": "Pharmaceutical Formulation Facilities",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "22cb9b5bcb5592d552b11405ca5dcabc",
    "title": "FDA flags 10 observations in another Form 483 for a Zydus plant - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxORTRTdjd0QmlpWWxyOE0xODZHdlVYanJtNkUybmVSTnhoZUtKVUM2ZFRSRXZzX1VmNE5JdHI3TmhZZTk0a193QTdyY0hKVTBSSjY3c21YQkpVTllDSXdUSGlfNV9OQVdXUjM5SU1icDFJWWtWM3BMQVMtSDVGaWtBQ1NkX2t0VXlLY2hzQjhkc25LNFFFcmZ0WnNTQ2JCQQ?oc=5",
    "date": "2024-05-06T07:00:00.000Z",
    "dateFormatted": "06/05/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA flags 10 observations in another Form 483 for a Zydus plant  Fierce Pharma",
    "company": "a Zydus plant",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "ec03420c13143893cb2ddbe0e7bc55e8",
    "title": "Piramal API plant in Michigan hit with FDA Form 483 write-up - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOa0NYYjJTU1JqZElDOEs4UmRJajRJSll4TE0weU5Sd2NHNnd3MUoxZW9ubHdUX19vX1dqZ2U5VHRmekpDYU52M2V4cEtzM1FQWnB0VkhRZjIwT01fM0hFcE1Cd1VzT0VLbXp6bklIb2RHVWFOMmlyZy1Ud1N1ek1SNXE3c3RFM2ptNkJDUUhkd3JMM3lad2c?oc=5",
    "date": "2024-02-09T08:00:00.000Z",
    "dateFormatted": "09/02/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Piramal API plant in Michigan hit with FDA Form 483 write-up  Fierce Pharma",
    "company": "Piramal API plant in Michigan hit with FDA",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "7f89873eb4ad6c5a83f950b9447d01f6",
    "title": "FDA slams Eugia with Form 483 and posts older reprimands for AGC, Baxter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR2lJNDJYc0N5QUMyWi1HdjVMSlRIVUtqOXlDY2l5ZlF6Q3kyd0lEQVFnckRrelhBYmo2N0thblpwTkwxemJmWFRkNlR2NnNrbl9odlpXRmpFYk0weDJ2ckxqUzd4NnhKQ3VNcVR1V0lPZVJrdlczMFk5dC1FN3J4QjVkdGhDWi1IWk9oWW1IR2FTT1BxTVZrTE1zakZDamdWY0hTeWJhZ3Y?oc=5",
    "date": "2024-01-31T08:00:00.000Z",
    "dateFormatted": "31/01/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA slams Eugia with Form 483 and posts older reprimands for AGC, Baxter  Fierce Pharma",
    "company": "Agc",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "a44a43f684cacc91533c242258ce4929",
    "title": "FDA slams trio of Indian drugmakers with Form 483 filings after December inspections - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVS16dVlxMldRdUJWNDJVRG1Sc3QydmtUSDQwOUFqamViaE5ROTBGRjhiNWR4cGpSSmVHVk05Z2I0bE1sQ1Fvd0dMb1pkZkVfOUR3V0pQRlpzdU11RldzN005a2R4aURwZ1BXQlF2cFY0M1h2VXNaUkl2VDl0ZDhXakotWW1DQlpqd054bGZla3F3bW1vMzlyYVFPY2VlMm5fNEp5SHljTkRQendxYWN4LXh3?oc=5",
    "date": "2024-01-03T08:00:00.000Z",
    "dateFormatted": "03/01/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA slams trio of Indian drugmakers with Form 483 filings after December inspections  Fierce Pharma",
    "company": "FDA slams trio of Indian drugmakers with",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "76f5d2131e9ce99a7a4e0e3f09b1e55a",
    "title": "FDA hits Torrent Pharma with a Form 483, citing 5 observations - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQMVRfMW1odTNyNTBRMkR4bnFoZEs5WFdnNXJkX1RrSzMzNjVzVy1hWWRBcktWX1hMQXZnT2h5Ym5LUURrV0JrUGZXa2FPd3ZCc0VQYzhULTdabjZPaG9HdVd1NGQ0Q3RYU3lwN1J1dEFUdWVsU3BWNEszcDJ3VUtvamx1Y0RnRWFHaGVyT2c3amM5Vl83ak5rVWZZUktOTTRmZ0E?oc=5",
    "date": "2023-12-13T08:00:00.000Z",
    "dateFormatted": "13/12/2023",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA hits Torrent Pharma with a Form 483, citing 5 observations  Fierce Pharma",
    "company": "FDA hits Torrent Pharma with a",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "5e420e1a1fccf32d9e557a6460d19735",
    "title": "FDA puts New Jersey drug ingredients maker Spectrum through the wringer in scathing Form 483 - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQU0JFWlBzYnRLcHQ4VUNmRHFRbVFlSnBySzhHMllXTlRaelBMdVk1WkpHVGoya0VNWmVVMTFyN1huc2llaTBGZGFBaTJmRWZSTXRxZk10bmF4NGhjTzdESFNhQ2tWbVZhMlk0MjVLUHMwTUtQZ0xMbVB4TUFPRjVyWEF0OWtnRFZyTHVrQ1lYandpRVNvcnBRWjJUbjdXRzFPeVlzdEhrWGxLUFBKdUlqNl9Zbw?oc=5",
    "date": "2023-10-11T07:00:00.000Z",
    "dateFormatted": "11/10/2023",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA puts New Jersey drug ingredients maker Spectrum through the wringer in scathing Form 483  Fierce Pharma",
    "company": "FDA puts New Jersey drug ingredients maker Spectrum through the wringer in scathing",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "2902bc7d7305c7eb29cef9beb4d0f5fa",
    "title": "Alembic hit with Form 483, citing 4 observations at Panelav plant in India - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNVlBZemFGZmV0cjBwZ3ptbEUxbGhoSnJ6bmZESXNQS2xPR2FzOHNkMGNhT0IzLUZHSjc4eGx2SEg4QVV1N2hWNmswa0F4V0dEdkFLZjdfRFhTTDkyZ1BNWnh1cFgteG9BXzNJQXltUW5EbFQwMVR4MmNKNzdQMzZxT2xQTlk3WDdhSzk4MmRKZjUzcDJxcGhHbmRac1FHZE9RTW9hS3E3dURoT3Vwa2RZWEZLTGJXNVZYVnc?oc=5",
    "date": "2022-10-20T07:00:00.000Z",
    "dateFormatted": "20/10/2022",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Alembic hit with Form 483, citing 4 observations at Panelav plant in India  Fierce Pharma",
    "company": "Alembic hit with",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "e5fc5b4fa2d5ce60ec01511fe749741b",
    "title": "FDA FY2020 Drug Inspection Observations And Trends - Pharmaceutical Online",
    "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNSGdpeDRlNmR1U0R3NW5YMkljdHQwNHVkNjRqMHN2M3hCZ2dpdFFuNldVM1c2bmpSOTNjcC0yUW1QVWp4UnN1Y3dYRmFXb0ZDRmotTC1pOXY5Wnh5QkMtbV9iX2FGWUtIRWJGS2xFbHlzY2pIQlFWaWNyc3hIWDAtXy1rSEdjNGVuMFpRQ3FlRm9MUjZKZ3Jv?oc=5",
    "date": "2020-12-09T08:00:00.000Z",
    "dateFormatted": "09/12/2020",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA FY2020 Drug Inspection Observations And Trends  Pharmaceutical Online",
    "company": "Fda Fy2020 Drug Inspection Observations And Trends",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "0d3669831ae29e8b1d37fe3ad38737b4",
    "title": "FY2017 FDA Drug Inspection Observations And Trends - Pharmaceutical Online",
    "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQQ3BsXzNPcFIzY1Aya1FJcUlWMUhmRVZqV0JvWDNmWkd3VWtyeElVQ0NCdFJHNUVnZnRzWlBPc1c2NXoxS0JPTFNmWjVFb3htTHhieURHazFsTkRIYkR6U0t2dmxsZC0yVk54b05SSkRSU3dndDNZYkhKVW1nZko2QjR3b1d0dDJmVlJmTjE2SGRHUDVIUWw0?oc=5",
    "date": "2018-04-18T07:00:00.000Z",
    "dateFormatted": "18/04/2018",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FY2017 FDA Drug Inspection Observations And Trends  Pharmaceutical Online",
    "company": "Fda Fy2020 Drug Inspection Observations And Trends",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "f524fa7e1fc54d5dcf7ed0924e9ff444",
    "title": "US FDA Inspections in China: An Analysis of Form 483s from 2015 - Regulatory Affairs Professionals Society | RAPS",
    "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOdmZlN2FoYjk2UlBZNG9JdW9uZENla095VUdGamZtQ0lNelVEOG55UnAtMERuME1GYjVRcFhkQ21Pc0ZobHczUXNVR0p3MldyZjhjSHB4ekJWUEpDX01keUh3N3dKUW9ILWhGTDN0OWhhNGhQZ0xyaHlSc05hbVBndWxFZDhMSktkR1Zla0kzZ3YzRnFtcHpYNXFUX1RoSDdSSmdmX2hJQmR1ckdnb3c?oc=5",
    "date": "2016-02-10T08:00:00.000Z",
    "dateFormatted": "10/02/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA Inspections in China: An Analysis of Form 483s from 2015  Regulatory Affairs Professionals Society | RAPS",
    "company": "Us Fda Inspections In China",
    "types": [
      "form_483"
    ],
    "severity": 6,
    "priority": 3
  },
  {
    "id": "183d75dde4fd1d8daadfe6d6c21ec398",
    "title": "INSTRUCTIONS FOR COMPLETING FORM FDA 2253 – TRANSMITTAL OF ADVERTISEMENTS AND PROMOTIONAL LABELING FOR DRUGS AND BIOLOGICS FOR - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAxNUVsUHFxaVMzYnVkMGZkSVdFRDJzeS13SGFobVVSVVk5TmNyNkpueDJRM0JKY2tqQnVWWlF2a1Fja1BBWlduaDZua0FDWVdsMHVV?oc=5",
    "date": "2019-11-01T09:36:26.000Z",
    "dateFormatted": "01/11/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "INSTRUCTIONS FOR COMPLETING FORM FDA 2253 – TRANSMITTAL OF ADVERTISEMENTS AND PROMOTIONAL LABELING FOR DRUGS AND BIOLOGICS FOR  fda.gov",
    "company": "Instructions For Completing Form Fda 2253",
    "types": [
      "opdp"
    ],
    "severity": 5,
    "priority": 3
  },
  {
    "id": "cbdaa6314b5b50774523d4f7f72f49c0",
    "title": "Providing Regulatory Submissions in Electronic and Non-Electronic Format - Promotional Labeling and Advertising Materials for Hu - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9tZDI3aFBOLWpBSFRNSU13OVBZQkxpVUN1WWpRMFl6VDBOdzRydlRwdWhicTNCRHlNNVpfUG5EbW5UUUNsc3RYcGRBSm1ZQU5xX3gw?oc=5",
    "date": "2019-06-21T17:04:33.000Z",
    "dateFormatted": "21/06/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Providing Regulatory Submissions in Electronic and Non-Electronic Format - Promotional Labeling and Advertising Materials for Hu  fda.gov",
    "company": "Providing Regulatory Submissions In Electronic And Non",
    "types": [
      "opdp"
    ],
    "severity": 5,
    "priority": 3
  },
  {
    "id": "6938eeff587d75ba2173b135c572136c",
    "title": "Drugs@FDA Data Files",
    "link": "http://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files",
    "date": "2025-09-08T12:36:13.000Z",
    "dateFormatted": "08/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "e4736d8a9792f230430aebeb7f6a8c41",
    "title": "Biotech vet Harvey Berger steps into CEO role at Arena BioWorks",
    "link": "https://endpoints.news/biotech-vet-harvey-berger-steps-into-ceo-role-at-arena-bioworks/",
    "date": "2025-09-08T11:00:33.000Z",
    "dateFormatted": "08/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Less than two years after making their public debut, the founders of Arena BioWorks have tapped longtime biotech pro Harvey Berger to take over as CEO.\r\n\r\n And he’s just completed his first task by narrowing ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "512822f64494b6d0ae386be489ae0859",
    "title": "STAT+: Biotech veteran Harvey Berger takes over as CEO of billionaire-backed Arena Bioworks",
    "link": "https://www.statnews.com/2025/09/08/arena-bioworks-harvey-berger-ceo/?utm_campaign=rss",
    "date": "2025-09-08T11:00:00.000Z",
    "dateFormatted": "08/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Arena BioWorks, the research institute that launched last year with $500 million from a group of high-profile billionaires, has brought on a new CEO.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "07d7b5242ff750ccd24d823318cc7fc3",
    "title": "STAT+: Rapport shares soar after successful mid-stage seizure trial",
    "link": "https://www.statnews.com/2025/09/08/rapport-rap219-focal-seizures-epilepsy-trial-results/?utm_campaign=rss",
    "date": "2025-09-08T10:55:13.000Z",
    "dateFormatted": "08/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "A Rapport Therapeutics seizure medicine succeeded in a mid-stage clinical trial, sending company shares soaring.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "db7b0a7e78e92f40c69e6e045c2f5cf7",
    "title": "Rapport reveals promising open-label study data for epilepsy pill, heads to Phase 3",
    "link": "https://endpoints.news/rapport-reports-promising-open-label-study-data-for-epilepsy-pill-heads-to-phase-3/",
    "date": "2025-09-08T10:00:35.000Z",
    "dateFormatted": "08/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Rapport Therapeutics has posted topline mid-stage data indicating that its epilepsy pill can cut seizure frequency.\r\n\r\n The biotech's shares {$RAPP} jumped around 130% premarket after the results were announced Monday.  ...",
    "company": "Rapport Reveals Promising Open",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "b4cdcb6388f0a4386826b930231bc57e",
    "title": "Driving precision oncology development: Integrated biomarker testing solutions that deliver impact",
    "link": "https://www.biopharmadive.com/spons/driving-precision-oncology-development-integrated-biomarker-testing-soluti/759259/",
    "date": "2025-09-08T09:00:00.000Z",
    "dateFormatted": "08/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "Driving precision oncology with integrated biomarker testing that delivers results.",
    "company": "Driving Precision Oncology Development",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e678ad7060d6d81399dae8be1ffeeecf",
    "title": "How sponsors are staying ahead in the obesity trial landscape",
    "link": "https://www.biopharmadive.com/spons/how-sponsors-are-staying-ahead-in-the-obesity-trial-landscape/759209/",
    "date": "2025-09-08T09:00:00.000Z",
    "dateFormatted": "08/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "Aligning digital innovation with thoughtful design is accelerating progress.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7f0d4ec89b00ab122d7d9a0154e1a60b",
    "title": "Harnessing the power of AI to detect ATTR-CM",
    "link": "https://www.biopharmadive.com/spons/harnessing-the-power-of-ai-to-detect-attr-cm/758919/",
    "date": "2025-09-08T09:00:00.000Z",
    "dateFormatted": "08/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "From accelerating drug discovery to improving disease detection, AI is transforming the way we understand and manage health.",
    "company": "Harnessing The Power Of Ai To Detect Attr",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6d139c5a89710f4abb2e56ee0cbea425",
    "title": "#WCLC25: AstraZeneca’s Tagrisso combo extends survival by 10 months in EGFR-mutant lung cancer",
    "link": "https://endpoints.news/wclc25-astrazenecas-tagrisso-combo-extends-survival-by-10-months-in-egfr-mutant-lung-cancer/",
    "date": "2025-09-08T08:22:44.000Z",
    "dateFormatted": "08/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "The combination of AstraZeneca’s Tagrisso and chemotherapy cut the risk of death by 23% compared to Tagrisso alone for patients with advanced EGFR-mutant lung cancer.\r\n\r\n In the FLAURA2 study's key overall survival endpoint, patients who ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "c8eb2f13f8be031f13b0157f41a7f522",
    "title": "#WorldSleep2025: Alkermes’ success in Phase 2 narcolepsy trial is clouded by side effects",
    "link": "https://endpoints.news/alkermes-success-in-phase-2-narcolepsy-trial-is-clouded-by-side-effects/",
    "date": "2025-09-08T07:15:52.000Z",
    "dateFormatted": "08/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Alkermes’ narcolepsy drug candidate alixorexton significantly improved how long patients can stay awake in a mid-stage trial, but a high rate of vision-related side effects could cause trouble for the treatment.\r\n\r\n Back in July, the ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "59bc5e9061f2e40bb49a839cc7d9ea88",
    "title": "#WorldSleep2025: Takeda’s Phase 3 narcolepsy results could make it first mover in multibillion-dollar market",
    "link": "https://endpoints.news/takedas-phase-3-narcolepsy-results-could-make-it-first-mover-in-multibillion-dollar-market/",
    "date": "2025-09-08T07:15:19.000Z",
    "dateFormatted": "08/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Takeda has shared detailed data from two Phase 3 trials of its orexin agonist in narcolepsy type 1, bringing the Japanese drugmaker a step closer to a market that Wall Street says could generate sales ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "648329f085793ba6166de4de43106fa2",
    "title": "STAT+: Alkermes, Takeda show encouraging data on narcolepsy drugs",
    "link": "https://www.statnews.com/2025/09/08/alkermes-takeda-narcolepsy-sleep-medicines/?utm_campaign=rss",
    "date": "2025-09-08T07:15:00.000Z",
    "dateFormatted": "08/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Alkermes and Takeda released data on drug candidates that could fuel the race to develop a new class of therapies and transform sleep medicine.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "829365b4471db5ac9c9af61d9f59f7c4",
    "title": "Mitochondrial startup gets £50M to test lead drug in ALS, Parkinson's",
    "link": "https://endpoints.news/mitochondrial-startup-gets-50m-to-test-lead-drug-in-als-parkinsons/",
    "date": "2025-09-08T07:00:40.000Z",
    "dateFormatted": "08/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "A British startup trying to target a mitochondrial pathway for neuro disorders has a heap of cash to work with, and it's going after a new frontier in one of the most challenging drug development ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "493590dfd75c15b85b11dea33f8c65e5",
    "title": "Servier buys Medicxi startup's fragile X candidate for up to $450M",
    "link": "https://endpoints.news/servier-buys-medicxi-startups-fragile-x-candidate-for-up-to-450m/",
    "date": "2025-09-08T06:30:05.000Z",
    "dateFormatted": "08/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "French pharma Servier will pay up to $450 million for an experimental fragile X syndrome drug from UK-based startup Kaerus Bioscience, the companies said Monday morning.\r\n\r\n The deal for KER-0193, an oral small molecule that ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "d326b94019255efc232222de46678ddd",
    "title": "China biotech Epigenic raises $60M to test CRISPR epigenetic therapies",
    "link": "https://endpoints.news/china-biotech-epigenic-raises-60m-to-test-crispr-epigenetic-therapies/",
    "date": "2025-09-08T02:00:04.000Z",
    "dateFormatted": "08/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Epigenic Therapeutics has raised a $60 million Series B financing to ramp up clinical tests of what it hopes could be a cure for chronic hepatitis B, using a version of CRISPR gene editing that ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "f13c17fb2e5a6aa4174ea70ececb7522",
    "title": "#WCLC25: Merck and Daiichi Sankyo head to FDA with ADC for small cell lung cancer",
    "link": "https://endpoints.news/wclc25-merck-and-daiichi-sankyo-head-to-fda-with-adc-for-small-cell-lung-cancer/",
    "date": "2025-09-07T21:31:10.000Z",
    "dateFormatted": "07/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Nearly half of patients with an aggressive form of lung cancer saw their tumors shrink substantially after receiving an antibody-drug conjugate developed by Daiichi Sankyo and Merck, according to the results of a mid-stage trial ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "2b774adb41d00eb68abe5f9a8067d7d7",
    "title": "STAT+: Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster",
    "link": "https://www.statnews.com/2025/09/07/summit-therapeutics-lung-cancer-ivonescimab/?utm_campaign=rss",
    "date": "2025-09-07T08:45:00.000Z",
    "dateFormatted": "07/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Summit Therapeutics may have a geography problem with its lung cancer drug ivonescimab.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "bdfb6afce4c2ec79b2610a6ca522639d",
    "title": "#WCLC25: Summit reports full Phase 3 data from first group of Western lung cancer patients",
    "link": "https://endpoints.news/wclc25-summit-reports-full-phase-3-data-from-first-group-of-western-lung-cancer-patients/",
    "date": "2025-09-07T07:30:43.000Z",
    "dateFormatted": "07/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Summit Therapeutics released a much-anticipated cut of data in North American and European lung cancer patients on Sunday, trumpeting a new analysis in which its drug ivonescimab, when added to chemotherapy, reduced the risk of ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "31953a9ee4706caf8347117f18a1ff16",
    "title": "Maraganore, Meanwell team up; FDA publishes CRLs; Endpoints 11: Where are they now?; and more",
    "link": "https://endpoints.news/maraganore-meanwell-team-up-fda-publishes-crls-endpoints-11-where-are-they-now-and-more/",
    "date": "2025-09-06T10:00:53.000Z",
    "dateFormatted": "06/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Welcome back to Endpoints Weekly! It’s almost time for the Endpoints 11 event in Boston, where we’ll unveil our team’s choice of companies shaping the future of biopharma. Until then, check out Kyle LaHucik’s story ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "7e73741f601194e506d41da3584d53dc",
    "title": "FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-vonvendi-von-willebrand-disease-including-certain-uses-children",
    "date": "2025-09-05T21:34:10.000Z",
    "dateFormatted": "05/09/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Food and Drug Administration today approved expanded use of Vonvendi [von Willebrand factor (Recombinant)] for routine preventative (prophylactic) use in adults (age 18 years and older) with all types of von Willebrand disease (VWD) and on-demand and treatment of bleeding episodes and perio",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "b6e10871a130874dcf18f029d112ca8f",
    "title": "FDA chief says agency is probing Covid-19 vaccine deaths in kids",
    "link": "https://endpoints.news/fda-chief-says-agency-is-probing-covid-19-vaccine-deaths-in-kids/",
    "date": "2025-09-05T19:30:39.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "FDA chief Marty Makary said the agency is investigating whether the Covid-19 vaccines caused any deaths in kids, building on the government's monthslong effort to question the safety of the products.\r\n\r\n In",
    "company": "Fda Chief Says Agency Is Probing Covid",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "de866a7a2cbf34af28190cfb899a5254",
    "title": "US FDA tightens control over obesity drug ingredient imports amid safety concerns - Reuters",
    "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPNUVkeGR2M2RqYjNiU3VMQlV4eGpCZVR5Q1ZGNGY4REEtS2V1Ukxpd3NBRDNMWGdIQV9VT3BoOUpmazZBcVNlTUpSR2Fya3ZlRVVrclU1QkdFaEhReFlfMjN1SExsOTRRRC1QTGhyX0ItN09SUUtiRFFSckE1ejhWSlQ4aGY5MTlIcnA0RmtqN2NVcDd5bUs1WDczdllFUlYwOExvZ0lQblJxTHJxSHlyZ2c5U3JKWVNaSkpEalZ0WFRPeEQwbVlSeHRzWlpTemFienJkdjNSc1ZNZjlL?oc=5",
    "date": "2025-09-05T19:01:25.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA tightens control over obesity drug ingredient imports amid safety concerns  Reuters",
    "company": "Us Fda Tightens Control Over Obesity Drug Ingredient Imports Amid Safety Concerns",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4d456dcbba2acbc467f30a1cbe2c75ac",
    "title": "STAT+: Patient groups cheer as the WHO adds diabetes and cystic fibrosis drugs to its essential medicines list",
    "link": "https://www.statnews.com/pharmalot/2025/09/05/who-medicines-pharma-biotech-diabetes-obesity-cystic-fibrosis-vertex-lilly-novo-sanofi/?utm_campaign=rss",
    "date": "2025-09-05T18:48:39.000Z",
    "dateFormatted": "05/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "For the first time, the WHO has added various high-cost treatments for diabetes and cystic fibrosis to its list of essential medicines.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "82c5694c1b8491319494fb51bf218c40",
    "title": "FDA is readying more surprise inspections for foreign drug sites, Makary says",
    "link": "https://endpoints.news/fda-is-readying-more-surprise-inspections-for-foreign-drug-sites-makary-says/",
    "date": "2025-09-05T17:36:12.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "BETHESDA, MD — FDA Commissioner Marty Makary said the agency will soon begin inspecting more foreign drug manufacturers without advance notice, a move that's been in the works for years and would align its oversight of ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "4c316000830392ea4f392a1e8a37abbe",
    "title": "Biologics Electronic Reading Room (eFOIA)",
    "link": "http://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/biologics-electronic-reading-room-efoia",
    "date": "2025-09-05T16:09:17.000Z",
    "dateFormatted": "05/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "The Biologics eFOI Reading Room provides access to documents posted throughout the \"Vaccines, Blood & Biologics\" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "a7d0af91873f0821b29cdce8f40f0ef0",
    "title": "US FDA tightens control over obesity drug ingredient imports amid safety concerns - Yahoo News Canada",
    "link": "https://news.google.com/rss/articles/CBMidEFVX3lxTE5JZjVQcElqc3V2SUFfVFdid1lac1ZXS1ZuWi16ZzNZRE9hQWJ1bEk3QWk2TFQ2amp2YXBfOHRpeEhSSS1fYmFnTzMwaXdOV0hNSkNQUHluT1ZoUXR1dmRaTXliR21wZkw3a3pMamlnS0daWnp2?oc=5",
    "date": "2025-09-05T16:06:43.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA tightens control over obesity drug ingredient imports amid safety concerns  Yahoo News Canada",
    "company": "Us Fda Tightens Control Over Obesity Drug Ingredient Imports Amid Safety Concerns",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "5aa677fe18f296c2dcb973f485c8ed27",
    "title": "STAT+: FDA commissioner says agency is looking into question of pediatric deaths from Covid vaccines",
    "link": "https://www.statnews.com/2025/09/05/fda-investigating-childhood-deaths-from-covid-vaccine/?utm_campaign=rss",
    "date": "2025-09-05T15:36:02.000Z",
    "dateFormatted": "05/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "Commissioner Marty Makary said the FDA will release a report within weeks on childhood deaths that he said are linked to Covid shots.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "0b6ad26d958d4d34486ea356a75a4bac",
    "title": "Aurobindo Pharma Under US FDA Scrutiny: Eight Observations Made - Devdiscourse",
    "link": "https://news.google.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?oc=5",
    "date": "2025-09-05T14:46:24.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Aurobindo Pharma Under US FDA Scrutiny: Eight Observations Made  Devdiscourse",
    "company": "Aurobindo Pharma Under US FDA Scrutiny",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0d2bf2b8d6dcf12d3ba127bbb54b0d12",
    "title": "'Several concerning observations': FDA sheds light on rejections - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNSnluVHU4Znp2MXRyZ2dXUDFUcXh4VTB2aXNsdzZsVHYwN2poQXZmVHc2TjNtT2xVYWRRQnZJTDlXMXFqV0FuR1NCbUVHUzE3NFFXenBVOS1abklsTDFfLWpITUhFT1FsUnoxN0toazNBYjZ3ano3V2ZJbFU3Z1JXS3VQNmtidkNZWjRBM3dLeGtKcTZEYWdzdDEyQmk5SURBR0pOcDB1bDc?oc=5",
    "date": "2025-09-05T14:45:39.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "'Several concerning observations': FDA sheds light on rejections  Fierce Biotech",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f7465fc70e089a67856876008dd97e57",
    "title": "Bravehart, a stealthy startup, looks to China to challenge Bristol Myers heart drug",
    "link": "https://www.biopharmadive.com/news/braveheart-hengrui-hypertrophic-cardiomyopathy-china-licensing-deal/759365/",
    "date": "2025-09-05T14:20:24.000Z",
    "dateFormatted": "05/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "Led by the former CEO of Hi-Bio and backed by notable investors, the startup licensed from Hengrui a drug it claims is superior to Bristol Myers' Camzyos as well as other, similar medicines.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c536855ef44b6da3a60cf553ca23af3c",
    "title": "Rapafusyn Pharmaceuticals' $44M raise; CAGE Bio's atopic dermatitis data",
    "link": "https://endpoints.news/rapafusyn-pharmaceuticals-44m-raise-cage-bios-atopic-dermatitis-data/",
    "date": "2025-09-05T14:19:49.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Plus, news about Octave Biosciences and Mineralys Therapeutics:\r\n\r\n 💵 Rapafusyn Pharmaceuticals closes $44M Series A: The molecular glue discovery company wrapped up an upsized and oversubscribed funding ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "c159a09f545642430b29879099656e3a",
    "title": "Regenxbio trumpets one-year data for Hunter syndrome gene therapy after FDA extended its review",
    "link": "https://endpoints.news/regenxbio-trumpets-one-year-data-for-hunter-syndrome-gene-therapy-after-fda-extended-its-review/",
    "date": "2025-09-05T14:14:19.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Regenxbio released new data that it hopes will get its gene therapy for a rare disease across the regulatory finish line.\r\n\r\n The company said Friday that in a one-year look at 13 patients with Hunter ...",
    "company": "Regenxbio Trumpets One",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "36c0f74ea2fe4b4b48609dbe3bf5c9aa",
    "title": "STAT+: Up and down the ladder: The latest comings and goings",
    "link": "https://www.statnews.com/pharmalot/2025/09/05/jobs-biotech-pharma-ladder-sanofi-genmab-merck-icon-iqvia/?utm_campaign=rss",
    "date": "2025-09-05T13:49:40.000Z",
    "dateFormatted": "05/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "9df26680ccc790e7b8141d52f01073d6",
    "title": "Japan-made generic drugs will be exempt from Trump’s reciprocal tariff ",
    "link": "https://endpoints.news/japan-made-generic-drugs-will-be-exempt-from-trumps-reciprocal-tariff/",
    "date": "2025-09-05T13:34:38.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Generic pharmaceuticals from Japan will be exempt from a 15% reciprocal tariff on the country’s exports to the US, President Donald Trump said in a new executive order.\r\n\r\n The order marks ...",
    "company": "Japan",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "55d7359abea223cf632edeadad69a721",
    "title": "STAT+: The FDA is getting more transparent about drug rejections",
    "link": "https://www.statnews.com/2025/09/05/biotech-news-fda-lsd-gilead-pfizer/?utm_campaign=rss",
    "date": "2025-09-05T13:32:27.000Z",
    "dateFormatted": "05/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "And more biotech news stories brought to you by The Readout.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "e11b0098158bb88a15ec045e63d870f8",
    "title": "STAT+: Pharmalittle: We’re reading about PEPFAR and a Gilead drug, the FDA’s rejection letters, and much more",
    "link": "https://www.statnews.com/pharmalot/2025/09/05/medicare-trump-gilead-pepfar-hiv-aids-fda-crl-cvs-wegovy-zepbound-novo-lilly-jnj-bristol-india-weight-obesity/?utm_campaign=rss",
    "date": "2025-09-05T13:11:53.000Z",
    "dateFormatted": "05/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "The FDA said it would start releasing rejection letters soon after they are provided to drugmakers, a victory for those who wanted more transparency.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "cdccbd16e4384e0466bfb32ba55be083",
    "title": "WHO adds GLP-1s to essential medicines list",
    "link": "https://endpoints.news/who-adds-glp-1s-to-essential-medicines-list/",
    "date": "2025-09-05T13:00:18.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "For the first time, the World Health Organization has added GLP-1s and GLP-1/GIP dual agonists to its registry of essential medicines that should be available “at all times” in functioning health ...",
    "company": "Who Adds Glp",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "0b2448e59cde8059cc3bcf58e02f5138",
    "title": "BioNTech and DualityBio’s ADC hits in late-stage breast cancer trial in China",
    "link": "https://endpoints.news/biontech-and-dualitybios-adc-hits-in-late-stage-breast-cancer-trial-in-china/",
    "date": "2025-09-05T11:04:34.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "BioNTech said its most advanced antibody-drug conjugate has succeeded in a Phase 3 China-based trial in hard-to-treat breast cancer patients. The win will raise expectations for an ongoing global late-phase trial of the drug.  ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "60c4bd6b2bbf8ddf27420254eb536586",
    "title": "Merck KGaA finds its next R&D leader; Exelixis retools management team as medical chief leaves",
    "link": "https://endpoints.news/merck-kgaa-finds-its-next-r-exelixis-retools-management-team-as-medical-chief-leaves/",
    "date": "2025-09-05T11:00:32.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "→ Merck KGaA has selected David Weinreich as global R&D chief and CMO for the healthcare business sector. Weinreich’s experience with larger pharmas goes back to his days at Amgen as ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "05d751430a879c24ca8440eb4780b154",
    "title": "Biocon Biologics’ Bengaluru Unit Gets 5 US FDA Observations, Shares Up 1% - Equitypandit",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPamxjOEVXM2RYbDhPdnpRaXNCNTk1b05RV0lCMU0tYzg2Ml9KMEZ0QURRbzVfa0xZMnR6azBOQ2xrWWdqWlNFWER2bEFLejBpRzNmMkM4NnRZX3ZtVW9zNDl6aUUwSzlOMlphQ3NRNnF3Z04zTlhRd21pemQzMlV2MGpzTllvZERZWFowTnF4VldlVENnZEZWVFJoRkdKb1ZzTXc?oc=5",
    "date": "2025-09-05T08:54:26.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Biocon Biologics’ Bengaluru Unit Gets 5 US FDA Observations, Shares Up 1%  Equitypandit",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "05c8fc88d282dcb8b5ca628d4447f3da",
    "title": "STAT+: Donavon Decker knew a gene therapy experiment wouldn’t help him. To help others, he still said yes",
    "link": "https://www.statnews.com/2025/09/05/gene-therapy-pioneer-donavon-decker-remembered/?utm_campaign=rss",
    "date": "2025-09-05T08:30:00.000Z",
    "dateFormatted": "05/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Long before there was Sarepta's gene therapy for muscular dystrophy, there was Donavon Decker and his offer to test a gene therapy.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "c3c9e6142031d45014978ec3bedb01de",
    "title": "Hengrui does another US deal, this time in Cytokinetics' cardio arena",
    "link": "https://endpoints.news/hengrui-does-another-us-deal-this-time-in-cytokinetics-cardio-arena/",
    "date": "2025-09-05T08:01:47.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Jiangsu Hengrui Pharmaceuticals, China's leading drug developer and producer of one of the largest pipelines in the entire biopharma industry, has outlicensed another candidate to a US biotech.\r\n\r\n This time, Hengrui is teaming up with ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "6ee9af4a96562891ecc34f4a59f7c9d7",
    "title": "FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOeUpYZ0JlQzltX2t3WFVraHZCLWl4VEszY2N3MDAzdnVud2xxT3B5Zi1tTGx5VEU5aGFEYVlBUndraXlTU0prcU5Sd0c1SHVQN3d2aGszX0ZOUFVzcU0tOUoyRzhySzd5NkNCVzhzNDhsT0huMkpXY2d5ZjNSdDhWYkh2OGhSQUZFemw2dFdyeGd4YkxYTTRJUFljdWtMd3VFQ1ZLQzVIdkptMW9rVW5xYTN2QmJvc3hobFRlZ00yTjA2LVpQZ3dPNGFFUDVzZw?oc=5",
    "date": "2025-09-05T04:00:00.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients  fda.gov",
    "company": "FDA Launches Green List to Protect Americans from Illegal Imported GLP",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "09aa7501fd640e5680c1ab2eb8357fda",
    "title": "FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNc25Xa2plaGx0Z0dkRlpVdm9mRjlnbmdQY25SMVYtcnN4RXJ3N21ISHRvajRDZzhXWFUyVl90UjJ6LW5XOS1WVlUydENiTFVUeEVjYy1ranE2Mk1DVkxqbm9SNGpTR2M4dEU0S3NnRi1hUk9Nemk0WDlLMFYzSU5oN2NfZmp2cFpDbUtYM0F0N2wyNnFIdUxFZDZka01xZndoMjF5UzlOdm16eHNTaDl4QXZTQW5Dc2JHVEw0S3ZLUFdMRFh4XzdDUkVsMGFudTFQcnRLc3FXNlE?oc=5",
    "date": "2025-09-05T04:00:00.000Z",
    "dateFormatted": "05/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children  fda.gov",
    "company": "Fda Approves Expanded Use Of Vonvendi For Von Willebrand Disease, Including For Certain Uses For Children",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "260a290df4c2e4af619dcaccd394e6d0",
    "title": "STAT+: Trump administration confirms plan for PEPFAR to distribute Gilead’s new HIV prevention drug",
    "link": "https://www.statnews.com/pharmalot/2025/09/04/gilead-hiv-aids-pepfar-trump-lenacapavir-licensing/?utm_campaign=rss",
    "date": "2025-09-04T20:56:03.000Z",
    "dateFormatted": "04/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "\"This is a really significant moment in the fight against HIV and AIDS.”",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "a8f58a1dfdb6ab7835b30513b470a129",
    "title": "At Senate hearing, lawmakers express dissatisfaction with RFK Jr.’s vaccine moves",
    "link": "https://www.biopharmadive.com/news/kennedy-rfk-senate-hearing-vaccines-cdc-crisis-acip/759319/",
    "date": "2025-09-04T20:17:00.000Z",
    "dateFormatted": "04/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "Robert F. Kennedy Jr. faced criticism Thursday even from Republicans over changes to federal vaccine policy as well as a leadership crisis at the CDC.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "73112ae993508905f877ce5150b1cc6a",
    "title": "RFK Jr. battles growing GOP frustration over vaccine policies",
    "link": "https://endpoints.news/rfk-jr-battles-growing-gop-frustration-over-vaccine-policies/",
    "date": "2025-09-04T19:03:50.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "Senators on both sides of the aisle lambasted HHS Secretary Robert F. Kennedy Jr. on Thursday over the upheaval of CDC leadership and recent agency decisions that have muddled Covid-19 vaccine access in the US ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "2a785a844f51779b748e1ccb276cf1cd",
    "title": "J&J, Bristol Myers lose appeals cases challenging Medicare price negotiation",
    "link": "https://endpoints.news/jj-bristol-myers-lose-appeals-cases-challenging-medicare-price-negotiation/",
    "date": "2025-09-04T18:29:54.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "The government won another challenge against Medicare drug price negotiations on Thursday, as an appeals court threw out cases brought by Johnson & Johnson and Bristol Myers Squibb.\r\n\r\n In a majority opinion, the US Court ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "f6dfe1a60295f68b9309d5620fa42705",
    "title": "Atlas Venture reels in $400M to grow its biotech startups",
    "link": "https://www.biopharmadive.com/news/atlas-venture-opportunity-fund-3-raise-september-2025/759281/",
    "date": "2025-09-04T18:05:00.000Z",
    "dateFormatted": "04/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "The venture firm has closed its third \"Opportunity Fund,” which complements its early-stage work by supporting startups it's already backed.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7287d17bb9d2817734f467d173548a0b",
    "title": "FDA moves to publish drug rejection letters in real time, releases new batch including Replimune's high-profile snub - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPcThla0JHRzd3ci1sWnVhWUluMmliSWFmeEFQUTdNaG5WREpNU2xQZHRURGNuSFV6ZEpzaTNObDZ2OWkxWHVJS3Bvd2xmS3dfNjhiNUEyb2NKMU9CQUJTd21EbVFiVWFzak5oM1ZCcllXVnNDN2VqNHoxVlFDbDc0TkJQanpNd2FQbDZsZXoyVnhvZTdMRUZiQ1FqX1BqXy1JTkJaZ2FHeUZqdEc5V1RDRWFpVUhmRlN5ZFNhQ2o5ZEJxRkF0?oc=5",
    "date": "2025-09-04T17:45:28.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA moves to publish drug rejection letters in real time, releases new batch including Replimune's high-profile snub  Fierce Biotech",
    "company": "Fda Moves To Publish Drug Rejection Letters In Real Time, Releases New Batch Including Replimune's High",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b7f9f08bd4941ed0add2aaae621acf12",
    "title": "STAT+: In major shift, FDA to start releasing rejection letters shortly after they’re issued",
    "link": "https://www.statnews.com/pharmalot/2025/09/04/fda-crls-rejection-letters-transparency-makary/?utm_campaign=rss",
    "date": "2025-09-04T16:34:54.000Z",
    "dateFormatted": "04/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "The FDA said it would start releasing rejection letters soon after they are provided to drugmakers, a victory for transparency advocates.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "a3c3c88d861e796b8455fb0e9ebd3298",
    "title": "FDA outlines new review pathway for drugs treating ultra-rare diseases",
    "link": "https://www.biopharmadive.com/news/fda-rare-disease-evidence-principles-drug-reviews/759237/",
    "date": "2025-09-04T16:20:32.000Z",
    "dateFormatted": "04/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "The agency's two main review offices will work together to flexibly evaluate medicines for serious conditions that affect fewer than 1,000 people in the U.S.",
    "company": "Fda Outlines New Review Pathway For Drugs Treating Ultra",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2e8eb3de21b106c5ec4edb931584edb3",
    "title": "AstraZeneca ends manufacturing license at Indian plant as it exits the site ",
    "link": "https://endpoints.news/astrazeneca-ends-manufacturing-license-at-indian-plant-as-it-exits-the-site/",
    "date": "2025-09-04T16:16:12.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Endpoints News",
    "sourceCategory": "trade",
    "summary": "AstraZeneca is terminating a manufacturing license at its factory in Bengaluru, India, after announcing its plans to sell the facility last year, a company spokesperson confirmed to Endpoints News.\r\n\r\n The manufacturing license at the site ...",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "efc6bdab2223420fd187a09fecdab9bc",
    "title": "STAT+: Swing Therapeutics raises $11 million, adds former Pear CEO to board",
    "link": "https://www.statnews.com/2025/09/04/swing-therapeutics-raises-11-million-adds-former-pear-ceo-to-board/?utm_campaign=rss",
    "date": "2025-09-04T15:35:54.000Z",
    "dateFormatted": "04/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "Former Pear CEO joins Swing board — did he invest? My colleague Allison DeAngelis spotted a familiar character pop up in a fresh SEC filing from Swing Therapeutics, developer of…",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "f6d4c11902a31a6b9cc4ce2551e184bd",
    "title": "Sanofi’s touted eczema drug hits study goal, but data fall short of expectations",
    "link": "https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-atopic-dermatitis-study-results-disappoint-analysts/759231/",
    "date": "2025-09-04T15:16:00.000Z",
    "dateFormatted": "04/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug class once viewed as particularly promising.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "068537de3576397c29e2a82519e82379",
    "title": "A drug discovery startup banks $150M for immune and obesity drugs",
    "link": "https://www.biopharmadive.com/news/enveda-series-d-immune-obesity-dolsten-board/759080/",
    "date": "2025-09-04T15:04:00.000Z",
    "dateFormatted": "04/09/2025",
    "source": "BioPharma Dive",
    "sourceCategory": "trade",
    "summary": "Enveda Biosciences has raised $300 million over the last year to make drugs to treat atopic dermatitis, asthma and more.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "5efb01b4c6e32c6c149d5e6acf61f97f",
    "title": "What’s New for Biologics",
    "link": "http://www.fda.gov/vaccines-blood-biologics/news-events-biologics/whats-new-biologics",
    "date": "2025-09-04T14:47:45.000Z",
    "dateFormatted": "04/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "Latest news from the Center for Biologics Evaluation and Research",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "6507fa9713157b51b29edf34bcdea1ca",
    "title": "TACHOSIL",
    "link": "http://www.fda.gov/vaccines-blood-biologics/approved-blood-products/tachosil",
    "date": "2025-09-04T14:25:57.000Z",
    "dateFormatted": "04/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "Product approval information is indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery, when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "a5ba289fcd7ef5060a1518b16b282ac8",
    "title": "Biocon Biologics’ Bengaluru facility gets five observations from US FDA inspection - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2025-09-04T14:19:05.000Z",
    "dateFormatted": "04/09/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Biocon Biologics’ Bengaluru facility gets five observations from US FDA inspection  CNBC TV18",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b8eca8673bb82e9c4d316441084f3891",
    "title": "STAT+: Treeline expands Series A another $200 million",
    "link": "https://www.statnews.com/2025/09/04/biotech-news-treeline-atlas-sanofi-pfizer-agios/?utm_campaign=rss",
    "date": "2025-09-04T13:41:43.000Z",
    "dateFormatted": "04/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "Plus more biotech news from The Readout newsletter.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "faa4a6d78a7c8ad405818beb8753073e",
    "title": "STAT+: Pharmalittle: We’re reading about FDA and Covid shots, a Sanofi setback, and much more",
    "link": "https://www.statnews.com/pharmalot/2025/09/04/pfizer-bourla-trump-covid-vaccines-nobel-sanofi-eczema-amneal-contamination-novartis-argo-cardiovascular-jobs-layoffs-fda-prasad/?utm_campaign=rss",
    "date": "2025-09-04T12:58:36.000Z",
    "dateFormatted": "04/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "FDA memos show that the agency’s vaccine chief overruled staff scientists who favored widespread access to Covid shots",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "97423d02d55ceaf949676fdfcf3cacf6",
    "title": "STAT+: Biotech VC raises $400 million ‘opportunity’ fund in sign of possible industry rebound",
    "link": "https://www.statnews.com/2025/09/04/atlas-venture-biotech-opportunity-fund/?utm_campaign=rss",
    "date": "2025-09-04T11:00:00.000Z",
    "dateFormatted": "04/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Prominent biotech VC firm Atlas Venture has another $400 million to invest in drug companies.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "6b383d58831232b5cba748ab63694e27",
    "title": "STAT+: Sanofi shares drop after disappointing trial results",
    "link": "https://www.statnews.com/2025/09/04/sanofi-amlitelimab-immunology-atopic-dermatitis-eczema/?utm_campaign=rss",
    "date": "2025-09-04T10:33:01.000Z",
    "dateFormatted": "04/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "Sanofi shares slid Thursday after the company reported underwhelming results from a closely watched trial in the skin condition atopic dermatitis.",
    "company": "Reported",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "7d86440adf4d14b5f87d30d4023eaaf0",
    "title": "STAT+: Is biotech back? Don’t jinx it, but the signs are encouraging",
    "link": "https://www.statnews.com/2025/09/04/biotech-back-encouraging-signs/?utm_campaign=rss",
    "date": "2025-09-04T10:30:00.000Z",
    "dateFormatted": "04/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Is biotech back? Industry stocks, collectively, return to positive territory for the year.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "592a75f18662df58e45ebd320f4371c8",
    "title": "STAT+: Amneal Pharma is scolded by FDA for using contaminated bags for a sterile injectable drug",
    "link": "https://www.statnews.com/pharmalot/2025/09/03/amneal-infusion-sterile-epidural-injectable-fda-contamination/?utm_campaign=rss",
    "date": "2025-09-03T20:54:12.000Z",
    "dateFormatted": "03/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "A pharmaceuticals company relied on contaminated bags for a sterile injectable drug, among other infractions, the FDA found.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "9ec28794289a689d35c87cc76bb83bd3",
    "title": "FDA Advances Rare Disease Drug Development with New Evidence Principles",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-advances-rare-disease-drug-development-new-evidence-principles",
    "date": "2025-09-03T17:59:25.000Z",
    "dateFormatted": "03/09/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "FDA advanced Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability for the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "31d8339726401fa93f6b5c3e41e75f71",
    "title": "Recently Issued Guidance Documents",
    "link": "http://www.fda.gov/vaccines-blood-biologics/biologics-guidances/recently-issued-guidance-documents",
    "date": "2025-09-03T17:07:21.000Z",
    "dateFormatted": "03/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "This page lists Recently Issued CBER and Cross-Center Guidance Documents.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "0ccaff837848a5d1c598369cd537bae1",
    "title": "STAT+: Why biotech stocks did unusually well yesterday",
    "link": "https://www.statnews.com/2025/09/03/biotech-news-xbi-index-acip-rsv-gilead/?utm_campaign=rss",
    "date": "2025-09-03T16:03:08.000Z",
    "dateFormatted": "03/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "And more biotech stories brought to you by The Readout.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "28e2103430f617a72a8e0b327f2789d7",
    "title": "Patient Engagement Collaborative",
    "link": "http://www.fda.gov/patients/learn-about-fda-patient-engagement/patient-engagement-collaborative",
    "date": "2025-09-03T15:53:06.000Z",
    "dateFormatted": "03/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Public Engagement Staff.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "29a5bccb6b58245d06127e887e1f7521",
    "title": "STAT+: Pfizer’s CEO defends Covid vaccines, suggests Trump may deserve a Nobel Peace Prize",
    "link": "https://www.statnews.com/2025/09/03/pfizer-responds-trump-covid-vaccine-safety-effectiveness/?utm_campaign=rss",
    "date": "2025-09-03T15:10:19.000Z",
    "dateFormatted": "03/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "Pfizer CEO Albert Bourla defended the development of Covid vaccines and suggested President Trump may deserve a Nobel Peace Prize because of Operation Warp Speed.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "14d220343532d82b2898b0490170834f",
    "title": "CDER/CBER Rare Disease Evidence Principles (RDEP)",
    "link": "http://www.fda.gov/industry/fda-rare-disease-innovation-hub/cdercber-rare-disease-evidence-principles-rdep",
    "date": "2025-09-03T13:54:40.000Z",
    "dateFormatted": "03/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "CDER and CBER propose a new regulatory process for the approval of drugs to treat rare diseases with very small patient populations with significant unmet medical need.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "4843a8be0c63d8a5bd1c1ca98466e63b",
    "title": "STAT+: Pharmalittle: We’re reading about Gilead price hikes for HIV drugs, a Novartis China deal, and more",
    "link": "https://www.statnews.com/pharmalot/2025/09/03/gilead-hiv-drugs-novartis-china-deal-cdc-novo-vaccines/?utm_campaign=rss",
    "date": "2025-09-03T13:11:33.000Z",
    "dateFormatted": "03/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "Gilead is seeking to boost prices significantly for several HIV treatments distributed by state AIDS Drug Assistance Programs",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "36c2cab91cfbf185a67a296cb80f10b3",
    "title": "FDA-TRACK: Prescription Drug User Fee Act Meeting Goals Summary",
    "link": "http://www.fda.gov/about-fda/fda-track-agency-wide-program-performance/fda-track-prescription-drug-user-fee-act-meeting-goals-summary",
    "date": "2025-09-03T12:06:32.000Z",
    "dateFormatted": "03/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "FDA-TRACK: Prescription Drug User Fee Act Meeting Goals Summary",
    "company": "FDA",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "cbcace9092001d2d5460efaf3d37d76a",
    "title": "FDA-TRACK: Prescription Drug User Fee Act Procedural Goals Summary",
    "link": "http://www.fda.gov/about-fda/fda-track-agency-wide-program-performance/fda-track-prescription-drug-user-fee-act-procedural-goals-summary",
    "date": "2025-09-03T12:05:51.000Z",
    "dateFormatted": "03/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "FDA-TRACK: Prescription Drug User Fee Act Procedural Goals Summary",
    "company": "FDA",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "87c2e0ac0ec6ce7dba541cecf82d2e1f",
    "title": "FDA-TRACK: Prescription Drug User Fee Act Review Goals Summary",
    "link": "http://www.fda.gov/about-fda/fda-track-agency-wide-program-performance/fda-track-prescription-drug-user-fee-act-review-goals-summary",
    "date": "2025-09-03T12:05:28.000Z",
    "dateFormatted": "03/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "FDA-TRACK: Prescription Drug User Fee Act Review Goals Summary",
    "company": "FDA",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "32b58a3b98b3d78aed46bcf170dacc19",
    "title": "FDA Advances Rare Disease Drug Development with New Evidence Principles - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNLUJvcWxQNGxCelFnUTZDUHlZUlRETmduY0VPRWxtLTFQa2lKWm5ZOWxFaFJTOWsxYzlncTV5dUpjSzd6dGtYU1YyMmdTYllia3pDRHJoX2NqbEMzTHBFY0dZMnk0V0RtZzc5ZmtKMzhlUjk5STVvcXBwb3owRHdyR29VOFZoVDlLamNxVFRraElGX2RqTkFoQlhITGpBMm9IVWlKMVlwMEQyd3pCSVVVRGV1YzZGYUtSeXc?oc=5",
    "date": "2025-09-03T04:00:00.000Z",
    "dateFormatted": "03/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Advances Rare Disease Drug Development with New Evidence Principles  fda.gov",
    "company": "Fda Advances Rare Disease Drug Development With New Evidence Principles",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7096421ae1b2ab06b1452cd887770e71",
    "title": "FDA Notifies Pet Owners That Tests Show H5N1 Contamination in Certain Lots of RAWR Raw Cat Food Chicken Eats - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNMDRQQUdMUWcxVTJ2b1Ffa20zcHFxTlZrdXdrSW5PaU9IVlNFVUtBSkxVTWg4dFNPa2ZIUzA4ZVQwYldHRjRnQjlIRmpxd25LVmhqbGJZVXBnVXN0Rl80YUxiNWhyaFUyTjhvTDZUQzY5YVh6aDM5a2psNzB3Ym9VaHF5YmZNbDN0SDJ1NlprbHc2T2VTSHJ0VHUyS3pMWXBrZ2g2TFlnanBGYXMycEJkVE5xUE9LWERWdmFqSEFQblViOWhwbDZSVzJhbVZBZ1hUM3dTMUg0d0N3MzVKbFczTg?oc=5",
    "date": "2025-09-03T00:00:00.000Z",
    "dateFormatted": "03/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Notifies Pet Owners That Tests Show H5N1 Contamination in Certain Lots of RAWR Raw Cat Food Chicken Eats  fda.gov",
    "company": "Fda Notifies Pet Owners That Tests Show H5n1 Contamination In Certain Lots Of Rawr Raw Cat Food Chicken Eats",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0a2c5335fc794a09f14426792ea04b0a",
    "title": "CDER/CBER Rare Disease Evidence Principles (RDEP) - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQbUFhbXdHeEgxS1BpSVBIVTU1emVXV1FMTWhHREhpRWhtWFM1amE1NTVpVzFlZUhaU1p4MlVGM2c5eEpqa1Z0TW1xM3EzS0E4ZENkSnBfZzhudUVNbFdWX2lLNk5QZy0yLUU3Y2Zna21walJkbTZWLWpXTG1Cb1BMMVJObkZHbXBvVVNiemdHMUZoUmdmcjFuQ2h2aF96cjBzTXdMcmduU3Q1U2s?oc=5",
    "date": "2025-09-03T00:00:00.000Z",
    "dateFormatted": "03/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "CDER/CBER Rare Disease Evidence Principles (RDEP)  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "35cd9650b977c75f409b9789ce672649",
    "title": "DG Gel Card 125445, 125449, 125450 - 125457 ",
    "link": "http://www.fda.gov/vaccines-blood-biologics/dg-gel-card-125445-125449-125450-125457",
    "date": "2025-09-02T20:12:24.000Z",
    "dateFormatted": "02/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "Product approval information is for:\n•DG Gel 8 AB (x4) card is for the determination of human A and B antigen on the surface of red blood cells in four separate blood samples. For use with the DG Gel System. For in vitro diagnostic use.\n•DG Gel 8 A/B/D card is for the determination of human A, B and",
    "company": "Dg Gel Card 125445 125449 125450",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "0a96a25566fcc571529c24533146394a",
    "title": "STAT+: Gilead wants state AIDS drug programs to pay significant price hikes for HIV meds",
    "link": "https://www.statnews.com/pharmalot/2025/09/02/hiv-aids-drugs-medicines-pharma-gilead-adap-prices-inflation-descovy/?utm_campaign=rss",
    "date": "2025-09-02T15:47:01.000Z",
    "dateFormatted": "02/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "Gilead Sciences is seeking to boost prices significantly for several treatments that are widely distributed by state AIDS Drug Assistance Programs.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "090c1ee5a95df0370f722e04331ebcc7",
    "title": "Consumer Updates",
    "link": "http://www.fda.gov/consumers/consumer-updates",
    "date": "2025-09-02T15:10:26.000Z",
    "dateFormatted": "02/09/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "Science-based health and safety information you can trust.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "6a370276d93456e609718980b216c2b1",
    "title": "FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing Reports of Accidental Exposure  ",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-urges-nicotine-pouch-manufacturers-use-child-resistant-packaging-following-increasing-reports",
    "date": "2025-09-02T14:59:10.000Z",
    "dateFormatted": "02/09/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Food and Drug Administration calls on nicotine pouch manufacturers to use child-resistant packaging to protect American children from accidental, harmful exposure.",
    "company": "FDA Urges Nicotine Pouch Manufacturers To Use Child",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "3f2028c41e7725dc0a09f60087c89855",
    "title": "STAT+: Trump pressures drugmakers amid CDC turmoil",
    "link": "https://www.statnews.com/2025/09/02/biotech-news-corsera-ionis-replimune-cytokinetics/?utm_campaign=rss",
    "date": "2025-09-02T13:36:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "And other biotech news brought to you by The Readout.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "74309b2d53112bf88d8332f2ba5dc114",
    "title": "STAT+: Pharmalittle: We’re reading about Trump’s post on Covid data, a Merck cholesterol pill, and more",
    "link": "https://www.statnews.com/pharmalot/2025/09/02/fda-teva-saxenda-novo-wegovy-lilly-mounjaro-glp-china-trump-covid-vaccines-merck-cholesterol-sanofi-ionis-triglycerides-pancreas/?utm_campaign=rss",
    "date": "2025-09-02T13:24:36.000Z",
    "dateFormatted": "02/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "President Trump called on pharmaceutical companies to publicly prove that their Covid-19 products work",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "e5cb6da6472fdcd6255d5355cffc6f69",
    "title": "STAT+: The key health care fights to watch in Congress",
    "link": "https://www.statnews.com/2025/09/02/cdc-in-crisis-trump-rfk-jr-healthcare-policy-congress-dc-diagnosis-newsletter/?utm_campaign=rss",
    "date": "2025-09-02T12:37:42.000Z",
    "dateFormatted": "02/09/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "187d177aa81d66e05388d58d59d1b0ac",
    "title": "STAT+: Ionis drug lowers triglycerides, reduces pancreas damage in late-stage studies",
    "link": "https://www.statnews.com/2025/09/02/ionis-olezarsen-triglycerides-drug-study/?utm_campaign=rss",
    "date": "2025-09-02T11:00:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Ionis Pharmaceuticals released new data on a rare disease drug that opened up the possibility it could become a blockbuster opportunity for the biotech.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "7fdde49714868e3b06076dc1e1385225",
    "title": "STAT+: Biotech veterans John Maraganore, Clive Meanwell launch new heart disease startup with lofty goals",
    "link": "https://www.statnews.com/2025/09/02/biotech-corsera-maraganore-meanwell/?utm_campaign=rss",
    "date": "2025-09-02T10:30:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Biotech veterans John Maraganore and Clive Meanwell are launching Corsera, a new heart disease startup with lofty goals.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "0715b255c6c5cd78ec424de46d291c4a",
    "title": "Pouches Can Be Dangerous to Kids if They Use, Touch, Chew on, Eat Them - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQnpTT28tYmlkcklyRXV3WDVWV1BOclNiVHQtcDEzcTEyYXNSbWZuUU9FbnlpSGNBa2RJNGJVTzl4YnVITlNRNDJrdUVUbmNPX2owVnduN0JRX0hZY3FobnVDcU1aeXpSUkozVGhFYmo1RTM3aW9MZE00bEI3czl4SGlCWG1fNjJrWGdkWUdsN3JpN0E2Ni0zSk5UV2dnTndrOXJ5OE5vWGdXRGswN21NQVRWYVAyY2ZCUFBVN1JTZWpzZw?oc=5",
    "date": "2025-09-02T09:00:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Pouches Can Be Dangerous to Kids if They Use, Touch, Chew on, Eat Them  fda.gov",
    "company": "Pouches Can Be Dangerous To Kids If They Use, Touch, Chew On, Eat Them",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "73aef51c29205ebd34dc2532108704b7",
    "title": "Ice Cream Factory Issues Allergy Alert on Undeclared Almond in Vanilla G.Nutt Ice Cream - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxONGJZQThsbEIyT2ZtQ0JVcW8tWVhMcFY4cUFjQUkyZ1NPVDVPVlNTQ1g3M0MtcFBLQTMyRTQtSzFraERHNFVkak1fVTZlQ0VDT0E5b1pxTEJJdjc5djB3WU1yc2xuMXdKeXRHQktYT0lhUFBHN2lqMi1YQUV2azRWb2pHdGtHdDl4THRTdzQwbmxRRDN2RWIyTWR6QWFrWWNPd29vb0xsMl9EVXY1cnlpWGRzZVgxSDZxQTNoWDVSVXZ2c2J4Ujkxdlg5Z2Y1cG1fWjM3cUhKbk1UajFROVlyMHhR?oc=5",
    "date": "2025-09-02T04:00:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Ice Cream Factory Issues Allergy Alert on Undeclared Almond in Vanilla G.Nutt Ice Cream  fda.gov",
    "company": "Ice Cream Factory Issues Allergy Alert On Undeclared Almond In Vanilla G.nutt Ice Cream",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "06b083c8e8dfaab12fdcd58ebeadc0f3",
    "title": "FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing Reports of Accidental Exposure - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPMnR2SDZWaGg0eGFiMGdrcERVdkNqQldUVG9XTndsaWxsajdfc3lrcm43emlBXzRLUjlHODJrLV8ySXp5Z2pnZ0t3ZXQzRnRrdVlDdHFuOW92Z1BDWGdYcTdQeDYzbVFhWFFldXJIaFBaU3ZMallyZXhkcjdTWGZqMnJjYVdQZWZGcGI5M19xdGZ2dUhFQk9PaldRZmN0cXhILURpeW9zb1JYTmRkeFZsSTNQM1g2VmNKYzJ5VU1za3RfYVNJRTBISldQRERCeF9KSUNfckRkZ1Bfbk40ejlqbjVjaw?oc=5",
    "date": "2025-09-02T04:00:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing Reports of Accidental Exposure  fda.gov",
    "company": "FDA Urges Nicotine Pouch Manufacturers To Use Child",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "5be4971b5e13cc94c7f6b485f3df20b9",
    "title": "FDA Approves Drug to Treat Adults with Persistent or Chronic Immune Thrombocytopenia - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPTGg2SkV3VFQ0V2dLOV81Tjk3bW1hUGFDMlpSRng3X2dPM2VYZFhLa2s1Uml1UXppX0J3QTU5SmcxTDhKOEdlQTN6c2Y4M3NrM3gxaFZNU1ZJcF9CdjlEMUZqZmEzcUZxZ1FKdDVBU0ZpR3VmaEtYLV9INHB3dDFNd1hTdkRyZTFKSzUzUDd1ZF9CVUZ1X3M5RWlQUU1FTEpPMVZBeGp5S2ZxX0plMGNmUkZHTVlSZHlqcHNXT1VQSHY4SEtC?oc=5",
    "date": "2025-09-02T00:00:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Approves Drug to Treat Adults with Persistent or Chronic Immune Thrombocytopenia  fda.gov",
    "company": "Fda Approves Drug To Treat Adults With Persistent Or Chronic Immune Thrombocytopenia",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "278c75ffc62a82e5110dd07db6811286",
    "title": "Assessing Novel Efficacy Endpoints in Ophthalmologic Rare Disease Drug and Biologics Development - 09/17/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQb1BsYnRhWHlLQ2F6VWFSWGxnUFFXZHVBVThreVdSVW44XzVqZ3JCb1l4dEw4Ymlhc1dYM2hLQ25DNGV1SWRJZERwLTJjN3ZTOWprTTktQlAxSEdMeHhqSkdFMGVuOHl3TnJTZ0gyQnZFSmtYTThUaHhOZW9HeDFuc0ZBOUxPVkQyUHU1STNNUXdRUFJBS1VORnhGTGZkWTRpZGJBbkxpT054VDFLVWU2UlU3ZlU2ckRsb2JuVTdKd3puRjJ6V21KVVMyc1I0dXhSZUZQQzJPX2tWR0E?oc=5",
    "date": "2025-09-02T00:00:00.000Z",
    "dateFormatted": "02/09/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Assessing Novel Efficacy Endpoints in Ophthalmologic Rare Disease Drug and Biologics Development - 09/17/2025  fda.gov",
    "company": "Assessing Novel Efficacy Endpoints In Ophthalmologic Rare Disease Drug And Biologics Development",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6b3c78486dd90a2411761d182deca94a",
    "title": "STAT+: Alnylam’s hypertension treatment did not significantly lower blood pressure in mid-stage study",
    "link": "https://www.statnews.com/2025/08/30/alnylam-hypertension-treatment-study/?utm_campaign=rss",
    "date": "2025-08-30T14:30:00.000Z",
    "dateFormatted": "30/08/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "An investigational therapy from Alnylam did not significantly lower blood pressure in a key Phase 2 trial, new data show, but the drug is being advanced to a late-stage study.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "4b2755c744ecb5305778531ef1753c93",
    "title": "STAT+: Cytokinetics drug yielded benefits over common therapy in patients with heart condition, study shows",
    "link": "https://www.statnews.com/2025/08/30/cytokinetics-aficamten-hcm-study/?utm_campaign=rss",
    "date": "2025-08-30T07:18:00.000Z",
    "dateFormatted": "30/08/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "An experimental medicine from Cytokinetics showed strong results in patients newly diagnosed with a common, inherited heart condition, according to new study results.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "ec0b5993cfc231f4c62954a2d3783e54",
    "title": "U.S. FDA issues five observations to Aurobindo Pharma arm’s API plant - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2025-08-30T06:03:00.000Z",
    "dateFormatted": "30/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "U.S. FDA issues five observations to Aurobindo Pharma arm’s API plant  The Hindu",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b822d9a5d84915147ea160a3d8ce5197",
    "title": "Coronavirus (COVID-19) | CBER-Regulated Biologics",
    "link": "http://www.fda.gov/vaccines-blood-biologics/industry-biologics/coronavirus-covid-19-cber-regulated-biologics",
    "date": "2025-08-29T17:09:00.000Z",
    "dateFormatted": "29/08/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "5ccb6b3e882a61b1e8ee63e3d9bb9c63",
    "title": "Health Fraud Scams",
    "link": "http://www.fda.gov/consumers/health-fraud-scams",
    "date": "2025-08-29T16:39:27.000Z",
    "dateFormatted": "29/08/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "Learn how to spot health fraud and avoid it.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "f614a6bddad58951c87ad1b867c627ab",
    "title": "STAT+: Pharmalittle: We’re reading about Lilly and a China tech giant, Cassidy and a CDC vaccine panel, and more",
    "link": "https://www.statnews.com/pharmalot/2025/08/29/astrazeneca-lilly-virginia-manufacturing-obesity-diabetes-china-cassidy-rfk-cdc-vaccines-uk-gsk-uti-antibiotics-alzheimers-fda/?utm_campaign=rss",
    "date": "2025-08-29T13:12:12.000Z",
    "dateFormatted": "29/08/2025",
    "source": "STAT News Pharma",
    "sourceCategory": "trade",
    "summary": "The chair of the U.S. Senate health committee called for delaying a federal vaccine advisory panel meeting after a mass exodus of CDC leaders",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "5064e7696238cf2e26c961a339abe628",
    "title": "Green Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products  Following FDA Findings",
    "link": "http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/green-lumber-holding-llc-issues-consumer-alert-counterfeit-products-following-fda-findings",
    "date": "2025-08-29T04:00:00.000Z",
    "dateFormatted": "29/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Costa Mesa, California August 28, 2025 - Green Lumber Holding, LLC (“Green Lumber”) is alerting consumers that counterfeit products misrepresented as genuine Green Lumber have been identified and may pose health risks.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "f47e392a267e5866fa865f3b05aa480d",
    "title": "Roster of the Vaccines and Related Biological Products Advisory Committee",
    "link": "http://www.fda.gov/advisory-committees/vaccines-and-related-biological-products-advisory-committee/roster-vaccines-and-related-biological-products-advisory-committee",
    "date": "2025-08-28T19:19:13.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "This is the Roster of the Vaccines and Related Biological Products Advisory Committee",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "2141f7330bdfbd438875205eb2a5b140",
    "title": "Roster of the Cellular, Tissue and Gene Therapies Advisory Committee",
    "link": "http://www.fda.gov/advisory-committees/cellular-tissue-and-gene-therapies-advisory-committee/roster-cellular-tissue-and-gene-therapies-advisory-committee",
    "date": "2025-08-28T19:19:07.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "This is the Roster of the Cellular, Tissue and Gene Therapies Advisory Committee.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "d5f4d5276fadbef64e0fde4600b7cf9c",
    "title": "Roster of the Blood Products Advisory Committee",
    "link": "http://www.fda.gov/advisory-committees/blood-products-advisory-committee/roster-blood-products-advisory-committee",
    "date": "2025-08-28T19:19:04.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "This is the Roster of the Blood Products Advisory Committee (BPAC).",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "91e3d9796a8662c7fcec5da055cffb55",
    "title": " NUVAXOVID",
    "link": "http://www.fda.gov/vaccines-blood-biologics/vaccines/nuvaxovid",
    "date": "2025-08-28T17:56:16.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "NUVAXOVID is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).\n\nNUVAXOVID is approved for use in individuals who are:\n\n65 years of age and older, or\n\n12 years through 64 years of age with",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "7a9923ab24db4cc881cd6319ac3b4bc8",
    "title": "SPIKEVAX",
    "link": "http://www.fda.gov/vaccines-blood-biologics/spikevax",
    "date": "2025-08-28T17:51:53.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "For active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).\n\nSPIKEVAX is approved for use in individuals who are:\n\n65 years of age and older, or\n\n6 months through 64 years of age with at least one underlying condition",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "7e873b599e94848172abbec23648b911",
    "title": "COMIRNATY ",
    "link": "http://www.fda.gov/vaccines-blood-biologics/comirnaty",
    "date": "2025-08-28T17:38:50.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA CBER Biologics",
    "sourceCategory": "official",
    "sourceType": "biologics",
    "summary": "COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID 19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).\n\nCOMIRNATY is approved for use in individuals who are:\n\n65 years of age and older, or\n\n5 years through 64 years of age with",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "d07ec61bea9ffca71a162807d7e188d3",
    "title": "Outlook Therapeutics’ outlook dims as FDA snubs reformulated Avastin in eye disease—again - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOdnhCOEtJcEJFMEd0VEFDdjB5R3k3ZG1ZcUxvNHhSX0tSeXpmSWNkczA0ZGVST0swdkJoNmV3X05XYkpZZXBzVHdfNzFiVnZGZUNGWHVYNGpKSFVGNElKRFZtM01NVFhrZ1pFTUpEWWlTTURseWFIV2RQdlBoaEt4OU5mb2dDRkdTSXF4VzN3TEg2Tjh2MDhGZGdCSUJWbk11SDBDMzlkdjEwcWR1aTd4NEVOTEZhelV5YWc?oc=5",
    "date": "2025-08-28T14:55:37.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Outlook Therapeutics’ outlook dims as FDA snubs reformulated Avastin in eye disease—again  Fierce Pharma",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "81796a95267a730150ac17fe23f5669a",
    "title": "STAT+: An under-the-radar biotech finds FDA more receptive to an alternative to Covid vaccines",
    "link": "https://www.statnews.com/2025/08/28/covid-invivyd-monoclonal-antibody-moonlake/?utm_campaign=rss",
    "date": "2025-08-28T10:30:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Invivyd's CEO doesn’t want to see Covid vaccines disappear, but he does believe the monoclonal antibody candidate his company is developing can be an effective alternative.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "ba3e80cd6b27c4bacebe49d21ef72191",
    "title": "FDA flags issues in review of Telix's PET diagnostic agent for kidney cancer - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOem9yN0VVLVNDdDBEbHdycExVVDhVZ1BEZk1JWEJ2X0xab1FFWTdLRXZHWmZYdVdMUWRlWUdwU1RTM21LbnU0bXIwVTBnYkdWSVZPVGJmVDNSc1MwNVhhNkR2SjdzTW03UXk0LTJVVUFnMVcyX1NqUG1BUjV5NjR6VTdPNkZPeHZiYnYtRHpOZm9uS3RtWV9URlIzdVBkMHVkVUYzVXZn?oc=5",
    "date": "2025-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA flags issues in review of Telix's PET diagnostic agent for kidney cancer  Fierce Biotech",
    "company": "Fda Flags Issues In Review Of Telix's Pet Diagnostic Agent For Kidney Cancer",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a2c12cc275aa657731be389a3be2e394",
    "title": "FDA Requests More Efficacy Data: Outlook Therapeutics' Novel Bevacizumab Eye Drug Hits Regulatory Roadblock - Stock Titan",
    "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQTkhRc0ZnakRlRHJUNWwxTGNmZXJQYWo5X1g5NV9sRmdwU3BjN0E3UlBQRVczMG9WUDNpbnZYZnNIdVZtUzgwLXdQc0p6ZGtCYW14TDAyNWtpem1qdHpLNzJkSmVnR2d6eE1iQk1Ja2w5UGtXZ25vRUM2SnJNcjJzeGdNalJTV1A5M3BFZmpMd1lNU0NFSWVmTncwb1FRc2RHN3FWVkcySDJOekQ3eHZGcnpNeUNJdzRLTjNkSmt2YzI?oc=5",
    "date": "2025-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Requests More Efficacy Data: Outlook Therapeutics' Novel Bevacizumab Eye Drug Hits Regulatory Roadblock  Stock Titan",
    "company": "FDA Requests More Efficacy Data",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7fad3bd555491afbe696ac1c59d5ff88",
    "title": "Ventilator Correction: Hamilton Medical AG Corrects HAMILTON-C6 Due to Risk of Ventilation Interruption from Defective Circuit Board",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/ventilator-correction-hamilton-medical-ag-corrects-hamilton-c6-due-risk-ventilation-interruption",
    "date": "2025-08-28T04:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Hamilton is repairing certain HAMILTON-C6 ventilators to replace a defective circuit board that can interrupt ventilation, risking serious injury or death.",
    "company": "Ventilator Correction",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "c7daa857bfaee9ee131ce77d0834675b",
    "title": "Infusion Pump Correction: ICU Medical, Inc. Issues Correction for Plum Duo Infusion System Due to Software Possibly Resulting in Pump Becoming Unresponsive",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-correction-icu-medical-inc-issues-correction-plum-duo-infusion-system-due-software",
    "date": "2025-08-28T04:00:00.000Z",
    "dateFormatted": "28/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "ICU Medical is correcting the Plum Duo infusion system due to pump software issues that may cause the device to become unresponsive.",
    "company": "Infusion Pump Correction",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "28ecf4ea851f8c4da99876dbb3adce1b",
    "title": "STAT+: Third Rock tops STAT’s annual VC ranking",
    "link": "https://www.statnews.com/2025/08/27/biotech-news-akeso-summit-keytruda-third-rock-harvard/?utm_campaign=rss",
    "date": "2025-08-27T13:33:11.000Z",
    "dateFormatted": "27/08/2025",
    "source": "STAT News Biotech",
    "sourceCategory": "trade",
    "summary": "Plus more biotech news from the Readout Newsletter.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 2
  },
  {
    "id": "e5d7c45b1e625ed96668022268f8926b",
    "title": "Amneal Pharmaceuticals, LLC - 709894 - 08/27/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd1YwdlVFRDRBZDdQQXVscFdMYjA5bjJHZ2JTaGVQUkl2QTR1dVlKTWJpWnZvRHo0bnJZWWc4X2xTaGpiOG9Yb29STlQ2RkRxZHNEQXluWnEtaTg1OWw2LTlia1BDQjNhcl9KTFVoeE1HVHA3YmpkOW9DU0ZrdEs2bEJCRlVaTjE3UFE2N0lpOUlNdHZEbTh6MDhDakM4VlBhTUI1Vkk1Yk9TMXZxRnJfdWl0WklyNXhsN3c0a3RTZDVqcUc2WktUV0Y1cW1MR0EwMHBzMnFuSVQ?oc=5",
    "date": "2025-08-27T07:00:00.000Z",
    "dateFormatted": "27/08/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Amneal Pharmaceuticals, LLC - 709894 - 08/27/2025  fda.gov",
    "company": "Amneal",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "764b99b9915b310c38183a121d49170a",
    "title": "FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Suspends Biologics License: FDA Safety Communication",
    "link": "http://www.fda.gov/safety/medical-product-safety-information/fda-update-safety-ixchiq-chikungunya-vaccine-live-fda-suspends-biologics-license-fda-safety",
    "date": "2025-08-25T04:00:00.000Z",
    "dateFormatted": "25/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "On August 22, 2025,the US FDA’s Center for Biologics Evaluation and Research has suspended the biologics license for Valneva Austria GmbH’s Ixchiq (Chikungunya Vaccine, Live). This vaccine was initially approved by FDA under the accelerated approval pathway in November of 2023 for the prevention of",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "27bb88025106f3989674aa7ef12db976",
    "title": "Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices - Letter to Health Care Providers",
    "link": "http://www.fda.gov/medical-devices/letters-health-care-providers/follow-instructions-safe-use-hyperbaric-oxygen-therapy-devices-letter-health-care-providers",
    "date": "2025-08-25T04:00:00.000Z",
    "dateFormatted": "25/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "The FDA is reminding the public about the safe use of hyperbaric oxygen therapy devices and is providing recommendations to help reduce potential risks.",
    "company": "Follow Instructions For Safe Use Of Hyperbaric Oxygen Therapy Devices",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "2f8af515c1db3498f209acf83c14502e",
    "title": "FDA Begins Real-Time Reporting of Adverse Event Data",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-begins-real-time-reporting-adverse-event-data",
    "date": "2025-08-22T15:46:16.000Z",
    "dateFormatted": "22/08/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Food and Drug Administration (FDA) today began publishing adverse event data on a daily basis, giving the public faster access to information on serious medication errors and product quality complaints for prescription drugs and therapeutic biologics.",
    "company": "FDA Begins Real",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "96faa635a51264ac73124c82156ebe4f",
    "title": "FDA accelerates Stealth Bio's rare disease application with a decision slated for next month - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQcHpvelRIeWdVRzktOEN6bkRKOUhBaEo3YzJFMkpna1pReW1RSHJyeUFwX280RjhuaVU3QTFVMHhsQ3lXT09ucnB0NjI3M09Sa21OVVlhckh6M00waENmUnJoWWpDd0plODctYnVsOUozeTVEcVlTQkNxNEZpTzlhR0JsaW9RNmVSVFRIZ0hFS3NSZjdNNTZ4WE5GdmtBLUdrS0llQS02YmpFVWR3ZzlPU21IVEN2bFM0OWc?oc=5",
    "date": "2025-08-21T07:00:00.000Z",
    "dateFormatted": "21/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA accelerates Stealth Bio's rare disease application with a decision slated for next month  Fierce Biotech",
    "company": "Fda Accelerates Stealth Bio's Rare Disease Application With A Decision Slated For Next Month",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c4c283a2ac56aba66beeb3d7337b9b44",
    "title": "FDA Advises Public Not to Eat, Sell, or Serve Certain Imported Frozen Shrimp from an Indonesian Firm - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPZzByTDhrNk1RNzlzVXZ4ZnhZLU82UjdGX2tKazFkbk1aUTNVN3BPbzBuYnItRnFYSkN5RFk5WV9KOTRmNktIV2RuWW9mMjhQSWYzUDNzcUdEaGpESElPajN0SWx4dzZoOU9sTWQxRE5xYTZqVV9ydHBiT3FuSVJBS2EwYU15Q2hxbVFrU040Nl81U3FlZ05MNUptX0gzc1lldkFtZGVmWE5BOGNQYnoyUHFQcERza05OVFdMR29xdlV2ajhFem1NNzZqckpmN19xR2FPU0FKWGxIcFdibnltRU9LYw?oc=5",
    "date": "2025-08-19T13:10:09.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Advises Public Not to Eat, Sell, or Serve Certain Imported Frozen Shrimp from an Indonesian Firm  fda.gov",
    "company": "Fda Advises Public Not To Eat, Sell, Or Serve Certain Imported Frozen Shrimp From An Indonesian Firm",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "fb0dab11d565868c89c9d92a86f4fe0f",
    "title": "HHS Allows FDA Emergency Use of Animal Drugs to Combat New World Screwworm, Protect U.S. Food Supply",
    "link": "http://www.fda.gov/news-events/press-announcements/hhs-allows-fda-emergency-use-animal-drugs-combat-new-world-screwworm-protect-us-food-supply",
    "date": "2025-08-19T12:45:21.000Z",
    "dateFormatted": "19/08/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Department of Health and Human Services (HHS) today issued a declaration that allows the U.S. Food and Drug Administration (FDA) to issue Emergency Use Authorizations (EUAs) for animal drugs to treat or prevent infestations caused by the New World Screwworm (NWS).",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "d56b5458bdb8dda7b97c197bb857efd6",
    "title": "FDA Issues CRL for SC Daratumumab Plus VRd for Transplant-Ineligible or -Deferred, Newly Diagnosed Multiple Myeloma - OncLive",
    "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQSFVVVi1aUTFZUDJYMWF3U085ODluNXUyLVNSMENQODNUQ1p5UDU5U21uMVVZZzRwOU1acWxTVlpLWWxqRlEyejFUSlV6cmhnSi05N3F5anNfcldYNDl0al9HSkNmU3JxR1RCSEtWVGJZc1ZXeGIzWnpZT3hhQ3lXQXBRenpDVV9FTGV4S213MTJzWkRmZ05iLXZhM0dpWG5hTnJoOVNkeG5PcTVCcGtKNWcxeFJKQVpyaEJKMVpJUWR1RDA?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for SC Daratumumab Plus VRd for Transplant-Ineligible or -Deferred, Newly Diagnosed Multiple Myeloma  OncLive",
    "company": "FDA Issues CRL for SC Daratumumab Plus VRd for Transplant",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ba0e85e4e7f903df540b44a507d27091",
    "title": "FDA Denies Approval for Friedreich Ataxia Agent Vatiquinone, Citing More Efficacy Needed - Neurology live",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPUjVKMU9XR0ZDSjNDOFdNYV9NX19CbXp4QnhkWm1qNV9ZZUoxVTlheHJBNjBlZUkxQW1EdVdDREJndTdxdnU4OVZDQTdycEk5dkx3ZnFQajlNM0FWYmhfMy1TQjJwS0JXOXQ4WVR6SE9TUmhSalZndzhrWjlMLUtyYV9sbWhDTGluWEtXV25Bakt4akZlMEZHenhnLWxJclBPbjBnTTFwQXNfejZMYnc3X2p6WXZFRWg2MXc?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Denies Approval for Friedreich Ataxia Agent Vatiquinone, Citing More Efficacy Needed  Neurology live",
    "company": "FDA Denies Approval for Friedreich Ataxia Agent Vatiquinone, Citing More Efficacy Needed",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f800411bbcee3c3b025456964acb7df2",
    "title": "FDA Denies Approval: PTC Therapeutics' Vatiquinone for Rare Genetic Disease Friedreich's Ataxia Hits Setback - Stock Titan",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOeVZPeDFtLTdjUkpQVjA1Q1U1LTExRUZ1UU9YMHo3Nk1fcXczeW9EeXhMSWlFdk5CWkc1Smk2WS1CY2I5OUgyNjlSVE51Q1lXcGVuaWtYM1dJcTJEODZOWHZHQjVEdWE4WVd0WEM4RjU2ZUtNNHRBR1pHTDR6YmJlcFlEVHB1UHpuSHo4ZVBUSnVGN09vSHRialR2a1RjcjFZd2ozcGhfWWFNNklHUDFCSWxZUEFYMU1WbEc0Vkxn?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Denies Approval: PTC Therapeutics' Vatiquinone for Rare Genetic Disease Friedreich's Ataxia Hits Setback  Stock Titan",
    "company": "FDA Denies Approval",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "3d376b1b17fbcbdfd2d36a2f5a8ba2aa",
    "title": "US FDA declines to approve PTC Therapeutics' oral drug for rare genetic disorder - Reuters",
    "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOMng1aGpKMmxPMmxqSVN5X3ZFWG5YY19QemEta0l3MVRsMjZBLWE0RWVzQ1hVNTUwTzdaWl9zN0ZUQl85Njg0SVhNZFMwc0dLWGdWaHdFMnJMb0dtTGYyU2plN1lBUWVOTUZHVXBjblRtNVZ4eHRvcldkV3Z5SXdEWTJtX1FjTTMtVkxXelRTdF8xMzV1djN4bV9ON2hBME5CME5aT3IzVXlJdkFaQ2JaVTR4eGw1RmtzY2dnVDYyenhoMGxqcnVtQTNBRG1jYlNWZ0gzV2dKT2dNN2M5?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "US FDA declines to approve PTC Therapeutics' oral drug for rare genetic disorder  Reuters",
    "company": "Us Fda Declines To Approve Ptc Therapeutics' Oral Drug For Rare Genetic Disorder",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "faa1014ba2da44fb8f008317920810fc",
    "title": "Interest In PTC’s Sephience Launch Overshadows FDA’s Vatiquinone Rejection - insights.citeline.com",
    "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxNZU4tTHNKWEJ1NHh4WUVuR0lVT3laZHFxSldwUHk0OC1ka2M0WkRMWjNjcnpWOUdTY1BUNDZkYWdSRFRrcFlmXzI4bjRoMWlDZlhpM1ZoaWlKQjRDMTU5LU5qNzZPSzRLVVl4VENuaTZzVkJfVXRKbl9lU1FpMWs5Z3N5bE9IZUhXMVZwRkRPTExhcjA3XzU5emxuU0V4QUxlVVFXWG9QeGFDREstVGRaeTVTS3BNcjRkd19hZ2VsRFc1dFZRYU04ekE1U05BaXg1VzFLR2ZydXltVk1rQVNISGxIYUVuaXlOQWtLSmZjcUdmUQ?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Interest In PTC’s Sephience Launch Overshadows FDA’s Vatiquinone Rejection  insights.citeline.com",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6920f6e01cf1e394ac91fa3d4a3eeeb5",
    "title": "FDA rejection derails PTC Therapeutics' rare disease hopeful - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOek1NVEJyLTYtTGwzcHlZUzRyUWF6eUtIclc5Zl9vQ1dnUjNvODVrb0xVSmxLbjRZRXB6bklCRlpoOXRCTExIVlU2d3dFcTJMV0xiUzNZeWluaGpab1BjYy12YUFuNjZPeXktTm1jNi1VUmNjQ2xFX3pYeGZVcE5UQ2NfYThRTDBoS2JqNUM4ODFhNmRsOEtSaU1ZdnY?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA rejection derails PTC Therapeutics' rare disease hopeful  Fierce Biotech",
    "company": "Fda Rejection Derails Ptc Therapeutics' Rare Disease Hopeful",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "64b12595e77174824de0aab0f3b4e785",
    "title": "Nicotine Pouch Products Authorized by the FDA - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQUkJHN21oX1A5VFZxUkRrQjdPWDJXakFKNTFFMllJZk5TNVRhSTdab0tZMTZYVlJXRWpDZE13dzE0T3pCSXhpR2hXQUFIZHp0NVRDVUZ3NkFZNjBVYmViYXMwTXBnaDlMckJYNHNqbVdhbjhPblJNS05HLVR1ZGNYeUZGSDU2ekJwREJFZG5MakJHLWhyZkdPSVZjOHdYc1BTMERybXJ5N0RNTjZMZGRIeGQwTQ?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Nicotine Pouch Products Authorized by the FDA  fda.gov",
    "company": "Nicotine Pouch Products Authorized By The Fda",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "093403fb022566bc19dec76278782f4f",
    "title": "Stealth Bio submits third FDA application for rare disease candidate - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNMDQ0VjFsZEhhcHYzM1IzMHJrZWNvd3FsSkItRDJHZ2hvcnVsZ19PNGllNmt6OW81TE9qTFh6VkZlUlVIUk5PSTBsWHd3WXQwXzBmc01iWmNialhJcDVNRGxxTl9XRzZFNGFjNEppV28xUUVfWFlkeTRORXJ2OVp4YkVxdmJIZXdoaW93Rl9XeWdEaXM2czBCcGxqVTF1TGpNdmVaVEF4WExTWXprNEE?oc=5",
    "date": "2025-08-18T07:00:00.000Z",
    "dateFormatted": "18/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Stealth Bio submits third FDA application for rare disease candidate  Fierce Biotech",
    "company": "Stealth Bio submits third FDA application for rare disease candidate",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f95c47b757e2d6cc2aad5a12d053c98f",
    "title": "Early Alert: Infusion Pump Issue from Baxter",
    "link": "http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-infusion-pump-issue-baxter-0",
    "date": "2025-08-15T04:00:00.000Z",
    "dateFormatted": "15/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "Correction Issued for the Novum IQ Large Volume Pumps, Syringe Pumps",
    "company": "Early Alert",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "4f2108f9ebd5c44887fddffd9900507c",
    "title": "FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-approves-first-immunotherapy-recurrent-respiratory-papillomatosis",
    "date": "2025-08-14T22:11:48.000Z",
    "dateFormatted": "14/08/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "FDA approved Papzimeos, the first-of-its-kind non-replicating adenoviral vector-based immunotherapy for use in adults with recurrent respiratory papillomatosis.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "b005ed07e3a8c37cf20a62cb1e549608",
    "title": "Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7-OH Opioid Products",
    "link": "http://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-marty-makary-md-mph-florida-restriction-7-oh-opioid-products",
    "date": "2025-08-13T18:43:49.000Z",
    "dateFormatted": "13/08/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7-OH Opioid Products",
    "company": "Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "26fdf813306e7f2614a9c4888da6ccd0",
    "title": "The FDA Let Substandard Factories Ship These Medications to the U.S. - ProPublica",
    "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5OTWtuR3hWVllaRF9Zd1BrcVYtMnBvTlBNMXNWVG1sT1psNmUzdmhkeUhVTWtqSDk4UkNkXzVGeEJqQ1FlOVBYT1hvMm5YQWxET2Y1clBMLU5lZTloREpkclBCY2czQ3paMzVsOWwzZ1k4aTl0ZmpCX2pQUy1iWDg?oc=5",
    "date": "2025-08-12T07:00:00.000Z",
    "dateFormatted": "12/08/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "The FDA Let Substandard Factories Ship These Medications to the U.S.  ProPublica",
    "company": "The Fda Let Substandard Factories Ship These Medications To The U.s",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c6ec6e450bb82af6bc36aff7bd73832c",
    "title": "Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps ",
    "link": "http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/tandem-diabetes-care-issues-voluntary-medical-device-correction-select-tslim-x2-insulin-pumps",
    "date": "2025-08-12T04:00:00.000Z",
    "dateFormatted": "12/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "SAN DIEGO – August 7, 2025 – Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker-related issue that can trigger an error resulting in a discontinuation of insulin delivery.",
    "company": "Tandem Diabetes Care Issues Voluntary Medical Device Correction For Select T",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "74cb825e6577502078a288bd12a0b108",
    "title": "FDA Commissioner Makary, USDA Secretary Rollins Celebrate Proposed Modernization of Orange Juice Regulations to Benefit American Growers",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-commissioner-makary-usda-secretary-rollins-celebrate-proposed-modernization-orange-juice",
    "date": "2025-08-08T19:30:37.000Z",
    "dateFormatted": "08/08/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "U.S. FDA Commissioner Dr. Marty Makary, M.D., M.P.H., and U.S. Secretary of Agriculture Brooke L. Rollins this week announced plans to support American citrus growers and cut bureaucratic barriers by proposing an update to the standard of identity (SOI) for pasteurized orange juice.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "25cb421cfbc67307fa6ecfa346b2dd81",
    "title": "A Statement from FDA Commissioner Marty Makary, M.D., M.P.H.: Announcing Resolution of the IV Saline Solutions Shortage",
    "link": "http://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-marty-makary-md-mph-announcing-resolution-iv-saline-solutions-shortage",
    "date": "2025-08-08T15:25:35.000Z",
    "dateFormatted": "08/08/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: Announcing Resolution of the IV Saline Solutions Shortage",
    "company": "A Statement from FDA Commissioner Marty Makary, M.D., M.P.H",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "2287e6ec4bc32cbdd96f01f65db8c9de",
    "title": "Stealth Bio questions its own viability as FDA directs rare disease biotech to resubmit drug application - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPNnN5SE0yeE5kaTB2Sk1hVEdGaVREMjVEME56M3dNQkhkdXM5UjZ6SGFteUFVZjdVaG5wbUdYM0dmdzJIWFJJdGE3b2Z3VW5rX3pmaFAtSm5ua2I3MzhJQ19kYkxnUGpSaWUwODJCdHc5anFFRUxsN2ZINGhDVkZMRGdLLWxGcnpSbVhkZmdqei1HMkZUWHhrUmNYUXNxN3VWRS0zUW5CeTJVUTJYdEZfX1c0QmRaYUxIOGc?oc=5",
    "date": "2025-08-08T07:00:00.000Z",
    "dateFormatted": "08/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Stealth Bio questions its own viability as FDA directs rare disease biotech to resubmit drug application  Fierce Biotech",
    "company": "Stealth Bio questions its own viability as FDA directs rare disease biotech to resubmit drug application",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6a92b10455bfcb8e42acac8b60dffed8",
    "title": "Approved Drug Products with Therapeutic Equivalence Evaluations | Orange Book - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPSmhvSjhWWWZJRm5GcUtDZU83NjBHa09IZ3ZteThncWlHLXJBcm15TWFSaG9iTDlqbFEwcXdHeHR2Q0ZvM3J4Tkx0NGtkektSNzBZejNtOThJNUlQM3JMejNycE51SGlrVWJ1Ui0xZGxIVVllRWpra25zTWl4N1BaR1RyeS1yVmNNSERlRGRJTUt4WDlkTUQySG5hMHM3MlFfenNPLTZxcXBVTG9NVkhEamJmdEp0YnF3SzlKYWR2OE1HRXc?oc=5",
    "date": "2025-08-08T07:00:00.000Z",
    "dateFormatted": "08/08/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Approved Drug Products with Therapeutic Equivalence Evaluations | Orange Book  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b02eed8aa0077513c75806e9159a3c36",
    "title": "FDA Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-announces-new-fda-precheck-program-boost-us-drug-manufacturing",
    "date": "2025-08-07T13:32:05.000Z",
    "dateFormatted": "07/08/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Food and Drug Administration today announced FDA PreCheck, a new program to strengthen the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of manufacturing sites in the United States.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "6972781fd14c84196ae2188537b6784b",
    "title": "FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live): FDA Safety Communication",
    "link": "http://www.fda.gov/safety/medical-product-safety-information/fda-update-safety-ixchiq-chikungunya-vaccine-live-fda-safety-communication",
    "date": "2025-08-07T04:00:00.000Z",
    "dateFormatted": "07/08/2025",
    "source": "FDA MedWatch Safety",
    "sourceCategory": "official",
    "sourceType": "safety",
    "summary": "FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Removes Recommended Pause in Use and Approves Required Updated Labeling: FDA Safety Communication",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "3a85867bb9e9af4e75f284df1dcb6065",
    "title": "For a Second Time, FDA Denies Approval of Odronextamab in Lymphoma - Targeted Oncology",
    "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNb21KUHZqZjMxc3ZZSXlKbVpzSmdkSU5iak9xN2ZReVVjY2l4eVZ5WmdnZ3JJeTJkZ1JUektHR1dwZ1JwQ2p0aUdiU0M4OVhpcU5aYXloVG1nWnNldjFMRGhwVEh6a1VEOUtmclRSSlBmUWpmZ3AzUWRNSFVGT3E2ekdXeXdPZ1BQOThnT182Sk1oSzFPMk1ISDFkT1RYZG8?oc=5",
    "date": "2025-08-06T07:00:00.000Z",
    "dateFormatted": "06/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "For a Second Time, FDA Denies Approval of Odronextamab in Lymphoma  Targeted Oncology",
    "company": "For a Second Time, FDA Denies Approval of Odronextamab in Lymphoma",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "3a112976aec51478d5a44f979eee2c91",
    "title": "FDA Names Top HHS Lawyer as Chief Counsel",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-names-top-hhs-lawyer-chief-counsel",
    "date": "2025-08-04T19:42:12.000Z",
    "dateFormatted": "04/08/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) today announced that Sean Keveney has been appointed Chief Counsel at the FDA.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "e7d883727056f5db28fed8cb4fbfe205",
    "title": "FDA Issues CRL for Odronextamab in Relapsed/Refractory Follicular Lymphoma - OncLive",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPU1kxZmpPbjFNMFl6dFd4emhZV2RqLW9NeXd4TFpFNEFMVlhBclIwb2llQVQ1REw0a3loTU96Yk1nUjYza1pGSWJIclhCNXJ0V1ZJMlRMS0Z5UjRIVGpSay1hcHA4dU5tQnhqTTRTeVctRTdWdHZXNDAzVExoWEYyazlBcmNuYWhpUTZHWlppTllRS2pSZ1dyb1BYeWhxQllOR0RCczl3?oc=5",
    "date": "2025-08-01T07:00:00.000Z",
    "dateFormatted": "01/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for Odronextamab in Relapsed/Refractory Follicular Lymphoma  OncLive",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b1761d31e96db52cebe03fbeaa7745c4",
    "title": "Regeneron says Novo plant problems caused another CRL and will delay 2 Eylea decisions - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQWlnbWlmSFhGYXBOTHc3MkRaMTB3QXIxbHdZU2VEMklXVVJ1X0tHZVZJRUxHMXJDU21fQjgtY2x1YlBzRWpWZlBUS19FZkF2Z2M5dVE4b0NPdldSemFpRUd1eERNQXZHWG1WRExuNlN4Sl9WT1pOYjRWZkx3X0ExTklVcExlWHIzc3puN1BCRVR0WEJsQmpocjUxLWl6THd2d05mVkJCSnJUcFhfLUZ0OW52bWZ3U0NoTnkydHJ3?oc=5",
    "date": "2025-08-01T07:00:00.000Z",
    "dateFormatted": "01/08/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Regeneron says Novo plant problems caused another CRL and will delay 2 Eylea decisions  Fierce Pharma",
    "company": "Regeneron says Novo plant problems caused another CRL and will delay 2 Eylea decisions",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "bc8600df4e9daf9c4e3b95c37bb9fe0c",
    "title": "FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-requires-major-changes-opioid-pain-medication-labeling-emphasize-risks",
    "date": "2025-07-31T19:24:28.000Z",
    "dateFormatted": "31/07/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "84b4d048ca262174c94a85bc72fba13e",
    "title": "Reduced or Waived Medical Device User Fees: Small Business Determination (SBD) Program - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMikgJBVV95cUxQWGdjZk9td0VZMkwzRFFTNHQ3NFlIYUJwcjhwM2NZbmtLUHNyVnMxWGtyOEh6ZHJHbkNiUXBsMTczWmVvWnZkSHFXZHFLa24ySWFjeFphdzZISFYxLWw4MXhqLTZTcWl4Q0VkNFh5S0t4bTltYXRMMGU2d0hJeXh5VUN5ZTdvaVdHNWp0RFlBOWJ0UHFPSW1xSVN0V3laOFotUThsUy1wdWp1VzFjc212LWQtVmEwVGVKTS1MQUY4RmV3aHNoZ0tmUHlnSnFYTzhsS1laOThKWEQxTFRteE5DMlBfUTRjSldZWEpONVhMUGxDWUQ0Tmo3Y3EtaVZBQmV4TEFPazV1dWhnS2tTeXdYWkp3?oc=5",
    "date": "2025-07-30T07:00:00.000Z",
    "dateFormatted": "30/07/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Reduced or Waived Medical Device User Fees: Small Business Determination (SBD) Program  fda.gov",
    "company": "Reduced Or Waived Medical Device User Fees",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "08cc94ddb8d36bf06e31f7540d8ed28a",
    "title": "FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers",
    "date": "2025-07-29T14:41:37.000Z",
    "dateFormatted": "29/07/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers",
    "company": "FDA Takes Steps to Restrict 7",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "f3301b25429f687a781d4ba12487f6dc",
    "title": "5 Cs For Responding To FDA-483s — Strategies For Effective Compliance And Resolution - Clinical Leader",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVEgxdUZlOTlRTnhhbWcxLTFxVmxsQkxKZkRjek1CbndhMHFGME9pcF9waTExRV9hcGNTMk9VUjU3NDh1YjBuU2Rrdm1TQ2YxdHdnVXk5YmltQ2lzVG9YT2dkbDV2clFTajhuM0NLelpFclBiREh3X1h0WEF6RVdHR3ptcjU4a0h4bG82eG14Y1NTVGFRdkdHcmlGZ3dPZHlpanlQXzVxUjg1eG1qZjhLUFNONDI3d3ZT?oc=5",
    "date": "2025-07-29T07:00:00.000Z",
    "dateFormatted": "29/07/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "5 Cs For Responding To FDA-483s — Strategies For Effective Compliance And Resolution  Clinical Leader",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "32d6e7a50f97aa59c6db6dc95709ede4",
    "title": "FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-recommends-removal-voluntary-hold-elevidys-ambulatory-patients",
    "date": "2025-07-28T20:21:55.000Z",
    "dateFormatted": "28/07/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "32047c3a4fa892c26703890943820083",
    "title": "FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-investigating-death-8-year-old-boy-who-received-elevidys",
    "date": "2025-07-25T21:25:06.000Z",
    "dateFormatted": "25/07/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Food and Drug Administration is investigating the death of an 8-year-old boy who received Elevidys, a Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy.",
    "company": "FDA Investigating Death of 8",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "91658bbbe837ad3a82c647545da825d9",
    "title": "FDA Crackdown on Trial Design: What July’s CRLs to Replimune and Capricor Mean for Sponsors - Applied Clinical Trials",
    "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOUlFwSXd5dEk5eHNMYl8xWlk1WS0xby05a1lZNGtmQ1ZXSXRib2lxYzVqb2tWbnMyVlAzalU3eHVBSVpIRUhSQWYyVDNRUkJ3Z1VfUU1VTzRxNXhmbzVUZVpWRVY3cDFQcnA0ZTZHcmsxM1p6cUVvRWIxc2FhV1NBR2d1Z1B3ZXRJVW5NVkcwLUtOWXJRam9JdHFtcjY5STA?oc=5",
    "date": "2025-07-25T07:00:00.000Z",
    "dateFormatted": "25/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Crackdown on Trial Design: What July’s CRLs to Replimune and Capricor Mean for Sponsors  Applied Clinical Trials",
    "company": "FDA Crackdown on Trial Design",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "261407f383dacb13768b88054abc6069",
    "title": "Replimune CRL Fallout: How Biopharma Leaders Should Manage a New Layer of FDA Uncertainty - Pharmaceutical Executive",
    "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxNTkF4SjBPS01MdURwbjNoanNMQWJTczdSY3BvU2NkS1p6S1FpUEw0eUpJdE16RnBfOHg4OEJjdmoxQVhiZFpRRUJqRjhXajBlRWtnY3ZsT0E2UUhySHNVbmRIMmN1T3dqQ2I4c1Q4bFJEUUtPS05xTHBlazRwZ01rdkhrc2dOVUpaUXpQcTFLU0RMdXF6dHhVT2daai1BQQ?oc=5",
    "date": "2025-07-25T07:00:00.000Z",
    "dateFormatted": "25/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Replimune CRL Fallout: How Biopharma Leaders Should Manage a New Layer of FDA Uncertainty  Pharmaceutical Executive",
    "company": "Replimune CRL Fallout",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "409c3ec5b9ce1f664c932fb8c7b0bfe8",
    "title": "DLBCL: FDA Rejects BLA for Second-Line Glofitamab Combo - Medscape",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOaVI5eGY5ZUstSlZiSHdoaEpoVGF2LUFSampJTWQ4LXpyNFlRODd6eGNzRFlUQm5nbjkyZXNzeThhOHhsUUhZSnlodmRRV25OR2MzVDRZSUVuSkxjQ2dvSS1BUUNsdk5IYUJwcEtVU0xRdUVOTl81Vm1iWUNDX3Ztblh2TXk0dkZwOXFmamY5U0xIX2M0SkVaLXpPSHp6aG51dlE?oc=5",
    "date": "2025-07-24T07:00:00.000Z",
    "dateFormatted": "24/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "DLBCL: FDA Rejects BLA for Second-Line Glofitamab Combo  Medscape",
    "company": "DLBCL",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e0ffd1fc32027e7a244b05fff179670d",
    "title": "HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods",
    "link": "http://www.fda.gov/news-events/press-announcements/hhs-fda-and-usda-address-health-risks-ultra-processed-foods",
    "date": "2025-07-23T21:44:12.000Z",
    "dateFormatted": "23/07/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods",
    "company": "HHS, FDA and USDA Address the Health Risks of Ultra",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "35c393e056a76be68026513920823932",
    "title": "HHS, FDA Praise Consumer Brands Association’s Vow to Remove Artificial Colors from America’s Food Supply ",
    "link": "http://www.fda.gov/news-events/press-announcements/hhs-fda-praise-consumer-brands-associations-vow-remove-artificial-colors-americas-food-supply",
    "date": "2025-07-22T18:17:07.000Z",
    "dateFormatted": "22/07/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "Today the leadership of the U.S. Department of Health and Human Services (HHS) praised the Consumer Brands Association for its pledge on behalf of the makers of the nation’s food and beverage products to remove certified Food, Drug & Cosmetic (FD&C) petroleum-based colors from America’s food supply.",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "46061954564178b57854369a4dac3138",
    "title": "FDA Issues CRL for RP1 Plus Nivolumab for Advanced Melanoma - OncLive",
    "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQZEl1ZFBnQWVDQlhPSWQ4N1ZwUkJuREc0WHJERS1HUV80emJFRnFmZ2F6NXA1aURxMnBiTUxUYXVtVVVIY3NMWjdWSUlVU1BNUEx3RTlDZlk0WmpUOUZacUhGZGhTTXBBajBfR2VYakhkenE2Wkt2VmpXTHAxWDVZWGJacVRnNFd6cTFHdDIyX3l2Zw?oc=5",
    "date": "2025-07-22T07:00:00.000Z",
    "dateFormatted": "22/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for RP1 Plus Nivolumab for Advanced Melanoma  OncLive",
    "company": "FDA Issues CRL for RP1 Plus Nivolumab for Advanced Melanoma",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a6ec2d687bb63ab04b6d6840f1b429c8",
    "title": "FDA rejects RP1 for advanced melanoma, says IGNYTE not a ‘well-controlled’ trial - Healio",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNbWJBZlpidVZBdy1nNUVfTkJHZ0xKSlUxRHNzZkFhYzlfSk5EZXpsVmhFclFZRkFZVDJwTWh5aDZwVjNzOWpGZzFYdzFmRWQ2OGI3WDJiazVGR0dGS0ZNWWhLelJKVlczS2d5d2RhMUdDUmYzblhCM3dqWnNZZ05PelNuV1hUS1dxcFNXdDYwSTBXalRGY2hPZ01tVFJ2R19ENkNpNTduZm54SDdvaVZsZWhKY0tkRXdsNUZ0bmJOT1lVNE5DR21HejVubkE3UQ?oc=5",
    "date": "2025-07-22T07:00:00.000Z",
    "dateFormatted": "22/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA rejects RP1 for advanced melanoma, says IGNYTE not a ‘well-controlled’ trial  Healio",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "aac256ae9551d63bb49a2899e75d1fcc",
    "title": "FDA Denies Approval for Replimune's Advanced Melanoma Treatment: What's Behind the Rejection - Stock Titan",
    "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQOXNhTTNEQmVOU18zeVU2RllzaHNkcEN6Q0hLbjdyd2trczhvQXR6QUQtbUc1VkRIVGoyV1YzSWZVNWJrajBENzlvRFNKTHlkMHFyRVpLbGp2N2ZUTFJlT0lyV0tOMlRsalZ3Smp6YjZvUnc2TWhzblVNMzZFcUVFQU5iUmhNSU9ER0NGT1NPZmZ3eGZ2bnZCOG10ZzlGd2E5VnR5TE5qRVAweS1pdUJJNFEtOEQ5QQ?oc=5",
    "date": "2025-07-22T07:00:00.000Z",
    "dateFormatted": "22/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Denies Approval for Replimune's Advanced Melanoma Treatment: What's Behind the Rejection  Stock Titan",
    "company": "Fda Denies Approval For Replimune's Advanced Melanoma Treatment",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "62a22870700461a26912b90c48f12cde",
    "title": "FDA Issues CRL for RP1 and Nivolumab in Melanoma - Dermatology Times",
    "link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNVjFfVW80YVZIT1NnUVdMS0ljYU5JTzFQaDExX2JpUmRfMHk2LTZEdjZqV0JoeGhOcmhrTG1wSGZIV1lDcnI2SnBYWDlxVUNGQjJmcXljdEh0WENsYUVTeEpwanNWZndEdnlqa3hVWWFGdXNydEVrbmZxRDBJM01tcWFMS2FJUmJzMndzMUFqcw?oc=5",
    "date": "2025-07-22T07:00:00.000Z",
    "dateFormatted": "22/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for RP1 and Nivolumab in Melanoma  Dermatology Times",
    "company": "FDA Issues CRL for RP1 and Nivolumab in Melanoma",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c4ee2eea6c342c42ccad5d4a1c2ae6f5",
    "title": "FDA Issues CRL for Vusolimogene Oderparepvec in Advanced Melanoma - AJMC",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNM251Q1hxcTBwYmhzMnc3d3V2TWdKbWF5aTdnc0p1QVhnSzFfQTZhTjhYN3p4S0lTQXdoMl9IUlBrc25BMTVtY2x4dHRfVXNNLXYyT3ZFSUVkN2ZwQnpMbFc1cURwc0ZRWVg5eTdrWHpZSlNUVjFGeTJkWXpHZ1JFcENsSkJDeTZQWHVtbDhUcDNwN3V5cXc?oc=5",
    "date": "2025-07-22T07:00:00.000Z",
    "dateFormatted": "22/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for Vusolimogene Oderparepvec in Advanced Melanoma  AJMC",
    "company": "FDA Issues CRL for Vusolimogene Oderparepvec in Advanced Melanoma",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0f6d1e22a5bc33783f620543eb9ec7ae",
    "title": "Replimune's shares crater as FDA rejects melanoma drug - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQSE43LURlWlUxWlJNQmlQRWkyOXdxc3ZkZE9SNVJjZW9xOGtBZjFCRzlwVGxUTS1oNWdpZi1XNzF3eDJKU05zQ3ZibEZwa1ZHRDJFV1JWQ0lzaUtDc1NWTmFpZzJEVDBvNG1YRzhYV2pXR3lrb2NNenA1NEphMVJCbUd6cFN3U0NiVmV6VUVBSFpxNjB6NEtLWldkb3Ytak9JOE1PNlpR?oc=5",
    "date": "2025-07-22T07:00:00.000Z",
    "dateFormatted": "22/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Replimune's shares crater as FDA rejects melanoma drug  Fierce Biotech",
    "company": "Replimune's Shares Crater As Fda Rejects Melanoma Drug",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "352e5aeb46696c53972e33404ea86773",
    "title": "Stanford faculty member George Tidmarsh, M.D., Ph.D. named Director of Center for Drug Evaluation and Research",
    "link": "http://www.fda.gov/news-events/press-announcements/stanford-faculty-member-george-tidmarsh-md-phd-named-director-center-drug-evaluation-and-research",
    "date": "2025-07-21T10:57:14.000Z",
    "dateFormatted": "21/07/2025",
    "source": "FDA Press Announcements",
    "sourceCategory": "official",
    "sourceType": "general",
    "summary": "The U.S. Food and Drug Administration today announced the appointment of George Francis Tidmarsh, M.D., Ph.D., as Director of the Center for Drug Evaluation and Research (CDER).",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 1
  },
  {
    "id": "e0807896d5e3346c4efdab074b9d61a3",
    "title": "FDA Issues CRL to Glofitamab Plus GemOx in ASCT-Ineligible R/R DLBCL - CancerNetwork",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQQVhucUF6ZTNFTW5XS2hKcGVxRG9HeUFsb2dpR0l0S2tHWi05SXAwaVQyY1JaaWRZTWliM2c0WFFCTGRyVjh4UDNBc3U1TVVZQW04N0JXYkVRRjY4V2pJV28za0R1cG9TMHhzdEhFZ1VVNWVBUjF2V1FKaUpXUnBnQkdTTjZ2bGRZR3BtSy1Kak95c3JlbU02LVBLSHJvSXpGSGFOdVV3?oc=5",
    "date": "2025-07-21T07:00:00.000Z",
    "dateFormatted": "21/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL to Glofitamab Plus GemOx in ASCT-Ineligible R/R DLBCL  CancerNetwork",
    "company": "FDA Issues CRL to Glofitamab Plus GemOx in ASCT",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e72005ea5d19dcdc5cd10f6e3be0d9bd",
    "title": "FDA Rejects Glofitamab (Columvi) for Diffuse Large B-cell Lymphoma Indication - Oncology News Central",
    "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNZlJkekliM19uc0dzTm9pMGlUSXRVRjdZLW9GS1VuR1JCTU5hbi1RTmN4Z3dta1cwbnhSNXBtWngyQ3dRWGFJTHZQc0JlQUYtUHdJYWpheXRGWGZkS1dNTXBZS1JKTHVyNWlvUG9oMVlKdXVRLUhZb0x6d3p1SGsta1d4Yk51OWp2dm4tOG5ydjM4STQtVWczM1Y2NHJ6ZFRnT2U4UjhTY1FGbWZRckZyRUJySlk?oc=5",
    "date": "2025-07-21T07:00:00.000Z",
    "dateFormatted": "21/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Rejects Glofitamab (Columvi) for Diffuse Large B-cell Lymphoma Indication  Oncology News Central",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2307af4e778e96db81ad5027fdadd532",
    "title": "Dr Reddy's Labs gets 7 USFDA observations for Srikakulam facility - Medical Dialogues",
    "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNZ0QydC1Dc1U2NnFtR2I4VWxYWDdjQl85MU5sX1g5cl9CYklXSm1vMTVkMjBlaE9fSmtTQm9rVTFGWkdWeUQtQXBJTW5mam5Wb2VQLW5xTGxBNDBrcEJUM0FDamltN1Z3S1l5Q2w3bHZSUm5idEpsNjQxY1YtNjBFcWw1UVZybjM5dUFUa2V2eDdIMFFMd1BENE5yWUtrVnpCdFhPR1JoUXBaMGZlWlQxSE81S2ZTbHczc0JCatIBwgFBVV95cUxPREFBQ2N0TGZjSU9Ybk14Q25QQ0RQbmhQWG5tbG5XUm4xTnRvS3lRSDg3U0NfUms4ckFoV2JEQTRFemI3MllzMkJXZkdFT05lRXQ5M24xQWVDdVVxRDJSb1ZDUGFvOGQ5V0dVRjZVdkhkdHlzNWZHNGJzdFZYbUJSWDl0d2FGV0xNUTVQR0dpWXZWb1JsSElYVmNONGpUaVNRYTNtbmdfcjY2aTBSNHFJYlItVzBtT2FJOHI3eVUwcDM1QQ?oc=5",
    "date": "2025-07-19T07:00:00.000Z",
    "dateFormatted": "19/07/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr Reddy's Labs gets 7 USFDA observations for Srikakulam facility  Medical Dialogues",
    "company": "Dr Reddy's Labs Gets 7 Usfda Observations For Srikakulam Facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8b189303ccfb258afc37bdea9304aae7",
    "title": "FDA Issues CRL for Glofitamab Plus Chemo in R/R DLBCL - OncLive",
    "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPTXJ2V0o3azZmTnIxeTZRclRDS0dwcFUwYWVuMGxyOWVBekJXbzF1WGQ1WUN6TTBwSlpDcTNkUzRXOE1XYk5odDVjQUZaOE1URjJQLURSb3pSMFBpcTd4YUpwcDZvY2laNE9mSzI5Rm5KWGpBV011UWI5d296V0lOejRqVlMtTC1aMWc?oc=5",
    "date": "2025-07-18T07:00:00.000Z",
    "dateFormatted": "18/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for Glofitamab Plus Chemo in R/R DLBCL  OncLive",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "d007e47697cc14718d3ae119dfeae979",
    "title": "FDA rejects Roche's Columvi in earlier diffuse large B-cell lymphoma, citing lackluster US data - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMmFYcDkzS3FTbVRYZXozazVQU1N6RzAwMjctaXhfQ3Ywak82N25TRmtpRllTbnNQN1ZPaHJELWxRRXNmTF9neFNjTVhRUW9JX2ZNVU9RVFRSRG9VVlpwUk5yMTQ1QkVfM1RpdGxESlVXRm9uOXN0VkdEbmxfeDFNYUdrYk5haU1wSzhwRHlkZVZXajFJUDJoaXJId0NManFmNlB1QVFPMU9uZUV5ZHgyQVZyTHIwcGViZnYyNzF3YnQ?oc=5",
    "date": "2025-07-18T07:00:00.000Z",
    "dateFormatted": "18/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA rejects Roche's Columvi in earlier diffuse large B-cell lymphoma, citing lackluster US data  Fierce Pharma",
    "company": "Fda Rejects Roche's Columvi In Earlier Diffuse Large B",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a58c2c2d42b55f5fd4bb8d434a01e883",
    "title": "Lupin receives USFDA observations for two Pithampur manufacturing units - Medical Dialogues",
    "link": "https://news.google.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?oc=5",
    "date": "2025-07-18T07:00:00.000Z",
    "dateFormatted": "18/07/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Lupin receives USFDA observations for two Pithampur manufacturing units  Medical Dialogues",
    "company": "Lupin receives USFDA observations for two Pithampur manufacturing units",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "9c2edecadacb9896c1f996a764f010e7",
    "title": "FDA’s Published CRLs Deliver Insight Into the Drug Approval Process - OncLive",
    "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxONjFGNFRLejRrYVdvZk5DbWlVVWNZZlZmUlpoZFUwUnBxb2w2bC04LWwxeDlpbDcxZVFoTG50MTNVTEtkWFYyeHZzRHpNOTEyc0RkbHNLcU5qT1hCNFVKM3lwZ05IaXpsb2wwTXJCVEltbHc0LW5hbHdnWmtwLWFScW9WNmcxVHRQWVBPUGxDMnFSeW1OeC1vS0J3RVU?oc=5",
    "date": "2025-07-16T07:00:00.000Z",
    "dateFormatted": "16/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA’s Published CRLs Deliver Insight Into the Drug Approval Process  OncLive",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f61a67fd93cecac44bbf1d7e675ec8ba",
    "title": "FDA hands down citations to 3 drugmakers after inspections found contamination, testing concerns - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPc3FLZkRYR0xpWXNvdHA0SmxXOGk2LTBkTk5RVGxpUG81d180WjE2Yld4MUVpX2I3dW52YzZHYWJPOHY3M21DaHhVdDZMNFpSOXlBVF9WdTJKdHRDMEw1dTBEeHJzSVVRaFRSdk9vcURMSC1kR2FDUF9fSmJaSDRNR2xkOTlra2twOFAzMWtod3I3RGdUNnFsOEtrLWNZdW1XZlRrNGY4VS1EN3JONjNOWVY0bkdtS2lUSHc?oc=5",
    "date": "2025-07-16T07:00:00.000Z",
    "dateFormatted": "16/07/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA hands down citations to 3 drugmakers after inspections found contamination, testing concerns  Fierce Pharma",
    "company": "Fda Hands Down Citations To 3 Drugmakers After Inspections Found Contamination, Testing Concerns",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e4f8efe52d8066a16c09ea17733d76fa",
    "title": "An FDA inspection revealed significant problems at Empower’s new outsourcing facility - Partnership for Safe Medicines",
    "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTFByaWtYV1dtTzNHams5eWZPSDU3elRxOUxQR2toT3VWVnlnZG9oNTM0bnZ4cW1TUlMwX0xfQnBKYzFjNDI5VzU5V1RYSWY1OVJSSFBjM251dWZJN0NaZGY2MmZoVjNfclZIdGhKT1hQSnlOREtiZ1VySjY2Szg5eTQ?oc=5",
    "date": "2025-07-14T23:11:33.000Z",
    "dateFormatted": "15/07/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "An FDA inspection revealed significant problems at Empower’s new outsourcing facility  Partnership for Safe Medicines",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2d934ce2a0a5a681212a25adc954a432",
    "title": "Ultragenyx takes another hit as FDA snubs AAV gene therapy over manufacturing issues - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPRktpSHB2MXBlSHhSUGhMdVpISE55Z0MtZl9iV1BwaUpmbEdHVjBBUU44R0pMcDQtMDdxZk9xcjRwNUwxV1ZKeHFlYWhubzQ1ZXNyZjFRUXg4QTFrN0c3Z1ZBcG5mUHpkdDVydDRfUHZlSm4zQzQzRTI5MXRfZ04yaHVoTzYzUm1OczJzQWs5WDJVNWRPY1hTdXkzVkp6S1B2YW5lWmRjQS0tQVZ1Q3UtUGxQUkc5cjFJ?oc=5",
    "date": "2025-07-14T07:00:00.000Z",
    "dateFormatted": "14/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Ultragenyx takes another hit as FDA snubs AAV gene therapy over manufacturing issues  Fierce Pharma",
    "company": "Ultragenyx takes another hit as FDA snubs AAV gene therapy over manufacturing issues",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4533ea69a43fb35846c24ba81efee384",
    "title": "Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits - MedCity News",
    "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPc2QycUNxMXR0RnVTUUVIQnhlMzVfVlNzZG13LXgyQ1JUUnNLTUozYlFhRTZ1QUhER25YWEwyZ1dTWm10aGQ3YWNYQWotc3pRUmdsTzh4REl4cnIzVV8xam9OWklQNTVMT2ZHbTlsUGJtRTFTY25QckpsM2VMd0ZBQnlCMmpNUUYyWEUzYWZrOXhUVGc?oc=5",
    "date": "2025-07-13T07:00:00.000Z",
    "dateFormatted": "13/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits  MedCity News",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "94e033d417a3734a82b4c57e35cc800a",
    "title": "‘Weak’ evidence and an ‘unpleasant’ odor: FDA sheds light on drug refusal process - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPT2VnQ2dpOVVYRjBlMnFvNG9HcTdPOHFfTUhYSV8tOVZ4LVpMUjRydUJYcS1obFdiS01ob2dac1F6akEyUFBEakZ6emc5U2RBQ05KQ1Bxd1Z0Y2UwYnpHV2YyQk5WMzZPRklHb2hrdHBCblNqRVZ4MENLYjhlMFRaLXFqbGF1VDFnc1FFUU9TYU52S2tUbzExaEtKcm5rRWVjcjRYYUxjUnBlSVk?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "‘Weak’ evidence and an ‘unpleasant’ odor: FDA sheds light on drug refusal process  Fierce Pharma",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a119f0210012e900401a16caa658f86e",
    "title": "New FDA Initiative Reveals Common Reasons for Drug Application Rejection - Applied Clinical Trials",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPN0xiLW1pcG5NdDB0cmhKWUpNLXRZN0ktMmdqZWJqRlg0OFByX3hCQWlvSzJra3hkVzhsQnk3U2QyOURiZGlDRDJteEM1SS1EdVA3N0ZpdW1raFlaRXRPMlExc3FQRnE2R1dBamdjZDRPWC1ZMnhqQVo0aDFGUFdGbEI2bzUzRU1YMVc0UHhoRC1QYkM1T2s2MUNKeU1taG4wcl9SbHJHNnJHdzE1ckVDZTlld21BWkw1?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "New FDA Initiative Reveals Common Reasons for Drug Application Rejection  Applied Clinical Trials",
    "company": "New FDA Initiative Reveals Common Reasons for Drug Application Rejection",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4c0b0e886881d47caf2aba648e520719",
    "title": "Capricor Plunges on FDA Rejection of DMD Cell Therapy - BioSpace",
    "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQMUlxSDhVN0UtanB6bm9WUzZzOXpNY29QdHk4NUVDZ083WFBEZjJPSjV1eDRMNnVEVHNtRl9rRWI4N2YxR1lLaXY3R09WaTgxMGw1d0pQZGtJYldMSWlZMGhmckFFeXllMG4wVDNVQU9hTDJ0UXR6aDBXaUNkOGdaX1ZLZTUzTVB0VlE?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Capricor Plunges on FDA Rejection of DMD Cell Therapy  BioSpace",
    "company": "Capricor Plunges on FDA Rejection of DMD Cell Therapy",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "00e9965bd9b3e1842ad6f9f8f961398f",
    "title": "Capricor’s BLA for DMD Cardiomyopathy Cell Therapy Deramiocel Slammed With CRL - CGTLive®",
    "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOSHMyUkY1Nlp0Zi15dm9VeVZCRTVIeXBPSi1PVDhnemVpNVd0MlJHbjk3ZDMwemYxYlExYWJUVDFEMWplWnhvdlFTbXNOZXFlQTF3VmZTeFpzbTdiTkRVUENHaXlUNGZLMGsyb1pSZkRhTndwRTg1V2Rna0lual9SQVJtaFFHaEFfLW5Tb3htTDZDYTBUMDJieFBfNVU?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Capricor’s BLA for DMD Cardiomyopathy Cell Therapy Deramiocel Slammed With CRL  CGTLive®",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "22f7d7f39fbd826ba1cd58489102c3f5",
    "title": "Ultragenyx Gene Therapy Faces FDA Delay: Clinical Data Strong, Manufacturing Issues Fixable - Stock Titan",
    "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNRjFYdWEzT0pObThZbExVVTc0RS1SQjhhZGs0NGRETFkwbnRrSmRsWnc3dmVYaU9sTUhUdTRnY2FzQ0U2WVhheVBhZ3dRSzVwa0hISWJhUzBaczZxLXhqb2RGanlLMnF4S2lIeG9GNkJ1ZUg5RW8zQW9Db1ZaSUhpWXpnVTBPVWZaazdkYTRxS2RxMU91UFJyWVNmNlVjTlZKRHZ5eFBHSUkzTFRRYkR2dENQU2xDUE9vbTBodUNJUQ?oc=5",
    "date": "2025-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Ultragenyx Gene Therapy Faces FDA Delay: Clinical Data Strong, Manufacturing Issues Fixable  Stock Titan",
    "company": "Ultragenyx Gene Therapy Faces FDA Delay",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "d9488612141c32532870526da6c47144",
    "title": "FDA releases ‘initial batch’ of more than 200 drug rejection letters - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPX0NhamdGMWx4NmFfUnNkZ2NKQlQ0Q1N2alpSdnVZc3lxaU94eWJuY0UzXzNLcWxlSzlpa3pZQWVtMlRKakE5OXd6SUJhaUkyS205UEpVRnpidldrMVJvcUtjM3VjTmlQeEFQSWNxRWVaLWNnWTBVTTMzbkxaaUE4VXVqT1V2RjA2MFdwek56TUJuaU9Kcnc?oc=5",
    "date": "2025-07-10T07:00:00.000Z",
    "dateFormatted": "10/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA releases ‘initial batch’ of more than 200 drug rejection letters  Fierce Biotech",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4f5f4d708d19899ecad3817af57fc611",
    "title": "FDA Releases CRLs for Previous Drug and Biologic Product Applications - OncLive",
    "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNWVh2d1FXVWZSeWU3b2g2OFpKSTIzdEE4WHU0OVVuQUk1UGUyM2M2T1VmVXhreTllVjJUX3FOdl94clRiZXhtV0l0cE04MjhtaWtMNjdkYzhTT1gwaWt3ZWtLbUpxSXJhZVQ3Y3haSy1qWW1Bb2lZQ2g3MEdwYktZWUNmTkFVai1sR2VweHM5WEJRT2RIMFNEOUVtZm5CUUU?oc=5",
    "date": "2025-07-10T07:00:00.000Z",
    "dateFormatted": "10/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Releases CRLs for Previous Drug and Biologic Product Applications  OncLive",
    "company": "FDA Releases CRLs for Previous Drug and Biologic Product Applications",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e8494c2dcdce1261ce0c9a60c4f8b60b",
    "title": "Updated: FDA publishes repository of 200+ drug rejection letters, promising more in the future - Endpoints News",
    "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNa1NadUpmeHdvZW54R1NsLWs3MGVzS3o1WHlFcmczOTdxMkRJVGVsNmo4Um1BUmQ3eDlSSFdFTGZ6dkJncHNBSW9kZGN2VlZud2VtbTR5RUJMaGVnYzlTWmFxLVJlWWVGOTR5WHctd09KbGtRMFRodUpOaThuSW1kUlNMSHVBVkk?oc=5",
    "date": "2025-07-10T07:00:00.000Z",
    "dateFormatted": "10/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Updated: FDA publishes repository of 200+ drug rejection letters, promising more in the future  Endpoints News",
    "company": "Updated",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "32f1cf5a8b320a3d9b9dc52db1e40d00",
    "title": "FDA Approves Linvoseltamab to Treat R/R Multiple Myeloma - AJMC",
    "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOMGQ2X3REc2dndmI2ZlFRN2tVOW5wSlpJeUktYWhxT29MTlctN0RpWDVDZDhoRnlaOWNZQmJORVBhRU1Sa1pNZWVkVW1PQkRIbWNaeGlZS29fLUZwSE5fQTVnZHctZ29NaXZZckN3SDU0cGxFa1R4eXlfU2trRHpBc0h4QVlORklCa2c?oc=5",
    "date": "2025-07-02T07:00:00.000Z",
    "dateFormatted": "02/07/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Approves Linvoseltamab to Treat R/R Multiple Myeloma  AJMC",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "daebc9544d86b100e2959ae07ad88624",
    "title": "Unicycive Therapeutics Announces Receipt of Complete - GlobeNewswire",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-30T07:00:00.000Z",
    "dateFormatted": "30/06/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Unicycive Therapeutics Announces Receipt of Complete  GlobeNewswire",
    "company": "Unicycive Therapeutics Announces Receipt of Complete",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f78d1068d05c4e3642ea377983ad8e74",
    "title": "Granules arm gets U.S. FDA observation resolved - The Hindu",
    "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPTDRKT0k5c01hdFEwTnFwckFSQmR3NExWUFpldVYtWXo3SnZBQ1FWSE51RFI5bDBMNW5sSldYSU55Vk0waWFfX3Z4OGFhYnhQTFA3bm43TVlCUldMcnVDeHRXeVVRdXlzaDl1eVVTWEJHbC1PRmZZMDBSZmdsM0YzdkE1bW9YZjVXVGpnaUlDRFhvVDVPWktQQk4wR1JXNEV10gGnAUFVX3lxTFBYQlR0cnRHWDhxeUU3NTNWczdXc1REWHNzRUlXeGx1TlRNTkQ2RFVSWVh2TWlIM1FxQnJBSmc1V09xY2tCYzR5VTV4RHc0VUlKRnlDYm8ycFJpdDBkNHJ3czZud0xNU0VWZUZQS253aER1allRRm9ERmVRNVBuQ3pudDAwRnJ2SlNfRmhlLUhtOFJIZHQtMGlBMzV1cWxERzFaQTI2OTBJ?oc=5",
    "date": "2025-06-28T07:00:00.000Z",
    "dateFormatted": "28/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Granules arm gets U.S. FDA observation resolved  The Hindu",
    "company": "Granules arm gets U.S. FDA observation resolved",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f6149d054610fc2530ca96b1a1905244",
    "title": "Granules India shares in focus after US FDA flags observation at Telangana API facility - The Economic Times",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-23T07:00:00.000Z",
    "dateFormatted": "23/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Granules India shares in focus after US FDA flags observation at Telangana API facility  The Economic Times",
    "company": "Granules India shares in focus after US FDA flags observation at Telangana API facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4a4cb95b91e1c6b61ba321726aaea711",
    "title": "Granules India's Bonthapally facility completes US FDA inspection with one observation - CNBC TV18",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQOThNQ1hHdDZUSFB1LWRRSGI4dVVZbmtuREl6SllJbXh1alUxVGw4Nm5WWEpETHJPOUtWU1N4b2h4TWFvdmJSYkpUdzA3UndTMVJkUnhMd3JoTUFBa0VHdnJCUG45c0RqNFVBS3N5U1poYmJKWDlibHctZjVhNmcyUWJyVHhpTEUyTWJkdWRneVVzR3JWS2FSYWFvZVRHUWJzUTRENmJISUFmdldnWC1MTE9uLUVEV2V2dWZLX2Nna1lJMTNOQnp6MlVRT2otMzRXSU5lMWxLYUXSAd4BQVVfeXFMTUJCa3FFSkVlZFBwYWZMSWpYQURZbkU1OGhuVUtQQ1h1cE8zaDlFeFJPQkhBTDF0Z2JzUjRqbGhzTy1wcFBPOFZzN2ZMYll4ME1kTkdCaWZ0S2NibVlTbEJjOFFTN3lwdUoyNWFLSW9ma3FVWFl6QkNRRDNLWTJDdnpkeWN6V1B6SE5vNTh3U25WcEZtLUhLZUNITjFwbGhSQll3NzJzZzRPQ2FBd05EOHRxOHpIeTV5VjR2eUhaT0ZObERlMnM4VGdGblZpODNRaTRWN0kyLVB5MUc5Mnhn?oc=5",
    "date": "2025-06-20T07:00:00.000Z",
    "dateFormatted": "20/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Granules India's Bonthapally facility completes US FDA inspection with one observation  CNBC TV18",
    "company": "Granules India's Bonthapally Facility Completes Us Fda Inspection With One Observation",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4dec3617c7434b5f787143fd5eca5189",
    "title": "Granules Indias API Facility In Telangana Gets FDA Observation - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxNMlE1bHc2MFBURzVkdzdIOTY3YTJ1aE5jYmptNmpMM2lZd2hlTTB2Q2oxVDN2MFRWYTFzdXhHRDI1cm52bnBKcklqZWRiaGdFb2hBRDgxSDBJQWR1ZjdsLWJER0xWQ08tU1dDR1BvTmwxWDNrSXRwZkNLYS0ta184TVJpZ1pTMUhoWnJ6UXhOTmhDZU1LVEwySWpIdVBlZ9IBowFBVV95cUxObmVaSjZpdmlKamp5aXlxb29uWWVleXVma0hHelE3THhHVU9LYlFDVVBrYmZIa1plX1VHaFVBelZ1ZF9hNlZrUHRzZk9EQkNub2M3cW5VZnBpRUdZMTZYOWFJOHdmYUo3WXBnek9HMHpEUzE2Q3Z1S1hWY1VLNHJnemx0ZnNldVVzVzFQbzIxZ01uLUR5OEdNbklLSDllSnVyaXBJ?oc=5",
    "date": "2025-06-20T07:00:00.000Z",
    "dateFormatted": "20/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Granules Indias API Facility In Telangana Gets FDA Observation  NDTV Profit",
    "company": "Granules Indias API Facility In Telangana Gets FDA Observation",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c6ba827af0210c8267e46e9e8c1a951e",
    "title": "U.S. FDA issues 7 observations to Natco Pharma’s formulations unit in Hyderabad - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-19T07:00:00.000Z",
    "dateFormatted": "19/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "U.S. FDA issues 7 observations to Natco Pharma’s formulations unit in Hyderabad  The Hindu",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0e17bd2bdd321d62396b6d9bebf8c3a5",
    "title": "Natco Pharmas Division In Hyderabad Gets Seven FDA Observations - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxObzd2UjVFS2pSaUxQQnpwMmlvbkNGdW9KcHplaGFfTUtxaW5Pb2FMSWpSdXFVNERDSkFNYTZIN2d3SGZ6dmlsV3psaXlURzk4SGZMWFQ2OFFDUzFuLUJmOU1TSmVIRGFKUnhjRE9ieTFCbnpXTmNpYUhZLURsVXA2VERRd1c1S29MbE1CWWpJWG9sdUFVMTljNldtRnVPSXI5dVFHRG9tdGRDd9IBrwFBVV95cUxQMlY0anNaVXE3bDdLR3p0ZWNBbVFKUzdmb2RCSFZqeXRZc01QX1VUTUtndmN0ZnM4cnhkNlY5WENKZkQ3TkJDcjZiWDM4NElERlE1UzFCT1FXTDFyd19uNUl2QTBwU1ZHQndtdHVxNmtZejVuRGg4NUJ5Sm1XYldseDNIQVkyMHltWW9naTl0Ukd2dkhzeFBlSU9PVlI0YTNySDZmNDNpZjZfaTd4dDhJ?oc=5",
    "date": "2025-06-19T07:00:00.000Z",
    "dateFormatted": "19/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Natco Pharmas Division In Hyderabad Gets Seven FDA Observations  NDTV Profit",
    "company": "Natco Pharmas Division In Hyderabad Gets Seven FDA Observations",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "51c281ad0d926057aa5a00ec027f2d17",
    "title": "NATCO Pharma gets 7 observations from FDA for Hyderabad manufacturing unit - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-19T07:00:00.000Z",
    "dateFormatted": "19/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "NATCO Pharma gets 7 observations from FDA for Hyderabad manufacturing unit  CNBC TV18",
    "company": "NATCO Pharma gets 7 observations from FDA for Hyderabad manufacturing unit",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c9a0a0d3dc7ab5919382a484f127bd55",
    "title": "Glenmark Pharma’s North Carolina facility gets five U.S. FDA observations - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-18T07:00:00.000Z",
    "dateFormatted": "18/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Glenmark Pharma’s North Carolina facility gets five U.S. FDA observations  The Hindu",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "3a08cd840833438f044f274ab003fe7d",
    "title": "FDA observations, leadership change keep Sun Pharma stock in spotlight on Monday - The New Indian Express",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-16T07:00:00.000Z",
    "dateFormatted": "16/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA observations, leadership change keep Sun Pharma stock in spotlight on Monday  The New Indian Express",
    "company": "FDA observations, leadership change keep Sun Pharma stock in spotlight on Monday",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "06ecc9bdd9d8a409b951843e483472f2",
    "title": "Compliance review: US FDA issues 8 observations for Sun Pharma’s Halol plant following GMP inspection - financialexpress.com",
    "link": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxOU3JpNVdJOUVuYmlJWHRxMVM4WENyVzZHM3prTFNMUW5falhsMkdZc3JwRXZKSndUSWFmc1JuR3M3RGo0bWh6YnVMSHc0VFBYMy1pOUcxWTJEci1uN21kSGt5ei0yQnJUTDJoVEZ5RWpVSVRoZDJTZTFQaGpRWHc5d1hTZWNYRFMtWS1PYnMzbzRBS0NlMnFzd3d5VWdaeUI0Y2NoYlZWa09fUElMbkpoMkw3cEhCRGZmRk1yTTFSdVNHb3ZJSy1aY05wZEdqN1M5SDNpNjAwWmJDWFVZM1hCeTRPSkl5NEJYR2h1Rmk0N1J0bG9WdUE?oc=5",
    "date": "2025-06-16T07:00:00.000Z",
    "dateFormatted": "16/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Compliance review: US FDA issues 8 observations for Sun Pharma’s Halol plant following GMP inspection  financialexpress.com",
    "company": "Compliance review",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f347148dddf7963e9f0a81af88c8020f",
    "title": "Sun Pharma Shares Slump 2% on 8 USFDA Observations - Equitypandit",
    "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPeU9yNWsxd3FhMll5ZGxvUFd3ZndJQTF5Q05TRDkzTm5zME9sN3VRRlRkUS1JSlNUaUkybnlhQ2E3dUFGX0VsckpLTW9oYWhvTkJTWEwtdjhKcGttUWZHWnJSd0pVc25qSC03SUVsUWJjQ3JodHF3UXVkckc3N29XQzBCcVFxQQ?oc=5",
    "date": "2025-06-16T07:00:00.000Z",
    "dateFormatted": "16/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Sun Pharma Shares Slump 2% on 8 USFDA Observations  Equitypandit",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8e26c4fdf4085e5cbf3efd1895749d53",
    "title": "Sun Pharma shares in focus after US FDA issues eight observations for Halol facility - The Economic Times",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-16T07:00:00.000Z",
    "dateFormatted": "16/06/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma shares in focus after US FDA issues eight observations for Halol facility  The Economic Times",
    "company": "Sun Pharma Shares In Focus After Us Fda Issues Eight Observations For Halol Facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7d712b8ce8dc7900f85f1ba3eb12f359",
    "title": "Syngene's Bengaluru-based facility gets 'NAi' status from US FDA - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-14T07:00:00.000Z",
    "dateFormatted": "14/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Syngene's Bengaluru-based facility gets 'NAi' status from US FDA  Business Standard",
    "company": "Syngene's Bengaluru",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f9fe7783bc382cf313393646cfc28efe",
    "title": "USFDA issues one observation for Natco Pharma Mekaguda unit - Medical Dialogues",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-14T07:00:00.000Z",
    "dateFormatted": "14/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "USFDA issues one observation for Natco Pharma Mekaguda unit  Medical Dialogues",
    "company": "USFDA issues one observation for Natco Pharma Mekaguda unit",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "566e3b10b055164b6df509382cfc0fd0",
    "title": "Sun Pharma gets 8 USFDA observations for Halol facility - Medical Dialogues",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-14T07:00:00.000Z",
    "dateFormatted": "14/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Sun Pharma gets 8 USFDA observations for Halol facility  Medical Dialogues",
    "company": "Sun Pharma gets 8 USFDA observations for Halol facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "41af34e2ce9a27fb54e2b49edb400985",
    "title": "Natco Pharma’s API plant in Hyderabad gets U.S. FDA observation - The Hindu",
    "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNTzc4RU95ekRDdTRVVXR0b2RBTWFEbWd3VFlXN0ZSNjJjS2tSNzFlVENlVzRxNERsZDhOb3pxZU9BNlhLamVVdzFSM1BqeXlMMUJvLVV5cjRIMG5xYkFVQ0pTeVlHaFp3Y0dLYW41bjd1ZnFvbEhib0xPajlUSk02bktaUktNNVVGRGNJT2s0R0p0YWtFNmdSandKcFFVSTJJdHVlb3BkZkdOdDFiaHROeW9kczDSAbsBQVVfeXFMT2RjN1FQV0dxMXBwZEphTEtMLWY0WjBKbUxyampITVUxUmJaLUt3M0xhaElqLTB1a0Z0RUdnUVFSV0trajd5dHNOYl9VOWFHQ25rOV9LUHR0VHhBVUN1VEhKT04yY2dTdF9ZZ1doNDZ3MHh1VElyZ1l3VnF2WnNvaHZoS0pfdUlZcFRqLVRjZVIwWmNSRFF5dHNJU1U1TXpSd0puT1U0OHVmUmc3Z3B2emdMa084aXNralJWSQ?oc=5",
    "date": "2025-06-14T07:00:00.000Z",
    "dateFormatted": "14/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Natco Pharma’s API plant in Hyderabad gets U.S. FDA observation  The Hindu",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c1aebe0472d80ec772de4a6ce2b20fd6",
    "title": "Sun Pharma’s Halol facility issued eight observations by U.S. FDA - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2025-06-14T07:00:00.000Z",
    "dateFormatted": "14/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Sun Pharma’s Halol facility issued eight observations by U.S. FDA  The Hindu",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1f84b54f33ce4f31971056c9d5509ded",
    "title": "Sprout Pharmaceuticals, Inc. - 709942 - 05/29/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQMEdDdXdDMDBVV3FET1FvVlVRM3F1UGV6dklJb29pYk12czQzZFlXNTNTY1lrdHZfVVZ4R2NOcjd4NjI3NXdvUVhkeU8tWU5yZGV0QThjVUZ5eUpRYmV4WGhJQWxxNVRmWTJ2MFAyaU9qYjd5OERsSTVVZi1rYTZuX1d5TVV0dk8ycWtKbzQtT1JiSmlIc3Zockc0SkhQc25sbUpwTEN4V21IbHFjVmlzTFZ0LVhKUDN0aFpEbng2QVFVZHZ4RWsxUURDejRCRmhCNWZDSDMwX1Y?oc=5",
    "date": "2025-06-10T07:00:00.000Z",
    "dateFormatted": "10/06/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Sprout Pharmaceuticals, Inc. - 709942 - 05/29/2025  fda.gov",
    "company": "Sprout",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a16da69663b853bcb8ee5978c9a4dd43",
    "title": "At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQQWxlR3o5YlZ0UExNc2NjVURMTHd2TDlveFloQjdzOGo2Y0ZMY3pHeF9laU93Z2lkT1QtOTVzWDd1dWhDMkgyX1R6VVRkMk1HQkUtWVZ1STJYTmtJZUU5TkNyeEEyVGNYWFBCb2JiUXdEMWJpZ1hvdTVRZDgwWklWbnVfN1paTmRjU2VVbkxWTnFfMkpKMkJScWlVVTZRWEdMRDJuUnlYdVg4ZUhsd2k3VVVMT0lGemlPcjhHQzhsbnZOaVM1N1FVSm5TRU55bTA?oc=5",
    "date": "2025-06-03T07:00:00.000Z",
    "dateFormatted": "03/06/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions  fda.gov",
    "company": "At",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "746d9ca70b9877cc3243c58371fe8312",
    "title": "At-Home OTC COVID-19 Diagnostic Tests - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNSXVTMmVqQ0Q2M2VPck0zdmxVTGh0czY1X25ZRlNYclRhNnNsMlh2YnBVRWlIT19ZdmZ4Tm5Yekp4bm43VWczM0w3YmQxUDFfcWRTUE1uTlhiQzYweUk0S0IxNG1CQnRSWkV0U2tMOHk3RGtwSnZvTWpXZnFiSkFpZkcxVGEtWjRneDdid0NrMjFIaDlLV1hYb09FRHVWYUw4VDRmM1ZVeWNGTVA1WUliaA?oc=5",
    "date": "2025-06-03T07:00:00.000Z",
    "dateFormatted": "03/06/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "At-Home OTC COVID-19 Diagnostic Tests  fda.gov",
    "company": "At",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "badedc942d1d7169e0cb3a7ec0192274",
    "title": "Mayne Pharma Close-Out Letter NEXTSTELLIS - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1lTDRQSlFFSHpXMXl5bTA0djVRU3lfVXBJaXZrQXhQOEdJblE3QWVfeklJUUxoUTdfSjZGVGRDZGhQdDl6MVItRzlYTmxXVFo4Y3pN?oc=5",
    "date": "2025-06-02T07:00:00.000Z",
    "dateFormatted": "02/06/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Mayne Pharma Close-Out Letter NEXTSTELLIS  fda.gov",
    "company": "Mayne Pharma Close",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8ce945337c66bae4a6942755dc2cfe9d",
    "title": "Vaccines Licensed for Use in the US - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPLXNYWFc5ZTl0U0NhMUdKa0JRVkl6S0FqYi1MNmlnWXZQeXJKTGhaZkpCOXJXLXVsdWFqby04aVIyUUcxUnBjNHRvWjRyenFEc05uSWNIQUFGdDV6eTNialBTSDBMOV9jcjJqLU1oSkhtVGsydjdXcTRuNmdPcWNIRGloeV8tNGJibEVnU3g0S3loQUU?oc=5",
    "date": "2025-05-31T07:00:00.000Z",
    "dateFormatted": "31/05/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Vaccines Licensed for Use in the US  fda.gov",
    "company": "Vaccines Licensed For Use In The Us",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "40e352f02c63fbc197098e8dcf012a07",
    "title": "USFDA issues one observation for Cipla Bommasandra facility - Medical Dialogues",
    "link": "https://news.google.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?oc=5",
    "date": "2025-05-31T07:00:00.000Z",
    "dateFormatted": "31/05/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "USFDA issues one observation for Cipla Bommasandra facility  Medical Dialogues",
    "company": "USFDA issues one observation for Cipla Bommasandra facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1911c599e3315e3f9849511f11181340",
    "title": "Cipla's Bommasandra plant in Bengaluru gets single USFDA observation after cGMP inspection - CNBC TV18",
    "link": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNUHZSMS1mSWFQNkZpY2lfN0xoTmViVFJfVkJwVWFqc2lQYVBKNXJtNklyR1pwYWRYSmc2U19pWl9ySTI5ak43Z09tVjY3VndxZmE3QVJZMGtLLURvMFh4bGwzOEV2OWVWTlVXb21sbkkyenNUUy15NzlYYUk0NEZ0NmpUc1o4R3RPdFFmeEtmb2hPUXhmTDNRd3VTdXFBVDd6aE85LU9HUDZ5YmNoeGxqa3IzSnJuelNnVG9ocndwWmc2dnFrVnp2RHdKTHlEZUF5OVR2YWNhQjc4YWR5VTY1dmhHai1Jem_SAewBQVVfeXFMUFRNVUNDbE5OUFU0VnhIS1plSng2eXNHMzZ3MTd0UUxrcFVNeElnX1NIa3cya1N5aWkxaF9pZ01rSzBzWHJNSGwtbTdHcFJhVWxjcWg2V0oyTGhEbHBvcS1TcEpLR092ZXZUclVGbmdhQ3RsRFB6UjRpQzNwNEJ1bXNGbThYUG55dGFLdktiWFlWUm9TZk9fWFdvaWFLX01SU2d2SlluRTE2VWNKNFFyNDZLQmNwZmM3bnRaNkR3M01lZkdOYTRRVGVvUkttWkIwSGY2eTdIUS0xSEJ0Ym00TEl0RDlUZEZwbFFEMGY?oc=5",
    "date": "2025-05-30T07:00:00.000Z",
    "dateFormatted": "30/05/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Cipla's Bommasandra plant in Bengaluru gets single USFDA observation after cGMP inspection  CNBC TV18",
    "company": "Cipla's Bommasandra Plant In Bengaluru Gets Single Usfda Observation After Cgmp Inspection",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "df59bcb9b3c5061ba0b57a46923aeb19",
    "title": "Stealth hit by FDA rejection to twice-delayed filing as it lays off staff - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOcXpCbnZPTFRLNmNrOHpMVGFzZm1KX1ZJUHZFMVNSVmM3ckYzRTJJLVdZUldFMXpNdXdERkRPc1VmSElTaDkteV9vVUEwaHRJbGRVendaQU9aQmJTbWo5RHNhSXpzbTNtYllxRHVuUi1XaW5GT0JFTEcwNC1CcW9JRDhfaDZhS1o4aUdySHRyal96RGVibGpnSkRZVXVhT0R6WEwzUGZnVjNWV0EybnVBaDBTSQ?oc=5",
    "date": "2025-05-29T07:00:00.000Z",
    "dateFormatted": "29/05/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Stealth hit by FDA rejection to twice-delayed filing as it lays off staff  Fierce Biotech",
    "company": "Stealth hit by FDA rejection to twice",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "88148a85970691f7f747197276eb25cc",
    "title": "'Hanging on by our fingernails': Stealth CEO questions efficiency behind FDA rejection of rare disease drug - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOVWNOZDk3YXJidTEyOHFPWHQ2VXlkcGprZHd2RWtXZThJX2diNlhMcDFDTGpyQmxsc2FvbVIta1luSy12TlpZTFpCR3BPMU5zeXNyakNWR2xmN0NzWVVEdEF0Y3NVbDlLRk5wSHBHanlJM1Zob1hHb3J4dTNCZzlJMnNCTXhSVnUtOFJ1NFFGNU1PTUJIZGdFVHloeXRxY0ltQ19Ra0pxeTlYREs1amNaa0t2dzFEZDM3ajJrNmp0a2RvVzFtVXc0?oc=5",
    "date": "2025-05-29T07:00:00.000Z",
    "dateFormatted": "29/05/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "'Hanging on by our fingernails': Stealth CEO questions efficiency behind FDA rejection of rare disease drug  Fierce Biotech",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a6cb464ebca4e9410a44376d19297765",
    "title": "U.S. FDA issues two observations to Dr. Reddy’s API plant in Telangana - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2025-05-24T07:00:00.000Z",
    "dateFormatted": "24/05/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "U.S. FDA issues two observations to Dr. Reddy’s API plant in Telangana  The Hindu",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0bc7331cdc0642a71dc1565b6ab8e3d2",
    "title": "COVID-19 Vaccines (2025-2026 Formula) for Use in the United States Beginning in Fall 2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPZGhnRU9jcmJIOHN2YW90RzNTRHVnZUlvSWd0R2RHXzVYbXdybjhkeVBKYU4yMHFWRTA2bTNhMHRkdWxTYnJrOGJtcVFrSWNqSFdqWGVCUUgyS2t0MDg3RVI0N1o2Mm9Fd241VGcxRXRFWXJDbHBZR25wTG5PTnJfbUd5TDJTTDMtelhaV3ZmR0tFamNxMm40X3lpRUxqVTFNcF9OUzlEam51OGpHcWJpTmVmVUZhVmJ0LXlqUllJVDJTb1BidkhXV1haUkt3SDdTaGpJ?oc=5",
    "date": "2025-05-22T07:00:00.000Z",
    "dateFormatted": "22/05/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "COVID-19 Vaccines (2025-2026 Formula) for Use in the United States Beginning in Fall 2025  fda.gov",
    "company": "Covid",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "76e3fd53469383e4b2a32cc0033d4aab",
    "title": "Sarfez Pharmaceuticals, Inc. - 708901 - 04/25/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxPS0YtQTRYOThjNmtMWVNIYnVoQVA3ejlUZThxbE1odldFcHZ4ZlhqRF9Qa1otaDhCVW9tajVTOFN2dzdTSHBDSTNKZkFlMGVFeWtHYndVY3RnNVZ1VDcwR2w1emhscFdxMHlMb0t2RU5kWTRTRjBOZzd1Sm9XR1JxUlZpamN4NXpHRzhEcjdVNllhUzZneV9FZTlWSTRpeWNfYjJTVjcxVTM2aC0ya3p4dVEzVDgzakhqQ1BkYXZXcVRteVMwbEZFNlU1bkFlYUhIYW5aSzBIWng?oc=5",
    "date": "2025-05-20T07:00:00.000Z",
    "dateFormatted": "20/05/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Sarfez Pharmaceuticals, Inc. - 708901 - 04/25/2025  fda.gov",
    "company": "Sarfez",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "14fb1153ede66a570505b67a5d4a0ced",
    "title": "FDA Delivers Blow to ImmunityBio - Los Angeles Business Journal",
    "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5RVktfaXR0Zm9RYUY2a2RsWDFua2FrdW9IbHgwSVBnMlRKbmdpODU2QzFzTjBZTDlCd2N1SllJbUNzTXBROHBnblhFQXU4M0pNa2E0QU02MkRXcHViaWVWanA0QzFaZUlTdTVYUE5TYjBkWXVpYldHcHQ0VDE?oc=5",
    "date": "2025-05-19T07:00:00.000Z",
    "dateFormatted": "19/05/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Delivers Blow to ImmunityBio  Los Angeles Business Journal",
    "company": "FDA Delivers Blow to ImmunityBio",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8db0f8ad98f641640b304ffc23c42b68",
    "title": "Dr. Reddy’s Labs stock in focus amid FDA inspection report, Q4 results - The New Indian Express",
    "link": "https://news.google.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?oc=5",
    "date": "2025-05-19T07:00:00.000Z",
    "dateFormatted": "19/05/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr. Reddy’s Labs stock in focus amid FDA inspection report, Q4 results  The New Indian Express",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "91984a3c3557f6a142d46b03fb92e425",
    "title": "Dr Reddys Gets Two Observations From US FDA For New York API Plant - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE5RclFGSzNCQUZ4XzVRR3UzWTloZ0lFTXdoR2dfN0VJUWdoWnNhSGJHQnpYcWFNNHdBYnlid2ozWE5XSEs5OWcxcFB4cmZDZUxJQktuMDVtVlpfakZRZmJZ0gFkQVVfeXFMUEwxNXdZSE5pczdyUVRBRlY0c3g4d0dNRktqcHRzeDMyNUhuVjh3MlIwa3puM1M4aGZDSWZJNFlQSGpVUkJaMjJ1RVdWX2pVRDIxTzMxSllHRmE4M3lrYUU4Nm81UA?oc=5",
    "date": "2025-05-17T07:00:00.000Z",
    "dateFormatted": "17/05/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr Reddys Gets Two Observations From US FDA For New York API Plant  NDTV Profit",
    "company": "Dr Reddys Gets Two Observations From US FDA For New York API Plant",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "cee72705e4f70927382a4fe7252192cd",
    "title": "FDA Issues CRL to TLX101-CDx for Glioma Imaging - OncLive",
    "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOcU9TZGNfSjhtUTZsWTNYQ0NiNUR6YmhGQW5vVjZEY3FSMFg0UmZ1RXBoSWhaSlRzYUtSeXFUcEdNSnVPQ1Nlank3blAtQjhrdlJlSGNzd3Utb0dldUV1dlNFUlZrM1pzNnREWmtTQUhBQUVVdlBJUFdFSkZvZzBKanlR?oc=5",
    "date": "2025-05-01T07:00:00.000Z",
    "dateFormatted": "01/05/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL to TLX101-CDx for Glioma Imaging  OncLive",
    "company": "FDA Issues CRL to TLX101",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "aaf2d25c22022ffb089e2df2120f2150",
    "title": "Mandy Edwards, Manager, Regulatory Affairs and Operations Mayne Pharma LLC 3301 Benson Drive, Suite 401 Raleigh, NC 27609 RE: - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE4zQlMzbjkzLVRhTnpjRmRKcFRlNjVuMVhCcURQMEV6SFlnZWVUWjRUaXNhRVZZR0RSaGZjQm9rQWwwUFBiV2hPY2VMUnB5WFQ1S3BN?oc=5",
    "date": "2025-04-28T07:00:00.000Z",
    "dateFormatted": "28/04/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Mandy Edwards, Manager, Regulatory Affairs and Operations Mayne Pharma LLC 3301 Benson Drive, Suite 401 Raleigh, NC 27609 RE:  fda.gov",
    "company": "Mandy Edwards, Manager, Regulatory Affairs And Operations Mayne Pharma Llc 3301 Benson Drive, Suite 401 Raleigh, Nc 27609 Re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "bbf0120a644f0bbe99ca5f060b796f04",
    "title": "Marksans Pharma arm New York facility gets 1 USFDA observation - Medical Dialogues",
    "link": "https://news.google.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?oc=5",
    "date": "2025-04-28T07:00:00.000Z",
    "dateFormatted": "28/04/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Marksans Pharma arm New York facility gets 1 USFDA observation  Medical Dialogues",
    "company": "Marksans Pharma arm New York facility gets 1 USFDA observation",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "678bd3fd2659d009767a38b000a03a9f",
    "title": "Empower Clinic Services, LLC dba Empower Pharma - 700962 - 04/02/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxOQktfRFZKbndkaTc0S292a0tlcmFWQ2JnX0M0bV8zakJpdW50bjFpVDlnTHZYQl9jV3dGLVhPZjY3X3lMVjM3a3VLbkxzMTJob3FCY1hLOHFNRGhZb24ySVhad2MyZlR6eHFRcXBxZjRpaEFlTnBTbmRyR2FVd1p4OWJJNmlONGtPOWo3aGIwZzlMYTRyalMxZXBGVjA0THE4NnNGWWlGOGlxelNlRUVIMGtrZmpOQmNjMUs5bXFzbkN6LWF3LU5QN3FNUmE5Y3JRcHdLbFk5bHdYRWUzeUlLTXdGdnBOazdlU01LYXA1ckxESEU?oc=5",
    "date": "2025-04-22T07:00:00.000Z",
    "dateFormatted": "22/04/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Empower Clinic Services, LLC dba Empower Pharma - 700962 - 04/02/2025  fda.gov",
    "company": "Empower Clinic Services, Llc Dba Empower",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a30aac457600fbf348ebc5871c9df5db",
    "title": "FDA Issues CRL for Extended Dosing of Eylea HD - Managed Healthcare Executive",
    "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPWHNrTUNjUEtXVDZaRzNzNi03UFZidUthM09WRzl1Q1B5d0dXTzFGeWJYel9BQVdTTlc2WnRjMW5CdVR5Y3AtVEZkeno0RkZIQXZrclB1RUdibUx2MUFMaGJBRENSb2d0bTF0UjN4aUdWdDhWZmg5NGtuZTA1MmsxUTRNamRRZHk4cF8xYTFtVFlQdF9HcVpraG1B?oc=5",
    "date": "2025-04-21T07:00:00.000Z",
    "dateFormatted": "21/04/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for Extended Dosing of Eylea HD  Managed Healthcare Executive",
    "company": "FDA Issues CRL for Extended Dosing of Eylea HD",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b49759b536ec57cd412d2f5c27f311a1",
    "title": "Drop off unwanted or unused medicines at a drug take-back location - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOTkxGUFB2bDUwbEs2dnRRbHcxbjNDWlJhMlpfdFB3R1hYazl3ODc0RUY5dm1pRU82My1nUkd6OTkxdkNTWXRRVTcwTFlKXzhCNDJtbUNQMEp0UV9RVzFLSUJuQ05VbkxjODh6STN4SGc1RDlmcGNjSjVXTW9lbE1KblNSOU9xblFHblBOSm5R?oc=5",
    "date": "2025-04-16T07:00:00.000Z",
    "dateFormatted": "16/04/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Drop off unwanted or unused medicines at a drug take-back location  fda.gov",
    "company": "Drop Off Unwanted Or Unused Medicines At A Drug Take",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "acc1338fd20ea7a653c684f3c764d715",
    "title": "Aurobindo Pharmas US Plant Gets 11 FDA Observations - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQSlBpLXVWT0JKWmZfTi1kcXJmeC1sSld5ZGRWNjRwdXljdnZjSVlJbTNnbUM3d3dwZTJIcjRiWnVYcG1DOHg4QTNzdUF5NjBsYklydV9XbXp5ZEtTNExzM3lYLVEwdVhLMVlYX0NOdlpvcURwWE82OGd4QlREZjdITlpkZWFPTURReFFwblVmbV_SAZYBQVVfeXFMUEJDWDZEMWRHY1FUTGhjdEwxYVJIbG9CcEY3dS05QmJsS25ISkV6cHdpb1h0ZFd1RGhxVnBsYTNwZERpOWZyaDlSaU5VM1Q2ckVoSGVJOXFxcE1raFJBY1NkbUxncnRUT3FDVER3YUVnSnd2ODItNlFsMTNESzlfTXRPODQ5R2hDODlBdlZDeko4MTFYMklR?oc=5",
    "date": "2025-04-11T07:00:00.000Z",
    "dateFormatted": "11/04/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Aurobindo Pharmas US Plant Gets 11 FDA Observations  NDTV Profit",
    "company": "Aurobindo Pharmas US Plant Gets 11 FDA Observations",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "eaf34aecc31e7c9f136dbcf4db5c810b",
    "title": "Aurobindo Pharma arm gets 11 USFDA observations for Raleigh Plant - Medical Dialogues",
    "link": "https://news.google.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?oc=5",
    "date": "2025-04-11T07:00:00.000Z",
    "dateFormatted": "11/04/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Aurobindo Pharma arm gets 11 USFDA observations for Raleigh Plant  Medical Dialogues",
    "company": "Aurobindo Pharma arm gets 11 USFDA observations for Raleigh Plant",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "550b8f2f3523f45ecb4d2576fff4905a",
    "title": "Shilpa Pharma Lifesciences’ Raichur API facility clears second consecutive FDA inspection with no observations - Express Pharma",
    "link": "https://news.google.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?oc=5",
    "date": "2025-04-09T07:00:00.000Z",
    "dateFormatted": "09/04/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Shilpa Pharma Lifesciences’ Raichur API facility clears second consecutive FDA inspection with no observations  Express Pharma",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "bcaf8d2b01d11297b829e89e52a79d39",
    "title": "ICU Medical - 702535 - 04/04/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOVzVicUdpbFU5YXI1elZlcGZHS0pyb3gyX1RzaVE1VU96d09tbUhJR3FCMS1CM1FyazdPaEZRaVpWYXNtS01LdzFCWS1FdEVfbFZIb0JJdmZ4YTg0N0NHWDdFQVBENGtGSWV2cjAwR0ZrTUVGdGFqV0FycXJ4YzJFdlZkSThOS2pkRWdVMmI1OFdmV0RZSGJZYUFqTUJiWDMzLUVUSmN1UmY2THNTTlpyTDRFR0NORDliOGZSdnpGVDd6WDRU?oc=5",
    "date": "2025-04-04T07:00:00.000Z",
    "dateFormatted": "04/04/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "ICU Medical - 702535 - 04/04/2025  fda.gov",
    "company": "Icu Medical",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4e5b0fe608f8889fbe6b5ba977e92145",
    "title": "FDA Issues Second Camrelizumab/Rivoceranib CRL in Hepatocellular Carcinoma - CancerNetwork",
    "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPRU56Uko2UXR2bkx3MVBSTThVSnNyTjNKYW9LSEdwaHQ3Z2c3emkzXzZpaThrVTU1NGFXbmFPZ3BqYXpuM1BWd3RJdGhFS0ZEUUJBUTM2b25QOHlBQ0Z5QXE2MktlSHZZYWJOR3lhVm42cExlWFhDMmlpcDkyQThVWlgwYi1xX3U4cjg3dnpfcEV4c2JMQW93Q3YwZjlCVzBfeU1JMG9Uak1hNTQ0LUE?oc=5",
    "date": "2025-03-21T07:00:00.000Z",
    "dateFormatted": "21/03/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues Second Camrelizumab/Rivoceranib CRL in Hepatocellular Carcinoma  CancerNetwork",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e5f340c7ca38d5235b5ea67512b1503e",
    "title": "Vegewax Candleworx Ltd. - 675099 - 06/14/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNNENkRFJFbUY3OXdvakhYR3dmc2ZCWHB3UjFFRkdjZkFDMl9Zdzc1eTc2SHN3UjgtWTJEdjJneldUUWh5RUhMREdCaDQwMjkyRFBROHpWLUc5TXFBSVNoMjJya0V3THAxVFljTnIxbkw2dTU4ajQyMUVfUkNOUm4zdndaeVJiR1NrcmNOT2RYQ2VnMDlsd2JvVW1MRmIxZF9XZzYxR0dSdVlMUHZER0JlQmNPeEhCOFJKVlZwa1dyeGxXVnExSTVPUG5QN3lBQW9mbzNR?oc=5",
    "date": "2025-03-18T07:00:00.000Z",
    "dateFormatted": "18/03/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Vegewax Candleworx Ltd. - 675099 - 06/14/2024  fda.gov",
    "company": "Vegewax Candleworx",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2061aeab8d7ec11a84ee29197196f76c",
    "title": "MG Infusions - 696890 - 03/10/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOSjZicXNMRjd0bFhpNUExWTZEQzB1cXRPOTRaemRjTlI2T1IxVkRmVjMxMmpXZ3BtazVpbWFyTkVmWU1RaS1TMjNCREh2TGhtTXVZa1JBRnMtTzdhbGtvMDlSQk1EdzFBQU91ckxKTXVka3B3S0ZRNkZ1Sk1FdnVObFdISkFHSVBCdk82Y0Z5NkN5OXpqVDlfamZaZmJMb0xOQkJOdlBIc20xcm9WUldUaVVKSUxPSVptbGh1dF9id2ZqaUItUVE?oc=5",
    "date": "2025-03-18T07:00:00.000Z",
    "dateFormatted": "18/03/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "MG Infusions - 696890 - 03/10/2025  fda.gov",
    "company": "Mg Infusions",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "65e47b1a77172c8dc7a87dfb3a6be83d",
    "title": "Linghai ZhanWang Biotechnology Co., Ltd - 697983 - 02/25/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQOFRVeERwdTF2WEtpVjczTEVBQlV3N3lkWV9fVmZySnBLbnE0cGFVdWk4Yjl0VEdrY0FFNlNwQy1EdTZtc3Z1R2ZjamJtMVFNeUwtZWxjOTVLdVp3clNNRFFPVjNSRGtTc19QSTFnMjR6WkNrTzZOV05ySmgzaTd4TExBeW1BQjQxRGhlNThEelE1azhsdlV4eEdFU0prOFlKd3VlNWRBVC04VjZzZHZFVUg2SUVXa2FYUksxVVRYWktjWlJxMFpVaW5aWGNtSzRfaHZ3a0hmS3JPVWlyOE9VQjF3VkwxZ28?oc=5",
    "date": "2025-03-11T07:00:00.000Z",
    "dateFormatted": "11/03/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Linghai ZhanWang Biotechnology Co., Ltd - 697983 - 02/25/2025  fda.gov",
    "company": "Linghai Zhanwang Biotechnology Co.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6793fb18da828b55b7c8764a228ab2ff",
    "title": "US FDA ends Alembic Pharma's Vadodara unit inspection with one observation - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2025-03-07T08:00:00.000Z",
    "dateFormatted": "07/03/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "US FDA ends Alembic Pharma's Vadodara unit inspection with one observation  CNBC TV18",
    "company": "Us Fda Ends Alembic Pharma's Vadodara Unit Inspection With One Observation",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "9f364c859cda36248d0e647e5ab9b959",
    "title": "The Bad Ad Program - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPa3pNLThkTWFSMXNRZ0lxS1c4T3kxRjhUakhHMnBaaURZUHlFYUJjU24wMy1Kc1JVSVppT1JDWE1NbVBiZ3BnUmM1akc0aXpFQVg3N2hoNVpZQ2RzX0dCaEtwYUlCZy1qY2piMWxlWVN2UUxtb1duNWlyanY4NXp1YQ?oc=5",
    "date": "2025-03-06T08:00:00.000Z",
    "dateFormatted": "06/03/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "The Bad Ad Program  fda.gov",
    "company": "The Bad Ad Program",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6353b5c16bb40651f1aea6ca1f1947c8",
    "title": "Shree Jaya Laboratories PVT. LTD. - 698690 - 02/28/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOQUxXaXQzSHdCRGlJeDJfVWpuNVNuY2REOEF5Q1Blc1pZTlBqamZEelFfdXh4RUNCUTFrM1k4S2tnT3JJMjJJVkdyYzRwMGxOX0NvQVNXLTFiWjZCWEhkQjZEcjlyZkhfNkhXZnFrRG5aaktmblE3OGM1ZEZlTW43WUVCNWs1UnV0d2F2bTVhOWlxOWEtM2tiS3otNHJLRUhrcEU4QWNyWFlLNWFvM1RQUl9NN2dpT2R0RXprclRfUS00NE5wZ3p0SUJTaWFCUUYyTXlBUl9qTGYxZTZld004?oc=5",
    "date": "2025-02-28T08:00:00.000Z",
    "dateFormatted": "28/02/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Shree Jaya Laboratories PVT. LTD. - 698690 - 02/28/2025  fda.gov",
    "company": "Shree Jaya Laboratories Pvt.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "415da84e8dc12e336a57410cb7b6d5d6",
    "title": "Aspartame and Other Sweeteners in Food - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOYzhOdjVRa3VqTmlQWkRfN1pCVGR4OHMxTk9mXzRvNlFsbEpJMFB6U2p0emx6SG41RGh0UGpUMXZPN01zNHZXZlFacm5FUGhpT2hNdElYdTVVSTFhWW90MjVEU2hnTVd4RlBGTlh0cFZvS0VRM2ZvUWFRdHFERkd0Z1BLOThTcVZRR182X2dB?oc=5",
    "date": "2025-02-27T08:00:00.000Z",
    "dateFormatted": "27/02/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Aspartame and Other Sweeteners in Food  fda.gov",
    "company": "Aspartame And Other Sweeteners In Food",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7ae063920488ae389f596670879d37a6",
    "title": "The Vapor Club LLC - 700095 - 02/27/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPRDMzdWluMjNfVTNfLWg0UVVKTy1neEthR0paN0VuN3NtREJsbzZTRTJLN0tEazB6VEVaNkE4cDNaSl9TaUVhcDN4anBlLVQxWkxNVmtJRk5MZzZTUmlZTnExcG10dXhxNGpFY0tqLWhMWUxUYmo3VWx4ZzZ1blhTWVhILW5GMWcwRjJ5ZnpEbnZVTzJEc2liMUdYMzJHWGtwUlJVUGUxR3pydWJXS0xpYWFnT2dYY3lWRnlYSGQ1WjJJWGdEcG5xZg?oc=5",
    "date": "2025-02-27T08:00:00.000Z",
    "dateFormatted": "27/02/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "The Vapor Club LLC - 700095 - 02/27/2025  fda.gov",
    "company": "The Vapor Club",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7e9b72dc3f4bb40173c02b02dac8a420",
    "title": "Gland Pharma Gets Three FDA Observations For Visakhapatnam Facility - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNZ24zUm1pbklnbklLbmJGWFZaOE8xV0FKTVFoUmd5VmpaNVJEbVl4Slh6OUlVTVdvMHJ3VlZHYzV2c3ZsbnJBV3NnWUJ0LVNhOW84TjIwMVZRZG0wbHFnV0hvRUE1MzhkS0J0cFM5RjhoNWZZYTJyLV9UR3ltOERod3FUVk5BWjZQci1odVp1N1hwUU84dTBRRG1Zc1JzR2prTGszNnFB0gGrAUFVX3lxTE4tNzhEMGhqdUV4ejVQRDJ4Q2Fqemd6Sk5ISGtEWUhfS0w2Mmt3NVB1LWZnWGQxNWRISXhETVQ0Y0t3OXRQVm5wQ09jUE1CNXdDaXZnTkViQjlldWJ0MDdCa2Mza2pCLUVLblVqYnFwT0ZpMTZvOUN2bi1yTmE4QjJvNlA4MHlGelBUWWxNcFJQOG1iQXZjYzFTU0Z5WDR5Z1pYSVZvbXZsOGN0NA?oc=5",
    "date": "2025-02-25T08:00:00.000Z",
    "dateFormatted": "25/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Gland Pharma Gets Three FDA Observations For Visakhapatnam Facility  NDTV Profit",
    "company": "Gland Pharma Gets Three FDA Observations For Visakhapatnam Facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ad574f9119518502caeba88de888e9d6",
    "title": "U.S. FDA issues three observations to Gland Pharma’s Vizag unit - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2025-02-25T08:00:00.000Z",
    "dateFormatted": "25/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "U.S. FDA issues three observations to Gland Pharma’s Vizag unit  The Hindu",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8e30e3c2d722e2a73abe8f2b8e820fa5",
    "title": "Syngene International gets 5 USFDA observations for Bengaluru facilities - Medical Dialogues",
    "link": "https://news.google.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?oc=5",
    "date": "2025-02-24T08:00:00.000Z",
    "dateFormatted": "24/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Syngene International gets 5 USFDA observations for Bengaluru facilities  Medical Dialogues",
    "company": "Syngene International gets 5 USFDA observations for Bengaluru facilities",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "636d8d29cb44d013a4c93f0ee0a900b0",
    "title": "Mastering FDA Inspections: The Prep Work For Regulatory Success - Med Device Online",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOUEpyNGdaVlV4WkNqMnJGMUFMT3dLMGM3SnRqTVdGUzQtUEpteDNmZ1d6OVZaX19GT0txNEw4TGxVT2U5b3dlVGNOcFNYeGhIZFNXcWcyeG02TXoycHA3Z29uQ0JWZXJCMDRpaUZfWFFTdk1zUWJuSC1tVHZ1ZjNoR2lyTlJYRWVvRUs4SzVMaFNfNDhXUGVOajRUaW05LUpqS0l1dzVn?oc=5",
    "date": "2025-02-21T08:00:00.000Z",
    "dateFormatted": "21/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Mastering FDA Inspections: The Prep Work For Regulatory Success  Med Device Online",
    "company": "Mastering FDA Inspections",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "18b7e81477520cb3d1f1911fe8b97f41",
    "title": "Aurobindo Pharma slips after Andhra Pradesh facility gets 5 observations from USFDA - Business Standard",
    "link": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPYlF4YUtaaTdfRmMyc1Y1Q1hWUDlNbUNvMWNfMnlCbG5BMlpxSmlYZThBdGx5WThORGk0eU1sT1lfTFRxckJnek1tVlRwWGlUcXQwdHpTUzVzMzZSZFJzUEVuQ3lvUjM5NllhYlpOZ2M4Si1WZVgzSHVFbzFqZDU1SnZuY1NyWlJLNGRpYS1lSGlCRVJMaTdHRmdObjBmMVVEbXUxSHh0TkU3NjBORjJ6Wk1QS2ZNeDdfZEdhZXlzQ2dkU2dmaGRQWWVPcUxGaHMtaDlmUF9henE3TnZ6dXU5ZU5taXdyeVMzdWlFeHRUZkJEeGZHVjNpVdIB_gFBVV95cUxOdEt3MktIMVlsTVpHZUo2dVpCX053eUJRZ3hRX3F5SU9xcXNQdVZwT1BFRnVFMFZMVlV5aFFra1EydXBNVHo0OTk5cEVUMFBNQXU0cFJHNVFYYURGSDdqZ1o0S3cxZXZLam9XQkZsMTBPZUJ5SlY1MFNaN2lqcmpXMEVrcGpFbGNBWThZMWQwZHdOZEtkdVlWWlhjbHhmS1FZYmQtVDlwTEZOYjZBbHREV1N1NFBMY1c4RDM0bEV2WU1FX1ljSDd6aXN5dGplY0twVDBUTGNHa0hBYlRfQWlZd1hmR3JkQ19heUhqMmpUemxac0N2cm0wTU5iaC0wdw?oc=5",
    "date": "2025-02-19T08:00:00.000Z",
    "dateFormatted": "19/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Aurobindo Pharma slips after Andhra Pradesh facility gets 5 observations from USFDA  Business Standard",
    "company": "Aurobindo Pharma slips after Andhra Pradesh facility gets 5 observations from USFDA",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2f0c0f592965e2d57360824619cd9a2a",
    "title": "Piramal Pharma facility gets six U.S. FDA observations - The Hindu",
    "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNQi1Nd2d4YnhRQzhvY250dXlZX0hYaUxLekhLbDc0NkFwaWNDOEFja0VWOUUtSThRNWszYXJCU2lDQllLYmJHOUc3TVZ1d0doVXNTWW9nUEZHNXZFdjJxNmxXZFpMYU05Z1h5eXdFZnc5eWlnNVBwM2VMemVKQVZjaGhuOFl0b1I3aDJLeGZvTE5YeXFaVjJRazBsWXc5bkJyVlk5SkdRWXBzUdIBsAFBVV95cUxOeC1IUDRPM1p2ZlZYc0pZdW9kdEtEajl2TnZkVjF0ck9TRFU1Y2VDdzRhQ0RGbnB1YjZlV0xkNFhKMS1ITUtFZlZrV3owUTdTNlBvY2NuSkVDSjkwdTltOVQyTzBReFNZT195NDUtbGQ0djU0MVh0Unc2MGE0MXViaW04X0Zad3ZXNDE0T0J4aXlXd2ZZWVpCekx1Y190MTJ4RDRfVmNzTkNUQ0FSUWFuNA?oc=5",
    "date": "2025-02-18T08:00:00.000Z",
    "dateFormatted": "18/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Piramal Pharma facility gets six U.S. FDA observations  The Hindu",
    "company": "Piramal Pharma facility gets six U.S. FDA observations",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "94483c5f0104227cd12fd63a06a387ae",
    "title": "Piramal Pharma's Mumbai facility gets 6 observations from US FDA inspection - CNBC TV18",
    "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOamhDeHhrb2dkUWt3cmVmNks2QjlGZ08ybFdTajNNZk8wYkd0dVdCUVY1dmtWZUdCS19JVDZqT1NHbjB2THZ5eUlxTFAtM1ltaHpaT2tuSS1aVTZiOEtSdERfbHExcll0WWptY1c4bGJRQTM0MElOZVkyZHNMakMyWHJBbGNIUjVPNmM4cVN3NmlkNGFfdldQU21BUjBuR1l1ZEQ5UG9zXzZjU3dlTHlocHFlSjZsVW9QMVpDRHF0NDhDOTdieXh0MEkySWlJbDduS3VsUkxwWjJXZVlFODN4NWpzMkFNd9IB6wFBVV95cUxPYmt1Z1E1S2VKa21NQW4zcHUwbE1iaDZlUmtwd2hKUTFPb2VPazdBT1RIQ0pZUnF6cndEUlZXeDJZdnZsd0d3U3pXWjNySklCUGliMU1hNFh2Snc5dURaTkFVYWl1QUFKdWpwTm9aZ2NDdURreF9lcTdmMUFiZGdTT2dUVXNodXZyZHB6ZEJZX21vTW5oYnRRZE5CN0FzSm1zWVRmcGZ0V2pFYmsyVUZvdjBsbXJLVk4wbkVOWWFIaWxmMjdhTF9GcEJIcDVTVDEyTm83bWtTRE9OYnJRcElaY0hZLWt5U1JKX1JZ?oc=5",
    "date": "2025-02-18T08:00:00.000Z",
    "dateFormatted": "18/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Piramal Pharma's Mumbai facility gets 6 observations from US FDA inspection  CNBC TV18",
    "company": "Piramal Pharma's Mumbai Facility Gets 6 Observations From Us Fda Inspection",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "9e81acc42e5850e6997c85140b765e2b",
    "title": "Aarti Drugs shares rose 12% in fag end of trade today, here's why - Business Today",
    "link": "https://news.google.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?oc=5",
    "date": "2025-02-14T08:00:00.000Z",
    "dateFormatted": "14/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Aarti Drugs shares rose 12% in fag end of trade today, here's why  Business Today",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1f10b13f3d0b04ec3a3ec3399e345a39",
    "title": "Marshalls Traditional Healthcare CC - 697697 - 02/10/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOdHpSdktYWWh5WGpZc2VmS0NSZFBndzVNNFF6aU8yNm5VRkllQVJfRzJFRE9Gcm1RYWJMYXdVQ0R0clF6cDNzTk80dHdIOGpid24zbHhwNC1GYTZxU0RkR1RZRm5hbW5tSkNFT2szTkh5U1hEWGN2TmVuRW9naEVWTWZUWE1pQUxndzItUXJCOVhjbGI0dkhULTV4YlBjRUF4QnIyT2Z4aFA1NzNBWlQyZWMyWVdlUHJOVkxFWWZQS0JzS1NQMnN2cWctNHU3dWRkMklncjk5X2FCQWIxdExGanEyWUk?oc=5",
    "date": "2025-02-10T08:00:00.000Z",
    "dateFormatted": "10/02/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Marshalls Traditional Healthcare CC - 697697 - 02/10/2025  fda.gov",
    "company": "Marshalls Traditional Healthcare Cc",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "20245ba123c742ae0a68accc88db02ea",
    "title": "ABR Laboratory LLC - 696872 - 02/10/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOWHVCZ0o0R19oMEk2UGNlU2NQMWt3Y2tPSzlOWGlHRDA2Qlp6aVRXNUlPaWxOUnlTNDVHTllyY0l3WjFsX0FwSXBPcFQtcHdiWjBmWEllSG9Sa3k0eTdPWjVXSy1zNUpodzJuYzB5Wk04cndVVnh1eThET19tc1RleXhIQ2JlWUdPT3djR3VWOEYwTkRyWWxVSlBXb19tRkt4cEx4NDB3Qlg4ODluVEx0dkJuaEFOMERfRk14UE1EbnlmemdLT1ZPcUhoQVFIQQ?oc=5",
    "date": "2025-02-10T08:00:00.000Z",
    "dateFormatted": "10/02/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "ABR Laboratory LLC - 696872 - 02/10/2025  fda.gov",
    "company": "Abr Laboratory",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8f4ab704bb7c39eb3f4e046cebce1b10",
    "title": "Dr Reddy’s Laboratories Hit With 10 USFDA Observations For Its Hyderabad Facility - BW Healthcare",
    "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOTXY1X3RJYXJGbk1Gb1VPYjZEZlBmOTRmdmFXOVdtdlZEY2ZrMXc5NzRNWkpEb2hLZDFjakJyVXZELUZyTXRjbXBEM1dDb29VMF9MNV92T2xEX1ZQV1FhQjNzWFE4UFVyaG9JdzE5TldUcVJpSnVTSlo0c0xZTFRrTC1ybDBzQ3puYU5PZE9zUzRzSGlqWXpFWEttRzV3bVQ2aWZSbVVBNzA5OG1nMFpNNnVpT0owU1FDTmhXT2hFNkYwNHl2N3hMYVpvYV9yNE10bXNTUg?oc=5",
    "date": "2025-02-09T04:03:13.000Z",
    "dateFormatted": "09/02/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr Reddy’s Laboratories Hit With 10 USFDA Observations For Its Hyderabad Facility  BW Healthcare",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "d78a7ba633a50ef81d3478dd86a2223c",
    "title": "ISOThrive, Inc. - 688547 - 02/04/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOa08zNFRjaHpsZWw0eXJ4eEh4VVQ4bUhsZUFZbUxZNTZLOURtNTVPWGl3QXM2NVRETDBuUElBakV1X2IwOEVUQkVCWWFtVUtTdHhpUnY1bGk0Y0dJck5jNXY1U1NXX1Q4NnpuTnZZT2NZME1haFA1V0s1cmRZUGtxOTJQc3FWR1V1QURJcE42Mm96VE5Gdkp0Wk1uR0N1QU11N2t4bHBySVZvd3B1RWJCYUpqbDY5NEdLZDRNa2JrMnF5RFhMWUo4?oc=5",
    "date": "2025-02-04T08:00:00.000Z",
    "dateFormatted": "04/02/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "ISOThrive, Inc. - 688547 - 02/04/2025  fda.gov",
    "company": "Isothrive",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "52c19a97dca61976c836bbb823ba8426",
    "title": "BioStem Life Sciences - 673788 - 01/17/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOeXRQZXVGSWdvbmhQV2pDa0xyS0lZYUxXMHVQWFMtVmlpbWRONnhTYjVwbm1DT1I1NEVkOEkybXhIVzQ3N2dzZkdGZXo4RTlXVHVGenFoZmtsc0wxYXNWZ1BhNXlYa2FhMGtjUmRPeFhaYmhCLVN5cGNfY0lEZmpUc3dGWTZYclpiaWFmNjR4ZEh0azQxbUMtaFFUY2FmVUdLZUtKQWczQ2JYODAyejA1UU44MUsxUWtUOGVCX2JsbGJnY2JUbzJ6TDdCNGY3U2RSVGc?oc=5",
    "date": "2025-02-04T08:00:00.000Z",
    "dateFormatted": "04/02/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "BioStem Life Sciences - 673788 - 01/17/2025  fda.gov",
    "company": "Biostem Life",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b558980aa6b634d0c116a9ae4f9fdd02",
    "title": "Fagron Compounding Services, LLC dba Fagron Sterile Service - 698861 - 12/19/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMigwJBVV95cUxOV3BiRUYyR25vT1R5NnNid1AyUVRKeDl6ay1PbE5odFYwdXE4d2lfRWRQdHJUVFJ1NmFtaXVqLW01UUxOdk5zSW9MMzFHTmpUQXByUExoX0JjUzBURnItTjdITE9KUmFWYnJZVU5rb1A1OHFDZTdIZElzT2huZ3ZTd2Qxa0F3QW1EbXZ2dDVGcFh6RkQyQVhncURSOUhKSFpQbHAtZDdlV3haM1V2ZnFFRzRndHBPR2RhQVRXSlpxYnNzVnQtVnBxUkZkc3VWQ3haOW5ibmdmYmV0YV9IQkYySGgwa3pwZTBaaS1mblYyN0NqSW5zdVZHVFBwTmY0SXRyUjBB?oc=5",
    "date": "2025-02-04T08:00:00.000Z",
    "dateFormatted": "04/02/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Fagron Compounding Services, LLC dba Fagron Sterile Service - 698861 - 12/19/2024  fda.gov",
    "company": "Fagron Compounding Services, Llc Dba Fagron Sterile Service",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ba73d1b1a06899bcc48d28a0cde08e7a",
    "title": "Strukmyer LLC dba Strukmyer Medical - 692686 - 01/30/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQUExPQVM4Z1JfYXlPdzk5SXQ2ckhyakgwYXhla3lQczlwY0J4QkpfOHB3V1Y4Tmc5dXlnVmVESlZwa00wdGR2X1RpRG9jNnBqZnNGVi0wRF9ocTdhUFBJSXhDWVJUOE1VVlpGd09jU20zUTZWLXVkbkZrYmxsVnZhU0xPN2hpdENxUEdZbHZJRGpLTWE2WVNVS2FyMDR2a0RBR0JsZGNDeWpSRFlZaXZWOE9mTXR1WWdRYXhjUWVRSnRiYmlheUhvdTI3eGFPXzJIVVI0TU9hcE4xQ0VqS3ZKeEtGRGc?oc=5",
    "date": "2025-01-30T08:00:00.000Z",
    "dateFormatted": "30/01/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Strukmyer LLC dba Strukmyer Medical - 692686 - 01/30/2025  fda.gov",
    "company": "Strukmyer Llc Dba Strukmyer Medical",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "607c5f79b22f52fb833f1709a54ac578",
    "title": "2024 Trends In FDA Observations For Sterile Drug Manufacturers - Pharmaceutical Online",
    "link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQY0gzZEdCMEdiRTZqdUFUa0w4MWtheTY0VE9VV1F5Tkt1Q3NyRmhVckZfbjdBc1RSTW1YVVVSa3VaaGtDd2pzbHBNWThnbG1RSE02MXJRTFFQakZua1owM2Zuc1R5dFlRczdyR01BV0lMV0ZRQ1pEU0VlVndzYklvSlpiZDE0c1VQQnlBWFFFeXVYN3lmck9BNzJpS1RIdG96aXI1cmNOQUJkb3M0?oc=5",
    "date": "2025-01-30T08:00:00.000Z",
    "dateFormatted": "30/01/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "2024 Trends In FDA Observations For Sterile Drug Manufacturers  Pharmaceutical Online",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7107a62c04bf460567925fa4af101716",
    "title": "Evolutionary Biologics Inc. - 681586 - 12/30/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOR21hcEt4b0xxMm5peDRpcFZTem5pbWs3OWhxSmJ5MFpvMDlBRTNBR3FvNUJ4M2ZMQVBrTDFGZWo3TFl4bFNIRjlHYW1tY1FtWXBGNVlCR2ZTY19tYm45aS1VeTE1dTY1X09vQkoxY3Vlb1A2dU1oTWJuX291S1VlenlGOGFPVmRORG9GcU00Sm4xeGhYS25RRWl1OTlxQ2RhYmI2c3Fzckg4TlRFemtxWEhtcUk4VkE4NkllQ0toOElTVGplcGF6alBVUnVTSDVhdE1OWVhsdUs?oc=5",
    "date": "2025-01-28T08:00:00.000Z",
    "dateFormatted": "28/01/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Evolutionary Biologics Inc. - 681586 - 12/30/2024  fda.gov",
    "company": "Evolutionary Biologics",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "63e4970f8c45237bc1f40c3569a50787",
    "title": "Abbott Laboratories - 669353 - 12/12/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPeDN5R01rRVBEYVR3dXNSY2ZRc2k1OTlxb0oyU3FSSzVqcWY2Y3JuQzJ5eWRURF9Tc21QYWRSenlmQXpobHRJVHlWLXVqNkF0ZDAzbURKdkJFZTYwa2hoeWJsMUhRX1VGSEg5dHd3V2xzb3dxX0RoWndVWVgtdTlHOGhaRnlteVRUWTRuVXFtemVIeVRUSGFid1VKY25fdDNkVkk0TlFSalNSSlBQa1Zad1VoNC1FSTdqQXZ0aFdXRXpnaWJJTWY5NE5nY0xqZ0k?oc=5",
    "date": "2025-01-21T08:00:00.000Z",
    "dateFormatted": "21/01/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Abbott Laboratories - 669353 - 12/12/2024  fda.gov",
    "company": "Abbott",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e43ae7825a6ba7847606ba5a592aa27a",
    "title": "Cipla Goa facility gets one USFDA observation - Medical Dialogues",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPMUdDS2ljUGlxV0p4dExEanBacGJ2dURReFRtb0hIQmNDcW1TZ1RweXc0Nm40dmNLczJwZFgyWVRqLUdPYjI1REpQSmVfZUsxRUVMM2dEOW5PR1E0OVdFck85cWNyM1hISzZrbWlwdkFTenU1OE9vb29wUWs2MWJVZFJuLXhhOEhtRDdRY2hrNVB6Z3Q2b3dPU3lxQ3hfVG5wQVBF0gGoAUFVX3lxTFBsVk1zTFZQRDdiVV9TU1NJUk13OS1MaEtMQktaRVR1RXZxdGxRVllkNFJYZUFxWWt1LVlGWXNHZGZaQzdEWUNzZG5VcmVzWmhvd2lNamxZTTBaWFBzWTJXc1hPNDloNHVkWUlRbzRfaFYzQ1JvUW1nbmgxdGtXdXJ5YmNFWUFPRWdSR3FRUS1UalhaZ2dQY3V1NHpzS2w5RnNuTFdOUm9zNw?oc=5",
    "date": "2025-01-21T08:00:00.000Z",
    "dateFormatted": "21/01/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Cipla Goa facility gets one USFDA observation  Medical Dialogues",
    "company": "Cipla Goa facility gets one USFDA observation",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "795398ab034ac7c69a5dfbdee822f368",
    "title": "Cipla's Goa facility receives single USFDA observation following inspection - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2025-01-20T08:00:00.000Z",
    "dateFormatted": "20/01/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Cipla's Goa facility receives single USFDA observation following inspection  CNBC TV18",
    "company": "Cipla's Goa Facility Receives Single Usfda Observation Following Inspection",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1de9cdfcfd24108a6fd0e0e7e04a153e",
    "title": "FDA Issues CRL for Atara Biotherapeutics’ BLA for T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD - CGTLive®",
    "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxONG85cUZMcXZGUy1kUEtGY1FWNDNCUDIxRDJ1dmdRVzBOd2tjY2xxZFdUSnFtd1A0ZVItYVZxNDJCMHlxejNFemtSUk8wTlBXUEswUUtIQnk2V01ObVIyQ2tHNG1jZVBSWkozTThySEJDWjRoczFWQTI4SnU2YTU3WC13dGZmOE1OdFJHeE1BQ0huckhhQTNQUU56NElHTktJb29fNkJDclN1R3RveWc?oc=5",
    "date": "2025-01-16T08:00:00.000Z",
    "dateFormatted": "16/01/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for Atara Biotherapeutics’ BLA for T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD  CGTLive®",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b4de17f7d771100de4eb455c4b517fee",
    "title": "Reedhill Ventures LLC, d/b/a Vape On - 699902 - 01/08/2025 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNSHJEc0FoQjEtSVZZdmRtNjAtZG9EWDgzQk42NnpibWlwcnl5STFweExwRGRreDVJbjlYeE9oZWtxa2JzTldHWTVBY0EweWJhaHRIZWxqdTJISmM0ZDVmSWMxdEtvVEVYbHhKSGlWRGlHb2FwekhNZmdnUFJSdlREcHFhZjVWeGNuRENrMUp4TXR6bURYeDR4MkN0WElNbmREa1lFcGpGSlVUeWpNV2ZiZnE4VE0xNnNicUZUSVJSd2JqM2lkMDgzVldsVWx5R0JFaVhFdG5mNXlHV09LNHc?oc=5",
    "date": "2025-01-08T08:00:00.000Z",
    "dateFormatted": "08/01/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Reedhill Ventures LLC, d/b/a Vape On - 699902 - 01/08/2025  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4a51a2cca193e5725b842abc111c52d8",
    "title": "Indoco Remedies Limited - 691594 - 12/16/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPUkxUVHF0NkRHaHJHaVVvWWNLaXR2dGhwU1ZYZm9vT3ZUc0RBRk0wSlBlSm9fQjJYVlZ4Y1dDUTB3M1lnOVBqcXZERkJlVmZ5WHZPa1FiWEpXZ1FVRkV4NmpNOUpEZ1BwcUdhWl9qODE0NmdjNnpUbjE3c28xWm9pQ1pUVUw2RjJCR3N2RlRiSTJTbHJLTzZ1ZmN4TDY3OTNLeGJ0b0NabDh1eEhvS2czR0oyRDNtU2czd1hZaGhCTTl3OHp6bVBMdjM5SllfbXVNM042Rw?oc=5",
    "date": "2025-01-07T08:00:00.000Z",
    "dateFormatted": "07/01/2025",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Indoco Remedies Limited - 691594 - 12/16/2024  fda.gov",
    "company": "Indoco Remedies Limited",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "bb647e5561d50809a328d2bd32290589",
    "title": "Sohgave LLC - 646874 - 12/16/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOOVRJa2dNbDNBVWFYY2cteENJZEl4aXVCaF8wZDhCMDhSQTRSeWJqUnBpc25wTk5ZdWNaYm1fVG0xXzJfWERfX2VQRVBxbWlJLUViSlpQbmZQWWpCcmFzbGtpYkRyQjlTLWRucFYxbXRxdkVBQ0t0TXVnMmxVblhIUUFrMW1oRFFndTV2YnpIeVg1NGYxOWVYZ1o3dXVjVVlROGtRSkNHdDUxUk9aV1lacS1MRWFfdmVNcnpkMFRpTUQ2TzJZ?oc=5",
    "date": "2024-12-31T08:00:00.000Z",
    "dateFormatted": "31/12/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Sohgave LLC - 646874 - 12/16/2024  fda.gov",
    "company": "Sohgave",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ccd4e235ab674611e570f8abbe3e1fc2",
    "title": "Viatris faces FDA import restrictions at Indian facility - The Pharma Letter",
    "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxQel9hWG5uOGoxeXNFZUJyTVBMR0hVSzhRUmJoeUhaNlNJYUJ5SFpNQklTYTREaXJEV2hmYk1RZlR5WENZZ0dqZGZVZ2xRNWV1Y1A3V0N4QUVSVnlXZTZXektuY2ZpTG1rQ1dyYTBEOTBqcTdwOTB1UDVzZ1A0VDNpX3hTZm5TUlh5OU81TzhjYTFDMXVoY05YUUROT3JGQQ?oc=5",
    "date": "2024-12-24T08:00:00.000Z",
    "dateFormatted": "24/12/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Viatris faces FDA import restrictions at Indian facility  The Pharma Letter",
    "company": "Viatris Faces Fda Import Restrictions At Indian Facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "d89c24dbcbb048f2d5a8369eb8f8e27a",
    "title": "Viatris’ Indore plant under U.S. FDA scanner, imports of certain products barred - The Hindu",
    "link": "https://news.google.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?oc=5",
    "date": "2024-12-24T08:00:00.000Z",
    "dateFormatted": "24/12/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Viatris’ Indore plant under U.S. FDA scanner, imports of certain products barred  The Hindu",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0e4c78fbaedfe21c7ea0938b14af06d8",
    "title": "U.S. Food and Drug Administration issues Complete Response - GlobeNewswire",
    "link": "https://news.google.com/rss/articles/CBMiwgJBVV95cUxNT01UMVJNcTcyXzlxd00tdlE4SjRBNTUxYkNvS25IUjlHSXRWa0hpdnlDX01vMjBxcDdMbTM2eTBlTjhZTWM1UDBSVnlOSkZvLWVGcTNJeW1yZGhPeG5wVEhLXzFXdmpxTjk2cENnSk5YaGlnbDNkMEtNYWpFMWYzRHRZSTI1SHdZZElFOVoxRFJOemZyaXN0RkJwcndWQ3F3dmx0cjQ3QTVLc2tOWi1FOE4xNWNBWldWR2p3dUFjMFE0dGI0UW1DaWlSQVRWODdYV1pPc0V6dU1ON19kUGJPX3JYc2N0Qk1SYnM1Vkl3QWh3Y2VMRVBUcE1SZUIzb0FiTkpUV3lpeWlpTC1lSlF6RVROLUs4NHZjLVczOXEtMzNBZ1lETFhkTWhKNEZ5YWE3R3NYNkhFb3NHRllnb1FKcXNB?oc=5",
    "date": "2024-12-19T08:00:00.000Z",
    "dateFormatted": "19/12/2024",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "U.S. Food and Drug Administration issues Complete Response  GlobeNewswire",
    "company": "U.S. Food and Drug Administration issues Complete Response",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "069e12452423f53e722db5f64ac0b7b6",
    "title": "FDA Issues CRL for SC Amivantamab BLA in EGFR+ NSCLC - Targeted Oncology",
    "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNNk9hR29fdnIza3V1UVpsUHN0djA2OFlQR01ReUx5U25DNnU4aXh4cTY1OHlsMEZocUxqMjI1LVl2UHpnbU85N010d2JMZ2pQYjM2ZnJzbWtRWEd1VE1NTk9BbUpNMzdUTk1rekxOeC1vanBlRGlLeTZ6RHdSTnczNmwyUU1IY3phWUY2Ug?oc=5",
    "date": "2024-12-18T08:00:00.000Z",
    "dateFormatted": "18/12/2024",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "FDA Issues CRL for SC Amivantamab BLA in EGFR+ NSCLC  Targeted Oncology",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7fa5ae15eb36a2bb21e14ec91900da8a",
    "title": "Micro Orgo Chem - 686458 - 12/03/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPNjJQaG9SeWZib0NDeWZxZGdSRTRZWmNFOU5iSW9xMW96MktnMFVmNGxHYlU4VEpzYm9UNEx0dHFFYTBoZHJDVGxZcU5OTU5ZNlFrNEE5VkFHbHljVDVvd1FFV0kzelR0ZGUxNVpoVU5id2Q4ZVlEbm5VUzZ5UW5qeXBlMGp0SHdYb0l5WjVBMUZiSVlnZmIyWWdSWUxIMDUxMEZNVVVEbTRLR3BkNHdueDhSNnZadkRoWnVFblRSZEVlUl9Wa0FDMUd3?oc=5",
    "date": "2024-12-17T08:00:00.000Z",
    "dateFormatted": "17/12/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Micro Orgo Chem - 686458 - 12/03/2024  fda.gov",
    "company": "Micro Orgo Chem",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "068b7a07fda614ca3fdef12a9bd83138",
    "title": "Compliance issues at Granules India’s Gagillapur plant - The Times of India",
    "link": "https://news.google.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?oc=5",
    "date": "2024-12-05T08:00:00.000Z",
    "dateFormatted": "05/12/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Compliance issues at Granules India’s Gagillapur plant  The Times of India",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "9a296a1639e72478cfe1153eaf0e3b7b",
    "title": "Han C. Phan, M.D. - 696989 - 12/03/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQbEY5VFFkTWNmeTl6UVE2b3Jzei1iOUFLdjNYSWQ1b05WaE1PdWdVb2hUTDBIdmU4cDlpa0huOGppaDVxaWk5ekszU0wza0N5TWZEVmlyd091Z2NCeURpSlliN3hwdjRCSzdfT2ZwS0k4VkgzVkI0SGRJSzBwVGN2VnJTS2lYbXNnVVNjLXpfb1JVemlxRDFPOWtIaEM1SFJyMUpyUi1ZWGxwTDg5OGc5UGJtUXVhVWV4MWFwZFhhc25oMnMwNzBR?oc=5",
    "date": "2024-12-03T08:00:00.000Z",
    "dateFormatted": "03/12/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Han C. Phan, M.D. - 696989 - 12/03/2024  fda.gov",
    "company": "Han C. Phan, M.d",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0f53db41376c58d1936b210c5936c400",
    "title": "Dr Reddys Hyderabad API Plant Gets Seven Observations From USFDA - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPOHdPRVFnUFU4UkZVdUVoZE9zaGZEdzgza0w3WTFHWnAyM1A3RFk4NTlVOE9tRHNmOThXNnJYTGF1S3F1SmQ0bzc1VjZSWDhTU2lNUnZxU1pRUWV2ejA5NkItRzg3U2FGLXNZVXl2WUlydzdCcjRXWGJsMjJOd0Raei1aa3c3VWZZUWpkbdIBkgFBVV95cUxPLWVDNkd5UGZ5OVRNUG0wT1BoaURWRFBkMUREQlh2aTdxNHBwaWR4emhKY2p6cllfWXJZcnZWYjh2UkdmNV9waWJDZ1p4cG1IWDdnWGV5QWdjelBnRlJjdnVINVVBMnhsYzhLTFltd0xzSkR1MGtCQXZYQVRiVHA0bWhjX2xZYU9iM2JZQ1d6VkJCQQ?oc=5",
    "date": "2024-11-19T08:00:00.000Z",
    "dateFormatted": "19/11/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dr Reddys Hyderabad API Plant Gets Seven Observations From USFDA  NDTV Profit",
    "company": "Dr Reddys Hyderabad API Plant Gets Seven Observations From USFDA",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2b74ab0fa1a768de9eaae4ca57917156",
    "title": "Cipla gets eight observations after FDA inspection at Bengaluru plant - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2024-11-13T08:00:00.000Z",
    "dateFormatted": "13/11/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Cipla gets eight observations after FDA inspection at Bengaluru plant  CNBC TV18",
    "company": "Cipla gets eight observations after FDA inspection at Bengaluru plant",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ad85d55338844a6bc383b5fcdcdc1691",
    "title": "Cipla Gets Eight Observations After FDA Inspection - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOQUpOdEJ6NDlNQ1pSTFMyYUc3ZWlKdkNjcE8tX2F5OXc5aDhIVm12aEVVS3BVMTZmWG1KbGxBUjBSQ1JKMHFNQjJFeXoxWTU1ODluelVMcVdZM2hUY1BtVmoxeEo1STBiV1hNQnIzcDJsUjJmRW1SbUZYWXlCa1Z6Y3g1U2h2S1REOWZsajBCaWJZQWZYSVZZVndRNE9NQdIBowFBVV95cUxOUzMxWUtNZEhGSGo1QVZSd3dja3dZOXRVOE1nRXl4aTRnNFBXTHBSTVIyeURLZ1psZXFkM05kUVpVdmpIX01PVTBWX0RtemJDdzA4MWJTQlA1RmZ1WGdteXZ6Q05mWWFjTko4Q0cydHg0czRiWDhaSEhFSnV4bU1ScWdMLXYxQW1KNGFoMnBuenh5YnFlbHVQM213aDh2Ukp2dU1Z?oc=5",
    "date": "2024-11-13T08:00:00.000Z",
    "dateFormatted": "13/11/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Cipla Gets Eight Observations After FDA Inspection  NDTV Profit",
    "company": "Cipla Gets Eight Observations After FDA Inspection",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1f0449fe660445291d3de789413d2303",
    "title": "Novo Nordisk hit with FDA write-up over production issues at critical semaglutide plant - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPMWdjQXQ3ZERyalE1VkpFMDdXZVNrQWpNb3UtcXdsX3NtZ1BrcnBmMkh0WWs3MkhCTzJZc2dnVUxEbmhNbEtXclFFWjNmUW1MZDFKREliSURWMVlWNldFLTN2eGlpNGhlWHlKdHFULUZfQVN2Tk1nYnNWckpIRl9Jb2YzY2xKR0FOUkVoUlJBWDdQaEN4ZDQ4NGZTVlBDUVVDdzV3bkIzNFRyX1g3TUVuOERNWGZnQ09XMW1tSDVnSng?oc=5",
    "date": "2024-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Novo Nordisk hit with FDA write-up over production issues at critical semaglutide plant  Fierce Pharma",
    "company": "Novo Nordisk hit with FDA write",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "48864093cbd9edcbe936578f229fa313",
    "title": "Rontis Hellas S.A. - 695160 - 10/28/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPbG1Fd3VGRGpVR0trRXNtQjM3Um9hU2FtdDQ1U3dHQmJqSWJPU0w4WC1KNlA4cWkwaDBIOTFMTnFuUlZsaEExUXM1MDAxdTlQZ1dMMGNiMHR3S2dVTFllRU1iY0hTb1Y5SDZDelA0N05BM0JGcHZsMnhUZEVSeUFpakZMeTg4VFIzLXF5OEdTalRIbndmaEQza3oxWDNSeE50cXpSUHpxNWpUNm5UQk5qbGlHbUYyZzFLRTltTUM2S0dXU0JpOFJQY1ZLMA?oc=5",
    "date": "2024-10-28T07:00:00.000Z",
    "dateFormatted": "28/10/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Rontis Hellas S.A. - 695160 - 10/28/2024  fda.gov",
    "company": "Rontis Hellas S.a",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6652ceeb67b206131197faeb398f61a9",
    "title": "Namita A. Goyal, M.D. - 677324 - 10/10/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOTFR0SU9vQzZMNkF3NkJzOVNkX1NYQkpNd2QxWkRNbHRGVTZEUHJzVlJ5MExlM29LeEZDMkhTRFRBa09jekZ0T0ttdGJ1a2xielJqOG1OOHZUbmViU016SUtEQkM4bkdsb3FjY3JveXZUSVJXNnNaS3d0TjBtM0R6cmRYQ1Q3SWItQk1TRjlWeGFIUVdfTnpVSmhZTVhxNkwxNGVLTlZOcmRRVVNoQkFaWTVFVkhGanB6cld0TDVjTDB2MDdwNXlGZzJn?oc=5",
    "date": "2024-10-22T07:00:00.000Z",
    "dateFormatted": "22/10/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Namita A. Goyal, M.D. - 677324 - 10/10/2024  fda.gov",
    "company": "Namita A. Goyal, M.d",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "fa6c1891acb2feb00623e169d07d77e0",
    "title": "Cutera, Inc. - 639552 - 03/09/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQek9qNEhCT3BQNDE2SDBpUzJRcF9sOGQ4ZnhhRml1MjhFZlhaWVY0aHE1bUJBS0FnVld5Rml0OXdwSGNBMFBPTGJxN3RYdjI5R3ZiVFhXVzlxaWpvNlNtVWpfS0JmTkdLOFV2bUt2RFdDSU12OFJYSkxQNTdKT2hCczVfSTRpSnhsanVOaFBoU2drMVE1aFlxUVJzb1h1amxsUXJZODItUk5IR3BQcWpVOUZwVndHQzY1TXRTeWVJQ0JtZXc?oc=5",
    "date": "2024-10-18T07:00:00.000Z",
    "dateFormatted": "18/10/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Cutera, Inc. - 639552 - 03/09/2023  fda.gov",
    "company": "Cutera",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "af1433e96597f2e282b1a488412c1e0a",
    "title": "Biocon Gets FDA Observations At Key Biosimilars Facilities - insights.citeline.com",
    "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPdW9IWHZYMVBWaGRBdUF5OHVFV3pkZ1JDRUFZU2psYWN5NFIzY0VsVDBfaFJqNGViY0wyNllqaDRISUtTWktoSElNemhYQzZGeEdqRzEyTWwtVE5vZUVTUUxNc19SVXlGTEhCaElLTENHcEwwMGZ2a0U5QVdRS1hPNEVkLVhNNFBlR2RzTWJLSWI0ZkllWjYwWVFkRTh3UjA?oc=5",
    "date": "2024-10-17T19:27:51.000Z",
    "dateFormatted": "17/10/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Biocon Gets FDA Observations At Key Biosimilars Facilities  insights.citeline.com",
    "company": "Biocon Gets FDA Observations At Key Biosimilars Facilities",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "621d4355071d08c712c37332ae28f3a6",
    "title": "Outin Futures Corp. - 684688 - 09/25/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNS3ZuUFFMNzdyb1hFamFvempVYjFkSnQ4ZWRqRzMtZkN3SGdrdld1WnRvbG9PVUhLX0JoejhnRENDZXZ6b2xub1JGZ25NRzVQcXVXUHRSSWlkSlpLYlc3ZFQxd1F1cnRfSDZZOW9DN2JDYW50TGxtV1owX1FOZld2dG5NYTd4NVMxVnBFYWtvQUE0dlR2bXRWQzZBcjM3ZGtSUzVPNTBBXzMwbGtvb2tNX1JEYl9LZ2pGaTZERFNTTlQ3Qk5SVEo3bGpUZ0stUQ?oc=5",
    "date": "2024-10-15T07:00:00.000Z",
    "dateFormatted": "15/10/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Outin Futures Corp. - 684688 - 09/25/2024  fda.gov",
    "company": "Outin Futures",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "18609974ae68d6f81067177674b7de91",
    "title": "The Brief Summary October 2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1jcGhkSkt2X3BxT3RwNXlUM2pIaGpqR054X2J4aGtEc1p6ZDBMUjJ2QUlwdVZlNmR4bVB2b3BGWXZRa0FtRU56Q09fWFdRazZOVGhR?oc=5",
    "date": "2024-10-07T07:00:00.000Z",
    "dateFormatted": "07/10/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "The Brief Summary October 2024  fda.gov",
    "company": "The Brief Summary October 2023",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "d54576145a61925d88356230d1223cc5",
    "title": "Pinnacle Transplant Technologies, LLC - 646783 - 10/01/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNNEw2UmJCamF2bVdCcV83Q0Q5empYQlpNRmhubFhsUjJiVzk4T0h4d3RiV1dzRUFkZ3RfdzVOZWVsUjBJTXlVX1FONllZbDU0WWpHbUtRMVdQeEM2ZzJzbk0ybzZYUzVNVkVFNWI2RGVWLXdJWHBzOFkxcUxjMTdSZkNRRWJyNGJ5NVpHUlp1a1FCUElMX2xYSEtTMGtfQzRmaVpkTGV0UjZLd010blQ1OXJNbkFNQlZCa1V3ZU5iT3J1NzV5YkFoQ1BPd1RtZXNnVmtWOVBlVHhERHBfbXV4OWVobF83UQ?oc=5",
    "date": "2024-10-01T07:00:00.000Z",
    "dateFormatted": "01/10/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Pinnacle Transplant Technologies, LLC - 646783 - 10/01/2024  fda.gov",
    "company": "Pinnacle Transplant Technologies",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "586997d674201015a5b086aadb035ba0",
    "title": "Diamond Chemical Co., Inc. - 687078 - 09/06/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOYW12eTAwOGp2UGRHdE8tNXd3cVRiR3l5bi0zd1J0cDBDb2pmRWV2MWpJZ2x3SU1PM1p4OVZCYUpEZVV4MWJLaF9MUFJ4S2ZHMHA2Rk55UnMzQjFLa2JxZDFON3M0ellseFo1eGxyZXc3ajZEMGZtbEZuMDB6WUJfV2xMQWlyS0p6UVoxLUM0ZzZxS3ZjaHdwSDA1LUFsek93a0huVU9mTzlBbDdNM2t4V09IRFdLMVZLN2pXRmk2R2R1dlFlbzBvYkJDSEZndlZqOTdzSw?oc=5",
    "date": "2024-10-01T07:00:00.000Z",
    "dateFormatted": "01/10/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Diamond Chemical Co., Inc. - 687078 - 09/06/2024  fda.gov",
    "company": "Diamond Chemical Co.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8223df5a64213c658161cabb5a6fab1b",
    "title": "Quicksilver Scientific, Inc. - 612476 - 09/30/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxORXZPNEF0a0xsYWVabzkzeWtaTks4b0dYMTZBTklVdmU3aDRyVFozN2pVazlfMmR6U3VnSDIwN3NZSnFiMGxHMVlsWFE5T2ROR0xsNVRqam9FcUYxMzAtY3J2LXRsblI3R1hCR1A5SXhCN0RhNXZ2dkg1bnRERWJDSDc0bkRXbllyY2NJZUNqUVN4eHkyekRlNFhnbDRsamhyWFdOLTBNdmNPdTNXSVJ0Mkk2RThZcTJVRW54V3gwQk5xQzAwS1EyeVY0akYtSURMTWlQaTYyMTI?oc=5",
    "date": "2024-09-30T07:00:00.000Z",
    "dateFormatted": "30/09/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Quicksilver Scientific, Inc. - 612476 - 09/30/2024  fda.gov",
    "company": "Quicksilver Scientific",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "fdb8785d9dae6cfcb4872953b422a949",
    "title": "Makra Kozmetika D.O.O. - 684125 - 09/26/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPZkRXbVNQckdqbzdTaGpIdHZ1a2VPLUlqWXNlMXRrZWdZdnRScDNhbklOQ3VETnZLbU9iaDJvd1hCa0p4RjAtZG9VdXhpS2daTU1MOEx4OTNIYTExNGNSbmVzSFpBZE9oRnNWblZGSTJfaTRQUWY3MGNndFlSb29vSDQwSGIyeEE4elFhTjVkaks4TzdxalVZWjM0Qmx1MkRNa0kxV3ZaT1ZWaUxrOG1QOXZoRG5nM2hCeDBnUXV2SW9uY1g5RGhNVTVlZkJONTg?oc=5",
    "date": "2024-09-26T07:00:00.000Z",
    "dateFormatted": "26/09/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Makra Kozmetika D.O.O. - 684125 - 09/26/2024  fda.gov",
    "company": "Makra Kozmetika D.o.o",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "286a513507ff1c6460b23f1677a44265",
    "title": "Wittman Pharma, Inc. - 683081 - 08/06/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOUHMyS1pYSU12Q202VWNGckJkTmZDN3NPZjVjVHpOYnZPVC0wU2o2N1FPTWkyWVFpd1VhNnVxZHJTSDVRcXUwZHV0dzZRRnljWnIycS1HNElDNXRYelloUVNDbVdFejlYeHlGbW05VjJVaVRPU2J1Yl9lWE9Xbk1RX3BJQUxneVhEZVU4dEJyZ1VIRzlReGhJa1hNblZKWFdjX2tKMmc3V0lGNmJ0S1RUX3NDalhvbFFveVQ2Y3lxU0VNdWgxczM1TVNTdGJVUQ?oc=5",
    "date": "2024-09-24T07:00:00.000Z",
    "dateFormatted": "24/09/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Wittman Pharma, Inc. - 683081 - 08/06/2024  fda.gov",
    "company": "Wittman",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0d0bb70917f48c169c9f51575ad3d83e",
    "title": "Accupack Midwest, Inc. - 680228 - 08/15/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxOOGxvOGNQN09xeTVxbWQwa0lqTkVKQVk1RTJSY1JQcTBYLUNyNmR5U2ZmYVNzTldGTEhsel9sR3NoVXduOXV2Y2J1dXFnN05jMGl0T0U5RW5vWklNSE1qMzZRSjFHb2IxWTNIV0JRTV9NWTdQTFpKTm9sLWFNOWV6SHB0eHU5QWZ5cjRuRDF4ZWZxdHNHeTBJQlpGV2dFYUJkbE1zV3dqMGNqaXBhclB3N1JOQnpFMG5pLW5OaXlxSFU1Yl9ib0xCdVFsR29ERFAw?oc=5",
    "date": "2024-09-24T07:00:00.000Z",
    "dateFormatted": "24/09/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Accupack Midwest, Inc. - 680228 - 08/15/2024  fda.gov",
    "company": "Accupack Midwest",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2a47a754d01a18d5e97b98841d64e25a",
    "title": "Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5",
    "date": "2024-09-19T07:00:00.000Z",
    "dateFormatted": "19/09/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection  Fierce Pharma",
    "company": "Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "73cee9b99a7e3cf0244f4526015eb548",
    "title": "St. Louis Calco, LLC - 669917 - 03/21/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOaVJySGFhVGVqeG1TZURPRWtqckRBM0VYMGNxYmpfeHIwU1V2a3YyWEJsNDUxNDlpTEJQdHZkTkZGalNLcFRBbzNQLUpYUzEyYkVCaTEyVG5RbXdEOXk5bUlzdV9KWm9WajZqdHhiUTU4Z1U3cXpocGRRUEZKcTFud3dwS25iVkxJMENXLTAtLUs2SHpiRmVJT3VmWExLOVM3U09UVklITGZBQWYwNWVWNXpzWWthdGh0YmxIZm0zNktxRV9ySzJ4OXJxMUdHZw?oc=5",
    "date": "2024-09-17T07:00:00.000Z",
    "dateFormatted": "17/09/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "St. Louis Calco, LLC - 669917 - 03/21/2024  fda.gov",
    "company": "St. Louis Calco",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6bdc5d5cdd594a84af1dae032fa68d5f",
    "title": "Eco Lips, Inc. - 631629 - 08/22/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPR0c2aUdrNERmRmYyRVVNN1ljRmtZdGRYb3VwRnljeWY2UFFndmxKblppdzZ4Y1dIaHBUbkhJc2FPdVVGX2ljSmhkLXdDZjRBXzFjYW9WT00yUUZYcVhVcUFzWHdEdXo4RnRENndnZ21QZFBkRWxlMkZDRXJ1bF9RYlBJXzBWSS1Ib3V3NTI5OEZZN3JuYlFfZk90TVBwbS1ReXdhdjZKVXJRVjlXTjczdmZieGpxMnl2ajE1UE5qUFdOLU9hOHc?oc=5",
    "date": "2024-08-30T07:00:00.000Z",
    "dateFormatted": "30/08/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Eco Lips, Inc. - 631629 - 08/22/2024  fda.gov",
    "company": "Eco Lips",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "87c5c995dded75ea65def970b8009221",
    "title": "Spilling the Beans: How Much Caffeine is Too Much? - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNc2lvMnJIenNxdUtYYUlXNnctQk9fZ1NaOTNfMGxDZDBuT3lLbDM4ZVlTUnBKMHJkekh1YkdhVmFpQU1ILXR3Ykx6UU5mSjJfOTZDdDNRZ2FwSERPOXN3R2s1aTFwQ2NmMDFEczZRclUwS2VwdmJCMFAwakg0WGdhZXMtZFd4RHd4NUlDRDRMNUdMQQ?oc=5",
    "date": "2024-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Spilling the Beans: How Much Caffeine is Too Much?  fda.gov",
    "company": "Spilling The Beans",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "3cbb107b7e30b4b0a0e0126e65f5859f",
    "title": "Adventure Innovations LLC - 676842 - 08/07/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOTTZaX2JMbUNlTjRMNnFkWmhsbmUwQmllZ05lWEM3X0tNdm02R3FycmUtSnJEWnZhZDNpQTB6LTVUNFlpd3hBOURjMWNYYTR1SnY3UUtpS0hvVTBvN0NhYURaNFhIRFVEUXFjcVItYy0ta3hld2dfbkl4ejVZUzNTQTFhRmJCWWVtRXBaS3hCNkd0RmFTcElleFhDdUo4UGdVajM0dzNadGRzNUU5ZkJsSzZ6MkdDNDlUd2RCRWQtSmRONUJURTRwM2RxbG55Ri1MS0lfT0RJZw?oc=5",
    "date": "2024-08-28T07:00:00.000Z",
    "dateFormatted": "28/08/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Adventure Innovations LLC - 676842 - 08/07/2024  fda.gov",
    "company": "Adventure Innovations",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "06ef104e4e81a20338ad05107f0e113f",
    "title": "CARsgen Therapeutics Corporation - 686504 - 07/26/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNdEFKYXpFT1ZoT05ENjJmcVpyWEJPWFJYTWtIdWVEbzlkMmFJeEdVUk0tNGl4TTBlSnJWYkNTV0Z2elUtc0lCQ1lJVFlUaTV4N1BKUTZObXJaZ19VdFZkZG5qZ3ZWb01PelFhRmE3aGRqc0JCX0VvT1RCdWZBTkdtelpRY2JyODhpNGFObklqTGh0UXowMUpGc2RYSmtrMFJCb0pJM1h2RnY1Z2hBN0pmajd2NEx4dkxzdDMteTlkVXFleDczZE1fMDV6LVhvSjJTQ1Q5N25zZWxtb2VpZHpnRg?oc=5",
    "date": "2024-08-27T07:00:00.000Z",
    "dateFormatted": "27/08/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "CARsgen Therapeutics Corporation - 686504 - 07/26/2024  fda.gov",
    "company": "Carsgen",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "17b73dbe7389c87c04dd5b98cc409fb3",
    "title": "Apollo Future Technology, Inc. - 690452 - 08/16/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNZUhvNGFGaWRsUm5tTlFwZkd1c1ByOEI0bS0wdnBub19IbFZvblFTZ09wY0dDWWpGMUxyMktIY2hRSFlTc3BUZzJxVlRhOG9LUWEwYlNkWDJQX1JMZ1kya0VTZWdqc3RhaFhvaGM4a2RzWF9RTGRmRHN2S3I5aThNRWluNUJPTl9CRDRWbHZ0eTF5M3pHV3l6NnhfQ1puV3FldXc2S2tsWUpvTTc2ZmZlVFlMVDhIb1hFTlYyUjRQcklxTVp1b0g2RzZBN29qbm0yVllnRHVHWENvX3M?oc=5",
    "date": "2024-08-27T07:00:00.000Z",
    "dateFormatted": "27/08/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Apollo Future Technology, Inc. - 690452 - 08/16/2024  fda.gov",
    "company": "Apollo Future Technology",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "47ff01c69e7c4ffd0eccc65217af84cd",
    "title": "Premarket Notification 510(k) - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOS0luR3hDTFg3YW01dGROMEZJbzE0U2tCMC1iMm9XcEpFWVNZbzd6SXFONGlSWENmQVFtUnpSR2w0U001YjllZjdyYXp5RF92d2tLT0tyeXJWWjR5bjY3ZmRUR1Atb000dUR5NnJ3dlBlX2N4eTdxQVMwX2FyZ0JuMUg3UkJBNUdKeWtNclhvRWZsTkx1ams1b09PaDU3aDROdkcwNWFjUG0zYlROdTNmSGZGZjFfb2JiVjJJUm9JdG51WGlnY3Vr?oc=5",
    "date": "2024-08-22T07:00:00.000Z",
    "dateFormatted": "22/08/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Premarket Notification 510(k)  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8aa33d7710ed0327007e08d0924c6d34",
    "title": "Oops, They Did It Again: Indian Pharma’s Frequent Flyers on FDA's Naughty List - BioSpectrum India",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQcXhIeFlXdlJhSGdRV18zdWhYRGUyVjQyZms3WFBSVGRoREIxZGZHckhLSXlzdTZ3WkhTVkJub2l0Q2puZkwyWTRKUjN5U01hS1ZUVElRUFRveGkwSVNwSEh1MENxekRFMk8wX0VXYm8xTkpHaG1kVS1MaDV5c2p5eEpiUHZMVXdWU0F1VGh4ZGdHeG1qY0hYaVhPbzhQNXdZWktYNXV6dFNwVEd0eE9wODBsZlE1amZVVFQ2cHlHdHNZZlFTelRCVnNHS1A5ZVFOcElac1FEQTJxdw?oc=5",
    "date": "2024-07-18T07:00:00.000Z",
    "dateFormatted": "18/07/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Oops, They Did It Again: Indian Pharma’s Frequent Flyers on FDA's Naughty List  BioSpectrum India",
    "company": "Oops, They Did It Again",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "02090b6e1ef4f24047bf3174571eb577",
    "title": "Donggang Wanrui Food Co., Ltd. - 678557 - 06/25/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNeEVxMVM2VmZLbUpjek5ycFBUai0wQTJiZ3JIYkVLWnFDRWlVYWRlVFV5R3pNUkx1RmZaakdKYnZocHBDdlN2WGphdGlDZHVGY2dVSTFNM3ZOcDBsWXVNbmhGMW1jNENFbENuODRrbkdkWVloSFFybzJJMHpPaUlxaVA0alotVzk5dlhUZW1BXzF5R3hoVTBQUUg3Zlo4OEpQeVVIOEM1UnVfVGNlV01KM2h2UnN5LXpzRERQMUxYdHVsRTV1SmF2WlJ1N0RqRjZoMFY1UjVjZmhRQQ?oc=5",
    "date": "2024-07-16T07:00:00.000Z",
    "dateFormatted": "16/07/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Donggang Wanrui Food Co., Ltd. - 678557 - 06/25/2024  fda.gov",
    "company": "Donggang Wanrui Food Co.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2d28327db6ca0a71e4c7423d4ee76c22",
    "title": "Art of Beauty Company, Inc. - 674144 - 05/22/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQQnpDdjVvUnRJaTNhWXlwdzJrT0oxUFZnbkozQ2lTWEhxTUMzcl9OYUF0b0xlNERxUmtkUi14UUpwODAxM25WYk4tckE2RXlsQVFOT1ZBWmhKbFAzQ1ZzOEVBdW8xcENfQlVsRU9GT1A5dGNUY2o1RGZQUFJOQ3NvenZMdDVMQjY3c0VBUEZQSlpXUUdIaFlNdy1iNTZlWXdZN3N3dG9rNzV4elkyWmt1ZzlnUzMtTW9Wbi11aUR4U0ktNzkydFFRdElGemRNNWFWVm5F?oc=5",
    "date": "2024-07-16T07:00:00.000Z",
    "dateFormatted": "16/07/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Art of Beauty Company, Inc. - 674144 - 05/22/2024  fda.gov",
    "company": "Art Of Beauty Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "91f3f039fb224057c8b75e7a485cab55",
    "title": "G&FIRE INC - 688176 - 07/15/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNckxjSXJXR3pGOHhlbFJuc0Y3bWh4aFgxa2phQVp4Z0FweFl4TS1fcTJhZzV6X2tlRjV6Ml9QUm8zZmVLS2JCNEl5bDlNV3MxcG9OY0o5ZFdYSFp2d2ZFc2tYZkZzb01iLXhnMkc5bTFqMGpjVWV1VU9Oa0RucndQY3BzZjBCRFYxRGlmM1lOUzRLNk9XcjdYTktLN2dneDRJNHQ0Y2ZueWEyY2lHOUFaV090b0M2ZGdGSmZjSHJqSHdOQQ?oc=5",
    "date": "2024-07-15T07:00:00.000Z",
    "dateFormatted": "15/07/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "G&FIRE INC - 688176 - 07/15/2024  fda.gov",
    "company": "G&fire",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "5bf2dc4d40f35cb97ebb9aa251848819",
    "title": "Jiangsu Hengrui Pharmaceuticals Co., Ltd. - 679790 - 07/11/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTmJWcUZ4cUtMV2FsbjBKT3VncERRUVVia3hyZ3VRSHhUVkpsX3FtU1o3NnhaakpWdjMtWlZmY2VpbHdubGp5U1BJUEJLNFhsQXJ2MXFKRkRLZ1JMS3NjaDI2eHVTRVZkMVNvSFlobFRaRGtmSXIzb2tRTXZrS0x3UVJObWJZeGNyZW5McVBuZ1JUeUR6SU41WmE2Uks4N0p4Vko2OHI0ZHFweFQ5amJHYmNqdEFnaHRtTEpDQ2Zha0dWYml3YW4xcUdwLW5ZMnhFLS1FWHVaSnU4RE4yWGk3RG03QWd6Sks1?oc=5",
    "date": "2024-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Jiangsu Hengrui Pharmaceuticals Co., Ltd. - 679790 - 07/11/2024  fda.gov",
    "company": "Jiangsu Hengrui Pharmaceuticals Co.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "380894e3d7b137b486892c707364518b",
    "title": "AKT Trading Inc. - 676865 - 06/10/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNcGZYcGlMNkl6SlFLajQteTZnSmpJd280Y0Q3SmFqbnVpLVBPcE94U3AwWVAtUUk3dGpwamVtRkxWSmNyLTNoXzRILTdaMlZYbVI0OGd4SUUxMTBWallQVS1VV0xuMENXMUxnNzhBVG11R3RTZ05MZHNtV0xSVlhFTm9ZVzI5Rk8zWVRsbC00VjlPZGFDY1BIcFRfUE14UHk1S3ZJZVJ3T08tM0otc2lkUUl0T1E2ZHdFZUpJeHV4VW91cENKZERQV1R3?oc=5",
    "date": "2024-07-02T07:00:00.000Z",
    "dateFormatted": "02/07/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "AKT Trading Inc. - 676865 - 06/10/2024  fda.gov",
    "company": "Akt Trading",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8016d9138768a6ceb901d70b34bacb95",
    "title": "FDA again warns Sun Pharma over Dadra facility - Regulatory Affairs Professionals Society | RAPS",
    "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZVRWX19LcnlWWGFqcWFrS3lORXNfUUR1cS1CdHAySkdBU1FzbFBSN0p1SmtUSmI2OUgxdUJZNENlaWhmeUNSNjFEOFp5d1YwTVNvVnlEWnZJUWpPaHVuak1OZUNQUlQ0QjRoRDRwdmF5aTVmSE9mRUlRZ0VGdHppX3RRVXlET1c3ZVo1TWF5Qm5CWmRwS3BydVhRb2RyVWdsUExTM2V4UFY5UQ?oc=5",
    "date": "2024-07-02T07:00:00.000Z",
    "dateFormatted": "02/07/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA again warns Sun Pharma over Dadra facility  Regulatory Affairs Professionals Society | RAPS",
    "company": "Fda Again Warns Sun Pharma Over Dadra Facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "26db08bd7763d3f09ae30a5bb1755eb3",
    "title": "Angela D. Ritter, M.D. - 681999 - 06/07/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPY3RJZG55SjM1NklIcHFPaFg2MkJIMlNvNDgwcFpncHQ4ejJYcGg1UXQ4Vlp5VWpPM3dZcTQ0RngwY1hIWVpzSnAyaG01SzZSOWY3SGkzS0Z3Nk5jRWc5T1k1X2M4dEJTbTQ3U1V1a1ZyTVlKM3l1Z3EyLWR2SURKVi1YQ0k4cEp3VUd2WThvQzhpYnRZQks0OUY1NzhvbjJjWFJJZGdsOHIxUjZ1QWZDTF9pcDdOUXAxcjNpRTZSOXU2aWdYTzhYZkxXRmszQQ?oc=5",
    "date": "2024-06-18T07:00:00.000Z",
    "dateFormatted": "18/06/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Angela D. Ritter, M.D. - 681999 - 06/07/2024  fda.gov",
    "company": "Angela D. Ritter, M.d",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "5921800aa037568b1e04c34ee3dcecf6",
    "title": "AstraZeneca Pharmaceuticals LP - 664789 - 05/29/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQX0RiY0NVSTBOZGxZYk5PMGpVSUZlTjQzU3hSbzgybG5LcFVBR2c5NzF1RWV6U1lFNEhoaWFRN1ZDM3FpSDBGZmRFZGJpOWk4RG1QSUxYMXMwbDhVZ1J1WXQ5X2lOTlF6am1vU0QybTc1WWNUZFNQVmNOZ01wMTVsSUR3YV9KbTZGclNFQjRvNzlzRjNUeHNuMUJIbi1Nb1lkM3N2aVczNC1qWm5sZ3MxLW12NzFIVVBqRXRxcE5aY21OeW5CMjFrcW52ZWJSb0gwQlY5YzE2Q0U1MzFJdmc?oc=5",
    "date": "2024-05-29T07:00:00.000Z",
    "dateFormatted": "29/05/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "AstraZeneca Pharmaceuticals LP - 664789 - 05/29/2024  fda.gov",
    "company": "Astrazeneca Pharmaceuticals Lp",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "239fc10264c26b2827b0408c9f4c3298",
    "title": "Natuzen Co., Ltd. - 677942 - 05/03/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQeXhielc2SGk2cmFOOC12U19TWUVFdjJkRkZVb2dWa1pIMG9lR2daMFlxYXIyVzFVYWNaaG9yOUtWMkdvM3FfdThudk12VkhZd2FfWHNheV9rbm0xc0F3em82WEFhYUY0LThxc2k0OGFWX09JMGNvb3NFdEg0aVdXM0VvZndYd0lGbGRGeEd2Q1ZpNXB6dVNjdF9uUURFcS1XUkswQ0JKcDlLYXVrY0twQTRnMnExY0x2MlloVUVpM3VWSGFLZGw5ZQ?oc=5",
    "date": "2024-05-14T07:00:00.000Z",
    "dateFormatted": "14/05/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Natuzen Co., Ltd. - 677942 - 05/03/2024  fda.gov",
    "company": "Natuzen Co.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "478ed0adaf4b0f40e19b668fc2fa7a75",
    "title": "Hacienda Mexican Foods, LLC - 663221 - 04/04/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOT0FCelJSQWhBNEYxczQ2eG9rS3g5WDZlNlUzOG96NTNwdmc4RGhxX2lkSEFGSi1zQm1mcmV5VXE4eGxZYVF1SnBDd0V4TDlwZk15MkxOUERud1NZVlhhcmNOV0dEMHBQRERjT1hiMkNfZS0zNFZHVVRlVFlzd2NpNEQ2dERPQktQTnRFeW1QcnBqMlduallGalhCSnJZMU9EQ1NUV2dabkx0Rl9FWUkzV1Q0bWFFTlRfWWNnMWNWSjlNMmlfRDJmdEFUbWRyXzJjWjdqWDI3QUk?oc=5",
    "date": "2024-05-14T07:00:00.000Z",
    "dateFormatted": "14/05/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Hacienda Mexican Foods, LLC - 663221 - 04/04/2024  fda.gov",
    "company": "Hacienda Mexican Foods",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "cd4536211a2c68672ff2703fe124ae56",
    "title": "Washington Fertility Center - 678931 - 04/30/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQWk9EQVpXaENhWDQ3TXNsdWR5anhLMlF3S1haUHhBTmxTa3B0QnJXTUp3a1FOdkw1OVdUcHNzbmZidWRfSWphZ3ZFdjdaUjRCeE9ZQlNaYXVuWHlxcl9WcFFJQ1JkMTZFVlZoTEpYUmtvRy0tMXBjd1RrVE5weXpiUUlXVndkUTY2Z2wwa3ZWVTQ5ZVRxTkdYTmVPdUNOb3FNenNpdk5hNlRuUnhoNk15Nmw3UExhQjBTMHNaa2VONE9IOTNTWlpGenFsQ0p2UUVoN04yNzFvTGUydw?oc=5",
    "date": "2024-04-30T07:00:00.000Z",
    "dateFormatted": "30/04/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Washington Fertility Center - 678931 - 04/30/2024  fda.gov",
    "company": "Washington Fertility Center",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4f05233fff2bc8628355c7d399115da7",
    "title": "Zen Enterprises LLC - 678407 - 04/18/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNM3JlU2JhOEVsd1puQmxwcHlDbzUtZlF0aUdxRlY4TVQ2WVdTSFE4ZWl4a1BGWVM1azlaaWRTb1lKVUpPNmloeHktUmJiOERtVV9nMnZubXp2azRpdlpZSDFJZG41ZHI4TmhOVE1XY3pZYjBVdU9qekw5VmxJOUhjdUFoM2dMb1pWY2dkYXcyOVNxdmpIRHBaS3NwanVRY0F3YTU1d2FWLXhBcEtBdExUc09BN0E5V3BMLXNkX1ZKaGk4MnhDUEdlclFVZWJYV28?oc=5",
    "date": "2024-04-18T07:00:00.000Z",
    "dateFormatted": "18/04/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Zen Enterprises LLC - 678407 - 04/18/2024  fda.gov",
    "company": "Zen Enterprises",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "eaf947ad1f4e92a417fb4ac3eb8f11b2",
    "title": "Appleton City Feed Service LLC - 662279 - 11/01/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOaFJMa3k0MGpZZXdMQmpyWHFRMnktbmFQcDJqMVl0dl9LM1Z2U0pGV3hENFphQWV0eWNZUVNvMEdGdHdpQ2c2Ukx6dHg3SUpxVDdTaGEtTU1iMHJscWt5UHpZeERZeUxqNkJaUzJXOVhBU2RtN3NyQThrTkZlM01NV0JzdmJWcDBuWFY0VzlfLWlxQzBHMTF0YnVZa29XNkN6WWtzV3VDQXpwd3A0S25sVHpraWhGV0phOWdaVG9LYUdPbWpqYVVXNmdheXhmc1VKdzIxcU9MeXZjcURRLXc?oc=5",
    "date": "2024-04-16T07:00:00.000Z",
    "dateFormatted": "16/04/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Appleton City Feed Service LLC - 662279 - 11/01/2023  fda.gov",
    "company": "Appleton City Feed Service",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "045545b925dfb91d785a00c751f0e071",
    "title": "Master Paints & Chemicals Corp. - 672462 - 03/13/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNQk5Ic2hmR3NxVWtDVmVFaGdQbE0xV1huSkpDamx1X0I2LU1EU1d2R1RUdHMyZGl4QnlYQkZUXzkxcWl0MjNzaGdRemRocHNxVWxZNFI0NUhQdjE4WHdNM1VnOFpUek81aUZHekhTTWstRkt6YkdTQnplV3hLc2F3UlVocGoxNjB2Z2h2emNoenA5ZVRsZFpxVEZtcUVYeDd4Y3hfcU1aVVI3NkdlVnNSUEEwZW5DQlhzcmRncVQ3UmNNU2JtVUJpLWF1OUFYU0RTN19MYnNvV1lrRTA?oc=5",
    "date": "2024-04-16T07:00:00.000Z",
    "dateFormatted": "16/04/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Master Paints & Chemicals Corp. - 672462 - 03/13/2024  fda.gov",
    "company": "Master Paints & Chemicals",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a62d611ef3b0f1276f4ce01c9a34d36d",
    "title": "Lipari Foods Operating Company, LLC - 669083 - 04/09/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNR0plWG9fU3FNV3M3Q19HRXZxUnVSZEJOZVVnZ2FvZDVRU0dKdlItWmJ2MGlWQ2NnZXQzUWlEZGJpMjhZeVdvZEQ4UWtPU0E3R19jVUVWTzk3N0M1RWdvTXRZWUxTclJ5V2F5ZkhUenBUeGRtd1RoZFJ1dFU2OWYyc3djNThCODkyalhNNzlLaUJYX0daY1I1bU5EME5iYk1WUnJRVWxHNWxVblVndURRYkdZcGh2bXNjbEh6TjVPdWUwb1MwNXpjbW4zOWdscHRKeGZHY0FpaHZVdng5c0ZDQkttUQ?oc=5",
    "date": "2024-04-16T07:00:00.000Z",
    "dateFormatted": "16/04/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Lipari Foods Operating Company, LLC - 669083 - 04/09/2024  fda.gov",
    "company": "Lipari Foods Operating Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "11567b7f365e54e9867e0bf4bb6f9232",
    "title": "The Brief Summary April 2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE00bjNRcEtSMEh4Qk5yOEZoSFpvZmd5Y2tRd2VMT2JwbjJJM2RWVlpocHZ1d3pqbjRkamhwRlRnQ05qUUQ5MmxmazJRdU0xUmd2Y1dB?oc=5",
    "date": "2024-04-10T03:40:45.000Z",
    "dateFormatted": "10/04/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "The Brief Summary April 2024  fda.gov",
    "company": "The Brief Summary April 2024",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8436a28cc8025381fa82841759856ea6",
    "title": "Vintage Chemical Inc. - 673930 - 03/27/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPMXF4RjljVElOM2NaZFh5SkY0Y1lKM19uYXBXdXhTSzV2ZExncTA1X1VONWRIY0FYQjVnbGZzOVlSRlJJY042QWUtZHEtTll1X1EzVVpoWDJoNzJFa0xOTnNyaDFsUkRKTFJjVnViVXRxWHZzclN1MGdXeXcyemxndU5EMkVxNTBTY09Lc3UtclU4d2dscU5jY3JUWVlPNFpPcUkxT1JReXJ6MGhzYW5RX3JuQTNLTjBiN0h6bWNpRG44aE45aFlkOHAxaUtyNVlP?oc=5",
    "date": "2024-03-27T07:00:00.000Z",
    "dateFormatted": "27/03/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Vintage Chemical Inc. - 673930 - 03/27/2024  fda.gov",
    "company": "Vintage Chemical",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a200a8104b76a304c04c92bbb6f3a392",
    "title": "About Warning and Close-Out Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPNGJFd0ZsMjZjTmN3SFJRekRCRmtpVy0wOEF0eWh0eXlOUUN6S0pZU0l6VHluRHdHRUFyaWtIQXk5ckZDRVUyMjE3SHN4b2xzUTgyc1dxSWR4TXdIa1hac2pKVXNLRVJkQkdNbTZtR25VbXFINTRoajVIV1RRTVhyam52TlRNV1J6MVo5NVBGLWEtX3Zqc0w2aXNUeFc2eGhmMDk2U0dkNmt0M0trLTVQV0NMbGVwZkkwLWY4eVJlei1rV1M5M0R1d3NfNHc1N1k?oc=5",
    "date": "2024-03-20T07:00:00.000Z",
    "dateFormatted": "20/03/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "About Warning and Close-Out Letters  fda.gov",
    "company": "About Warning And Close",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a74fb6d6762ca97efd3fa4a6806c90f2",
    "title": "Fresenius Kabi AG - 671249 - 01/04/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPTHh1TFJvc2VJNG5SMDQzRGw2eEtxZkRNdFBoNTN4SWNzZll5aTRrVm9nOEZVQVRYM1ZEUnNWMmQxRHZGQkl2ZGxsa2hQdl9UWG56SUJ4SGlaUVVZa0hCUmNWOEVwSExzX1dsbFNKbGxja1lZRVhwcjNWT3dxUEhHSldaeGVQV2Y0amVpM2VtMXdMeEhJXzB5RTNrWVRWNEhkZ1pGWnpobEJBeWxoN3BWSVZpZ2U0Tm5LcFBvM29sazZWOGtpNXJRSTFPOE4?oc=5",
    "date": "2024-03-05T08:00:00.000Z",
    "dateFormatted": "05/03/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Fresenius Kabi AG - 671249 - 01/04/2024  fda.gov",
    "company": "Fresenius Kabi",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "fddb99e3e25504d4b99bcdcbaebb9e4a",
    "title": "Colgin, Inc. - 670332 - 01/25/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONF9kRHAwTlhHeDQzU284U0Q0WFFuTjZlcXRpSC1TaVd0VmZmRGpGSm9yaUtSZVREQkdwRUV4NHpkWGpmdFVOMURQS25hSnp5Z0lvMEY4OFVyNURBZXh0R01Gb2R4LW93a3lNLV9SbjdldmpJZFkzalZ1b1dLVG1mZHRrT3FvZVRBQ19JNXlfQ3JHUTlkQjcyR1EzRmY2eWRUSF80T0p1TEprQnFmVEdGWU41Tkt0bWxIdERzNkFuNlhnb1k?oc=5",
    "date": "2024-03-05T08:00:00.000Z",
    "dateFormatted": "05/03/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Colgin, Inc. - 670332 - 01/25/2024  fda.gov",
    "company": "Colgin",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "af571c25f6b861c7fa647acaf27a1f79",
    "title": "FDA Warns Five More Online Retailers for Selling Unauthorized E-Cigarettes Popular with Youth - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQOTc2WWt4WnlTc2N3OUxxeWpLQzh0M3liQTl1ZERTb1FMYXJfZXd6MW9ubERBeUFDQVNXVDhZcFB5c2dMTFdSUXdxWnpkUGFxWXE4ZTZkX2ZFaDVGakNsZUtPOHhLOTVLRUtYSjFKYWQ5alBLNy0wam9uVVE2eWdrQ1Q1bEpJSXlGSjdjRkJXelJSaFFxUV8tY1AwekxMbEcydUxuNmFfY3ZVV1dpc0pQYVJwcjhFR2RtQ1I4eTRjNDl6dnBGQ0locHpsa1BKa0U?oc=5",
    "date": "2024-02-28T08:00:00.000Z",
    "dateFormatted": "28/02/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Warns Five More Online Retailers for Selling Unauthorized E-Cigarettes Popular with Youth  fda.gov",
    "company": "Fda Warns Five More Online Retailers For Selling Unauthorized E",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "db5626675f742c34b8c93df357c0c6b6",
    "title": "How a 15-year-old Genzyme drug shortage became a legal smorgasbord of pharma’s thorniest issues - PharmaVoice",
    "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTU4tTnYtcjJSWHBpaVJIYzVVUjNYNTJxQmhXNjlYSkNOTjZKQkp0Z1ZweGJIN3pFaFJyT0I5bW85N2UxY0d4LVkyNnNtR05DSEhaMXYzd2RUUkFMcmhsOURtS3JYQWIwWG5kUFdzM21tUjRheW9OTWtLU3R6UmVoQlFuSUp5NVU?oc=5",
    "date": "2024-02-26T08:00:00.000Z",
    "dateFormatted": "26/02/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "How a 15-year-old Genzyme drug shortage became a legal smorgasbord of pharma’s thorniest issues  PharmaVoice",
    "company": "How A 15",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ae214a58617011b5c294f0d3856524b9",
    "title": "Fabrazyme litigation back in play for Sanofi's Genzyme as appeals court overturns dismissal of 2020 lawsuit - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQUWwyYWFRcjBhTkdLOWhIOXlqQTl0WFBCR3daNjBRNzJPQmNfckFuTW0yZjdvbllpcXNEVnJhamExdkV4czRlQXlNNlI3cUdSSnV6TzBoQzNUSjNic09WTkk4eUhJR0FhVVU2QlJ5Mnk2Z1Z0aWJTNnJTeGhnMEtwOTJqZ2xYRzlqVWI0S010XzRTY19hUXlzbHgxRnN6STdfTFlEb2ZfOWhjLXduSjZENzFBdHFYNUp5djBuazd4VkNMRG1OTG5B?oc=5",
    "date": "2024-02-20T08:00:00.000Z",
    "dateFormatted": "20/02/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Fabrazyme litigation back in play for Sanofi's Genzyme as appeals court overturns dismissal of 2020 lawsuit  Fierce Pharma",
    "company": "Fabrazyme Litigation Back In Play For Sanofi's Genzyme As Appeals Court Overturns Dismissal Of 2020 Lawsuit",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "76583f592e20277dec181f7b3576f7c0",
    "title": "Nantong Furuida Packaging Products Co., Ltd. - 667984 - 11/17/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxQOFhwQXhEMHRlOHdweXBqeXdUSDJzY182UDk4S09seXpHNDJ6NkZ1VGlmcDdQbFNicEprNWVRV0cyMThja01HQmI2bHFadXI2OE55TUxYYl9aQWFlcUpFeXFTS3NWUHN2Qi1nUDJreE42Vm5TOVJLSXp6bC1oX3ZteXNiNy1kTlBReE0xOE5xVXVmdlIzeFRJeDlya2JlMWU0TlFGenJ0NDdhekU2RENnOGJMaGh6bzdFNnQxOGdPMHJCcEdmaVlSVUtfWTRTdGY3MXZjTVphbEt5X0h5eks0THUwV0NCLXZ3TUh6Yw?oc=5",
    "date": "2024-02-06T08:00:00.000Z",
    "dateFormatted": "06/02/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Nantong Furuida Packaging Products Co., Ltd. - 667984 - 11/17/2023  fda.gov",
    "company": "Nantong Furuida Packaging Products Co.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "175f42c40dc76e7510eeeb0390a5ac9c",
    "title": "FDA Warns Online Retailers for Selling Unauthorized Disposable E-Cigarette Brands Popular Among Youth - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNYXBCaVd6Z0FtX3lXOXBYNm43aUZTSFRqUGpZM19JUlNpekk0UlgwcGI0aWJmcUZnVlFUQmppd0c5QzNqejQxUmd5Z213VmV4dnNid3hEUEJ2MmJYV25qN2tscGFvUWhfMlZlbTRrSE1LMTFraHByODNWQ2ZuUEtIQm5yNzZLNWUtcl9Uall6Mlk3VG9udDZUUXZHMGRDUG9lelhHOFFTVWRKUHh5WmNxdXhramFYbzVfM3VVQ3BsdVBKV1FjVjN1Z1M2RnVtMVJSb1lXcUpYc3FLZjFRdzdhUw?oc=5",
    "date": "2024-02-01T08:00:00.000Z",
    "dateFormatted": "01/02/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Warns Online Retailers for Selling Unauthorized Disposable E-Cigarette Brands Popular Among Youth  fda.gov",
    "company": "Fda Warns Online Retailers For Selling Unauthorized Disposable E",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "3c0fb1668fd01dfca7afa4b4948f1df9",
    "title": "Philips' US sales of sleep apnea devices face years-long halt after FDA deal - Reuters",
    "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQT0pUakJLQXNLeXNaNXd2QUwtd01nRDFMWVI0c0VBNjNXYzhRQWVUVWM5UEtZaW5KLW8zdTlnOWN0ajFjNzN3Q25MeEw5TERLa05feV9CMlRZcnZsaWtfZmd3VW5rTTZzVHFsdFpJNHRnU2JEc2dGRkJHZkdtMUtDOWFPM3FiSGFreGQtbG0xZTRJZklmalF0aVVIUzhJelZ3MUtQUU5lbkVCY1lvcFYxVkZDNERSVHZxSTdTUFNFYU9rOElOdXJsLVZPTHVTMll1WHF1T1h2VQ?oc=5",
    "date": "2024-01-29T08:00:00.000Z",
    "dateFormatted": "29/01/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Philips' US sales of sleep apnea devices face years-long halt after FDA deal  Reuters",
    "company": "Philips' Us Sales Of Sleep Apnea Devices Face Years",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b44a183c45d14f92221a0e1df3526ab1",
    "title": "Sambrosa Care Inc. - 673321 - 01/24/2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNMnBlbkQtRkYtYk5nZi1vNkp0ZktVMU5JRF9iTC1xbUNFOUs2MXE2NjNZd05XREplYXctSUJWZzd6aFo3X29ycjFkMU9sMUxEMGxuM0g5Rk03djBWWVpPR0p3dUdadnNYNmJRb0cyVEJTcWF0RktkQm9udGM3dV8zX2piS1VHeXVPbS0yTGJPQUhxaEQ5U3pGWGI0YUg1cFpGa3ZEVWVqbnZzN3VOc3h0dHl5Z0Q1cW5ILWM4ZUhiM0k4RDN0MVhDaDFyWkM?oc=5",
    "date": "2024-01-24T08:00:00.000Z",
    "dateFormatted": "24/01/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Sambrosa Care Inc. - 673321 - 01/24/2024  fda.gov",
    "company": "Sambrosa Care",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ff883a78129ebed01221608abfa017df",
    "title": "The Brief Summary Janaury 2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE03ZUh6R0tmSktLZk1pUTZzZTJsSXNGMEVGRURvT1RaenlDT3RlVmNNeHJ0REdsWGU3OFNZYzF1LTNDNVhlejNWWnk5VjRhSzZGMGVJ?oc=5",
    "date": "2024-01-17T08:00:00.000Z",
    "dateFormatted": "17/01/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "The Brief Summary Janaury 2024  fda.gov",
    "company": "The Brief Summary Janaury 2024",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6f849304d94c0d1a2ae21d47c95c2304",
    "title": "Colonial Dames Company, Ltd - 659151 - 12/05/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNU1NKdzBtbEhvb1JBdXpVNVNxYi1yZFN4NUJLSDRoOGFkLUlqN0EzSHJZaG1YbTRjUXRPbmEzTFdVaEdNLTZhdFlwcGxJa2R6LU1RREVjQktFZE54Q1VYMFZ1c2VBWHdDbkhNMkdWWHRQR3pPNjMwc25BVXZLNjYtVUotWTNTREh0STdaeE1SYnhSNlV4b291dlJHYjd0Y25SbWFsSlNiNkRiQ3AzRXl1aGt3WjltYzlVRVNJOHNQTnUwWG9FUm5oMmxWZE9OcWg2d2F1R09FdzY?oc=5",
    "date": "2023-12-26T08:00:00.000Z",
    "dateFormatted": "26/12/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Colonial Dames Company, Ltd - 659151 - 12/05/2023  fda.gov",
    "company": "Colonial Dames Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "978481a464606a72cbcb9deb4b70535c",
    "title": "After manufacturing blunders, Pharmasol is shuttered by US court for distributing adulterated drugs - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNdThWVXh3R214Rk1MOWFLUGR5OGFuMzlHNUNlajRNN2Y1a1FFNnFBMW5mYkhnUy11cC1CdzhmOUhMR28xLVJ4V2UteU5Vc2VHMGgydDNUZmJNS0l2NVJwdW8wS0xYMTNrZklld1h4RWhmRzlWcllmeUptY3JELXh1am5PR0FBbFl4ZHpIaG5MM0JjVXp3TWUxR3oxUnRNNUIyWFNVUWctbzJXVm9VMC1vNmJjVlV2eHc?oc=5",
    "date": "2023-12-18T08:00:00.000Z",
    "dateFormatted": "18/12/2023",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "After manufacturing blunders, Pharmasol is shuttered by US court for distributing adulterated drugs  Fierce Pharma",
    "company": "After Manufacturing Blunders, Pharmasol Is Shuttered By Us Court For Distributing Adulterated Drugs",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2ccec849c31fe7a9e8bde786a92f3b5e",
    "title": "Experts discuss red flags that can trigger legal action against drug and device makers - Regulatory Affairs Professionals Society | RAPS",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOT3FGT1dxR2w0akRBSXBIejBUOExQWXVmOTFtUVRsejNrVDM2aHZmOVlmQTdGYW5ncGFTNEtVLXB3S1VubnQxbnc4bmlwM2ZlT1hqLTdWbFljZmF5NFlwZ3pZdUlGS0hUbDBHM05UR1JNR2xpdW9VVWQ3dnVHRjdMVmpOQUZ0NEZfaUMwaXZ3YVUzVm84aXp2cUVzQWNQbHN5QnVwRWZfeE9WLS1oZ25oVw?oc=5",
    "date": "2023-12-12T08:00:00.000Z",
    "dateFormatted": "12/12/2023",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Experts discuss red flags that can trigger legal action against drug and device makers  Regulatory Affairs Professionals Society | RAPS",
    "company": "Experts Discuss Red Flags That Can Trigger Legal Action Against Drug And Device Makers",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "9bcec12a814c75643af68c76c5dde1ce",
    "title": "Prestige 22, Inc. d/b/a The Vapers World - 671630 - 11/16/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPR1lTS3VhQ2RpVWJxY09HMFdoTDBTNWJ1TjI0Q1p2U0JXZHhLVzBBanpNVzlBeko4NDROY2J1TzFPUjNGYTU1c2o3NVE5YUtHNEFKeE5IUm8tLWxnbWdfSVNvU1FDbjB5REhnNDRVMm5GNXRDNXJxSU91VnpaMWlQWUdkUTRMbGhRbWk4S3EzdU5PcVB3b3dRSWtVMFRfbjlrbkdWQVZac2tER28wanctMWV5RWVZNnhvdzhIYW54Tncxc3B4MTFxLUNpNHQ4WUlUYmZxNnlNZWxCTFNUNmNURg?oc=5",
    "date": "2023-11-16T08:00:00.000Z",
    "dateFormatted": "16/11/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Prestige 22, Inc. d/b/a The Vapers World - 671630 - 11/16/2023  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7feca1c32b35ac735aa8e66af9f28eb6",
    "title": "Nortec Quimica SA - 639894 - 10/23/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNZ25JSjdSWkVWUnFNVVcyWl9laEtLTWk0MndwNWNjTzZtWWFzalJvMWoyRENNVFEwUkNiVFhReW1raHpHTE1SZ09IOG1fdk1ma3NGa1Mxa0RPbnlPQ2NNSGZfaUR1WHJjSjBidEVhWEwyRnFCWHlHckpQWTRuc1RjeUNhalFpQ2xmTktOQ2xrMEtnRGY5SGRydjR5M3NoZVUwdkJ4SXVka1piOXB0NXJJLVFUdVN6NldVZzlnYXl1N2hmbWtuYVRoYm00RDE?oc=5",
    "date": "2023-10-30T07:00:00.000Z",
    "dateFormatted": "30/10/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Nortec Quimica SA - 639894 - 10/23/2023  fda.gov",
    "company": "Nortec Quimica",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2a615ffae77a0f0a165089c1a2ddcfba",
    "title": "The Brief Summary October 2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5ZVGViOVNKY2tUNS1SdVRpWGNKcnZTdThaUGd6YkZCTjhNbmNyVUdMdDlUc3psbFh3amo0MUpzUy14RVFpSHJLWEpzeHN6cHpVVTI0?oc=5",
    "date": "2023-10-04T14:03:13.000Z",
    "dateFormatted": "04/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "The Brief Summary October 2023  fda.gov",
    "company": "The Brief Summary October 2023",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "415f1e4a4924167850852c417233d137",
    "title": "K.C. Pharmaceuticals Inc. - 654986 - 08/03/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNbU10cEZaN291X2FkbFBiR1Y1LUVqR19RNzM4am9ncE5KZ0RzNTBlQVFnZDNSYlQtUTZPaGlxVGNZazBvcVd1c3cxemtvcXUyaS1ocUViekRldVpaYzFkSl92cWpCMVFQZ1pLc1EyVlI0eW9kRnFwS2NodGRxLTNaWVhXMTJ3UVhZNGpyZmJxdDNHSzM0a2lxOG45d29nSmxucGVTS01fRmphZ1hDUDlfNDZBN0VXa3doakNCaWhXeHVwMWtTN1pIM19GX1R6cTZPOElN?oc=5",
    "date": "2023-08-29T07:00:00.000Z",
    "dateFormatted": "29/08/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "K.C. Pharmaceuticals Inc. - 654986 - 08/03/2023  fda.gov",
    "company": "K.c.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c7564158947f0f9ef9c695df0f89fcff",
    "title": "Educational Case Studies - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOdmN6MGxjQjhzUUNjOFV3bW15d3JxelBfMnY0NXdhMGNrOVhjVjFlV2hHb0F0c3FkUnVrTmN1X1NmdXZTQUotNzF2cDNrZlpwZ1hlQTQ5ZjhtVnlFZXRmQTFnWXY1SWtxek94dWdqZlAtU3BLNUY2Tk5xNTFoMmZGUzRkaEgyY1pZRjZrOHhB?oc=5",
    "date": "2023-08-22T07:00:00.000Z",
    "dateFormatted": "22/08/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Educational Case Studies  fda.gov",
    "company": "Educational Case Studies",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "edf761d3677efc8dae6e1368a3b22e75",
    "title": "AstraZeneca Pharmaceuticals LP - 664789 - 08/04/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNR3VHTmJPcU9kVjM1RHJ2TFlfcGRRN294VkRRb01hdlIxYlg5QW4yOTNWWTcyZC1WeUNmT09HNHdVYzFZbnI0T2V2OVpZcHp2d0ctZTBKTWtaUkpPU1JZQ0VlV08xbUtHRi1MRG5ud1p6VjM0YkxGTkZndXJwMFN6anNuYndpMG9ldi1yM2lPN0tDcjVXZ2VJaExxV2U2dE5fTjNINFRvMnotT21LdUtzclhKM1oyWEx6UlhoMUx1cjRsdkVCRDdPUE1FaHRGWF9ScEk1OUZlOWZJdEpwaEE?oc=5",
    "date": "2023-08-15T07:00:00.000Z",
    "dateFormatted": "15/08/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "AstraZeneca Pharmaceuticals LP - 664789 - 08/04/2023  fda.gov",
    "company": "Astrazeneca Pharmaceuticals Lp",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "fcbfb550e8ce48dc4a873c9c1725d914",
    "title": "University Fertility Laboratory, Inc. - 577584 - 08/03/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNMFFrb19CaEhpdFNEVDZFYm9LaEdLTEFya1VkS1hrblBZZzhwMDN3NHNvYWhIZC1PQlVKM05nTVdsVEZPam9hbG1XVWwtVVpTdlF2VFcxWHJKNmtWZlVnTi1QM0dRYWxfUEk3bEtlZndMWkN4ZHZubkl6VndRbE84V3NwNFdEZ21obk53bjBxWkVhd1YyNXdSSFNHYzZ5cndVYmNhYXhab2dqWnBXYUU2Zkp4REpvNUdiYm80YXRGOF8zdUZ5OGNuOHNwbDZhZl9haEFTR2hCd2h4VzR4YXV1Z3FoOGc?oc=5",
    "date": "2023-08-03T07:00:00.000Z",
    "dateFormatted": "03/08/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "University Fertility Laboratory, Inc. - 577584 - 08/03/2023  fda.gov",
    "company": "University Fertility Laboratory",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "285050a3a405bee62a567302009f8845",
    "title": "CytoDyn, Inc. - 626957 - 04/27/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQM0VlQ3gxZ3RQZDlZSDVDeDhKSFoxX19JZlhmMkVvaDNVRUVRQ28tOFYxcjRlSWh4TmROTHI0bDZCTXY2cDhpYUZSQnk5Um4yMERvU1d4OFFxV3d2Mi1iakVULTdGU216V0d3TjVrZ0NLYWlNTE1BU2QxbVN0UTdlQ3c1SWRvaFM1aGJIZ29IVk93N2F2bjkweWttd3hUSjBuLTN6aTUwekVoME55NkNlUmlJTi0zdU43U054MFVMZzF1eHM5?oc=5",
    "date": "2023-07-25T07:00:00.000Z",
    "dateFormatted": "25/07/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "CytoDyn, Inc. - 626957 - 04/27/2023  fda.gov",
    "company": "Cytodyn",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "44d779d9b263146f80428035254433d2",
    "title": "Wisetrade Corporation - 657707 - 06/30/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPdlJwQ0J3VDNTZm16MzRIX0g3WmlzTW84dzFPaFdNT25wRUxDeVhLR0NmOEFKcUR4bzdkcVd3Z3dKM1pxcEgxQ0ZGWXNXWXRBOVoyN1lnUlJqZ2QzSTZSSTJfY0o0a2E5NWRadTY2RENNbTJtWGpOeENreldtb1Y2Uk9GTWJaVGlYczhPYktqdnN6NXJyYU9Ea1U5UzBzc0R3bmtXVE1zNDZkcHpzekVHbW56TEVDVFdIQmFZa1BjdHN6Z1NrVXBXanY2eTlVTHJ0MWc?oc=5",
    "date": "2023-07-18T07:00:00.000Z",
    "dateFormatted": "18/07/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Wisetrade Corporation - 657707 - 06/30/2023  fda.gov",
    "company": "Wisetrade",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "787445fad559ce77a19e09103a3dade8",
    "title": "New Manna Food - 652996 - 06/12/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQaHMyQVJJTXNiMDJIWEZXbl9IWFptdTFzOGoxdGJsaFZqZkRCYzJTMjhpaG1fakNjVWNFRWU4QU1kR1ppU196dVAxNGdNRmdyaTQ1Q2Z2d2daV2hITGpXY0d3TVhXZXB6ZUVlZHh6MDJ5OTVxWnRvN25fSWF5XzJidU5DaWJtS3JtX0xJbEx3eHFEeWpPWjI4NUtMdVV2SEZVZHBMdmxRQ1N1bmVMcGNJckxmM0FEMnJOY3BuTTRmV3V3Q0c1UjhqUQ?oc=5",
    "date": "2023-07-11T07:00:00.000Z",
    "dateFormatted": "11/07/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "New Manna Food - 652996 - 06/12/2023  fda.gov",
    "company": "New Manna Food",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "35782669b3a8908f0693cc11830082d9",
    "title": "FDA slams Intas, Ipca over manufacturing shortfalls at 3 Indian plants - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOVFI4bko4OHpNX3l4LUxaczdsWmUtMmdEVkpuNUQyNzNaT3gxa3FNWWdTLTFESEl4eVNKWXZOaHMzSUlXNUVMVkpFQWZad3ptT2s2YnVNTmhCcW1Oamt1Y3VGbGpwS3R1dEZQZEtGTk4xWUxqMVZMOHRhc09hai1fV2hLeVpuX3h1SGZ3b0FYN1lzcGtJNGJr?oc=5",
    "date": "2023-07-07T07:00:00.000Z",
    "dateFormatted": "07/07/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA slams Intas, Ipca over manufacturing shortfalls at 3 Indian plants  Fierce Pharma",
    "company": "Fda Slams Intas, Ipca Over Manufacturing Shortfalls At 3 Indian Plants",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "3f82a96e803c7ad3b248360984b2845a",
    "title": "Suprimo Imports - 657631 - 06/22/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOSE0zLTVtaWlCNUVaNzZ0X1JScDU1Q3FlNHNGNkVXNXRvYnhKZWtUYmdPaDhTUko3em10QndjYWVEbGFKNkt2QkRCNnhLb2lWM2VaVThOTTlCaWp1azh3NVN1bFJCSWlBUVA2NGxJTFdlQ1ZRWUgtalJsVXc3NzEwbU1SWEJMOEVkM1dsYUlXVTh5RXE4TDRkVGhJQVptYnNSX2pfdzNYV0JMNVI0TXZ2TWZWMC1ZeG5OMG5ZR0g1M0VTcEFzLVpPX1hn?oc=5",
    "date": "2023-06-22T07:00:00.000Z",
    "dateFormatted": "22/06/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Suprimo Imports - 657631 - 06/22/2023  fda.gov",
    "company": "Suprimo Imports",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c6644096ef66e022285ec480fdbcce15",
    "title": "Yichang Jiayuan Foodstuffs Co., Ltd - 655593 - 05/05/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQMG11MTNtbjh3aF9LUWF0ZFhkU3NXaG1CYjVJOHRKXzVuQ0ZxNGExVlVrZWJsMEo5cWJqbWp2WjZyUjJVYVkzTW9iTE1IUzkzLXRfaGM4b2xGU3FnN1VaTUtTUUNNcUsyeDBDQV9qUld1dEotajFvUGJNSmg2aWNtelhaOXB0dWJpMEVDbkVjR1JxV05SMFJ3TlNfVzBXb1N2Q2xfN25kZjh1RE95WjlhdzJmZi0ta0lDdW5hUGZXZkwxZ0hMX0FqSkJwX2tHVDJhYkFMbU9Kdi13QjlJTV9vQ1Bn?oc=5",
    "date": "2023-06-06T07:00:00.000Z",
    "dateFormatted": "06/06/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Yichang Jiayuan Foodstuffs Co., Ltd - 655593 - 05/05/2023  fda.gov",
    "company": "Yichang Jiayuan Foodstuffs Co.",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e746a9646184b20ba89d80ed11ea2326",
    "title": "Champaklal Maganlal Homeo Pharmacy Private Limited - 656743 - 05/18/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPQzBXVGtVeG5TSGplOFlRWGpCZDkxWEczakZvbC1wM3R1RkFTb3lsNThuNkp2bnF4LWlCTVRoeFl1dE5KX1Y1NUdfcURReVpkcUJYb2MzYmFiNTB3TG9OMnRXQkFTcDNEblNKR21hZTlGN1JmVDlSTG1mVUFSMzRsUFRFOWgtaFo3VTRuR2JKRjNnNTJGUVUyc2w4ZXRTeTlPN0d1U0E1Um1jUmt0RUk2S2szN051Tk9QbVBWUUxvbmt6RkRFYVZNZm5oTXhYN2N0VTYxYWExMEV1VUJhUU9XLS1EWU1JVzR6T2gwRVJjbld2S0FvNDRaQg?oc=5",
    "date": "2023-05-18T07:00:00.000Z",
    "dateFormatted": "18/05/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Champaklal Maganlal Homeo Pharmacy Private Limited - 656743 - 05/18/2023  fda.gov",
    "company": "Champaklal Maganlal Homeo Pharmacy Private Limited",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "bfc7c798f02f3a8067026c3eb83b0fc9",
    "title": "Pharmedica USA, LLC - 648269 - 04/28/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQeUlfaENOV2YwdFZXNlh2TklxcC1yZ1FnTXRvZDhLM1pQeWY5ZEdmLS04QnRtVUdZY2ZxN3ZkLWFfeGdhS2QxMGpobktkelhvZ2YxWVJiWkVaOE1kcTduc1dqSGtBMjR5bXdUb3hYdUdsSlRZTFpJNUYxdi1jUTlNcHhDLXI1NW5xZlBLcFZlNWwtQkFqVFUyWjIzX3pMb0cyREpoeEd3Yy0xM3VKWnNrRXVOaUpIZGJMODAxbW84QmpKTHJ5a2UzaF94TXpWQQ?oc=5",
    "date": "2023-05-16T07:00:00.000Z",
    "dateFormatted": "16/05/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Pharmedica USA, LLC - 648269 - 04/28/2023  fda.gov",
    "company": "Pharmedica Usa",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "80f121589bd4477b12f388472cc39876",
    "title": "FDA orders Sun to hire manufacturing consultant for troubled plant as export pause persists - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQUWR3SHF6aDhNSTk0TFhUUTJaYzRMZm84QlZwd0ZOZGVoWkpoUlpMRFFHdU1qRlgwNnJsUFZKZXg3T19WanNaZFdpZnByTDRzdjRQZFZTS0RrOHB0QVNRUGhOQzgwSlNkdlVVTk1pS3psMEVvekhXekN5Yk1GRXpaNjQ4NHdsaWtlOFkxUVVhR1p1SU5VMGR6TzZ5dG9sQjg3RTJtUmF0OEo4Z3B4b0NTZjd6dw?oc=5",
    "date": "2023-05-16T07:00:00.000Z",
    "dateFormatted": "16/05/2023",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA orders Sun to hire manufacturing consultant for troubled plant as export pause persists  Fierce Pharma",
    "company": "Fda Orders Sun To Hire Manufacturing Consultant For Troubled Plant As Export Pause Persists",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "5c293a0f631109e22d9befd54ad97c65",
    "title": "Nalpropion Pharmaceuticals LLC - 610942 - 05/10/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPd0Fxczc5V1NDLXdIWEdfcjJPeVREeWNieFVwV09ub25jLWRLOGJ0TGlpckRuQmh1X0lnS0tIaU1TNHNBaEV3Tk1uR0tlZUlyS3E2ZXdhQjBnUDJQejg1a0RhRjk0b2J2d3lCaHBSdG5qclVDMTdYZmNsbW82eFg3RFlFSHQ5R215ZWVwMm5QS2tnbzktcjBna3VERVV6Q01veXBqVDBoSXNFT2RnV2FPWWszdEE5VlJaOUlVaXBxSW9kcFY4bEZYdzl3REhCeGlpM1V6VHN2eWlDZTRtOVE?oc=5",
    "date": "2023-05-10T07:00:00.000Z",
    "dateFormatted": "10/05/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Nalpropion Pharmaceuticals LLC - 610942 - 05/10/2023  fda.gov",
    "company": "Nalpropion",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ebf2ac46831bd011e229aad4ce8b8380",
    "title": "What FDA mandate? Sun Pharma halts shipments from a plant with a troubled history - statnews.com",
    "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNS3AyYU9KLUZqTHRuaWN2ZC16VlFiQjc1QWY5MDNoZnJxRkYwSWFrTHpEOXRJLTF6WHdaNngtM0JkU3UyZ0djaWJRTzRXVlVDU1NNd1FxdjJyN0YxV2ZNRjdmTmJaV1E3N2xBV3JjTmhuX0pTbWdNOGdZeDVDSVp5YjlkT0RDZTFSbmRuSjhKWWI?oc=5",
    "date": "2023-05-09T07:00:00.000Z",
    "dateFormatted": "09/05/2023",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "What FDA mandate? Sun Pharma halts shipments from a plant with a troubled history  statnews.com",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "81b079ab51ca976b28668b0ceae1bff2",
    "title": "Manufacturing operations for Eli Lilly, Rentschler reprimanded by FDA - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNY2JDQ1pBWXJNeXpLZnhPLUpTYnZGYnZudUdDRF9KblE2LUJuVXZKdUF5dG55THVwU1hTdW5vajY4ei1Uc1FBVk5pXy0xRWM2LUpzWmFCVmRpWFZoeTg1S1lueE4wa3VrbzVfWXJoT2xmc1dMOW4xNmRzMEFWRHRsUkdMZFpGZnRKOU0tQTZGOEFkTk52MEFkVWhvZjNHMjA2Z1FOTTY3YWQ4ME5Rc3E1ZU5vVmk5MGxTeGMzc09B?oc=5",
    "date": "2023-05-04T07:00:00.000Z",
    "dateFormatted": "04/05/2023",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Manufacturing operations for Eli Lilly, Rentschler reprimanded by FDA  Fierce Pharma",
    "company": "Manufacturing operations for Eli Lilly, Rentschler reprimanded by FDA",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "d9d480bead00ac4ee8d457234786d217",
    "title": "Advisory Action Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOUE9Rc1VJUE9idVgyS0lIamdFZ2NfdkVMLXphaVRHTUsxNWlwWGktZnFWYnlXOFdoWC1rc0N6SUx0N01ZZnBPN3JQd24zRU5uSkpfSXJIeENBSFBDSzdGcEo4N0NfTXFCQzBQbnRSRFlESlJIanVrWlk0OVVGb1NDb0doazB3bmdCMU90Wg?oc=5",
    "date": "2023-05-01T07:00:00.000Z",
    "dateFormatted": "01/05/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Advisory Action Letters  fda.gov",
    "company": "Advisory Action Letters",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a8e048322472c98bf0f82743d476d761",
    "title": "Sun Pharma pauses US drug exports from India plant after FDA scolding - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxNbHltb3ljeE1IaURpTVNNSWdCSV9xeGxBMmwxTTg0Mk1Hc0Zja3k4RG1RS25Gemlzd2cyU09TbXpPLVpKa3QtV1dodnBIZDRoMlNlMVhSNVhnMDRXWlJla083MTN3eEZaZXREdU1LX3NfTy1yRUotQ2lveTRZVU1Dd3pUYVpxS18xYUQ4MWpmSGx0S1NVTWp6dDk2bERNQQ?oc=5",
    "date": "2023-04-27T07:00:00.000Z",
    "dateFormatted": "27/04/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma pauses US drug exports from India plant after FDA scolding  Fierce Pharma",
    "company": "Sun Pharma Pauses Us Drug Exports From India Plant After Fda Scolding",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "372dcdd5f3398cdbbf979f5b615d172b",
    "title": "Sun Pharma shares fall after USFDA halts shipments to the US from Mohali facility - CNBC TV18",
    "link": "https://news.google.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?oc=5",
    "date": "2023-04-24T07:00:00.000Z",
    "dateFormatted": "24/04/2023",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Sun Pharma shares fall after USFDA halts shipments to the US from Mohali facility  CNBC TV18",
    "company": "Sun Pharma Shares Fall After Usfda Halts Shipments To The Us From Mohali Facility",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "652ed0ea1b863132db704818318b13a7",
    "title": "Sun Pharma temporarily halts shipments from Mohali facility to implement US FDA-mandated measures - Business Today",
    "link": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxNTDBEeEg2SkZoY1RISHlTSmNfRFdZbW8yWmJLQm1LYU5PN2NRM2pkeC1PSExQaFFfSk9SXzc4OWFJZXAtQWdBNEVzd3VVR0o1djdLT0FsVjZFWXNTOVVGX21MLWxVai0teGhhOWZUYjBxdklPZHRRYjQwTlM2S1ZQRzR6V3B3QkdIRktFcDFXYzV1VzRWaGNVVGdRMUkxaHFvczhoNWhPTG9qallOQ0RkSDhoN1phdDh4VzI1WnA3Rm9FcGUyV0pqbktXcmlBYUJYSG8yejZKOWtzN2JXaGJqQ1dBV1hod1lXNTI2ajZsaEZnb2prVmRVZWln0gH_AUFVX3lxTFBkTFQyVk9mOHFjS0V0cnZ2NTRfSDdJZkFjeUR0Z0NzZ2JiaUJvYmsxUDUxZGk2YzVYVnhXOUxUeG04TUR4MHc2VWphdjd1aE9DcURLY2FtTkNMWDd4b0NpcU5uZ1Nzc3VKNWZHUy1DSVhpNXhOZU9ISE5oN1FEeUJGX0RVNWhfTFpKVjE1eTRKVVl3a1dMSFJOTWhkdTlxTkxJV3VWVGJTbUxVSm9sbWZpQjFRaXMxaEg5S0N4Vi02ZzI0MHYzX3VnYmlFMWh3Vmh2VGNWcVQxWGtLaHYyblZldm1zT3dtU3VqNTBlcUczeE5OM0dVOG93Szlmak5KNA?oc=5",
    "date": "2023-04-23T07:00:00.000Z",
    "dateFormatted": "23/04/2023",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Sun Pharma temporarily halts shipments from Mohali facility to implement US FDA-mandated measures  Business Today",
    "company": "Sun Pharma Temporarily Halts Shipments From Mohali Facility To Implement Us Fda",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "68be052c68ff16c3e7d762187c41baa1",
    "title": "Accra-Pac, Inc. dba Voyant Beauty - 643600 - 04/20/2023 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOa1lsaGsxR181Snl0NnE0anBxQ1V3UkItU2o4S1EtZU5qTjc1Uzl2SXdWcTRydkVRWV9abnhHRkt3ZzJJdHYybHhCYmdZY2VzcGFyaTdRTzIzeHVfck43QXNDQk5jeTRRWFZ3UEx2ZENDOVNGbVdKemVGZElNOTF0WDQxQ1djeHlOV3JuY1k2V05MUENyMmJuLTY3dUJSdG01dWhVVVpjdkdnaU0yUjhwajF6RUdKeTE0aWtqSU9vWjJDak8wdGpqY0lvMlprMzdDREdaUW02Mzl3aVZCUVpZ?oc=5",
    "date": "2023-04-20T07:00:00.000Z",
    "dateFormatted": "20/04/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "Accra-Pac, Inc. dba Voyant Beauty - 643600 - 04/20/2023  fda.gov",
    "company": "Accra",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "052083791ad4a6d6e7601ef302978e26",
    "title": "U.S. FDA to restrict unlawful import of veterinary tranquilizer Xylazine - Reuters",
    "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQSFlGUVFsNXkxOEF5NXJCRFpoakhpUERRVm9UREhlTlY5SUU2T2R1QzF0T1ZVbFB5QnVRVWw5dWxYM3hNdjNCckJYYTE0ajJVR2EydmdQUEJxRXBpbEhWRUVxN2F4OWJXRmNCLS1NWkdQTUtLTmpabmVlQ0NSejctT2NXY1lfblM0M3g5Y3RKQ3diWEowbHNFNnZVUHdkRlR4SXJZZE5SdnBnNktrbklCSjlXMkpoZ3NrX0EyWlpRODIzblphLUo3ZXE1U0dqREtIV0E?oc=5",
    "date": "2023-02-28T08:00:00.000Z",
    "dateFormatted": "28/02/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "U.S. FDA to restrict unlawful import of veterinary tranquilizer Xylazine  Reuters",
    "company": "U.s. Fda To Restrict Unlawful Import Of Veterinary Tranquilizer Xylazine",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1d5a2e33580f42924a7e5fa79eb6b39a",
    "title": "Sun Pharma gets U.S. FDA warning for Halol facility; share falls 2% - Fortune India",
    "link": "https://news.google.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?oc=5",
    "date": "2022-12-19T08:00:00.000Z",
    "dateFormatted": "19/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma gets U.S. FDA warning for Halol facility; share falls 2%  Fortune India",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2c732ec5cc81654bd8a63dd68e11e263",
    "title": "What to Expect after an Inspection: 483s, Responses and Beyond - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQNmVkRWdET0F2Wm56eGFiMWY3bFpKV2VFM0YxQ05hS3luQ2lfcFdwUFlfdXc0QktYSmtpSFRwUE5rTjdJbndSOXdmMjFVS1NjcU9ndVZ3M0t5OXVZYnpGS1NCWC1RbjFQZHRrY05fMDk4X3ppRWRMQ09nUXJFd2VyU3NsSDRxUXdZdktFeThpM0F4ZVgzZUpnNmpOSEI4QTl6enNQZExKM1NCbFdZNHBWakh2WQ?oc=5",
    "date": "2022-12-14T08:00:00.000Z",
    "dateFormatted": "14/12/2022",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "What to Expect after an Inspection: 483s, Responses and Beyond  fda.gov",
    "company": "What to Expect after an Inspection",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1dd8e7aabca3ba390421d20adb1bc0d8",
    "title": "Sun Pharma gets FDA import warning for India plant, shares drop - Reuters",
    "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPZVl2RkZpYVNKUU40NEFxMnZzMTNXUklENzhyLVBNckx3UGc3SERlMmNybTB0bThrX2pmQWgzS3FVY2J2aGVPWjdhUjU0QVRTVWtsUU1paWFNNklSNGx6TnRrQnQ0aS1PZkNwNkpadVFkU1RSTmxYV2FuYmNqSmhHaUV1NmM1Y0RyNm0xV0g5UFdlVkM3RFo1WHVsOXNFTHFCaENEd1hCd21nRWdhS2NqeGptWkh2NmxPdjFaVk1XYmd0VmJlSFpYXzdQd2I2VDdYazBMWDhn?oc=5",
    "date": "2022-12-08T08:00:00.000Z",
    "dateFormatted": "08/12/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma gets FDA import warning for India plant, shares drop  Reuters",
    "company": "Sun Pharma Gets Fda Import Warning For India Plant, Shares Drop",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "be27c7b08ace7e22af1d9215d1e9b26a",
    "title": "CooperSurgical, Inc. - 613339 - 01/19/2022 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPM1ZsaEZ5dWVTTk03QmJjZzExeEJqTGdzTnVERTFqUjJ4YUhVaW9Ya3QzWk5pcGdlaW1DTE1pV2RqTVdPTWtKSGVWamxTR01sd3hPc0JQSTdNdjFoOEhyOWFCSkJFSVpPcF9SNmgyanBIZXBTaVVTTXlfMlV5TFphd2NubnNkeW9WYnRsdmwxVnFkSDhXdk41bWJqOGM3MWhnZTE4LUtMQ2loOVprbF9sd3VHUGdpNVlUWU5jUUw1MXZYMXh1TFhPMTBNbnpNQQ?oc=5",
    "date": "2022-06-22T07:00:00.000Z",
    "dateFormatted": "22/06/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "CooperSurgical, Inc. - 613339 - 01/19/2022  fda.gov",
    "company": "Coopersurgical",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8b078d6764037f826008763e965eac52",
    "title": "AcelRx Pharmaceuticals, Inc. - 613257 - 03/28/2022 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNWDJNTDh4Vm12SF9ENUFJTDFCenhPbHMzRWs1OTZUZWQzeE9RRFh2TXBxRDZkZnpkUmlHRnUyeDIyd0lUNUZ0SXYwbzlnWk1WNWhvamQwRXE0WFRKd3hoanV4OXVkSnRiNTd0b3RWUTVWSU5SdEIza2dpckY1QzZMWURoQUZnUXpMU29ETG9HZDNqdGZXeFZNN0FxZUZSRkZrZzZOVkcwTnJDQXNTOUZKLXNJdmRBSWNjVG9oZVlRNmNfSEp0Q3ZMaWFfQWU1M0lfbEhERXFVakY?oc=5",
    "date": "2022-06-22T07:00:00.000Z",
    "dateFormatted": "22/06/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "AcelRx Pharmaceuticals, Inc. - 613257 - 03/28/2022  fda.gov",
    "company": "Acelrx",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "17c2e88ab036012271f54bb942f183c2",
    "title": "The Brief Summary_June 2022 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5KbGJuaGxkSG9mRlRoMGZ4WUFndTljc0RmdE5HZ2ZKLVJpN3B4Nk1LVEdTYzJtaXRzbFBOS0FZZ3AyM2U5YjdWTTRpYUZOa0Q3SThn?oc=5",
    "date": "2022-06-02T07:00:00.000Z",
    "dateFormatted": "02/06/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "The Brief Summary_June 2022  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6febdeef70c5bb18dc9b426d024cf15d",
    "title": "Abbott, FDA reach agreement to reopen baby formula facility in Michigan - Reuters",
    "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPdHZTMFVMT1ZSLUtuMXhSNGRsYzVYZ3h4RlpXTy1FSjlic3ZKRzNpQk5qTEptT3loVk93dXlHQVg0Zmppd25oUF9XenNHcllzQzd4QkZTSDV1VVFPaWV6blp4VTJEMWpENmhmSVNUZTctQmY2ektENFVTbEItNl9qdzh6X3FZQTEzbEdJUUlvLXc4bmRhM19KdGhEc0VwSFVOWC1NU1NBaFJOTlA0TVA4c2NOM0pCZFZLYlRSRDdZRUJpdGxmZkMtclB0MUMzQkVGSmJ5RjFNZENMZlBY?oc=5",
    "date": "2022-05-16T07:00:00.000Z",
    "dateFormatted": "16/05/2022",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Abbott, FDA reach agreement to reopen baby formula facility in Michigan  Reuters",
    "company": "Abbott, Fda Reach Agreement To Reopen Baby Formula Facility In Michigan",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "aa9457495fcbd1cc1a0fec40a2eb739c",
    "title": "Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQV2hlNlNXc2EydnNFcF83RUpTVEhUTlI4QTR5OTFlRXpTa05iUW1VSVFteXRDX0N6WjlzRTFlOUMyWWJkVVA2bWlhaUFmWmVCcUxDQS00VzlXM0tfQnhNTFN0YXB0TEVUcVZ1TGJMdWtJOURZa1E2ZkJ3R1F1alUwQnNMZ3V2VWR5ZndRUTRqV1FPdThxTldXSW9ZWnVxWHpmYUJRMUxQZUo?oc=5",
    "date": "2022-03-24T07:00:00.000Z",
    "dateFormatted": "24/03/2022",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout  Fierce Pharma",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "28b83da49a6de4fde44f3ddb28db40fd",
    "title": "The Brief Summary Newsletter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAycE1qcVRYQlMzaUdsaXFoalNKTUo0X1RSbV8yVlpkSndBbDdaT1JvU2puRmRWMXhXSkRDVmRsWXVBUzNfUWtwMmtXR2luNDl5eTdB?oc=5",
    "date": "2022-03-08T08:00:00.000Z",
    "dateFormatted": "08/03/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "The Brief Summary Newsletter  fda.gov",
    "company": "The Brief Summary Newsletter",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8003d6c9f800d5865e25bbc08466f382",
    "title": "CytoDyn, Inc. - 626957 - 02/11/2022 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPTzJVYzRzeWFkRVJnQ01VQlREUFVHN0tQdUphWFJ1MEZqY2J4QlhNUXBSWjRnRkpObTV5ajUteWJmNXZaYTZFM1h0YmJmelNUZnNZY1FpSjZTWklzYkJmX3c2NWFQc2JSdENaYzFsWEZmUDZscWtzdktzQk5OV3BkV1VnTVFHY0lwTElScnpRZWoxaGk1bUVPTEZBOHRQcDFPVEMtaVhxTHZyUWFMRmk3M2lIMXllSjZxUWNWTzZ1bk81RzJJ?oc=5",
    "date": "2022-02-11T08:00:00.000Z",
    "dateFormatted": "11/02/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "CytoDyn, Inc. - 626957 - 02/11/2022  fda.gov",
    "company": "Cytodyn",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f9059802f85488d0ab2a0cab475410d5",
    "title": "NOV Letter | TRULICITY® (dulaglutide) injection, for subcutaneous use - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBQNDV5YWs4SGw1N0J4X0RLeTFxRU9rbkpGbzFUa0s3RmhsLUNXdVoxZkpXM3lBaXA2SG5xdzZsQkJmR1dDNmRlMXZSc3FCa015eDF3?oc=5",
    "date": "2022-01-19T08:00:00.000Z",
    "dateFormatted": "19/01/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "NOV Letter | TRULICITY® (dulaglutide) injection, for subcutaneous use  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "49e4b00f8d2ac1d796db1a5ca3a08136",
    "title": "Florida Compounding Pharmacy Punished by Federal Court - Medtruth",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNbEZNTTFfTjdIWFd2YzJTQ2JJQmtvSGE0MXBMdi0zQVlwU1Zleks5dVBqN3JIVzNYMUpVeGNIYzlDaDFDbmtUbF9EbjF0MHBCNzB2SWxQcndOWklaUEZOelZtT2M2OVpXY3BZbkszVGtzM0xlTklLeHloeXNmVFBsU3BOdThhTTdpVWxYR2lMN2M5Rmx4ZnFkZlN0cktuRnBIcFE?oc=5",
    "date": "2021-09-28T20:36:46.000Z",
    "dateFormatted": "28/09/2021",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Florida Compounding Pharmacy Punished by Federal Court  Medtruth",
    "company": "Florida Compounding Pharmacy Punished By Federal Court",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "48f5c84b604cf36a3d90f66ad0e9e4b6",
    "title": "Response to Notice of Violation (RNOV) - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB0U1AxNzc0ZGFGeV9CSGZUbnRpT3FiM0FxWEdmNEdNNlo3YmlpT0ZZVXgteXhZNkQzU05McHdYQlRUaUR0TGRrX0lyRXBfVm5KWUk0?oc=5",
    "date": "2021-09-04T19:57:33.000Z",
    "dateFormatted": "04/09/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Response to Notice of Violation (RNOV)  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1912c2db1d10ec0672f6bc47387f32cc",
    "title": "RE: NDA 213876 ALKINDI® SPRINKLE (hydrocortisone) oral granules MA 13 Dear Ms. Devarakonda: The Office of Prescription Drug P - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1QRjNVZnN6bmVrLTB1ZkE3OFpSOFZ3YUcyWWRYR1ZaVGxXVTZtVUMtMnE5alhBZl8tYllneDFYN3ZNcng3UXpHLWtqemw0bzJ6NHRN?oc=5",
    "date": "2021-08-09T07:00:00.000Z",
    "dateFormatted": "09/08/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "RE: NDA 213876 ALKINDI® SPRINKLE (hydrocortisone) oral granules MA 13 Dear Ms. Devarakonda: The Office of Prescription Drug P  fda.gov",
    "company": "re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6b3ccadff6f8a7f532ae5fcf84c39f8c",
    "title": "FDA blasts Syntec Pharma after importer stored drug ingredients with antifreeze, weedkiller - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOVVA4bmJsSGs5Yk9NdjRBeVdnUnJ5cEliRERvUExNbjdUU2RRLWlraXUwakk4RFh2TV9MQVdhVXlqT21KVlJKZnVGdnZ1Uk5lY1pFeXc4Mjdhc0tsMGc3Ry1GUDVBTkJvVDJpWlpOUWpVUHZUYnJMTHRfcnE2SVZSRWd3U1dzVy1vdFpHaDlOVzFIZTBacDBnemo2U1NpTXo2MzdmNnI2WWllUzhMVmd1NG4wUlhLRkptWjl1bm1nakJlS3liT1dB?oc=5",
    "date": "2021-08-04T07:00:00.000Z",
    "dateFormatted": "04/08/2021",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA blasts Syntec Pharma after importer stored drug ingredients with antifreeze, weedkiller  Fierce Pharma",
    "company": "Fda Blasts Syntec Pharma After Importer Stored Drug Ingredients With Antifreeze, Weedkiller",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8e3e9faa2c8b258c205be5093b525c1f",
    "title": "Neulasta Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFA1LVNjUmxvNk12alZ2dndfQ3hxVUNhZ0EteENIZFZkLVJvdmhoM2NwX19YdDBjeEpZQ2pqN2d1NEVpVDAySjFhWW8tRVYyVlpKSWlz?oc=5",
    "date": "2021-07-07T07:00:00.000Z",
    "dateFormatted": "07/07/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Neulasta Letter  fda.gov",
    "company": "Neulasta Letter",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "771bca7dff8f5cec4a9320068d38f4fd",
    "title": "Avanthi, Inc. - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPRVZxYmR0SE90Q3MyUGoyUm5lcVVqay1ETGljZ0xpaVFMWlNDYklnNmc1QmNHb3EtcDJnVlRKQmpYY3VJUGd1al9ZSkZjTlg1NVgtUExNSXM3akI4Zll3WkdIWklfZF9HMG5Nc1A0dm1JTG5HNTZITGpKQURPU2xDSGNLWW9KQzZ6RGxCblQ0T3pHdWdYLVYyd2hzV0h0eURrZ3FzRDlIMXNpaTN6TzJ2Vk9maEFUYlBKSHVN?oc=5",
    "date": "2021-04-14T20:49:07.000Z",
    "dateFormatted": "14/04/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Avanthi, Inc.  fda.gov",
    "company": "Avanthi",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7add41b16ad8dab0d45206a07fba1082",
    "title": "Sprout Pharmaceuticals, Inc. - 610569 - 03/15/2021 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxPZUdtNmx2cmk1WGpOT19QRHdza2d6azREd3d0c1EycTdTR2F3N0dVNDh1bVRod1BBbDl4N25aUjFTTWJpVWQtR2oxUElvSy1OU0Y1LXlEXzJPd0czME1fUVdIemwzbTN0TV9rTHQyVjhiV0g0eXlXdzBjUGx6UmVNeHRVcUFqeVM5MGw1RmNlYXdoWFlHQWlkY2Yza1RHWnB2TGE5dHdwcG12Q0pBWm5BRHpyMzVDT2xlM3AyRDhtLTk5Qm1hUDhiSWJiS3I3RnUwLW9qSUhMcE0?oc=5",
    "date": "2021-03-15T07:00:00.000Z",
    "dateFormatted": "15/03/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Sprout Pharmaceuticals, Inc. - 610569 - 03/15/2021  fda.gov",
    "company": "Sprout",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "47ad9e9c58aaa8576559276a6fe563fe",
    "title": "Marianne Frost, MA Senior Vice President, Regulatory Affairs Biohaven Pharmaceuticals 215 Church Street New Haven, CT 06510 RE: - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE54UlV4VFgtTzAwMHpMdjF6UU1iR1RXRXBNdXBnVjZ6VXhaaUliSUVVU1VkZzRtMjhSajBwM2tJbTQ1UTBwdG9wd09LNnlEcWVCczRJ?oc=5",
    "date": "2021-03-08T08:00:00.000Z",
    "dateFormatted": "08/03/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Marianne Frost, MA Senior Vice President, Regulatory Affairs Biohaven Pharmaceuticals 215 Church Street New Haven, CT 06510 RE:  fda.gov",
    "company": "Marianne Frost, Ma Senior Vice President, Regulatory Affairs Biohaven Pharmaceuticals 215 Church Street New Haven, Ct 06510 Re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ffe9fde57fc1047148cefd29ea87e3e0",
    "title": "CooperSurgical, Inc. - 613339 - 02/12/2021 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPN21QdzhIQnZkVkZmTkdKb2JuUHk3UkVfZU1id0FWS2VsS3RwTmwtMU9kTE1kcFRpRXRjaGR0WXhZQ0J2RTFVX1Q0QlhvN0MwVGhkYnpiQ3QxNUFvaXAzeUR3RnR4cllqTTlRQ2JqZ2locTBKNGsxNkpRMXNsSzdBdlc0RTE3VTV5VGdrVmhBQkp6OHA1czFTb3BiUVljakdqZUwyVXJHOTAtdlZBUDNYMzdGUktjNXYyVG9VTkpXaHdtTk1QazNJTWlOeEFpUQ?oc=5",
    "date": "2021-02-23T08:00:00.000Z",
    "dateFormatted": "23/02/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "CooperSurgical, Inc. - 613339 - 02/12/2021  fda.gov",
    "company": "Coopersurgical",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ae5b65de5d4b8ae93200622eea8c56bd",
    "title": "AcelRx Pharmaceuticals, Inc. - 613257 - 02/11/2021 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNMmdwZG1WTS1HWVhPZ0ZEclJzWjBCa2J1bkpES0NVa25hSXhsaHM3b3ZnaExVN3Z2ekN1aFVTMWJoS2I5WGRNYnl6bEpGOUxLdHdib0JURUxTdXNjUzB2THIyTEIxZ2t5d1NlM0g0SGw2UDZacjcwU1E3V1pTMEF6MWZUeWtKcGpuRmFDSTVjVzhQRlZxZGItSDQ1amZRR3Jxa1RITTRtVF90dTZxRWttUVFLMXhYUDZVcFI3VTlrR3FXYTdRa3dfLTRCOVFzNnlBR0tiaEt1REU?oc=5",
    "date": "2021-02-11T08:00:00.000Z",
    "dateFormatted": "11/02/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "AcelRx Pharmaceuticals, Inc. - 613257 - 02/11/2021  fda.gov",
    "company": "Acelrx",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2ef6f6cd372a1cc4aa20eb725efd42f5",
    "title": "OPDP's 2020 Achievements, 2021 Goals - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOVGpfbW9UV2lRRDU3ckNLY00zM093UkpYa0tVLTRZRzBWWWRnX3VFMzd6Q0FrRTZEQkJNYzZka1lJR1JySERnR3VvRVh0emR2b2wwT3lvdF9XblZyZFE5SW1tMXk3YlY1TUlBNEx6TG9jZm9nbFhiQVJtMGRpcmVHeHNuVWVMNElnd1c5ZGtxUW1nTmppeG1OMV9BU0RJWnNqclFQOWxvNDUwa0RNWW5EdjVLdE11UG14Tk10MUhfRXpfM2xVNFdoLWpNa2NZUUhIUWFSc21DWTBWS3df?oc=5",
    "date": "2021-01-27T08:00:00.000Z",
    "dateFormatted": "27/01/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "OPDP's 2020 Achievements, 2021 Goals  fda.gov",
    "company": "Opdp's 2020 Achievements, 2021 Goals",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "50f1684d3e123441d027053e7e0000d6",
    "title": "Korie Osborn Director, Regulatory Affairs Azurity Pharmaceuticals Inc. 841 Woburn Street Wilmington, MA 01887 RE: NDA 208400 X - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5sZ3BXODZQWHFVTkdSWTZBTEhvandSeUd2RGJmREs0TEJ5T2plM2hjQkdIczlMcFN4M3FoS1VLUlVNN0p6ZDM4U2tnRW9Fck1qVzJF?oc=5",
    "date": "2020-11-24T08:00:00.000Z",
    "dateFormatted": "24/11/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Korie Osborn Director, Regulatory Affairs Azurity Pharmaceuticals Inc. 841 Woburn Street Wilmington, MA 01887 RE: NDA 208400 X  fda.gov",
    "company": "Korie Osborn Director, Regulatory Affairs Azurity Pharmaceuticals Inc. 841 Woburn Street Wilmington, Ma 01887 Re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1880d1047ab1668972c9fc04641a7f62",
    "title": "Nephron SC Inc. - 610867 - 09/22/2020 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQbDZNN3ZrcVc4ZEp4b3I3bFJtSm9DN1ZYLVBycFBHYTdXbVViODRfdXY1eHg5NWFfX0pnR3FUbUxHbGNCWnQ4dW5xMVI3b0hlbV9mOGZrbUIzcnF0aWVwbGgwbWdGdzJxS2llRkF5TWQ4R1M5M1NQR1ljdDlneExmWnhMalVudXlibXlUZmdTX25fWFljeFpac3lRYkRzRTY1RWR2b1o5WEFmd0dEN2Rld3VkbVA2cHpOcUI3NEN1X1NfbHREdVpZLQ?oc=5",
    "date": "2020-09-22T07:00:00.000Z",
    "dateFormatted": "22/09/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Nephron SC Inc. - 610867 - 09/22/2020  fda.gov",
    "company": "Nephron Sc",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "82d427f71f0d03f67bdf07e7ab20365c",
    "title": "Nalpropion Pharmaceuticals LLC - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNSWowUHp0MVIxVDJXLWlveDJZbmNFc18xdHh2VU1vSXYyRTF4anhYWFZoT3VXdVRoMG5GTWM4Z2FTNlZvcDRsWE9pZUFvam9KcHpjMkgyX3ZORTJKekc2RjN0THppcXltNzFUQkI4Ty1TZjQxN3V4TmF3bkx5RUIwM3BLTDZuVHltRHp5VzN2ZlJIekM0cWVjR1dwc05iOE94UUQwTXhiVWQ4OTlSclAzcWd4cFEzaUxNUUJrbjU1WUZGaHVKOXg5YW05Um1lRnZ4ZGJFLQ?oc=5",
    "date": "2020-09-22T07:00:00.000Z",
    "dateFormatted": "22/09/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Nalpropion Pharmaceuticals LLC  fda.gov",
    "company": "Nalpropion",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "ea13bb6c79c7e03a75d032f7b90ac480",
    "title": "Sprout Pharmaceuticals, Inc - 610569 - 08/31/2020 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQYmE4dlVicWhyRE5PSzBhWEgweTZFZFZlQktJU1VFckZxWnFVLXhmZy1FVWp1VjVELVRmazVqQVVLU0lWSXVndkcxN1JqY1RCdThaVEx3RFFLX1U5Z3RfdVJhZlBDdXRaWVZ4Y0VhZC1XamQ2T2czLXVjQ2w1MUZhWk95SEJDYzJFTVo4akIxVmx2NC1BNEV5eS1odFRqVGFnREhKd3ltWndMVTdUdGtCdEo4VTJTeXZ5Z3lDa3NPaGJZc002c1pSS1V2VFRKV21CUU9qekVwc18?oc=5",
    "date": "2020-08-31T07:00:00.000Z",
    "dateFormatted": "31/08/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Sprout Pharmaceuticals, Inc - 610569 - 08/31/2020  fda.gov",
    "company": "Sprout",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "42e537140e1ed7f19be7d7fc548928fa",
    "title": "Michele Yelmene Vice President, Regulatory and Quality Assurance Xeris Pharmaceuticals, Inc. 180 N LaSalle Street, Suite 1600 Ch - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWRWFNX0UwQ2RWSTBnRVlqU2VFdjdFbHVMZGFWbk1fREhnTEFtOFl3WjRIMG9QM3ZmcUR3RXByZy12QUtjb2psbnJRdnM0TDBVSXFv?oc=5",
    "date": "2020-08-14T07:00:00.000Z",
    "dateFormatted": "14/08/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Michele Yelmene Vice President, Regulatory and Quality Assurance Xeris Pharmaceuticals, Inc. 180 N LaSalle Street, Suite 1600 Ch  fda.gov",
    "company": "Michele Yelmene Vice President, Regulatory And Quality Assurance Xeris Pharmaceuticals, Inc. 180 N Lasalle Street, Suite 1600 Ch",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "25addd90c3e4893bf871df35eb1d9dbf",
    "title": "FDA blasts California compounding pharmacy for facility 'contaminated with filth' - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNa3lHRmhEcXpDdkdDakVaQmxUNUpuenZnNHZHOW1BNk1NWGMwdkpXZUJ1ZV9PNVNoRXdEZktOeUI5dmpUVGxadG9odzFPNTRtNjk3b2lJalBSVFFISFRyQ2sxNjRhanJwNkxmOUNyVXRMNVhJaF9mNlI5SWJHT0hoaDl1eE44ZHRsYm1BQUtUVmE1Q1k2NGZDQ25vMXY0dDZVc0c2a1JkRlBOQngySWp1dlRIMFV4bHpm?oc=5",
    "date": "2020-07-02T07:00:00.000Z",
    "dateFormatted": "02/07/2020",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA blasts California compounding pharmacy for facility 'contaminated with filth'  Fierce Pharma",
    "company": "Fda Blasts California Compounding Pharmacy For Facility 'Contaminated With Filth'",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "cb4c80a9da8c74b0f8716a2dde5a92f3",
    "title": "FDA Purplebook - FDA Purplebook (.gov)",
    "link": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFBBN0o5aVRWVFBSaDdMS0xjUnFlRG9mdVljN1VKdEV4WHpjVFFrNDJOVkJtaU43NVV3UksyNXg5Mzhqb2l6ckstMg?oc=5",
    "date": "2020-02-24T18:02:48.000Z",
    "dateFormatted": "24/02/2020",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "FDA Purplebook  FDA Purplebook (.gov)",
    "company": "Fda Purplebook",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "27da477604a4ee248d620560a0981a7d",
    "title": "Outlook Pharmaceuticals, Inc. - 605071 - 02/21/2020 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPcFg5a2gtSDZrZEh4NDdQZGtzNjZBVVl0bjdXRERQUmVWbVBFOGtybm1WRlZKRjYyVFFERWRadVdOMHhRYTFPb2N6Vk40VllsaF9qUzUxTEFidFhiVEdsd2o0cklkaVVQeHZSTVY3bkhjTVZkYzFHYjNYSEo4Tm94Q3lhYnRxRXZoRmtIRzdFekxkUHJBU01HTkhOMU4yU1JYWWNVV212WFZiVll2akhwM1RCemFkRU5qVTQzNjRaa3VvcnlrMkI5dV9ZS0h6TXNFSmZOTWllNEhKZw?oc=5",
    "date": "2020-02-21T08:00:00.000Z",
    "dateFormatted": "21/02/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Outlook Pharmaceuticals, Inc. - 605071 - 02/21/2020  fda.gov",
    "company": "Outlook",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0c5826bbe9601a27045419fbc0be11c6",
    "title": "FDA Enforcement Trends: Reflecting on 2019 and Looking Onward to 2020 - Crowell & Moring LLP",
    "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOUDdLMVR6SzIwaVhDZFdCR0pnSjlDOWI4NHhUQzBJZFItYWhDUnRMSVZabXgwZXU4RDl1OEYzNVA4blFnRGR3MjB4c3ZGZDQ0alk3V0NoSE9zU0xRWFJIdnpGaXJ3cWgtcFN6NVRrWEdvdmR6VHR4ZVljTTVKQ2V6NDAzQ0lIby1OZUJuTWtqYXFDZmZJR1N6MTNrZFlNUi1EZ1VudlkwcFBLSy1WWE9aWjk4NVZ6ZjFnOFRZWUF3ZXBlZlg3Unc5bFFGZTZTT2N4OXkwMXNPMGE?oc=5",
    "date": "2020-02-12T08:00:00.000Z",
    "dateFormatted": "12/02/2020",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA Enforcement Trends: Reflecting on 2019 and Looking Onward to 2020  Crowell & Moring LLP",
    "company": "FDA Enforcement Trends",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "3ed7990fdad025bf0a1596b60d40ee50",
    "title": "Alkermes, Inc. - 597260 - 12/02/2019 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQckllXzMxNXphOFRiMnh2bFZtQjJneVdiM3FZM0o3NV90MmVjUEhYTUtVaEUxTjlYM0xYSU5ZOUpEcldaMnphejFpSldteE5sRmFwckhacmo4aVJ3WXpjc0tIUzhXakZHMGpPQ2lqZHFRMWhYakFWb3JfM19Hd1lsSEVSVXdBRVJZa280UzB5Ri1pVVJ2UmZVSXktNVp5ZWlwNXBnZ1lqUzlsZ2xBb2hRMndVYndfazNmU21LeENKQWNYa3l4V2c?oc=5",
    "date": "2019-12-02T08:00:00.000Z",
    "dateFormatted": "02/12/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Alkermes, Inc. - 597260 - 12/02/2019  fda.gov",
    "company": "Alkermes",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6cd15bf5f921c53de3a5993154112fa5",
    "title": "FDA Forces Actavis To Shut Down Plants - Manufacturing.net",
    "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQQ21qRkRaR2hBSmh5R3NnbEs0eVFwUk1zS3B4QWlDcFExWkpFQmE3bDRuSk51WHBXQWpDNXhyVnc2VXl0cEltWmNhTFJRTWNGa0dyekVySnEyR0c5S09pNFd3VXZpYnpCR05lTGpsVHN6M3REZTRacWhkaHFHb2tJYkpaNWNhb0VwbnNZOEg3bnFka1BNUjRiZA?oc=5",
    "date": "2019-11-21T23:16:15.000Z",
    "dateFormatted": "21/11/2019",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA Forces Actavis To Shut Down Plants  Manufacturing.net",
    "company": "Fda Forces Actavis To Shut Down Plants",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e898aeb1633a3ae59ef5bf1bab0eea5f",
    "title": "Luis Caveda Senior Director of Regulatory Affairs Rockwell Medical, Inc 30142 South Wixom Road Wixom, MI 48393 RE: NDA 206317; - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE91MzJCdldFY2NzYjZYLUlFYzdMV0pkUzJwNUlqX3U4ZUR5OEo4d1c5NUg4T3NFV2tBTTRzYjN5X1JWUV9LYXpBTE1DZHRLX3BNdjdz?oc=5",
    "date": "2019-11-18T08:00:00.000Z",
    "dateFormatted": "18/11/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Luis Caveda Senior Director of Regulatory Affairs Rockwell Medical, Inc 30142 South Wixom Road Wixom, MI 48393 RE: NDA 206317;  fda.gov",
    "company": "Luis Caveda Senior Director Of Regulatory Affairs Rockwell Medical, Inc 30142 South Wixom Road Wixom, Mi 48393 Re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c85b274497c879e1dc86592183b8c4b1",
    "title": "Bruce Merchant, MD, PhD Regulatory Contact for Nascent Biotech, Inc. M - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBQODBJVXI5Q1N5NW5nNkdJYWVPUTNxVkFWTGd5eTVscHgtUWkzcDFaOUVENU5zY3RObVExMUpZVjR3U2Nmdjg4V3VVbGZIZmNBNXVB?oc=5",
    "date": "2019-11-01T07:00:00.000Z",
    "dateFormatted": "01/11/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Bruce Merchant, MD, PhD Regulatory Contact for Nascent Biotech, Inc. M  fda.gov",
    "company": "Bruce Merchant, Md, Phd Regulatory Contact For Nascent Biotech, Inc. M",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "528297d6fc4e5a2d362402cf64adc583",
    "title": "Kimberly Skopitz, RAC Director of Regulatory Affairs Kowa Pharmaceuticals America, Inc. 530 Industrial Blvd. Montgomery, AL 3611 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE50RjcwS0lYeGJfM1QtRmVFUWhQTi1QRmFFUFVTeGNJX1R1bFdQUDNBOWlwQkJLQmVWV2pXUk9DUHJlVzY1SzkyY2xDUmxORm45QU9J?oc=5",
    "date": "2019-09-24T07:00:00.000Z",
    "dateFormatted": "24/09/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Kimberly Skopitz, RAC Director of Regulatory Affairs Kowa Pharmaceuticals America, Inc. 530 Industrial Blvd. Montgomery, AL 3611  fda.gov",
    "company": "Kimberly Skopitz, Rac Director Of Regulatory Affairs Kowa Pharmaceuticals America, Inc. 530 Industrial Blvd. Montgomery, Al 3611",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "9fb72793af53e660e9e4745a2ea61a78",
    "title": "Galt Pharmaceuticals LLC - 593156 - 09/13/2019 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQcUNxdFp6NFdnNEJaLXJGM3ZPOUVZbGU5a08zamFVNjRHSGhhbHp2SmtQM2t2VjJfYmgtaTRhRU1FeFJtOHRMSER0a0JCb1lxeFpJQ21sOGR1SzYyYk5qQjZ4X1VoSmQ4SXM2SVA0RzFxaTNHel9VV2VBeWhKQVBuajZ6UXRIX0luaEEyb095cHRzSlU1SGJVVHVOcWhGT1A1dnFaN1ZQazFwQ1RpMTFzQkl4WEFTWktjRUlQLUlCWUhRLU83bGJoeGs1RjJxNUJXeWlKNm1R?oc=5",
    "date": "2019-09-13T07:00:00.000Z",
    "dateFormatted": "13/09/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Galt Pharmaceuticals LLC - 593156 - 09/13/2019  fda.gov",
    "company": "Galt",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "432e3c4097841d6c7a450148a8ff006a",
    "title": "OPDP eCTD - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQSEZhNTBCVzVwa2R3Q1V3RnplZ0s2X19XTjNlUGZ5cGRBbHJmNC1tSVV3eHpsb25UUFB2T19qa0dQYzcyQWZsTVVIOG41Z0RiVDZ5RnpVODJ0R3B0cEdVZ2ZIWmRYeGRhTTNjT1IzbE5kMS1SeWpzQjVPUzhJcVNQUDNZUERIUDg?oc=5",
    "date": "2019-09-09T21:40:32.000Z",
    "dateFormatted": "09/09/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "OPDP eCTD  fda.gov",
    "company": "Opdp Ectd",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2bfafc0f1b01c7800efe16a85f0e3a5a",
    "title": "Metuchen Pharmaceuticals, LLC. - 590713 - 08/16/2019 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOSzVIeEhKSk1xMHNLbVBsdTJyb0NiUmJlNUMzOXhSVXpwUGdHRUFBMmNENXpEN2NzMlRoV0d0RmtLTkdBZ2cwSFdOeWJwUTFoSGg5ckgtMlg2R1NsdFY0UUcyc3Q3NDlTR2lUNnBfZ1hBa2xmR2RkQWpyUFQ1N0ZKUTN2VDZlYTNNSGVNelBDUnVMdm1uZElqWDlzcGJaMXRPS2w2dDVlSFlKS0EzTl9JcnVTVVhHQzVNanJLVWlJVTc2dHBmZHA0OUUwOVloX0dvSkZCRDlhVjltVmM?oc=5",
    "date": "2019-08-16T07:00:00.000Z",
    "dateFormatted": "16/08/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Metuchen Pharmaceuticals, LLC. - 590713 - 08/16/2019  fda.gov",
    "company": "Metuchen",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "06acd58bd2f3444ad4bd3365f809217c",
    "title": "Kyle Hooper Regulatory Affairs Associate CooperSurgical, Inc. 75 Corporate Drive Trumbull, CT 06611 RE: NDA 018680 ParaGard® - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9TSGJ0V1EzVXA5UGlpZ19Gdko2NlFSemNhNXo4Q1oyTGNJaUFNb3dVNjFsZDJRZWxkTEFvNnRSV3M2N1V4bUhURG1qUnJhbmljNjlJ?oc=5",
    "date": "2019-07-25T07:00:00.000Z",
    "dateFormatted": "25/07/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Kyle Hooper Regulatory Affairs Associate CooperSurgical, Inc. 75 Corporate Drive Trumbull, CT 06611 RE: NDA 018680 ParaGard®  fda.gov",
    "company": "Kyle Hooper Regulatory Affairs Associate Coopersurgical, Inc. 75 Corporate Drive Trumbull, Ct 06611 Re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "d99795d1373c423837d39f09bdf5a9f8",
    "title": "Direct-to-Consumer Television Advertisements -- FDAAA DTC Television Ad Pre-Dissemination Review Program - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE55aHlNRTZfcVA4S0dMTmxNMjZVNW1CSnpzdHZsRmIxcFhMNVo2dXZsNlBmQzM3R1FJMFloYXA0LUZTQWRTalVkVElIWjhSMm1jU2c?oc=5",
    "date": "2019-06-15T18:48:25.000Z",
    "dateFormatted": "15/06/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Direct-to-Consumer Television Advertisements -- FDAAA DTC Television Ad Pre-Dissemination Review Program  fda.gov",
    "company": "Direct",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b35d2c18402e172c834ded9053c7fea1",
    "title": "Colleen Matkowski Senior Director, Regulatory Affairs Aclaris Therapeutics, Inc. 640 Lee Road, Suite 200 Wayne, PA 19087 RE: ND - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9GNUI1NFRRS3dGWllTa1NRZmoza0g5V2xCWUJzMy1LSkxJNUoxemdnVlVRd3dubWFCdkM1bnhFU3pfd0h2SXF2Rm5XaktFUTlmZmRF?oc=5",
    "date": "2019-06-14T07:00:00.000Z",
    "dateFormatted": "14/06/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Colleen Matkowski Senior Director, Regulatory Affairs Aclaris Therapeutics, Inc. 640 Lee Road, Suite 200 Wayne, PA 19087 RE: ND  fda.gov",
    "company": "Colleen Matkowski Senior Director, Regulatory Affairs Aclaris Therapeutics, Inc. 640 Lee Road, Suite 200 Wayne, Pa 19087 Re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "bd35e242dce955cc244d22549d74b278",
    "title": "Compounding Pharmacy Ordered to Cease Operations - Drug Topics",
    "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOci01UC1zQldSX0pMWklLbE43M3Zydm1HWjEtWmplZDhoNE85ZWY3Tnd0SkpVdWFpb2NYQ2xUc2NtZ09CdnZrNTlENVZYeklLREU3VTl3SjlfWlJBTzNkdU5YM0hHZEJyT2hkcnlHZVc0ZkRpejJxZF9vUkdONms0ZkVCVQ?oc=5",
    "date": "2019-05-29T07:00:00.000Z",
    "dateFormatted": "29/05/2019",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Compounding Pharmacy Ordered to Cease Operations  Drug Topics",
    "company": "Compounding Pharmacy Ordered To Cease Operations",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a8f21132609aac36cc6b56b30c30d39f",
    "title": "Santosh T. Varghese, M.D. Chief Medical Officer VIVUS, Inc. 900 East Hamilton Avenue, Suite 550 Campbell, CA 95008 RE: NDA 022 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1VbjB3LW1zUEVBMjdqN1FqVzRPMDlvU1FjYzA5RTA2SDNxTEJrOTVsOEZDMEhpWU44MTBiOTR1MnE1V3pPYjgxZFhCY296TTdlemZJ?oc=5",
    "date": "2019-05-22T07:00:00.000Z",
    "dateFormatted": "22/05/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Santosh T. Varghese, M.D. Chief Medical Officer VIVUS, Inc. 900 East Hamilton Avenue, Suite 550 Campbell, CA 95008 RE: NDA 022  fda.gov",
    "company": "Santosh T. Varghese, M.d. Chief Medical Officer Vivus, Inc. 900 East Hamilton Avenue, Suite 550 Campbell, Ca 95008 Re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "9851408f7ed7fc5895c14bbdc32ea3ef",
    "title": "Vanda Pharmaceuticals - 576442 - 11/21/2018 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQVktiQzBibzZJSjFxRUY2YWt6b1FMc2RONEFySUhoa3pRY21PSG5ZbWpPRlBYenhCdGFpZ295NW9LVHJRWnFjUWlWZjFLWDRmWTZ4enZ6eG1OREZDdTFlVkdwSWRmVDhONWRrM1VzX1RPMDhrRmFsNzJvUU9wbDhYNDdNZ3R3Mm9oMWgzb1VwaTVZdjhlRG9LZk9KejlBUENGSTZQU0VvUmczTU91bVNzeXdGZEYyWGt1b2l5STVSTTlaQ2NodWtDS1ZXbGNfdHNnUEE?oc=5",
    "date": "2019-05-02T07:00:00.000Z",
    "dateFormatted": "02/05/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Vanda Pharmaceuticals - 576442 - 11/21/2018  fda.gov",
    "company": "Vanda",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "23d5029f67fcdda9a98e457cbe23e8ac",
    "title": "A resource for stakeholders that contain correspondence issued by CDRH - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNRENfajFwcURvSVlOcEQ0YXp6YWVFYktaX3NXWk5TR250RjUxWGZld3hhcGVvWE9WSUZRbzMyYWI2SmxOeFZ4cGgzSzF2Q2xQblpMaGkxWE5jMDZMZ1RtdDdNQ01UODZxU1lrYWNuVVVIc3ZkYTBfYkJ6YjJ3Q3ZTVjF5WQ?oc=5",
    "date": "2019-04-28T22:02:34.000Z",
    "dateFormatted": "28/04/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "A resource for stakeholders that contain correspondence issued by CDRH  fda.gov",
    "company": "A Resource For Stakeholders That Contain Correspondence Issued By Cdrh",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "add99738b27db42765f65d46fd4a482a",
    "title": "Vanda Pharmaceuticals - 576442 - 10/22/2018 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOU1pKMzhnN0NTcnBuYVRRQy01LU9GTmFJQ3cyN2REQW5aT2RBUmlNZTdIc3R6NkZmT0JNMUdLM2UxQm5mVU4tMmxDOGpOa0xsNzZMb0ROZjFoelRzUDUzWmphRjZfWVdYRGk3ZWMyLTZuVWtjWUcyMlYxREdXcmZFWTVaVWhlRU1LaW1IdGhtY1IyQUptcjVNVkRyOC11RTBNaFN0SXhlNlNZWmg5d25LT09DV2s1aGxOMmFsSDJMTnVjZEhfQW5OT0JTT1c3b09HSFE?oc=5",
    "date": "2018-10-22T07:00:00.000Z",
    "dateFormatted": "22/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Vanda Pharmaceuticals - 576442 - 10/22/2018  fda.gov",
    "company": "Vanda",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "aab6b04559fb12147db5dcd39cf9fa7e",
    "title": "Nada Glavan Senior Director, Regulatory Eisai Inc. 100 Tice Boulevard Woodcliff Lake, NJ 07677 RE: NDA 202834; 208277 Fycompa - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBjMFkzZnRkNlBQWlFlZ1dyQ1BOTFNJR2xXMFI1RktJV0M0UEF5YjFVeU8tclcxTGRhdjktRFV3STJKNDNHNkU1OGZROVhQWEF5ZFJz?oc=5",
    "date": "2018-10-11T07:00:00.000Z",
    "dateFormatted": "11/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Nada Glavan Senior Director, Regulatory Eisai Inc. 100 Tice Boulevard Woodcliff Lake, NJ 07677 RE: NDA 202834; 208277 Fycompa  fda.gov",
    "company": "Nada Glavan Senior Director, Regulatory Eisai Inc. 100 Tice Boulevard Woodcliff Lake, Nj 07677 Re",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0d7010cf93e200e1488acea90b34d3df",
    "title": "Actually, it's just one site: FDA corrects previous word on embattled valsartan maker's ban - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQTXZJdHBoZ3BwYW5lU0xiU0xCU1hEQWN2MmNqdHVoMmdUWTBwUl9xUU1zQXBOSjAyaXo3TDFnZ2FHbjU4Z2drRXNPRm5rakJlUEVTMVNSUndQazRhTmFNUGhtZF9jdFBoU2VDUW42OUdIdldwV1hyN0NWckZpcmZucEhlMWlUelk0bktSdkdpaHhqcHVHQXd4SzB1UkhrSlVoQ2ExQ1VzM1JPLTlDb19JNThIbVByN2doQjB4Sw?oc=5",
    "date": "2018-10-11T07:00:00.000Z",
    "dateFormatted": "11/10/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Actually, it's just one site: FDA corrects previous word on embattled valsartan maker's ban  Fierce Pharma",
    "company": "Actually, It's Just One Site",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6ef00a967a7d41e3a5bbdef67636a8ed",
    "title": "MannKind Corporation - 578282 - 10/05/2018 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPSnBtVno5bzAtTnE1MXNXQ3Zic1RsbmU5aW9ZZ29ISnBVSG1BWVZrVWdWMVJ5OC1MQkZyRzlSdzA3YTU1c0ZvcGZMUFM4Z3FHaThWdXVmRWNRcXhfUHVhN2lIb1pkSVB0ZDRvRGNFMWRxa3lNT2swRDEwRDJsS1V3a2hJQ1dyOHMzTFRTSnVNNG5ndFJQM1NhTHVGX1l2Q0NLQzNqYmVoOTZ0T0lzSm5WNnJXczBmZVlZMnhaVUJYWXFzeEFuQldISzNLMDBwZk1p?oc=5",
    "date": "2018-10-05T07:00:00.000Z",
    "dateFormatted": "05/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "MannKind Corporation - 578282 - 10/05/2018  fda.gov",
    "company": "Mannkind",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f258ebd35474c12a831deb58640a8b0b",
    "title": "With U.S. nod, North Little Rock-based Cantrell Drug reopens - The Arkansas Democrat-Gazette",
    "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQVFktbzA4ZWVFaVU4Z3BYN3N2aHM4ZFcxb2JRUUdzekk2cE9OaTE0ZnVFbXNJZWJMRWdSU1JCT1BtOWs1bnBHU1A1SXpFR01IWEdILXNTNVZQOFNqQUJSRWtyUzR5enJsSGR2MnFJS1RQVUxIUUNEREc1OV9pU1pOMEkxa3FJYTZzd1lHejVZdnJrZw?oc=5",
    "date": "2018-09-26T07:00:00.000Z",
    "dateFormatted": "26/09/2018",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "With U.S. nod, North Little Rock-based Cantrell Drug reopens  The Arkansas Democrat-Gazette",
    "company": "With U.s. Nod, North Little Rock",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4a8fea8807cb9f70001930deaf338718",
    "title": "Suzanne Strang, Ph.D. Executive Director, Regulatory Affairs and Quality Assurance ASCEND Therapeutics US, LLC 607 Herndon Parkw - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAtSi1PRjBCZnUwQ1RXYXdUWVV5cnMtT04zbVh3QkxkaU9xUlFOOGlreXBSWTR2ZjNKWTdjWkdxUERXTDlWak13ZFFURFlXUFlidW9r?oc=5",
    "date": "2018-08-16T07:00:00.000Z",
    "dateFormatted": "16/08/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Suzanne Strang, Ph.D. Executive Director, Regulatory Affairs and Quality Assurance ASCEND Therapeutics US, LLC 607 Herndon Parkw  fda.gov",
    "company": "Suzanne Strang, Ph.d. Executive Director, Regulatory Affairs And Quality Assurance Ascend Therapeutics Us, Llc 607 Herndon Parkw",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e6705535a4d3e53632ca8692e875d942",
    "title": "Peter Honig, MD, MPH Senior Vice President, Worldwide Safety and Regulatory Pfizer Inc. 235 East 42nd Street New York, NY 10017 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBDVDJiNXpEOWJvYXJ5UGRmTmZVLU5sTjlqT2U1cFA3cnBRemlXSU0yY3JiajdiMWJERmdta3NiLV93REJHdlRmZWVfTDdtWEg5OU9J?oc=5",
    "date": "2018-06-19T07:00:00.000Z",
    "dateFormatted": "19/06/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Peter Honig, MD, MPH Senior Vice President, Worldwide Safety and Regulatory Pfizer Inc. 235 East 42nd Street New York, NY 10017  fda.gov",
    "company": "Peter Honig, Md, Mph Senior Vice President, Worldwide Safety And Regulatory Pfizer Inc. 235 East 42nd Street New York, Ny 10017",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "3883c04fc2582bae9f2096af12e8e105",
    "title": "FDA bans Cantrell from manufacturing, distributing sterile drugs - BioPharma Dive",
    "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUG9ZdUNjejNIS3prVUdZbmJIWVR0SlNIbmV2RzQwSnhYai1hWEhhUU9qLUVUSkxWT3kxWHd1YWtlSjd0TDJzd2pSd0hyWUVEdEZEY01WbmdGVkdmRW9ic3BYdzlKS200SkxMZGExTkNnVzByUkJUUENpZVphM2llZnd6NDNzNDZ6SHMzVEhZcnUwTE5GUlc5dmd1d1IwLUlFakxDNGM5djZrdw?oc=5",
    "date": "2018-04-24T07:00:00.000Z",
    "dateFormatted": "24/04/2018",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA bans Cantrell from manufacturing, distributing sterile drugs  BioPharma Dive",
    "company": "Fda Bans Cantrell From Manufacturing, Distributing Sterile Drugs",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e44b965c0b3cbd84e568ea98427fb768",
    "title": "We will continue to engage external consultants, Biocon assures USFDA - The Indian Express",
    "link": "https://news.google.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?oc=5",
    "date": "2018-04-17T07:00:00.000Z",
    "dateFormatted": "17/04/2018",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "We will continue to engage external consultants, Biocon assures USFDA  The Indian Express",
    "company": "We Will Continue To Engage External Consultants, Biocon Assures Usfda",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "0b18c672d9b77ae83236f0d54c4c3f4a",
    "title": "FDA inspectors find 'vermin' in production areas of Indian API maker - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNbDRtZHV0UEx5dFlRd183SmVCYzFySHFWdGJ5ZUNRY2dab1hSS0V6dzRHWEdSZzdaM0oxc1M1eXRhbXRKeHJyV0ZJMWJFZ2kyQ0tPbEtUd0FzeHdJXzhpQ1Y0NHdMNnV4dzNpd09NTUxOSWcxUzVaZnZzaEZWRmUxLTBtREVKMGU1ZW5wclhYVDE1dVdhWUlIWUR4VDVJaDlsTjFncmt3?oc=5",
    "date": "2018-03-21T07:00:00.000Z",
    "dateFormatted": "21/03/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA inspectors find 'vermin' in production areas of Indian API maker  Fierce Pharma",
    "company": "Fda Inspectors Find 'Vermin' In Production Areas Of Indian Api Maker",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "cc30fbca8d1f4801570ce0557fc9d631",
    "title": "John F. Weet, PhD Vice President, Regulatory Affairs and Quality Assurance Collegium Pharmaceutical, Inc. 780 Dedham Street, Sui - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9CbzhROVR3anZiYWFieGpxZkhVcHBqRFctVjNWaWxhd2IxQTZDTE1rV3RhdXFrVmFOYVhSZjJKSGl6dnNCRmo0WDI0MFlxMjdaM0s4?oc=5",
    "date": "2018-02-09T08:00:00.000Z",
    "dateFormatted": "09/02/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "John F. Weet, PhD Vice President, Regulatory Affairs and Quality Assurance Collegium Pharmaceutical, Inc. 780 Dedham Street, Sui  fda.gov",
    "company": "John F. Weet, Phd Vice President, Regulatory Affairs And Quality Assurance Collegium Pharmaceutical, Inc. 780 Dedham Street, Sui",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "8fb423ac637c09e73e318c52d9664373",
    "title": "Medtronic's pain pump redesign OK'd by FDA - Star Tribune",
    "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQOXdZOUJjenNsNmZyNUJZang5M2J4YnpRaUYtNW50QlpnTWVRQnZ3SXFwankzRjR4aWxhZm90d1pTYzBNMHAxVTNOb2dnaFM1OVY5eG9GaTdsR21ycFpqM3h1Ync1MEtVN0psdUxGZmdLVVFJRE5qanBLd296UlA2d1NRZk1JMms?oc=5",
    "date": "2018-01-10T08:00:00.000Z",
    "dateFormatted": "10/01/2018",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Medtronic's pain pump redesign OK'd by FDA  Star Tribune",
    "company": "Medtronic's Pain Pump Redesign Ok'd By Fda",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "de9b728f0f7a9fee960152b3d17f71b7",
    "title": "Untitled - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5QMy1pdHo0NG5XVXpSZzZTTS0telR3c1RPTnMyekk1MDJxMU9iVzdqYTlMVDFyaDFBckZNcmZaYnNfWEo5d1lHVjlkTXhNNmlONmtB?oc=5",
    "date": "2017-12-28T08:00:00.000Z",
    "dateFormatted": "28/12/2017",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled  fda.gov",
    "company": "Untitled",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "1e218119fb818627c189217d060a93ab",
    "title": "Avanthi, Inc. - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNU05NLU1acDRuNFZkN1J4ajJ6bWZQNFE2MTdkeUxyTGpmSUF5akVEUFVDWlZGTXAzM3Y5NXljQkYtLVE4RVo3YVI4RGV2QWFaLVVFYTl0dXQ5S2IwT0RLTkM5S25ENkJMSUpfVndtRFhZVXRHSGJiT01Ea2lVS1NiZXYxNm9VNXZ5eEtMWV9sanM1OE5yd2JoUnN6eEtaSWNpM3o0cUROOXh2TTV5anJNZlNlanBNeFhpYWc0?oc=5",
    "date": "2017-12-19T08:00:00.000Z",
    "dateFormatted": "19/12/2017",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Avanthi, Inc.  fda.gov",
    "company": "Avanthi",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "7cd4732856811ce01a72baa744c40fc2",
    "title": "Cipher Pharmaceuticals Inc. - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPdkR0MUhwYW14Rk9GX1FpMkF3Y2h2NFBTVHJubU9kSmV5S0hJSG9ncXowOGlYZDVUZVhiNFFxUDVQTFBCUWl0c0JNUFZhMEpSLUFDb25tTDdMRjZ4c0hoYmx2eVk1ZGpYeEUzYmIyNV96a3ppN1kyZ2dNVS0zbjFPYVJjUGVvV0lUVXg5TmYzOEYzN1ZuSHZfdV9Oc3JKQ01LbmNiZUtuM1FZNlR3cEVVbzlTc3B3dnd3Zko5Wjg1TExRY2IwWE9SeUR3TVRwSzQ?oc=5",
    "date": "2017-11-30T08:00:00.000Z",
    "dateFormatted": "30/11/2017",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Cipher Pharmaceuticals Inc.  fda.gov",
    "company": "Cipher",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "14763096bb873966ff0e02a1e3f737ce",
    "title": "Amherst Pharmaceuticals, LLC/Magna Pharmaceuticals, Inc. - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxQZV9LLWViZl9lNFZMalBFMlhKYkgzQ0FfYy12SC1YWVZMd1pzV2FQVlI5ZjJsN1FxWTZOWnQ1dzZ1XzJidnhBcDQ4ajUtRy1aS3hVTkZXVFJKUmhKajFCMnZ0X0lFV2Uxc2dGSTBSVEc0NjdYcVNsdDVVOExCQ3dVMkE2RUVBcFd1YzV2TGFURnBnSEd1NU03RlllanFtN2JCQm5LUVp2amhkZzI1QnhBYjBOZWNzUWIzX3ViVWFCM2RFam9UVnNHbXJCQ2R5S1JFWmVwMVNaY3pycDJIQU84dGlhR3FLdGlTS0s2cU53c1JoZw?oc=5",
    "date": "2017-11-14T08:00:00.000Z",
    "dateFormatted": "14/11/2017",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Amherst Pharmaceuticals, LLC/Magna Pharmaceuticals, Inc.  fda.gov",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6402cc9dc806f5f895fc60f605f0e828",
    "title": "Cipher Pharmaceuticals US LLC - 460380 - 08/24/2017 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPekpKUEx0TFZQODRVcnM4Q1g3cnJ1U3ZpQVVERGZJVjdYRlFsY1c2UXR1RXlUX1FhcmctaVg5NXN5aVhDZ2pyZHhucVZ2RGpuRGhCdmJvRWlrLWFPNjQ5NDJjZF9nNHpyY25abWp1TmEtSTBjZmxUU3NIeDZNRnA1SkdmRzZJb3N2T09fVjZPTTF4R3dlTWpITzFOUVozNUEtQVRSSmU0M0dyQmZhRlZyOUpqdy1SRXV0S2tkMzJMNm1VcS1WcDJHcHRxal9jSlpoMzZ2TGZ0UEdzR0pH?oc=5",
    "date": "2017-08-24T07:00:00.000Z",
    "dateFormatted": "24/08/2017",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Cipher Pharmaceuticals US LLC - 460380 - 08/24/2017  fda.gov",
    "company": "Cipher Pharmaceuticals Us",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "d25be929a87dc9ce43460c1bee6addd5",
    "title": "FDA forces Carlstadt company to shut down - Bergen Record",
    "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUW9xcWtZLTNFRzFMZHhWc0lqOUR3aHNFUWpxdlE0LUFfT2N6UjFtbUtBR21sZzJYNWZzVEJfZDM4UU8xd3VjMjZPRVBlcXdRczJlWE1ENm9VQ19NQjVIaEV0ZVdiS1ZjWUVLMWd6RVdlU2VUUTFEUlpRMlZtcy11OTZiOTU5UC1yU2RFel9wTHNMM1BnM3FTUlVQZ1J2bEpu?oc=5",
    "date": "2017-06-18T07:00:00.000Z",
    "dateFormatted": "18/06/2017",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA forces Carlstadt company to shut down  Bergen Record",
    "company": "Fda Forces Carlstadt Company To Shut Down",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "27ad4a3795907f78626b77cda8700a66",
    "title": "FDA slams Indian API firm for faking certificates of analysis - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNdy11MlJ4a2M5c3BtUlpXUFBnWG9qVk1OVndrd2MyY0YxRVFpZU9RUExSYlJlVG9zTUJraE5fUXR1V0hzZlpEYjdpYVZTTlluQzBSZ0tKLV9xOHJSYnR5aktZZEJ2WmFxbHJfTUpfalRJc2hqOE1sS0xfWG5fZWFkejkwSXdaWl9HMndtdHVLMUUxcEtlTExyYWdWMzNuQzlrUm5Z?oc=5",
    "date": "2017-05-03T07:00:00.000Z",
    "dateFormatted": "03/05/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA slams Indian API firm for faking certificates of analysis  Fierce Pharma",
    "company": "Fda Slams Indian Api Firm For Faking Certificates Of Analysis",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "96c3274d4db5fae09a3914e48f3a7aad",
    "title": "US FDA ban on Sun Pharma unit lifted after over 3 years - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2017-03-15T07:00:00.000Z",
    "dateFormatted": "15/03/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "US FDA ban on Sun Pharma unit lifted after over 3 years  Business Standard",
    "company": "Us Fda Ban On Sun Pharma Unit Lifted After Over 3 Years",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "2f37c43a987cbab857c2a5fb0103dbf6",
    "title": "Sun Pharma reaches small goal in unburdening its regulatory load - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOcWFhRVFva2JSYmFLZlFWa21VT3F4LXRKOVFnMVdUVF8zMTRMWjdrMFBlY1d2b2tiOHNFaTNweGllMG1RWHhnN1UwakxpbXhGQkVudDY5RFVNMVF5amR2Qzh1TFkxT3g3Vjl5MHdCWmt2aWJxVFFLRzVyZjdDZ0ItUjh1QzdWU0QwOHIydmJlMVZVT2pmS2o3SktqRWdtUC1PcXZRYmdNcw?oc=5",
    "date": "2017-03-14T07:00:00.000Z",
    "dateFormatted": "14/03/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma reaches small goal in unburdening its regulatory load  Fierce Pharma",
    "company": "Sun Pharma Reaches Small Goal In Unburdening Its Regulatory Load",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "be83e61b05cdf30ce3b0f629284e1c0c",
    "title": "Xellia expects ex-Boehringer sterile plant to be ready for production in 2018 - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPQk52cV8xT2pOemp5V21pRjU0TXIxSFZRb2djTWJIUm5mcTVFdmlpdDM1N2hBSXNVU2gxNzhwaloydFZjQlQyUWFaNUc4N0hiRzNVQXY2SnZXUWdkTVZ3RW9QNmtkanVReFlhNFc5LU51MU5pREVIMEh4S2hRYUp4WWtPTHBCeXcxYXJjbEltYmdTTk5XR0ZFcjR5Y0R1Y2czakQtMEpjc0U5QWZGYTdrSW5XWEpuM2JF?oc=5",
    "date": "2016-11-15T08:00:00.000Z",
    "dateFormatted": "15/11/2016",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Xellia expects ex-Boehringer sterile plant to be ready for production in 2018  Fierce Pharma",
    "company": "Xellia Expects Ex",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "b5832f198d954e5556bba94c7b6ebfbd",
    "title": "More deaths tied to Medtronic’s SynchroMed II drug pump - MassDevice",
    "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBnYXZack9JcHozaC1LWTJJNVVCU3RQWGxQZ1RtN2xZMmxRVEM2a2V2VThqNmljamFkTzhiNzRQdEFkUEpZb2NGdm5GZWR0bXRkdWhIMm9fZTlPUUE4YTBCaE4xQjM5Q0x0SGVZYVJMazh6RFVEQ09TZkNfcVdMeGs?oc=5",
    "date": "2016-11-02T07:00:00.000Z",
    "dateFormatted": "02/11/2016",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "More deaths tied to Medtronic’s SynchroMed II drug pump  MassDevice",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "4185d88ab1c08bbe1050280f57a92616",
    "title": "FDA warns China facility over 'persistent' contamination - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxON0JKd0V4Z2JnYjYxb2JHaGhoT3gzSXdOdXk2Z3VjUWRRdllpLU9TYjF3ZFRBSHBiNUsybDcxTVBnNG9CNG9lZnBqb214MHAtMkx4Zi1pX0FEQlRnSmZMdy14MEtabzJjZ19NalJObkY2dWpzN1ZpcWNHQnYyWWlacV80aVJkUlBRN0FIdUZzNjNUQUJFUEdTakg0alZtUQ?oc=5",
    "date": "2016-09-20T07:00:00.000Z",
    "dateFormatted": "20/09/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warns China facility over 'persistent' contamination  Fierce Pharma",
    "company": "Fda Warns China Facility Over 'Persistent' Contamination",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e707ccaf1ba7656a5d427dfb9259057b",
    "title": "Sun says 'time consuming' remediation paying off - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNTUxsczk1WjYxOWhtR0pnLWRpaXY0d0NnN2hDcTNKOWhYQ18tNzloOXV3bzFzbzFpOUZvSmU4YkhGWE1OY3JWbUs4R3BUdHhSN3dhUzNNd0JCc3kyZnpDWFdlSXM2QmltcWV0bUs0N0Yzd3RJXzZzOGxONlp2bHFHV3UwVTZZQ1BubDVfVW5PeDRGMmc?oc=5",
    "date": "2016-08-22T07:00:00.000Z",
    "dateFormatted": "22/08/2016",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Sun says 'time consuming' remediation paying off  Fierce Pharma",
    "company": "Sun Says 'Time Consuming' Remediation Paying Off",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "6512c2fcaacfbfc7d1a3f3a3d32d9dc5",
    "title": "FDA bans a third Wockhardt plant - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPQm9oX2hKMk9yTGxJSVVMMG00anBJeXVoRDRKMmVtRk13MllpTzdVVnBvRG9zSTlRNEtRMVNyWUZ3MVUwV0FVRGZWNHZSZkQtejAwdGNmeDdiRTdGcGVQaEpzQUNla1VTMGZYNkQ1Yy1mTm1PNUlROE9Sck8zV1JSdg?oc=5",
    "date": "2016-08-08T07:00:00.000Z",
    "dateFormatted": "08/08/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA bans a third Wockhardt plant  Fierce Pharma",
    "company": "Fda Bans A Third Wockhardt Plant",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c2851ca3dc160225f4669745345c3a93",
    "title": "To avoid shortages, FDA allows imports from 8 drug plants banned for quality shortfalls - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZHVLM3NYTHFaWGJqc2FiNjRmWGFRNHl2aFhwWjQ2azlJUC0yTUtCTVR5UFR4cFMxdGFJaTc5QXdnOGFqa0hpdnU5LWJiNW8zZF9wTGlFbkE1UUg2eko1T3cxaFZ6RS10QXhad0VteXB0eWZYZGhxbDVRSlViS2Q3T0JBcjZGNm1qOUd4RVJQWHdoMkNNVEtYUHVwanRIRDJUUThnVkJ3UG9RUQ?oc=5",
    "date": "2016-07-25T07:00:00.000Z",
    "dateFormatted": "25/07/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "To avoid shortages, FDA allows imports from 8 drug plants banned for quality shortfalls  Fierce Pharma",
    "company": "To Avoid Shortages, Fda Allows Imports From 8 Drug Plants Banned For Quality Shortfalls",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a38ba0c6857dd34402ce82c386fcaec3",
    "title": "FDA whacks Megafine India API plant with warning for faked test data - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQS1lqVmdYMFkwaG5XcThtRmNuS0J0V1EtQy1JZV9CZDhTVm1yMkVWYThBeWVSZGYyNXM5eVROWlNCclcxNThMS2o3dlRybTQ3eURtaHlVVXZtM3JmOUt2ZlJ0MVpkSzR3cjljQ0FsWHplRjM1YXNJa2VlbzZvMi1GbG5pemJpdnl6ZGoya2dwU2pWVFMySmp6UHFEeTZzc2tXekIxSA?oc=5",
    "date": "2016-05-31T07:00:00.000Z",
    "dateFormatted": "31/05/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA whacks Megafine India API plant with warning for faked test data  Fierce Pharma",
    "company": "Fda Whacks Megafine India Api Plant With Warning For Faked Test Data",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a712b0fd7676ce82967aa56e4ca548ee",
    "title": "Xellia kicks off Budapest manufacturing expansion - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOM3h2QmxseFVscjBzVHNHNWNIYnd2c3JzTUJwNnN4bG1id0Zoa1hXVnJIbVZ0NzJKTElIUko4Y2V1cGNaTGhVZUsyZldHR1lLTXM0N1lVa3V3bFl2OGlKNkUyVllSWWVHSW9FZDVwWkxKcXI0MW1OYWktblN5VEcwc2NGSGVCcUJHTy1XYXF1bDRvbmlTVDhV?oc=5",
    "date": "2016-05-25T07:00:00.000Z",
    "dateFormatted": "25/05/2016",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Xellia kicks off Budapest manufacturing expansion  Fierce Pharma",
    "company": "Xellia Kicks Off Budapest Manufacturing Expansion",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "bab67808d13e3a7ff174ef573f08f823",
    "title": "Xellia Pharmaceuticals, FDA reach agreement on how to revive former Ben Venue complex - Crain's Cleveland Business",
    "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPVmJKaXR4VzBuZzd0S09sQ25vS1ZvQ3p6SktCUXBDTmpOM1U3dnFfdWN1Z216UWNGR0gyRmNRUkZ0dGg4eFVHWXp1TkhWaDZZaW9vTV9jRUh3NlR4UEk0RE13dWZuTnlRNUtSSkVMQm05eGZzR0ctLWw4ZWdtdHMwSDUzeXRqQWpKdUZwcTZzYjVxOEhscXVsRnVyLWRBY3lVV2k3azNxbWlMN2tkQ04xd1FhSkZYVnlKdmRsUFJVYXZIVDFiVmNSdUl3?oc=5",
    "date": "2016-04-28T07:00:00.000Z",
    "dateFormatted": "28/04/2016",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Xellia Pharmaceuticals, FDA reach agreement on how to revive former Ben Venue complex  Crain's Cleveland Business",
    "company": "Xellia Pharmaceuticals, Fda Reach Agreement On How To Revive Former Ben Venue Complex",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "e43711fb2dbdc245db0f882c1528a347",
    "title": "Drug Labeling and Its Impact on Promotion - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPbmpPb05fRTRwa1NKVUpyU0JFVndMdGVJN1Z2UTE5OGZLbVQ0VUdqbV9RVmNlWHNiZ0VkeEJteWhWZjJ0dlhuQU9feXZld2c4RkFYbjNJZ0Nhb1QzWDNWRkpSTUg5bkI1a0FFVjFYdHZBRHMtbW5uN3RwcFowYmpJRnBWb0txX1VLdVFGVUxLNmc?oc=5",
    "date": "2015-11-04T08:00:00.000Z",
    "dateFormatted": "04/11/2015",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Drug Labeling and Its Impact on Promotion  fda.gov",
    "company": "Drug Labeling And Its Impact On Promotion",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "433a7852ec98c6eb1c7691487b6d8b33",
    "title": "FDA Bans Imports From Major Indian API Manufacturer - Regulatory Affairs Professionals Society | RAPS",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNbVpxYmVEZVJwUS13MWJrUk9xX3ZUOHJmRk0wVTlGallGaE9KZ2RmU2paZm1XemstTkdIeUMwcWFISmJoZnR2VlB2VWNEQkJXTV8tZHlnZElRT1l4YzhlWEFzak1SVmNkellvbk0yU2oyeXJnVTZ3MDB5ZjFqbm9vVEJXemdyM0Faal9DMHppZEdxT25QbHFncm9DTmxrbFZtN2hyODJYUWRFNVYtVlBWNA?oc=5",
    "date": "2015-10-15T07:00:00.000Z",
    "dateFormatted": "15/10/2015",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA Bans Imports From Major Indian API Manufacturer  Regulatory Affairs Professionals Society | RAPS",
    "company": "Fda Bans Imports From Major Indian Api Manufacturer",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "f5002296b96337f2f46387d8e79c4bf7",
    "title": "Emcure India plant banned by the FDA - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9fdUFxWFhUSExMbjJ2UC1PU1BKdTVLZmw5aGM5UHEwb1R3QmZsVmpxVklTVGVGWnhHblZlc09kRHg1TzJFMlpMa19XWFJRMi1sUW1JY2IxV0luenF6ODJlVVZodTdnMWt6cXZKYjVUYUM1X3BIbUJZbklZY0g?oc=5",
    "date": "2015-07-14T07:00:00.000Z",
    "dateFormatted": "14/07/2015",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Emcure India plant banned by the FDA  Fierce Pharma",
    "company": "Emcure India Plant Banned By The Fda",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c4c28296cdecbcec7b591c3a41b2a069",
    "title": "FDA alert on IPCA Labs, US export halted from MP unit - Business Standard",
    "link": "https://news.google.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?oc=5",
    "date": "2014-07-25T07:00:00.000Z",
    "dateFormatted": "25/07/2014",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA alert on IPCA Labs, US export halted from MP unit  Business Standard",
    "company": "Fda Alert On Ipca Labs, Us Export Halted From Mp Unit",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "c7738ae4c06f0bbb75159093eea2ea9d",
    "title": "FDA approves generic Doxil to combat drug shortage - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQZ2h0eWRrdzR2YVM1QktwRTN4LXNrcWZ1ODBCT0tscmVBdFhVNnF3dTNwNTJGRXpWYjk5UTVfRnhVNjdsWXc3WVo3VnF0M2pzSUNfbF9nRndTcUYtdEVOdmRiN3hCMHdaaXdXTV81WGZWeWVpV25NVi0yMVhOLWJDY0M1cTZEV3hjUmFGbVM0dFo4ZUhDN2tVc296anNCZF9V?oc=5",
    "date": "2013-02-04T08:00:00.000Z",
    "dateFormatted": "04/02/2013",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "FDA approves generic Doxil to combat drug shortage  Fierce Pharma",
    "company": "Fda Approves Generic Doxil To Combat Drug Shortage",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "9b6c63cc61ddf8faa0c8d4d485e1edf5",
    "title": "Caraco Pharmaceutical Names New CEO - CBS News",
    "link": "https://news.google.com/rss/articles/CBMifkFVX3lxTE13cVJxdG1scU5Yb0dkc2VkaGhCQmpoX3hVcnRTS2E4YVNMQUJkRWtmT3BsdDdmbWxSalFxWXNyOUtwSnhySEpqUWE2ZFRCSlczR0Ixck11LU5lWU85b2lHazU3a1JfVEJOWVdQc0x1T1R6WkRaVFVJQV8tMTNCQQ?oc=5",
    "date": "2010-10-10T07:00:00.000Z",
    "dateFormatted": "10/10/2010",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Caraco Pharmaceutical Names New CEO  CBS News",
    "company": "Caraco Pharmaceutical Names New Ceo",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "99ed16601e94a3f79f6f0fdedd281829",
    "title": "Actavis Reintroduces Oxycodone In The US - Pharmaceutical Online",
    "link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPYXpvVnowU0M3M2tHWW8tRjhiQzFTa1doZzI3VXBDUnV4cjV3ajlIQlJ4bkFiaG9RODdSTkxiTVVSNHNVejVsVHRRVjNSa3NBV0JKbWVDNloxdzRLcHd3NkF1b0w2QWlQYkNWRE5HUF9zV2dYYlZ1ZWdteThtalFTTHVIeDF2VXpYNjlBNU43OA?oc=5",
    "date": "2009-04-21T07:00:00.000Z",
    "dateFormatted": "21/04/2009",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Actavis Reintroduces Oxycodone In The US  Pharmaceutical Online",
    "company": "Actavis Reintroduces Oxycodone In The Us",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "65fb845bdd676d5cac55048035a11006",
    "title": "U.S. Food and Drug Administration - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiN0FVX3lxTE91QXlENXNrYWFFQjFEUHhWUjFwMURtMXROY0FtV0FZcUdsSmhiVmJwaVdqWTh4Zm8?oc=5",
    "date": "2006-06-24T04:02:30.000Z",
    "dateFormatted": "24/06/2006",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "warning_letter",
    "summary": "U.S. Food and Drug Administration  fda.gov",
    "company": "U.s. Food And Drug Administration",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "31e9eee767442e58021a3aaf91399356",
    "title": "ALZHEIMER'S DRUG APPROVED BY F.D.A. (Published 1993) - The New York Times",
    "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPS1ZiLTJSb3ExNDZMZXJBUDVoaGhEZ1NoTUFMWU9xVmFTQkFZbFhGQk4wUFdTMVdpV19fZGFKR0xESGFpZmt2QjZCaTFkRy1ySGRXaTcybXZlekRRS1hRTXpqYXZXUmdXVWQ0SXVHdDhGOHFvSW9RcFpRUzFaTmJUTA?oc=5",
    "date": "1993-09-10T07:00:00.000Z",
    "dateFormatted": "10/09/1993",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "ALZHEIMER'S DRUG APPROVED BY F.D.A. (Published 1993)  The New York Times",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  },
  {
    "id": "a9e08c594eeb1fd75cab5eeec569a2e8",
    "title": "Syntex Settles With F.D.A. (Published 1991) - The New York Times",
    "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9qdWZlemJncDh3Y21RT2VaV3AteWNQMUhxTzNwS2o2Tnd6Z2ZQVG1IS3lUbkZpS2xWZ2VndVNSbTR4dm1fczA0YkVIMFBrcE53UEJyaGpVdkU3N3IxejNYb2pxMUNKMjdPWWFPVUtpdkVIZ3BDNTZUVzB5LVI?oc=5",
    "date": "1991-10-11T07:00:00.000Z",
    "dateFormatted": "11/10/1991",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "Syntex Settles With F.D.A. (Published 1991)  The New York Times",
    "company": "Unknown Company",
    "types": [
      "regulatory_news"
    ],
    "severity": 0,
    "priority": 3
  }
]